<SEC-DOCUMENT>0001193125-13-326797.txt : 20130808
<SEC-HEADER>0001193125-13-326797.hdr.sgml : 20130808
<ACCEPTANCE-DATETIME>20130808160635
ACCESSION NUMBER:		0001193125-13-326797
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20130808
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130808
DATE AS OF CHANGE:		20130808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARIN CORP PLC\UK
		CENTRAL INDEX KEY:			0000897448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21392
		FILM NUMBER:		131022219

	BUSINESS ADDRESS:	
		STREET 1:		FIRST FLOOR, BLOCK 3, THE OVAL,
		STREET 2:		SHELBOURNE ROAD, BALLSBRIDGE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		353 1 6699 020

	MAIL ADDRESS:	
		STREET 1:		FIRST FLOOR, BLOCK 3, THE OVAL,
		STREET 2:		SHELBOURNE ROAD, BALLSBRIDGE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMARIN PHARMACEUTICALS PLC
		DATE OF NAME CHANGE:	20000201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETHICAL HOLDINGS PLC
		DATE OF NAME CHANGE:	19930322
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d579867d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>of the Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of Earliest Event Reported): August&nbsp;8</B>, <B>2013 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>Amarin Corporation plc </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>England and Wales</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>000-21392</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not applicable</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(I.R.S. Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2 Pembroke House, Upper Pembroke Street 28-32, Dublin 2,</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Ireland</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not applicable</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code: +353 1 6699 020 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Former name or former address, if changed since last report </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;2.02.&nbsp;Results of Operations and Financial Condition. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;8, 2013, Amarin Corporation plc issued a press release announcing its financial results for the three and six months ended June&nbsp;30,
2013 (the &#147;<B><I>Press Release</I></B>&#148;). A copy of the Press Release is furnished herewith as Exhibit 99.1. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The information set
forth under Item&nbsp;2.02 and in Exhibit 99.1 shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of
1933, except as shall be expressly set forth by specific reference in such filing. </I></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01. Financial Statements and Exhibits.
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d) Exhibits </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:23pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">Exhibit<BR>No.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:37pt"><FONT STYLE="font-family:Times New Roman" SIZE="1">Description</FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press Release, dated August&nbsp;8, 2013</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;* </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: August&nbsp;8, 2013</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin Corporation plc</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ John Thero</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Thero</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit&nbsp;Index </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:23pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">Exhibit<BR>No.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:37pt"><FONT STYLE="font-family:Times New Roman" SIZE="1">Description</FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press Release, dated August&nbsp;8, 2013</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d579867dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g579867logo_amarin.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Amarin Reports Second Quarter 2013 Financial Results </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>and Provides Update on Operations </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">- Conference Call Set for 4:30 p.m. EST Today - </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BEDMINSTER, N.J., and DUBLIN, Ireland,
August&nbsp;8, 2013 &#151; Amarin Corporation plc&nbsp;(Nasdaq: AMRN), a late-stage biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health,&nbsp;today announced financial results
for Q2, the quarter ended June&nbsp;30, 2013, and provided an update on company operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Key Amarin accomplishments since March&nbsp;31,
2013 include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Recognized $5.5 million in product revenue from Vascepa sales in Q2, the first full quarter of Vascepa sales ($1.8 million in net value of Vascepa was
deferred at the end of Q2 for product sold to wholesalers but not recognized as revenue under GAAP) </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Normalized prescriptions, based upon data from Symphony Health, increased in Q2 to 47,335 from 10,484 in Q1, comprised of normalized prescriptions from
February and March only </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Improved formulary access by increasing number of lives covered with Tier 2 status to greater than 72&nbsp;million with over 190&nbsp;million lives
covered on formulary overall </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increased the number of physicians prescribing Vascepa to over 9,000 </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Advanced planning and preparation for the anticipated launch of Vascepa for the ANCHOR indication, progressing towards advisory committee date of
October&nbsp;16, 2013 and PDUFA date of December&nbsp;20, 2013 </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reported statistically significant reductions in median particle concentrations of total very-low-density lipoprotein (VLDL) by 12.2%, total
low-density lipoprotein (LDL) by 7.7%, and small LDL particles by 13.5% when Vascepa 4 g/day was added to optimized statin therapy for 12 weeks, compared with placebo, in post-hoc analyses of the ANCHOR Phase 3 clinical trial data
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continued to enroll patients in the REDUCE-IT cardiovascular outcomes trial in which the mean and median baseline triglyceride, or TG, levels in
patients participating in the study to date are &gt;200 mg/dL, a level which is intentionally higher than studied in recently conducted outcomes trials of other prescription lipid modifying therapies </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increased patents issued or allowed in the United States to 27, adding 5 in Q2, which include multiple claims covering the administration of pure EPA
to lower triglycerides with or without statin therapy (16 year-to-date), all but two of the 27 have patent terms extending into 2030, with more than 30 additional patent applications being prosecuted in the United States alone
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Expanded approved active pharmaceutical ingredient, or API, suppliers for Vascepa from one to three with sNDA approvals for BASF and Chemport Inc.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Completed an equity financing in July resulting in approximately $121.1 million in estimated net proceeds which, when combined with the company&#146;s
$149.4 million of cash on June&nbsp;30, 2013, provides a solid financial foundation from which to further grow the company and seek profitability </FONT></P></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;Since the end of Q1, revenues, prescription levels, prescribing physicians and lives covered under
Tier 2 have all more than doubled,&#148; said&nbsp;Joseph Zakrzewski, Chairman and Chief Executive Officer of Amarin. &#147;We have witnessed the awareness, knowledge level and utilization of Vascepa strengthen and expand across our group of
targeted physicians. The efficacy and safety profile of Vascepa for its approved indication continue to be well received and we plan to continue to drive increased physician awareness and managed care coverage to further grow revenues. In addition,
we believe we are well positioned for approval by the U.S. Food and Drug Administration, or FDA, in December to expand Vascepa labeling from our approved MARINE indication to the significantly larger population represented by our proposed ANCHOR
indication.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operational update </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Commercialization update </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin&#146;s direct sales force, consisting of
approximately 275 sales professionals, launched Vascepa on January&nbsp;28, 2013, for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe (<U>&gt;</U>500 mg/dL) hypertriglyceridemia, the initial indication for
Vascepa, or MARINE indication. Amarin reports that, since launch, access to clinicians has been good, and that it has yet to hear any significant negative reaction to the efficacy or safety profile of Vascepa. Amarin&#146;s sales professionals are
currently targeting the limited group of clinicians who are the highest prescribers of other lipid therapies and seeking, in particular, to increase awareness and knowledge of Vascepa among this group. Amarin believes that Vascepa is well
differentiated in this market based on its safety profile, which is comparable to placebo, and on its spectrum of demonstrated lipid benefit at 4 g/day, including statistically significant reductions in TGs, Apo B, VLDL-C, and non-HDL-C, with no
increase in LDL-C, also known as bad cholesterol. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g579867ex99_1pg002.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Vascepa additional indication progress </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In parallel with marketing Vascepa for the MARINE indication, Amarin is pursuing FDA approval of Vascepa for the ANCHOR indication, a second indication in
a significantly larger adult patient population, those with mixed dyslipidemia and TG levels between 200 and 499 mg/dL. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As previously
announced, in a clinical trial of the use of Vascepa in the ANCHOR indication, Vascepa demonstrated statistically significant reductions in a broad spectrum of lipid and inflammatory markers, on top of optimized statin therapy, including significant
reduction in LDL-C compared to placebo. The FDA has accepted for review Amarin&#146;s Supplemental New Drug Application, or sNDA, for the ANCHOR indication and has assigned a PDUFA action date of December&nbsp;20, 2013 for this sNDA. In addition,
the FDA has scheduled a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) to review the ANCHOR application to be held on October&nbsp;16, 2013. The safety results from the ANCHOR trial are included in the current label for
Vascepa. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The ANCHOR study, which evaluated the efficacy of Vascepa in lowering triglycerides on top of optimized statin therapy for adult
mixed dyslipidemia patients with high triglyceride levels (<U>&gt;</U>200 to &lt;500 mg/dL), was conducted under a special protocol assessment, or SPA, agreement with the FDA. An SPA is generally considered to be binding upon the FDA except in
limited circumstances, such as if the FDA identifies a substantial scientific issue essential to its determining the efficacy or safety of a drug. Amarin has not been informed by FDA of any such essential issue. Amarin believes that it achieved all
of the requirements of the SPA agreement. In particular, in the ANCHOR trial, with Vascepa 4 grams per day, all primary and secondary efficacy endpoints were achieved, including a reduction in LDL-C levels compared to placebo. Amarin is optimistic
that the FDA will approve Vascepa for this indication and looks forward to the advisory committee meeting as an opportunity to highlight the positive safety and efficacy profile of Vascepa. If approved, Vascepa will be the first drug in its class to
be approved for this multi-billion dollar market opportunity. Approximately one in five adults in the United States have triglyceride levels of <U>&gt;</U>200 mg/dL. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Vascepa exclusivity update </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin continues to make significant progress in its
effort to expand patent protection for Vascepa and now has 27 patents issued or allowed in the United States with over 30 additional U.S. patent applications being prosecuted. This patent portfolio includes claims covering Vascepa&#146;s
pharmaceutical composition and methods of use for the MARINE indication, ANCHOR indication and other potential uses of Vascepa. Amarin&nbsp;is also pursuing patent applications related to Vascepa in multiple jurisdictions outside&nbsp;the United
States. In May 2013, the European Patent Office granted a patent covering the use of Vascepa based on the results from the MARINE trial. All but two of the granted patents in the United States have expiry dates extending into 2030 and the majority
of U.S. patent applications, if and when allowed, are anticipated to have expiry dates in or beyond 2030. Patent protection for Vascepa is augmented by protection provided by trade secrets, existing manufacturing barriers to entry and anticipated
three- or five-year regulatory exclusivity. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>REDUCE-IT and other Vascepa-related clinical development </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">During Q2, the FDA accepted Amarin&#146;s sNDA for the ANCHOR indication, a precondition for which was that the REDUCE-IT cardiovascular outcomes study be
substantially underway. Consistent with Amarin&#146;s Special Protocol Assessment (SPA) agreement, and based on the company&#146;s discussions with the FDA, the company does not believe the final results of the REDUCE-IT study will be required for
FDA approval of Vascepa for the ANCHOR indication, although there can be no assurance that this will </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
be the case. During Q2, the mean and median baseline triglyceride levels for patients participating to date in the REDUCE-IT cardiovascular outcomes study has been confirmed to be &gt;200 mg/dL.
As intended, these are higher baseline TG levels than levels studied in other recent outcomes trials of other lipid modifying therapies. Results of the REDUCE-IT study will not be available until a specified number of cardiovascular events have been
observed, the timing of which is not expected in the near-term. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial update </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin reported cash and cash equivalents on-hand of $149.4 million at June&nbsp;30, 2013. On July&nbsp;12, 2013, Amarin completed a public offering
resulting in additional net proceeds to Amarin of approximately $121.1 million, after deducting the company&#146;s portion of estimated offering expenses, resulting in aggregate pro forma cash and cash equivalents of $270.5 million as of
June&nbsp;30, 2013. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vascepa&#146;s commercial launch commenced on January&nbsp;28, 2013 in the United States. The quarter ended June&nbsp;30,
2013 is the first full quarter of Vascepa sales. Amarin reported net product revenues for the quarter ended June&nbsp;30, 2013 of $5.5 million as compared to revenue of $2.3 million for the quarter ended March&nbsp;31, 2013 and no revenues in the
corresponding periods of 2012. In accordance with U.S. Generally Accepted Accounting Principles (US GAAP), and consistent with Q1 reporting, until the company has more operating history with the commercialization of Vascepa, it is recognizing
revenue based not on its sales to wholesalers but based on the resale of Vascepa for the purpose of filling prescriptions. For the six months ended June&nbsp;30, 2013, the net value of Vascepa sold to wholesalers was $9.6 million, and, as a result,
in addition to $7.8 million in recognized revenue, Amarin recorded deferred revenue of $1.8 million at June&nbsp;30, 2013. Cash collections from the sale of Vascepa in the quarter ended June&nbsp;30, 2013 were approximately $6.6 million for a total
of $9.4 million collected from wholesalers since the launch of Vascepa. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consistent with industry practice, the net price of Vascepa for the
six months ended June&nbsp;30, 2013 reflects the deduction of one-time discounts paid to wholesalers to stock Vascepa in advance of Vascepa&#146;s launch in January 2013, as well as the costs of a co-payment rebate card program and customary payor
rebates and allowances. The net price also includes adjustments for other customary amounts. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost of goods sold during the quarter ended
June&nbsp;30, 2013 was $2.8 million as compared to $1.3 million for the quarter ended March&nbsp;31, 2013. Gross margin as a percentage of net revenues improved from 45% to 48% in the second quarter as compared to the first quarter of 2013. The
majority of Vascepa capsules sold during the six months ended June&nbsp;30, 2013 included API sourced from a single API supplier. Amarin&#146;s purchases of API from this supplier in 2012 and early 2013 are at higher cost per kilogram than expected
future purchases from this supplier. The unusually high cost of goods, as a percentage of revenue, is attributable to a number of things including the geographic location of our suppliers, exchange rate exposures and lower volume and less favorable
economic terms than those with other API suppliers. Amarin expects steady state gross margin as a percentage of product revenues to approach the high seventies to low eighties as it increases purchase volumes and sources lower cost API. In April
2013, sNDAs were approved for two comparatively lower cost API suppliers, BASF and Chemport Inc. While current inventory is comprised primarily of inventory from the initial supplier, unless the company secures substantial price concessions from the
initial supplier, it anticipates shifting a substantial portion of future API purchases to these lower cost suppliers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under U.S. GAAP,
Amarin reported a net loss of $39.8 million in the second quarter of 2013, or basic and diluted loss per share of $0.26. This net loss included $5.1 million in non-cash, share-based </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
compensation expense, $1.0 million in non-cash, warrant compensation income, and a $18.8 million gain on the change in the fair value of derivatives. In the second quarter of 2012, GAAP net loss
was $53.9 million, or basic and diluted loss per share of $0.38, and included $4.8 million in non-cash share-based compensation expense, $1.9 million in non-cash warrant compensation expense, and a $18.9 million loss on the change in the fair value
of derivatives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the six months ended June&nbsp;30, 2013, Amarin reported a net loss of $101.9 million, or basic and diluted loss per
share of $0.68. This net loss included $10.0 million in non-cash share-based compensation expense, $1.5 million in non-cash warrant compensation income, and a $22.5 million gain on the change in the fair value of derivatives. For the six months
ended June&nbsp;30, 2012, GAAP net loss was $142.2 million, or basic and diluted loss per share of $1.03, and included $8.7 million in non-cash share-based compensation expense, $4.2 million in non-cash warrant compensation expense, and a $85.1
million loss on the change in the fair value of derivatives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Excluding non-cash gains or losses for share-based compensation, warrant
compensation and change in value of derivatives, non-GAAP adjusted net loss was $54.5 million for the three months ended June&nbsp;30, 2013, or non-GAAP adjusted basic and diluted loss per share of $0.36, as compared to non-GAAP adjusted net loss of
$28.3 million, or non-GAAP adjusted basic and diluted loss per share of $0.20 for the same period in 2012. Adjusted net loss was $115.9 million for the six months ended June&nbsp;30, 2013, or non-GAAP adjusted basic and diluted loss per share of
$0.77, as compared to non-GAAP adjusted net loss of $44.1 million, or non-GAAP adjusted basic and diluted loss per share of $0.32 for the same period in 2012. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Amarin reported cash and cash equivalents decreased in aggregate by $110.8 million from December&nbsp;31, 2012 as compared to June&nbsp;30, 2013. Net cash outflows from operations were $52.8 million in
the second quarter of 2013 as compared to $59.6 million in the first quarter of 2013. As stated previously, Amarin anticipates its first quarter net cash outflows from operations to be its highest quarter of net cash outflows from operations during
2013. Amarin anticipates that it will experience continued reductions in quarterly net cash outflows from operations with future quarterly results below the results of the second quarter. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">During the six months ended June&nbsp;30, 2013, net cash outflows included approximately $48.2 million paid for sales and marketing related expenses in conjunction with the initial commercial launch of
Vascepa, approximately $16.7 million paid in support of the REDUCE-IT cardiovascular outcomes study and approximately $16.3 million for Vascepa API, purchased in conjunction with the buildup of commercial supply and for clinical trial material. Of
this $16.3 million in API purchases, $3.0 million was included as a component of research and development expense because it was received from suppliers prior to qualification by the FDA and the balance was capitalized as inventory. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin&#146;s liabilities as of June&nbsp;30, 2013, excluding the fair value of the non-cash warrant derivative liability, totaled approximately $273.0
million, which includes $141.5 million for the carrying value of exchangeable debt and $86.7 million for the carrying value of the hybrid debt financing that we entered into in December 2012. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As of June&nbsp;30, 2013, Amarin had approximately 150.7&nbsp;million ADSs outstanding as well as approximately 9.9&nbsp;million, 11.2&nbsp;million, and 0.9&nbsp;million equivalent shares underlying
warrants, stock options, and restricted or deferred stock units, respectively, at average exercise prices of $1.44, $7.47 and $8.49, respectively. In addition, $150 million in exchangeable senior notes issued in January 2012 are exchangeable prior
to&nbsp;October 15, 2031 into an aggregate of 17.0&nbsp;million ADSs (based on an initial exchange price of approximately&nbsp;$8.81&nbsp;per ADS), subject to certain specified conditions. The notes accrue
</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
interest at an annual rate of 3.5%, payable semiannually in arrears on January&nbsp;15 and July&nbsp;15, beginning July&nbsp;15, 2012. The notes will mature on January&nbsp;15, 2032, unless
earlier repurchased or redeemed by the company or exchanged by the holders. In conjunction with Amarin&#146;s previously announced financing in July 2013, Amarin issued 21.7&nbsp;million additional ADSs. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Amarin&#146;s operational priorities </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operational priorities in the second half of 2013 are: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increasing revenues from sales of Vascepa </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continuing managed care migration coverage from Tier 3 to Tier 2 </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ensuring a successful ANCHOR advisory committee meeting </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gaining approval of the ANCHOR indication sNDA; PDUFA date of December&nbsp;20, 2013 </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Planning for the successful commercialization of the ANCHOR indication </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Obtaining additional patent awards from the USPTO </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continuing development of a fixed-dose combination of Vascepa and a leading statin </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Submitting an sNDA for a fourth API supplier </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Publishing additional data from Amarin&#146;s clinical trials </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Conference call and webcast information </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin&nbsp;will host a conference call
at&nbsp;4:30 p.m. EST&nbsp;(8:30 p.m. UTC/GMT) today,&nbsp;August 8, 2013. To participate in the call, please dial (877)&nbsp;407-8033 within the United States or (201)&nbsp;689-8033 from outside the United States. A replay of the call will be made
available for a period of two weeks following the conference call. To hear a replay of the call, dial (877)&nbsp;660-6853 (inside the U.S.) or (201)&nbsp;612-7415 (outside the U.S.). A replay of the call will also be available through Amarin&#146;s
website shortly after the call. For both dial-in numbers please use conference ID 416486. The conference call can also be heard live through the investor relations section of Amarin&#146;s website at&nbsp;<U>www.amarincorp.com</U>. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Use of non-GAAP adjusted financial information </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Included in this press release and the conference call referenced above are non-GAAP adjusted financial information as defined by U.S. Securities and Exchange Commission Regulation G. The GAAP financial
measure most directly comparable to each non-GAAP adjusted financial measure used or discussed, and a reconciliation of the differences between each non-GAAP adjusted financial measure and the comparable GAAP financial measure, are included in this
press release after the condensed consolidated financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-GAAP adjusted net loss was derived by taking GAAP net loss and
adjusting it for non-cash gains or losses for share-based compensation, warrant compensation, and change in value of derivatives. Management believes that these non-GAAP adjusted measures provide investors with a better understanding of the
company&#146;s historical results from its core business operations. While management believes that these non-GAAP adjusted financial measures provide useful supplemental information to investors regarding the underlying performance of the
company&#146;s business operations, investors are reminded to consider these non-GAAP measures in addition to, and not as a substitute for, financial performance measures prepared in accordance with GAAP. Non-GAAP measures have limitations in that
they do not reflect all of the amounts associated with the company&#146;s results of operations as determined in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures
used by other companies, and management may utilize other measures to illustrate performance in the future. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About Vascepa<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(icosapent ethyl) capsules </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">Vascepa<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP>
</FONT>&nbsp;(icosapent ethyl) capsules, known in scientific literature as AMR101, is a highly pure-EPA&nbsp;omega-3 prescription product in a 1 gram capsule. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><U>Indications and Usage </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vascepa (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (<FONT
STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>500 mg/dL) hypertriglyceridemia. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The effect of Vascepa on the risk for pancreatitis and cardiovascular mortality and morbidity in patients with severe hypertriglyceridemia has not been
determined. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Important Safety Information for Vascepa </U></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vascepa is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to Vascepa or any of its components and should be used
with caution in patients with known hypersensitivity to fish and/or shellfish. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The most common reported adverse reaction (incidence &gt;2% and greater than placebo) was arthralgia (2.3% for Vascepa, 1.0% for placebo).
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">FULL VASCEPA PRESCRIBING INFORMATION CAN BE FOUND AT&nbsp;<U>WWW.VASCEPA.COM</U>. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Forward-looking statements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This press
release contains forward-looking statements, including statements about the commercial launch of Vascepa, including the number of total prescriptions to date and the potential for future growth, expectations for revenue growth, product awareness,
receptivity of clinicians to and patient experience with Vascepa; expectations regarding managed care coverage migration from Tier 3 to Tier 2 and continued growth in Tier 2 coverage; the pricing terms of commercial supply for Vascepa; expectations
regarding gross margins and cost of goods sold (COGS); the timing and outcome of FDA decisions regarding Amarin&#146;s sNDA for the ANCHOR indication and regulatory exclusivity; the efficacy, safety and therapeutic benefits of Vascepa; the ability
of Amarin to develop a fixed-dose combination of Vascepa and a leading statin; Amarin&#146;s ability to obtain sufficient patent protection and regulatory exclusivity for its product and product candidates, maintain trade secrets, and take advantage
of existing manufacturing barriers to entry; continued enrollment of patients in Amarin&#146;s REDUCE-IT cardiovascular outcomes study; continued publication of study data; and continued assessment of collaboration prospects for commercialization of
Vascepa. These forward-looking statements are not promises or guarantees and involve substantial risks and uncertainties. In particular, as disclosed in its previous filings with the U.S. Securities and Exchange Commission, Amarin&#146;s ability to
effectively commercialize Vascepa will depend in part on its ability to create market demand for Vascepa through education, marketing and sales activities, to achieve market acceptance of Vascepa, to receive adequate levels of reimbursement from
third-party payers, to develop and maintain a consistent source of commercial supply at a competitive price, and to obtain and maintain patent protection and regulatory exclusivity. Among the factors that could cause actual results to differ
materially from those described or projected herein include the following: uncertainties associated generally with research and development, clinical trials and related regulatory approvals; the risk that Special Protocol Assessment agreements with
the FDA are not a guarantee that FDA will approve a product candidate upon submission; the risk that the </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
FDA may not complete its review of the ANCHOR sNDA by the PDUFA action date or grant new chemical entity regulatory exclusivity to Vascepa; the risk that historical REDUCE-IT clinical trial
enrollment and randomization rates may not be predictive of future results and related cost may increase beyond expectations; the risk that patent applications may not result in issued patents, trade secrets may not be maintained and that
circumstances that create manufacturing barriers to entry may not last; the risk that Amarin may not enter into a collaboration agreement for the commercialization of Vascepa in the ANCHOR indication under favorable terms or at all or market the
ANCHOR indication successfully on its own; and the risk that publications of scientific data may not accept proposals to publish Vascepa data. A further list and description of these risks, uncertainties and other risks associated with an investment
in Amarin can be found in Amarin&#146;s filings with the U.S. Securities and Exchange Commission, including its most recent Quarterly Report on Form 10-Q. Existing and prospective investors are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof. Amarin undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or
otherwise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vascepa has been approved for use by the FDA as an adjunct to diet to reduce triglyceride levels in adult patients with severe (<FONT
STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>500&nbsp;mg/dL) hypertriglyceridemia. Vascepa is under various stages of development for potential use in other indications that have not been approved by the FDA. Nothing in this press release should be
construed as marketing the use of Vascepa in any indication that has not been approved by the FDA. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Important information regarding
prescriptions data and product revenue </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The historical prescription data provided in this press release is based on data published by a
third party as of July&nbsp;16, 2013.&nbsp;Although Amarin believes these data are prepared on a period to period basis in a manner that is generally consistent and that such results are indicative of current prescription trends, these data are
based on estimates and should not be relied upon as definitive. These data may overstate or understate actual prescriptions. Based on other data available to Amarin and the history of such third-party prescription estimates in the early stages of
launch of other new pharmaceutical products, Amarin believes that the trends provided by this information can be useful to gauge current prescription levels. Amarin commenced its commercial launch of Vascepa on January&nbsp;28, 2013. Accordingly,
there is a very limited amount of information available at this time to determine the actual number of total prescriptions for Vascepa. Amarin believes that investors should view these data with caution, as data for this single and limited period
may not be representative of a trend consistent with the results presented or otherwise predictive of future results. Seasonal fluctuations in pharmaceutical sales, for example, may affect future prescription trends of Vascepa as could change in
prescriber sentiment and other factors. Amarin believes investors should consider its results during this quarter together with its results over several future quarters, or longer, before making an assessment about potential future performance. The
commercial launch of a new pharmaceutical product is a complex undertaking, and Amarin&#146;s ability to effectively and profitably launch Vascepa will depend in part on its ability to generate market demand for Vascepa through education, marketing
and sales activities, its ability to achieve market acceptance of Vascepa, its ability to generate product revenue and its ability to receive adequate levels of reimbursement from third-party payers. See &#147;Risk Factors&#151;Risks Related to the
Commercialization and Development of Vascepa&#148; included in Part II, Item&nbsp;1A. Risk Factors in Amarin&#146;s most recent Quarterly Report on Form 10-Q. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Availability of other information about Amarin </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Investors and others should note that we communicate with our investors and the public using our company website (www.amarincorp.com), our investor
relations website (http://www.amarincorp.com /investor-splash.html), including but not limited to investor presentations and investor FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The
information that we post on these channels and websites could be deemed to be material information. As a result, we encourage investors, the media, and others interested in Amarin to review the information that we post on these channels, including
our investor relations website, on a regular basis. This list of channels may be updated from time to time on our investor relations website and may include social media channels. The contents of our website or these channels, or any other website
that may be accessed from our website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Amarin Contact Information: </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph Bruno </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director, Investor Relations and Corporate Communications </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Amarin Corporation plc </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In U.S.: +1 (908)&nbsp;719-1315 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>investor.relations@amarincorp.com </U></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED BALANCE SHEET DATA </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(U.S. GAAP) </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Unaudited </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>June&nbsp;30,&nbsp;2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,&nbsp;2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(in thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top" COLSPAN="8" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ASSETS</B></FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current Assets:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">149,426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">260,242</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Restricted cash</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts receivable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,267</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,514</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,262</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred tax asset</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">936</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">937</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,171</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,253</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">184,714</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">285,694</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property, plant and equipment, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">706</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">811</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred tax asset</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,880</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,044</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other non-current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,335</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,951</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intangible asset, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,032</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,355</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">214,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">310,855</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8" COLSPAN="9"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" COLSPAN="8" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>LIABILITIES AND STOCKHOLDERS&#146; DEFICIT</B></FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current Liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,688</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,458</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued interest payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,555</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,520</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,833</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses and other liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,358</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,224</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,434</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,202</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-Term Liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warrant derivative liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">36,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exchangeable senior notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">141,457</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">134,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-term debt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">86,687</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85,153</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-term debt redemption feature</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other long-term liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">795</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">816</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">309,001</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">314,852</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders&#146; Deficit:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,893</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,597</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional paid-in capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">630,565</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">619,266</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Treasury stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(217</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(217</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(849,575</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(747,643</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total stockholders&#146; deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(94,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3,997</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Liabilities and Stockholders&#146; Deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">214,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">310,855</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED STATEMENTS OF OPERATIONS DATA </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(U.S. GAAP) </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Unaudited </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Three&nbsp;Months&nbsp;Ended&nbsp;June&nbsp;30<BR>(in thousands, except</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>per share amounts)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Six&nbsp;Months&nbsp;Ended&nbsp;June&nbsp;30<BR>(in thousands, except</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>per share amounts)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Product revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,842</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">OPERATING EXPENSES:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost of goods sold</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,844</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,131</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,489</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,066</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">39,327</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,822</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Selling, general and administrative (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,961</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,635</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,294</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,701</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">116,686</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46,484</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(48,794</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(27,701</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(108,844</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(46,484</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gain (loss) on change in fair value of derivative liabilities (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(18,930</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,461</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(85,139</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest expense, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9,345</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,317</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(18,205</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8,268</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other (expense) income, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(411</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(536</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss from operations before taxes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(39,709</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(51,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(105,124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(139,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Provision for (benefit from) income taxes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,904</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3,192</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,314</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net and comprehensive loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(39,774</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(53,904</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(101,932</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(142,189</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss per share:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.38</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.68</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1.03</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted average shares:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,694</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">140,550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,562</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">138,280</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A substantial portion of the Amarin&#146;s marketing, general and administrative costs represents non-cash warrant based compensation to former officers. Excluding
non-cash stock and warrant based compensation, research and development expenses were $16,691 and $12,924 for the three months ending June&nbsp;30, 2013 and 2012, respectively and selling, general and administrative expenses were $30,672 and $8,085,
respectively, for the same periods. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-cash gains and losses result from changes in the fair value of a warrant derivative liability and long-term debt redemption feature. </FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a reconciliation of the non-GAAP financial measures used by Amarin to describe its
financial results determined in accordance with United States generally accepted accounting principles (GAAP). An explanation of these measures is also included under the heading &#147;Use of non-GAAP adjusted financial information&#148; above.
</FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RECONCILIATION OF NON-GAAP LIABILITIES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Unaudited </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>June&nbsp;30,&nbsp;2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,&nbsp;2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(in thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current Liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,688</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,458</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued interest payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,555</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,520</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,833</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses and other liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,358</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,224</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,434</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,202</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-Term Liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warrant derivative liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">36,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exchangeable senior notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">141,457</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">134,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-term debt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">86,687</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85,153</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-term debt redemption feature</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other long-term liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">795</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">816</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities &#150; GAAP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">309,001</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">314,852</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warrant derivative liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(36,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(54,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities &#150; non GAAP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">272,973</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">259,998</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RECONCILIATION OF NON-GAAP NET LOSS </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Unaudited </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Three&nbsp;Months&nbsp;Ended&nbsp;June&nbsp;30<BR>(in thousands, except</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>per share amounts)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Six&nbsp;Months&nbsp;Ended&nbsp;June&nbsp;30<BR>(in thousands, except</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>per share amounts)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss for EPS</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#150; GAAP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(39,774</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(53,904</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(101,932</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(142,189</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Share based compensation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,090</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,834</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,709</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warrant compensation (income) expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,003</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,858</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,455</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,232</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Gain) loss on change in fair value of derivatives</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(18,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,930</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(22,461</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85,139</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adjusted net loss for EPS</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#150; non GAAP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(54,528</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(28,282</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(115,885</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(44,109</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1&nbsp;&nbsp;&nbsp;
&nbsp;</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss per share:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted EPS &#150; non GAAP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.36</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.77</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted average shares:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,694</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">140,550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,562</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">138,280</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g579867ex99_1pg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g579867ex99_1pg002.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@!J@))`P$1``(1`0,1`?_$`1,``0``!@,!`0``````
M```````!`@8'"`D#!`4+"@$!``$%`0$!``````````````$"`P0%!@<("1``
M``4#`@$$!PX-#P,0!@@'`@,$!08``0<1"`DA,1(30135%I875U&Q(E/4%956
MUI?76!EY87&!D3*35#55MAB8"O"AP=%RDB/3))1WMSAX&C8G1^'Q0E*",T.S
M-$1T)78WQSEBA$9F*$BRQ&6%)H;&I\+2<Z1%AV@1``(!`P(#`@<*!@T*`P8$
M!P$"`P`1!!(%(1,&,11!49'1(E('87&A,I+2(U.3%;%BLU15%H'!0J(S="5U
M-A<W"!CP<K)#8X/3E+0U<R1%X8+"-$16\<-DU)6CXX2D)V7_V@`,`P$``A$#
M$0`_`,R=['Z1-O4V\[RMT&WC'.)MK"V$X+RTJQS'G6<1S+[K*GA$DBL4D%W)
MY5Q[)T?9K*33Y",%@$)2PA`7;GO>]Z^A/9I_=YWOVF=+KU3@;EAXF.V1+#RY
M8Y6:\6D%KIPL=7`=OCK3YV\18,_(="6T@WN!VUC-;]*`XAE[Z>)_9;X%9Y^&
MBN__`,''5)/_`'O;?L9_-6'^LD'U3>45-_B?N(9KIXH-EFM^:W>7GG6_TO\`
M/14G^YQU4/\`UO;?LI_-3]9,?ZMO*/-2_P"D_P#$,M_HAV5^!>>?AHUI_@WZ
MJ_36W?8S^:J6ZGQE_P!6WE'FJ-OTGWB&7_T1;*O`O/7[&9[T_P`''57Z:V[[
M*?S4'4V.>(B?RBIK?I/?$-O_`*(=E>G_`&*SW\,]/\''5/Z;V[[&>J3U1C#_
M`%;^4>:I[?I//$-OR^*+95I_V*SW\,U/\''5)[-[VV__`(,]1^M.,>R)[^^!
M3_$\<0WL8BV57TY__P`$Y\^&:G^#CJD=N][;]E/4_K1CCMB?RBHV_2>.(9?3
M_-'LJY?_`')SWR?_`+SU3_@YZKOPWK;K?^%/3]:,?ZI_**F_Q.O$.\D>RKZ?
M>5GOX9ZG_!QU7^FMM^RG\U/UH@^J?Y0J/^)TXAWDCV5?2[R<]_7_`.^>H_P<
M=6?IG;OLIZH;JO&7MB?RBG^)TXAUN?$>RJW)>_\`D5GKS;6Y/\]&M^>I']SC
MJN]OOK;OLIZ@=68I_P!4_E%>`I_2E>((D=`-9V'MEP1#N7;MBT+SS<L/6AU#
M80?'/TK7UY+UE#^Y;U>T!G&];;8>#E3U0W6&(IMRG^4/-7OW_2=.(?;3_-%L
MJY=/_8K/=^?6_8S/?L5@C^YYU5>WWUMU_P#PI_-5P]68H%^4_E'FI;])TXAU
M_P#1'LJM].$Y]^&:I/\`<[ZJ'_K6W?93U3^MV*.V)_**FO\`I.?$.M_HCV4W
M^E"L^?LYFM4?X/.J?TUMOV4]4'K'%!X0OY1YJ6_2<N(??FQ'LJ\"L]_#/3_!
MYU3^FMM^RGJ/URQ/#"_E'FJ-_P!)QXA]N7Q1[*?`O/7PT4_P>=5?IK;OLI_-
M3]<L3ZI_*/-73</TGWB'H$_;(L/;+#B[#`$?5PO/5KEV'R6$+7,_-:_)>KD7
M]SCJF1]'WWMH]WE3U!ZSQ!_J7^4/-7BV_2E^(1?_`$,[,/`W._[.9[:UL!_<
MHZM/$;[MEO\`P<BJ/UVQ/J)/E#S5/;]*5X@^NGB:V8>!F=_AHJG_``5=6?IW
M;/L<BH_7?$';!);_`#E\U3?XI/B#Z_\`<WLPT[-^\K/-]/HZ6S/?DJ?\%75G
MZ=VS['(JG]><+ZB7RCS5RV_2CN(3?FPYLO\``O//PSU'^"OJO].[9]CD52>O
M,%>V"7RCS5/;]*+XA-[VMXG=E_+;G[R\\Z?USU'^"SJS].;9]C/3]>\+M$$E
MO\Y?-4W^*)XA/D>V6VOYEX7GK7^N:H_P6=6_IS;/L9Z@]>X`_P!1+Y1YJY+?
MI0O$*\C^RWF]I>>OAFH?[EG5O@WS;?L9ZI'7^`?_`*>8^\1YA4?\4+Q"?)!L
ML\"\]?#-4?X+.K_TWMOV,]3^OV#^;9'[VIK?I07$+OI_F?V6\O\`[E9Z^&>G
M^"SJ_P#3>V_8SU2?:!MX-N1+Y1YJY`_I/_$+O_H@V6VMYMX5GKX9ZG_!9U;;
MAOFV_8SU2?:#@@V&/*3[C+YJGM^D]\0N_-B+97]6%9ZM_P",]!_<LZM\.^;;
M]C/3^L+!'Q\:=??(\U36_2>.(;?FQ#LKO]*%9Z^&>H/]R[JL=N^[9]C/3^L+
M`/9CRV]\>:I[?I.W$-O>P;8BV5W%>W-WE9[\S7EOXYZC_!=U7^G-L^QGJG^L
M3`O_`/+3_!4W^)SXA_-XH=E>OF=Y6>O/\<]2?[EW58%_OS;/L9Z?UB8'YM./
MV14UOTG+B&\O^:793K;L=Y.?/V,SWJG_``8=6?IO;?L9Z?UB;?\`F\OE'FJ-
MOTG#B'WMK;$>RKZ7>3GOF\W_`+YZC_!AU9^F]M^QGJ/ZQ,#\WE^4/-4X?TF[
MB'"U_P`TNRCP*SWRZ_\`^Y[55_@OZKM_WS;?L9Z'VBX`_P#IY?*OFJ;_`!-G
M$0\DNRGP)SW^QF>]4_X,.J_TWMOV,]4?UCX'YM-Y5J-OTFOB(7OI;$NRF_/R
MVA&?.3_]Y^S3_!AU7^F]M^QGI_61MP[<>7RCS4_Q-7$0\DVRGZ7>/GRW_C13
M_!AU7^F]M^QGI_6/M_YO-Y5\U1_Q-7$0\DVRCP(S[\,U5#^Y?U603]^;;P_V
M4]4_UE;;^;3>4>:H?XFKB(:Z>*;9/K_V)SY;S\SVJH?W+>K2+C>]M^RGI_63
MMWYM-\I?-3_$U<1#LXGV3V__`"1GR_G9HI_@LZO_`$UMOV4]#[2L#P8LY]X@
M_M5&WZ35Q#[WTMB?91X#Y]^&>I_P6=6>'?-MO_X,]1_67MWAQ9_E+YJ7_2:>
M(A;_`$3[)^?3_(G/G[&:->Q0?W+.K#P^_-M^QR*C^LS;?!C3'_WE\U3_`.)F
MXB'DHV3^`^??AGJ/\%G5GZ<VS[&>J?ZSMN\.+-\I?-4;?I,O$0O_`**-D]OI
MPC/OPST_P6=6_IS;/L9Z?UG;;^;3?*7S4_Q,O$1\E&R;P(S[\,]/\%G5OZ<V
MS[&>H_K/V[\UF^4OFJ-OTF7B(WY/%1LF\",^_L9GI_@LZL_3FV_8ST_K/V[\
MUF^4OFJ/^)CXB/DHV3>`^?OAFI_@LZM_3FV?8ST_K/VT?_2S?*7S5#_$R<1'
MR4;)O`C/OPSU/^"OJW].;9]C/5O^M/;/S6?Y2^:EOTF3B(WO:WBHV3>!&??A
MGI_@KZM_3FV?8ST_K3VS\UG^4OFJ;_$Q<1+R4;)O`C/O[.9[5(_N5]6G_P!<
MVS['(I_6GMGAQ9_E+YJZJG])EXD`.KNDP[L>4V%TNLN?%L_(^KO;EMIT<MJ^
MG:_U-*NI_<GZI/Q]^VX'W,><_A85;;VK;=^XQ)C_`.^H_:KKV_2:.)7>UK^)
M78O;6W-ZQ;@.3Z'+E"U7/\$O4WZ?V_\`Y:;Y]4_UK8/YE-\M/-3_`!,_$LUT
M\2>Q?Z=F/<!>W+YO^="VE/\`!+U,!<]0;=;^+S?/I_6O@_F4WRT\U!?I,_$L
M#?3Q*;%K_P#W)G^W_BC5*_W*.I'%UZ@V_P#Y>;Y]![5\$B_<IOEIYJA_B:.)
M9Y$]B_L)G_X4*G_!-U-^G]O_`.7F^?3^M;!_,IOEIYJF#^DS<2T5M?$IL6M_
M]Q[@/A0JD_W*.I1_Z_@?\M/\^J6]K&"/_HIC_O$\U3?XF3B6^178M[![@+_^
M*%J?X*>H_P#[@V__`):;Y]4_ULX7YC/]HGFI;])CXEE[Z>)78M[`[@+^=E*G
M^"GJ/_[@V_\`Y>?Y]3_6S@_F,WVB>:G^)DXEOD5V+^P.X'6_U/&CK3_!3U'_
M`/<&W_\`+S?/I_6S@_F,WVB>:MT.P;>'Q>-_6"C<Z1%3PW<>-94VD<)%'9%C
M/=`^./;,=`WC-7W6M^9V]+8A79PMT`6!<0>A?6_+:OG+VJ^S7,]E75`Z7SLN
M+,F.+'-S(T9%M)JLNER3<:>)[#?A7>=.;]%U'MWWC#$T2\QDTL0Q]&W&XMVW
MK-GUHXT/E#X8'O-[K?AVKS6M]3UHXT/E#X8'O-[K?AVI2GK1QH?*'PP/>;W6
M_#M2E/6CC0^4/A@>\WNM^':E*>M'&A\H?#`]YO=;\.U*4]:.-#Y0^&![S>ZW
MX=J4IZT<:'RA\,#WF]UOP[4I3UHXT/E#X8'O-[K?AVI2GK1QH?*'PP/>;W6_
M#M2E/6CC0^4/A@>\WNM^':E*M1D+/?$_VVSW:Z;GIPV%3;%^<]T^)]N4D0XC
MQ[N%B\^:",H>OP02)B=)EEB2QWKFH3)K<I0D,"98?)I>W*I6Y:E*^4-Q?Y2^
M,W%=XAJ-O6]0F_*26G=5U)0[=89C?'%ABZ0PW%R]&W)7Z=_W2T1_9`A9;G[T
MR_PQUQ._@?>'^[7]NM?2.:S!2>G3$.-AGJC`%$@"F(N+I#O:UM=`:VL'GO\`
M0KZ7=(U%PH\E:&USZ-7_`$A9Q"4@"E1VPH+*#90I%:P0W'IJ8.VEK6L"PK\E
M:UOC>B!:JB!:]68?9T[W=59;0J[70$#N238)10^MZH70$=<1@1"]&/73Z%9B
MQ1A?2'I&K1`/:!7G@G$GMTK>N6O[I.1^P#2H,<8[0*"P[!7-:=26VG_6'T->
MH)OS_P"XJH"(\"M00!QKEM.I+?DLXVO;_HY-OU[@O58CA'[D5C22,>`)TU.&
M;R87_P#D.37E_@"/_P"2I*1>K5*LW@8CWJ[()I(Q6U[>MH&_8()UM?DOKIT+
M<EZH(BOV"J68WXGC7->:2+2]^WNC_P"CU)/+]'E!6/9?$*IU&N7OUD?)_+]-
M.2W\`3];["@1/"*BN2\TD71MJX?9=&U[]23:^G/I:]@6TJL+&#?2:GWA7C]N
MJ#SQ''F"--,'<0S;WO<5Q?[:_8UM:VGTJS8)CJY6GT+5;=%MJ(XU?*/.5G)M
M),$+^4$6ZA0'GOT@:=$5[]BPPZ7M]6M7F8X@F)`&EJK1@W&O<L+DUM?7L<M8
MG#Q"JC[G#WJFOK;3Z.NM_J^95`L>T#R59!U/8V(J%[7OI?D^CK^Q57`>`5C2
M&[$6'`U/<-N33LVM?G\WZ=/V!Y*IO4#"`'DF$FVM<LTL10KZZZ:VTM]6VNOU
M*D<.-AVU4HU`U;(XHQ*>:G';2Y([@Y=>4-K^@%:]K\MKATKHX'#Q@\.RJ+`5
M+?\`5RW_`&ZN</$*M%CV5REVY+7UO;7DUU[&O9IP\0\E4\?&:YKAM;3L_1UO
M^W4@#Q"K;EK]IKE!RVU[.OFW_;JKAXA5NU^VNT7J*]K6MI;3EY>6_8JEK:>P
M52Q;2>)KNATOR]G33E['ZM*L$`^`58NWA)J6UZNA%`X56>'C[/&:YRP7OH(5
MK6MKR<O+?S+\]".%6G+`7!-<]KWO;ZM]/HV[%4!5OV"K:V+BXKF+M:][Z^9]
M/Z-2P4=@'DJ\0!V<*YP6OR::!O?EM:_+V.7Z-JMNJ?&(%6=;G@I-ZYK7O85]
M`VZ5]--;VYN;6_T]*:$*WL.RK3+VEKZO?-<UKWMI^O\`J\S6K:JI-B!:J5[>
MTU'7LU>"(.P"KEV\9J?I7M:W-;3D^CI]+7L:5.E?$*F[>,URVOK:W9YOU>;5
M/+2]["J3<"]S4^E[:ZV^OKYM254\"!5LNYX$FNP"UK<E[6UO:UP_KWUTUJVJ
MJ>T"HN1X:FM?77E[&O/;77S?W.M4LJ@V`%+D^$URZ\E[WY-/IU4@!\`JT]P;
M"NN*^M[W['8U_P!>L@!1P\-4\?&:E^IY_P"W4Z10KJXFY-3!Y16_;OYGTZ:5
M\0I;Q$UR!M85^6^FM^2_8[%]+\W+RU!4`7`%Z=G$5/?GY+WY.36U[]CL\_/4
MJJKV`5CLS$]IJ(;:_4MR7^CV-:$*?`/)5-V\9KE[&M^?3EYJFPM:PI=O&::W
MY+VTT_;[.M1I7Q#R"ESXS4VM]?U=G]JIL!X!Y*@EK'B:C]6_UZ7'B%6;GQTT
M^C?Z]+CQ#R4N?'4VE[^;>UOH\EO-MKS4N/$*7(XWJ-K<NO-IS<O/;LV^E5Y!
MPOV&L=C<U&]]-/K=GZ_9JX;GPFJ:B'T/V/)^OY]6W13Z1[:6O4YO(/Z>EJMP
MJ&3CXZI0W6H:7M:W)S]G7L:>95WT5X#A4D@=M3!T]$"_)RVO;EO?E[/+S:5;
M+&_`U2;#TAX:Y;6MKS6YK_0[%4WJBI[6UMV+<NFOZ^FG-2]*C:^N@KW#:]K:
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MH26/,3=>4(FYQ5K7,`$=O1='I=FX;]CEY:Q4(4^"JCQ%4$#%[5;35Q7"TOV0
MDVUY+>ATZ%]=.?6L@9!O<BX%6;6)KMAQFTZWMZX+?H^A*O\`6]!5SO9/$1`B
MJ2I)O<BN3Q9-.O(N7:_N"?VJGO;?5"J.4Q_=&U3!QLUVY+K5E^2]N4!/)?\`
M>VY;56F4Y-^4/+5EDLUJY`XX:@7T[>57UMKIU9=].QYE[4[R?W41/[-2R`=A
MKFMCMKZ/2NL5\G('0)-O-O?DN'73EJGGW/\`!5;*&_"N4&.VL5M1+E5KVMII
M<)%_UNCK5MLDH;&(6]\4*6KD\7;9R6[=5<_/T"N6WTNQ?2H&9XD"_LWJFU4_
M((F2SDDJ2#1'$",L2*QH`!&$R_*$5NCK80;VM]>LW#D7)D,;"Q`OPJW(2!PJ
MF0D@!H(`;ZZ:_9::=GD\RL_DK>Z_@JUJ-K&JNBKE9"XA+,O_``"RP23-;VM8
M)NO\$._+S6OR7O6+GP<^+@/26I3XPJ[70M?0-@Z7Y+Z6O]>][]CEKG#Q-^RL
MGW:"#J.W+RVOIIKK>^OT?HU36'*Q$GHGP5&UN73ZG['/2K7::B*VOG:>9IR<
MU*-V\*Y+::6^ER_6I5:7%_%5*21'I8I>`-KZ?P)]M.72_P#O9E[VYK!YJV>!
M/9N2>PU1)X;52WZ_[-;4BQM6/79`'7DUY^76W)R>9YG+>E*Y!6TTMYEOUJD5
M:<\:Y2[:VT_VVO+YFGT/J5-45V0:\F@KWTY=-=+6#]+FY;5#?%-4M\4UW;WT
MM;3S>;Z]6E%SQJRHO?WJEMRWTY+?JYZN`6%37.`&G+SZ<O)R\W8T[&M4DUC.
M3J(\%<]14"_@KD!V>?7HWTY;VY>SV>6]7#;PUD\+<:[8+>AO?36]N;L\G)R^
M;KK5B2Q.GPU3P'$6KD#:VO+]:]M;WMV/1::ZU(L$MP[*QV()/&N6UK?1^O?]
MF]6!?P=M6AVU-IK?Z&O+I60.RKM3Z:7Y+Z<NGV.O/RZ:]FII7*'DTOR:VTTU
MMR?5M450[>"N4(;BORBOI_L>SK?6W.&VNEJ5;KEM>XNA?_96Y+Z>9R<^G-;2
MK3FQX5-3]`//I;S/K\_UZHI4QG('3F^AS=B]9"BQX5CW)-=>KM54I2HZ]GF^
MER4I7(7?2V@[6Z/[G7EOV;7T\VG@H:Y+VT_U;Z\E^7GJ?!6(>VN2W)</8M<-
MN;LWY.?2HI4W+K;6W8Y;Z\GUNS2E1^E2E35%623?W*4JFHVY[4I4W+KI?Z.E
MKZZ<GF:>92EO'4;6Y[^;YFO8^G62MM(]ZK#"S&HV_7UOY]5534;6\WFTOS\U
M692>`%&(\'CI>][\]]:NV`[.`M0`#LJ&O+IR_L5!`(XU!'"N8(=.6_/6/5JI
M[<_8Y/I?LTI4W):W/K?7733DMK;S.:II4X;6T[%_]SIR5%*_=E^CCZ?)\K_Z
M>LF_\3':_,7^^%_:LG\TXWX9*^@_9A_1H_QF3_X:WXBO:UM?V_V*^6?!7HG'
ML';6&N7-^NV;".YC!6T;(,]`TYPW#6<C<?QJR)08GLG1%*.TE#XZ7"%"U`D#
MBE&B;@B&(Q2J#<%@VYZVV)L6YYNVS[OC1EMOQ[:VOQ%Q?]FP[?%P\=84VXX<
M&3'ARR!<J2^E?';\'N>/]BLRK<VFNM:H&XO6;P'"FMO-M]>E*C2E-;>;2EQ3
M6WFU!('::4UMYM2387/92E0"#V&E0UMYMOKU-P!<]E+B]O#6KOB?\W#Q^=%V
ME>?/J4K:+2E?*IXKLA?2N+5Q`XZU`27+4;F%QXC#B1&#*";C?&]U)HKVO:U@
M@++]#]&]?IM_=02$^Q]9'!U#=,OP^['7$;^H.X$GU%_;K%V^@0B&,5K!`&XQ
MB%Z'0`;7N,0N7T.E@ZW\ROHGA^Y[*TO8*LHXY)=;+U/:!2/M,!HP)KFD7,-$
M3:]PA$8*X].72^G9TK-CQ@R7/;4:@;CW*BGR')CQ@*(2I5!I@NB620A-..,O
M:UQ7L622(9AE[6Y>2U[Z52T>/&-4M](]TV'ND]EO?JT3;B>RX'EX5R>,B1`%
M<`B$(;A%<(@"3&!&&]KWM<(PB%:X16%:]KVY[>94F#&N39N!\?;;PCQBJ6+K
M>XL0.P]O;:UO'[E=@60I,0$H9R$@@"@OK4XSF\XH"@K73K4XC;A">3KR=,%[
MAO?LTY6,25`;6.!&KBI\3"]U/OBJ9&9+<"`?&/%\'[=<?C'?KWY2T%M;\]DW
MF\]N4?T*N+'$HM9O+6,6)-ZY[9"?-=>J17UM]S\NO[^]0R1GL#>6INWN5S`R
M`]BYRT5N?_FW+_\`2JV5B4]C:O?JDNPX<*YN_P#>[<O4M]OI$"O^M<>E3:-N
M!)M47]TUR6R$^7TMU2+GU_Y/YG^ZY*H,,?[DU%>:Z29R>.KLLZKJR[](!1(.
M@785[Z7%>VM^D/3FO69CL,9_1M<U2PN+>&N`H76!M>^O+>UN7GTMR:?1K:*Y
M90P\-8Y%C8UV``%>^@;"$9T@V!8%KW'<5[VZ-@!M:]Q"UYK6MKK0@$<2!4$@
M"YX`5>UE/4G(RK+2%"582"Q2DE6G-2'VO8/\&:(H\!9E@FEVUL+32^E<MF1H
M)+Q%#$PN"""+>$W!/[-9*D$:/W?BX@CW>/@\1KUQIE74@4]K*.U1"N$*FZ<Z
MR<0PVUZL"FX+$",Y+^AL+72U_,K$#I<K<:P`2+C58VL=/;8W%C:L<D+<Z054
MV)XV!X<"?!VCRBN,%^?ZE_/JNW'P5;7TKL+6-+\M[W\RX;?1['8\RHJ54@U$
M0@@#<0KV"&W*(0KVM8-M;6U%>][6M;6]K54H+-I4$L?V?P577,-")8B/Z:<T
MQ**UR35`231$%#,M>X+&'6#U18[Z:VL*]KWM:_F5*.%D4`VE/[D]I`XDV\0'
M;XJLF[$F/T@`#PX\#P!\HJUUTAX55T191IRBQHB0%$EC.--%:][6L46588S1
M"TY+!M>]=#%(DD8EN`EN)/`#W3XA6/):,_2&W9\)L![]_!4Y=NB.X!V$`0;7
M"(%[7",(@Z6$$0;Z7#<-[Z7M?EM>JP00"#VB_P"QX#^SVCQCC514JQ5N#@V(
M["/V*CV?-M;EY>3DMR\OT+6M5P"L4GB?<_;-J]<IH=C`!&6SO)I0[6$682TN
M)A1@1WMT1%F`3"`,(NER7M>]KVJSWC&X_2Q<.V[J+'L(-R+$'@1V@\*GPGU1
MX?!Y:A=.>2<82>0:G.+TL:2H*&0<7>]K"!891H0&`N(-[7MK:W)?6I#I)'KC
M(:,FP((()'$@$<#:W&U4.;75N#6\/AKE%?L?1M1!X:M)X?>H$-Q?0MYO+^QR
MU72NT"UK<UK!MS:6YOI\O+5!XFL9A=[>[7-:VMNC;GY+_4O?7SOK]BHLRM=@
M0/'8^+_VU=0@>B3QN1^SQKE+TZ0>E:VFGT-+:6UN+EORZ?0UYJ2.%%P01[E2
M0&.G]UXNP^`>&WA-=OF[&EM>;FOK?G^M6+JU&XL3[XX5;ETA+`K?Q`B_DJ<%
MM-?,[%NS;37DO;3GJ3PK%/`7[:F_9UM]:_+];L_3JX@(8@@@@7X@^&JE!O>Q
MMQ_R^&I[!O?FO;S.?L]CZ]ZN7`[:N<;7`)%1#R7Z-[6OV?I7_8J>VI/"N;Z-
M15ES?A4X=;"M>W8TO?GYM;:ZU!('$]E4UVK>;ISVMS<W9_8O5BIJ:UM:`$\!
M4%@O;4AU]1<GT?\`Z5[<_-K65&";D<5O:_\`E_E:K`/#W?\`+MKCOR]C33DO
M;332_/R\E7#P-NT>/C8]O8?V*J!J%12HVMK>UK=FE*Y]--0WY[7M;DYN;EYN
M3DO0&_$5:=A;3X:4JS7,&UA6M;LV^IRV_;TH>R_;^U[]1Q\`)-3=G7Z&FGT>
M;FY]?UJE@5[:FQXBQN#;X+_!X?%3FOI?6U_,O:]N3L7MKV+]BA%O=[?';A:_
M&WNU2U[$?_AP]WLJ:J:LTI2IM+:<@KZ_0MRZTI2PKZ\]K6MSWO?D#;EUO;Z/
M)52KJ-JI9M(]VN3L6Y^S?EMI?GTY;<^O)60``+"K)U7(;@U0_7J#>WH]M17*
M+H=#732]]=->?Z-8XU:S>K84Z[5Q?M5DCL%7*B&VM]+=BVOU-=*I9@!QJ#V5
MV*L5:J.O):VEOI^;2E-;:ZZ:VTMR<W8TJ3VTJ>VM[:ATMV+_`+'8I2OW9?HX
MO_E\+OZ><F?\1':_,7^]]_:RO\U8W_YE?07LO_HT?XU)_P##69.Z7?RY[<,A
MO<.%C1L?V5ACC=)5\F<9D)D))1'HCUS@(Y-9G76)`WD$7%<8AZ"MYE?/&U[(
MNYX@F,H65I"H6QL?%Q[.)X5W>1E<G5J'H!22?>%Z_,GODQ=ECB,;?\H[\X7!
M7"*[HL"R!NW*0%X:7]Q7/#!@.(W(31?&#&V%MB493@@:T'?@(RP@F&KKG6Z/
MHM*]/V#-P^G-TAZ?G99-KR%,+W'`R,?2D(\(!/+'[!\%<=O.$^Y[<=VA!7<X
MB)$\>A?W/[-KVK]`6UW>X5O]X3SCN.B,X?('E9CP[+2)^Y0EP2H9#"LU8TBQ
MZUXZH)Z=:0%"Z.*0E<64:5<L]$KL'336]O/MWV-NG>JQMD\8?'YZ\L.#9XW:
MR]G;VV/O7KH-NW,;ILXS(S:8QG5XU8=OP]GCK!/AC\2W.F-G[=]M4X@^15N3
M\W8/B49W`8;FCHUM+$\YDQ3D2/LRJ/,+$W-21`G6N`WMZ;B48"BA#%=P$&][
MV*Y.AZJZ9V_*@Q-XZ>C$6!D2/#*M[K'+&?2X^!;7/'L'#MK6[3NV2DLV#NC!
MLF(!T/871AP%O"1X:[W"3W3[M,O[]^)!"-W.?)`_QW:XI;5;3!B`L+#CR!F2
M!6^*Y(UFEM[4G6O#=#420*1.H5'WO;M89U];COI1UAM&TX73^UY&T0!9<I?2
M:Y+.PL!:Y["3V>&JMFSLZ?=LW'S7U)`1I`%K7%[>Z:K#`7$\W$QSBD&X(W:(
MB(CMFWM0=%.-@JM6U)F83,C:%JU`U,,E7]64:9)LAH$QBPX@\P9A)IR((;!"
M=I5G/Z5VZ?I;[PV@L^Z84I3*`-P>PDJ/$O9P]WQ5,.\YD>]=RW$!<:=;PFWA
MOV'W:MUOAW69FQ'QI<#[:W/=!E7&6TG)>%7[*&4&1A5(K#9'%M;)F*RQA>44
M8=9.R-!!S&F-,)*N84#H#N+0(A5D;'M&#F]%Y&Y)BI)NT4VE"?""5[1J`-KV
M[*MYV?/#U'#@\UDQ)("S=EKBX]'Q>"JHV#[M=VVYC%O$K<S,K2_)6T+%*2=F
M[*MY?:,<AV5)FKB#2[NJUL-LUMJ9'(4+"I;R.DO5M:8U02.P#`"L;Z&CJ+:=
MHVS*VV-8HXMZE*]ZQQJ9%N0!VDV)![`>'[%9&V[AF9,>5)J#8*`\N0=IX'\%
MO=]_P5B=L\S3OMW8\+;#.;2M\&88?N?S/O'MM^;<C#)B:Z(L;$L=G!L;"UT"
M#&PM9Y722@Z\\'\HM8=QAO>]K!OM=XV_8=IZGR,5<**3;H<`RZ+MJ+<.PWX6
MOV>*M;M>9N&X;)%/SV3)DG*`FQ`/$"]NVKYX-XF.?W?%^Y?A_;[91)MM_$CV
M]8SG,LQQD^*G-4?1[B&>),+JYQZ90LQ<VG1UZ<UA)!9YR$I.(AT2VN8``#`'
M%!U^X=+[<,S&W_8%6;IW)E171KMR68^DK>$`=MSV$\:R\'=\K1)M>YGE[K&.
M#"P$@\#+?A?P?L5L!WDI7-)A?A/@>I)()>\'\0C9`O=I-*51*Q_>W-R9YFX+
MU[D>F3)$]SSU2D=^B64```Z!M;2U>=9I4YDI0*J<QK`=@`-A;W+5U$(*Q*&)
M8V'$]O[-;G*Q:NU\MCB@-9`.*IQ&'BX;"5*-RRY$`5^<L@C&V-Q"L&VO_"#'
MRW\RVE?IC_=4?_\`U!&@_2F6?ACKB=__`.X'_,7]NL"Y4E>%[4-`R@*L8JOU
M:DPP\)-RTH;:C`&][:WN;>VE^;DKZ2A*AKO6C-ZM07CJ27%:XBD=K<FO\L!?
M6UN:UK=&LV.>`O:0V2K5CX!<U>?`DAR-MUS;B?.T+[5*D^))]&IXT6$<6<6>
M9'G(A<H0J2!6N!2E7HRS"#2K\AA9EPWY+U:W;!V+?MIRMDW$LV!F8TD$@%AZ
M$RF-K'P'TK@]HM>_"M;N.)+DXDD:.(\JP:-OW2R(P>-D\%U=58>Z`+$<*V,[
MY]BKCD;B;M4)P`C)/QWON>L:YRP>:080F(217/W4.,F(*L78].03")26\$'"
MU$$%DG2%:UN2OGSV$]9P;#[/-TV+K>9OO3HN?)Q,EFNQ,&.#+!+QLS:L=XP#
MV%@5%R*ZGK3,.X8&+UEMZ%I-WQ$D"+Q(S!;'D338`-SU#*G9:1+V+5=;>!$-
MLVYW<7F.>95W6,6WC:'L^!`-D>W&&0B(E99SAD4C&K4)J72*$X?1O\;LHC#A
M*"7->[/1ZM.26(TLH-C!Z!MP/LQZHZFZ<V$;[#M.9N_6?5NX3Y\BDF'&AC]'
MEB;)*2%'Y6A4B"L6;6P*KQ&SWG:X\.3'Z3@DB3;-DV^)))6-S-D2EGR.4#_"
MR"7XS754A5;G6`&M%*>$0L=L\[,,<X#SD@R)BK?*QKI!BS)F0(*\8ME,82Q5
M7VED%NGF-S5;TL32".J"3@IDB)4J[?$"P0"M<5M?4]L]NF#'A=1Q]8;8^#U#
MTUC#)F@QY1F1Y$#H7B:"953TF&D,'5=.H>Z*YS-VV)=KQ-VVJ830Y6?W("4<
MG1E:PJAC=ARF#!N9?LOZ/9>Q&YW:?M-Q5$G1TPANUG.0,AQ2?&PB38=SGMQE
M>W^:O)!2LQM4RK&IAKS+FF2,3&Y)C0N';QS8<67T!%!-%T@AR^B/:GU#U)EX
M3[WL"XW3^XQAH<O%RDRUC+*71<E-,;1"066,KKO(=)`'I5G;ALN/@G*QGR#]
MY8O`KH(20A^7(L;]I9#Z9U*HY?&^HA3D0GX9.WC'B_&.(MU&]Y/@;=1ER%,4
MY;,;(</.,TQ3BAMG3=9QQPDW!9BO)6,F`KGX@PLY;9,WKP-R<RPQBOI>M7E>
MVO=-PW7<H.@M@.[['M$KQ3Y#9(@::2$GGKAQ&-^<5`LFIDYCV'"]8$.V1Q[9
MC;QO,K8^)F\8511+)RR=*RNMP%C9B"""6T:B5!4BK7XFX=D5%C29YZW1Y^#B
M?!S%ER18'@CW@Z`K]R<WS7DR)G"M)#\8QF..3(T.6/&)'8)YSX>XD$FA,"$D
M`Q<E\_J#VW;?`VV;7TEM>1G]4;I@KF#&R&[GW7':P'>V=69)BUT$2HQ#"[$*
M;U?3IW*;/S(3-"=MP)0DLZFZNSH7C6$#X[.HYA!TZ([ZB'&FKQ17A$@F6ZS;
M-AR,9X*>L![NH7-IUAS/UH(L9']*A@S$\+9!&LB8Q?W5`HB4TCCPVEI75-9<
MH3IRE(#BCCK>AK`F]NF-A=)]1;CNFV]VZSZ9@AER<%IPT4D<\@2*6'*13JA<
M:]+&,-JC92H!!.++@1?R7EX<AEVK<MS;"+:2)H940-(#%^Z-V7EV8*X8<000
M+7/VPO;[+<3YXDVU'>&GW#Y5VIQT<TSICQ;BAXQW&GR",ZGUMFLVV^3AQ>7&
M^4X["7/T2LU2C:C#$-K'E@OJ$-Z\;VU[AC2[;O/5/3^1MW0>[Y<>+C9G.626
M.6=E7&&9CA5Y`G)TK9W*N0K#XUMHG3@?<YNG3DQ#J6**>01?ZMQBJTF1&LM[
MF6)`25TV+!@"18GL8@V>;)WCQ(0K-^_HV)YOSVW,#XQX^P+A)1N$C>,&R6K"
M6R.H,WS=FF+,7#93VV.YSB@3)%PVY'T1FWZ=[@MT>^^TKK>#>]RVGH_IELW`
MVD$2Y&5D]R29U4NW=`\3<V*UE64E5=R`MZYR"'!3:8][W>?N^+,K.L:J7G"(
MS*6DCX:"]M4:7+E;EE``)LB?@V3[:=_#7MYFRYJ=95AW<W"8(^N;*)0-F=%#
M=-V$13DV]ME$JK(EZ,\!H0'``.UA:7M77=%]=;7[2.@%ZNVJ.2+&R\+(#126
MUQ.L<J21L02ITL"+J3?M%8W7>S3=/Q9FW2R+(.[HZ.O[J.9%DC8@_%9D877C
M9KBY[:W6<>4E!EO+C+N/B#26!S@>?,L;`<MMS6E`"PIA!'2\]PF[&DE^CL=)
M(5*CDA=[VU..2&Z>A!:UOCG^ZKN65MF3^JN=,S;?OVU#<\343I2?&G;"SHQ<
M6!(2"4F]AJ3@;$UZ7UF(#M4K/9<K998`Y(`OC9^''E1OP])M,JSQKX%"W(N]
MZN9ONBR*#<*;&.T6!-Z9TEF`=Y6WK%TS4LY99BZ49LRIAB8Y+F[&(W0%U)K7
M)9BF:R;7Z(K73V`/00.3'Z>WO+W[^\C@=9\V6/9=QQMV2%&MI[IM\T&-')V<
M%8QR2,>P%C8V-:;9DCVSHO?,/,&G.AP<+,E9AQ3ODL4R*1Q])<81AK=H(([;
M5AD5PY<`)\OI]G+UO9;VO?8<C;&P_'%\1/:K;\T91>F\IY:L/N^>RGKKD\Q.
M0J"DY@@,PTQ;@98KIZ<MO5H/;?O>ZX.7U5T[T]+F=`8;R:\CO"IDR10L4EF@
MQBA5PI#$*95)56/"W'4?<>/M\.,.H,E<3,RE1@FG7R><%,'>.PIS-2_%#6#*
M>PU;_'.Q3$Q6UZ<[H=SVXU[V_,N,]R3WMOET(9L3J,FS)RE+,UFF7;X4VH)&
MT7>I,!\*,+4)5%TJ4A`F//[8$,("AYV^^VPP;WLFS](;<-W_`%@VCOV(XFY2
MVYA'TMT;1%R@SE^+"0I'H](L&)T[EOF;QA9[+!)L^3%%(?C*W,56)4\#JNX$
M8M9QZ1*BLO\`:#LFP9BOB5;.XY,,G$YGP=GO%P<^[?W9=BLI0GR:C6,<I3$Q
M3)T)=GA0FA:Z.KF94H47$-R3]L)"2NB+K!7!R_5WM7WW>?9IU?M\&$VV=;[+
M&8<M!D'Z&*321DXTJJIENITA;(P)8ZA8$T2[1CJ=FW?$E:;8L[,5.84*,LT&
M1$&@:,]JNS(K->PC<DJ2"*Z^.\>[;Y'L(XBK.5N)>8=M[B.]3`3\Z9AE>(%3
M9-W-N;3)G9WB$*Q"R/CB-SD1SVJNW-":[@F3*RBK'&&$%]*P>!SNL^IHY_9K
MU!GXDLV]2[?GQ)$DFKO7,AQE@DDD(&A)0W-R"0QA&L#F,%U=1'AXT?5W6F!B
M<OEMA8O,N-,>.W>LAIE3MNL>GEPE0O,D*!@B$D4-MSVG0O!7$'X4F9,198/S
M9@?<[DM&^0&6OT*-QY,4+M!W7UDF46F\'/='L#,[,SHK"`'5JU`#0VO>]["M
M7K6\^TO*ZBZ)ZZZ(ZCV\;7U9MO3T\QC683PR0S8[O&\4@56)``U*5%@1[M<'
MN.U8ZX.U[YM4YFP#O^-BR:ET/'-%E176USJ22,,P;A?C8$%2=?&6]MJ%SP-G
M#>%'ITM?'6);X,DX4RSC8YB3$!@[=)'J3/F/)T2_)W12<L99(<A/0#"<D3`3
MJ2P@",?3#:NB]G'M'EP%Z2Z%W>`B#>>GTFQ<O62)<G'11+B%"MQ)R[21V=M8
M#7`M>NOZTVU<WJKJ>:"XR-LRXFY04'5C2V4RZKBW+D*QLH4B[H=7$VMMNBVY
M(]LY6W^/NTN5O63\MX"8<Z9#@QK&4U!Q&FG#DX6@L55KO7!4K<WEXC"0#@H"
M<G2"3==8'1$&]AW]&Z.]H"=7]3[[LF'C:=OV?-&,F1KU">5$4Y!"@640R-RP
M0S!K:O<'#/MG*V#`WN9QS=Q,KQQ6[,>.0I',6-C::Q9!IM8'B2#7Z(<RLG&/
M<\4</\GA[R7+S%AD>P';_9W;L:RO#C"B7Y'NS'B=C#&J<+B)"L=/6FR;I&%%
MW)$&UM!7%:^GQ]##[(<CVN=>CVM2Q1R+U%)W4R+,WT=W,EN2K`#6..JW;P%J
MZG`;<EZ+V<;$;Y)[YSM)%R1E.(^+\."<.%^-JP/XAZEID#KP^\:;Y<M15%O%
M(*R*R;V\C8N9X;.9_C?&R]XBH<0#S2WQ-8Q1]]RE&FTY88O3=M`5A1:\H_X/
MI][[(-P2/KCJ!/9-')D>S8[=`^&F0TD.)-N*"43OC2.&,<,OH(65+%[,5^-;
M'WU<Z#I"-^J%8]1]_+PJ-)G&WE;,9.('Q@'QD9A==0U`,#5A\^<-1?M2A6X/
M*>XC*0(QC2%OC1$-J[]%X^FD2W>/*):V)91$UV/4:AX;DR*`IH8K"M?'<!RH
M+:>$:<`#AAUOW>U?WA,/?FVC9MCVR:3K',R)(\_$D8I]VK`YCR'E8*S,>:-.
M.I1><"&)45BCI2,2SY:92MTS'AI/'EZ>$O/0OCQ*M_X4@$S+J/*52UV\'?-V
M%[=L:8ZPBY[GMV\MPEDK<'A\O-$)];MN<OR!M]C$9>[NA,239)S8S.Q0VAR5
M+6NQ;D6WM3B-!VR5:UC!"N&V7G^VCJ'+ZLW;IWHG8%W2+9)TAR=>6F/DLQ4.
M_=\<HW,!0MR2SH)'1P2H!:M;MVS8LVR8F_[G.\&#G22+%HCYA`C81EI?24)9
MR6*@EA"`Y%V`.LII:E$@?$<=BYA,E7NT@+C<?,:K*!)9`XJG2S.UF-EU!"=3
M=([*AEB)$86`?5F6N,(;ZVM[=MFYP[IMD.Z!7@BEB$C+*-+1"P9ED`O8H-0>
MQ-BIL37,[FD6WS3@RI)!$S6D6^B15)LRW`/IBQ4$7X@&QK:IA_;ML+6[HTFS
MS,1^[QWR6IRG"<'BG6))!A9OQZBR$L)1L^0E2Y!+XZX/XXZPSDX]&CNF$H,.
M2I;FB%<1E@!\&SO:)[3,_H7(]I71T.Q+TO#BYV8BY(RC*V%C(SP%>6ZH))HX
MF8A[:2R*.QF/2/M.)M6?'M>]-.N<T6*KQQ%5Y>1*?I$8.+%8@\2ZAQ+K)<"Z
M"IL5X'V`YPW%OT`Q\AWL,N,,68KS_.,HF2R0X.<,C25WP\F4GMK?C*T=C!S$
MG2.WK:=8P+FGN8+IE]&X/15K=R]I7M;Z?]E\O7V\XVPL\T>WMB+",GCWV2)6
M$ZO+>RK,I!0CBK'B+5L6V/9)^J\+I'$EG&9-N&1!/))HT!(<>>4,C*NH,9(/
M"+%2#>_"O"FFWS9_D3;3G'.&V=KWF8Y>]O8<<.\H0;I4F+UD-FC'D25)X:G9
MXS(<?MC*)IF#>O5A5!3*>O"K3%F=&P+@Z5;<=?>T7ISJ?9MHZU'3LV!O>8^'
M&=O>?O$4HB:5)&25W66$:2L@4!H]08D]E8$&#L^[Q9V/@=^CSL3;7S`950H$
MB8!T8!`ZLXXQDGTRI4#@2,191MAS["`9'-E6,GIC2XAB\,F>0G-:L9`LK%&,
MBB1@Q^ZDOQ3H8SOQ<T$O+LV%MIZP]7H9<L`K%&]#TV/V@]$SM!R=PA;O6X2X
M,26<2MEP`F:!HF42(\8!+ZU554JS,`RDZ"/:-QF?_P`O"QB.#WQ2""IQN'TP
M:^DI<VMJU:KK;4"*[&=\1-V."<43*(*'9QQCF_&;3D"#KWHU(I=D:]"J41?(
M<4=E*!&@2'KHE.6I62`P!!76HC$X[@M<5ZIZ4ZHEW7=]WZ;W-43>]HS`A":@
MDF-.O.Q)U5F-M<9T2`EM,T<FDV[*I<%!M.'O&*2<7(62-[GBF5`^B:,^,%#'
M,O9995!N1<Y6;)-I>-LW8LR_E?)>--WN7RH5-L>8_AN-]G+'&'[(#VZRQNDS
MU(7QW(E$<D"(F.Q-H82C#S`]3>UU(;:BO>P:X_VK^T?>>C-UVC8]BDV6*7<1
ME22Y&XR.F-CQXZQ:2S))$5:624(O$W([.VLWI_;(MTR\M9B[0XD$3E(P#*[S
M2F-%0$&ZA4E:3A=0!QXUA)E5N@J7*4L9,7,&38O#$DANQL$=S28P7RDS')QD
MH%S=.>]A(A8T[PF>`G`&602#JB[!L*W2L*O0>CL_?=PZ<Q\WJ-]OEW.2,N9,
M)F;%>,F\;1,Y9B#&5/$D$]AM6'O*;?B9;IA+D)#&GIK,%Y@D529!90`!<$("
M-5AZ7&LZW/A);QVPR5-@$.&WJ90OUG7R#&+#FN&KLHHH:]GM:=)E`Z#G')'5
M%BPKUU"8>]JNUTY*<HXZ]NJ+Z=_.%_O"^S)I`),C+BQ-;1OD/C2#&AE4.1!+
M.+JL[:/1B`+G7&+:FTC,CZ5WF>)9840RS8ZSPQ:UYV1&R*YY$?QI"NK2P%O3
M5U%["]G\@;#-PF/Y]A3'J!%`\O.6XRRP&%9#@?(T=RQ!)\I:W<3*^MS/,6(X
M#39;&UUK6<;&7`6D`+I"'T;#N'H-B]KG1744.XRQ2Y&$=IC$N5'G0/BRQ0LA
M=)S&]R8G`.EA<\"+7L#B;EL>X;7APYTH22">8P+RG5__`#`*CD&QX2G4-*=I
MKL9HV'YQP;%VZ;.KYA/)4*4SA#C-_E>#,Q1/+K)C[(;F9U3=#,CJHR:,4.?E
MXPF6*+4`N$8B#`]+I6M:^/TO[7^B^K=T79L!LS'W&6)I(%R\:7&[U&EB[8S.
M+2Z5(:P(.D@V[;7MSZ=W+:<'*W#*Y93!`.0B.KRP!A=3-$/216(*:N(U^B2+
MK>Y>6>%ONGPM&,H2"6'X0<7;#4>)FF1<9PW-D0E67X[C\]0A(*R(KQLWBL_E
M0D5G(DSMPP)8NJ%TNK[%]+M']X#V;[MG8V+CRYR8^7DC&3(DQ9(\5<DE@N/)
MD'Z-)G*V522"2+L.-KYZ/WQQH58CD]WYZ1\P<R:#2K/)#&;/($5O2X#BCCP#
M5E5$.&?C=HS)L#ATBDT)RDU;H,`SR;RV)PG-+.]3%?D=+%IW((\9&VN*DM[F
MWXW($T-R0IQN,9:AU`J2&#$(`K6X7J'V\[VD?7&%M&/+C;OL")W*23%*II18
M`ZY)D.CG2/([PJP`;'TRJH'$W]IZ?Q9L'IK><UX^Z[AN<<64H?MA?(E53&H]
M(E88@D]K\G(O&;FU8#Y)V";CL8QG&TF6D8NR,CR9D)'A]O#@W*T4RR.,YD<2
MDYZ3$TXO&E1J>+3P_MGJPHCC1VZTHP-QVTM<7J/1_MIZ*ZHD7;A//C;B-O;,
M!R8),>*?'C%YLC&DDL)H(_C,R``+9@+7TZS=.G<_:<3)W&5`,''FTRJ&5IL<
MR<8UR$%S&6/H#B?I/1[2M^#/6QK,.W:%KYW+99@.:LL>F"+'T]28;SC"\I2'
M%LY<0*NT8EDZ/1]19SB+XI5-ZE/8DP!EPJ4QI8KAN'6^9TQ[9.BNK=WAV;;3
MGQ394<CXKY&++!#EK$H9VQY6NDBA65P;@E&5@.-JKR^EMXP<:6?)$(F@2-I8
M>8O.B64>@9(SQ47LMQ<:CX1QJ&!-C6;-Q..'_,,-=L1Q/%\2F((-+9YEO*;!
MC&+Q)Y.9R7E$?(GJ1!`WMS4XEJ"DJ8ZY@AGKC`DA!KJ*V;UI[4^DN@]RQ]FW
MXY9W3+@:2"*"!IGFTL%:.-$.II!=FTVX(K,3PXZ[:]KS-YCGEPE`AQ=!F9R%
M$:2:P)">(T`H0S>`LG;?AZ1&P#<V;G^3[<548C+/-(;%19%E<K?)LPM.(&#%
MMT1#D7EAPRDJ.!'"\;K$2DLPESL*X3.ET;`Z5A6MBI[8>@?U/;K0Y;C:DRCC
M&,Q.,H9=](Q#C$<P9)/9'X00P8J0:KGZ=W5-TQ]I@1<C-RHUEAY3!TDA:YYZ
M/V-$H!+N!Z&DJ1JL#V'[A];D67*^)\2MK=C_`"`MSBVO#UBK(.,<DQF<89F3
M'&$YZJ:/;;E!L4!8`M<"3)#S'H9G0NB`0,5PBM:U[T[;[9.@]PV?<=XEGGPQ
MM2(^5!E0209,*R\(6:%AJ*SL0L++<.Q`X$BJ<OIW<\;NSPJF5!ESF"%\=UF5
MYU;2T'H_%E!_<-:PNQ-@;5I'^'U-$V<MMF.)?D_;Z_X\W#S\409\MX?S[`)Y
MCX8V)>WAFL?2SANNL:D,[;FU<7=(@4)Q6/4J2"[=(0[AMAXGMHZ6W+:]SSMK
MQ]S&Z[9@ME=UR<*6.:5-+B.6.&^J6'6A5W5KH`QX<#5K>^G=UVC%6=GQ6BDR
MH\8L)E9(IF9/1F(XP^BQ*LXTWMX>%<`]L<(BW$J:MJ+^[1F9XYON.:8&K[PL
MA$2P!D%=Y.-&C9W*8,%T_K?-D;1T279.#H*6Y?890M+ATK7]%>T[-ZP]C,G7
M$:O#O<.URRMJBTH<B*`N9(E-P^.7L8VXJZW\1K+Z[V-.F-\EP,9]6#WF/EG6
M#(L3Y*Q%)AP*3:;AE-BMP?"*\.*;(YYEM^RV^Q.68#PWBJ(YMGN*HK(]Q.=X
MCB)J?W:.21P1)XQ%ETN5&.,H=VIE`G&KN$O2W6AO<8AW%8.)T_[:]JQ^BNG]
MPZF3-R^J-WVN'*:'`Q),F0:U0&1XXP$B1I"0H!N2;6M8G9]1],=WZMWK;=KT
M1;-@9\L?,F=410'8(NMN-RJD@>JI)/"U6[F>T'-^/%FY=OF;0P,:_:4.+AS$
MD42-(::G*FCZB8(NLB8DY1Q,H1/"AQ3GE&%C+MVF:$W3G#;LL#VK]$;IM^S;
ME@Y,CXV^YAQ,8F,C3DJCNT.0";PR)RV5E.JSV'$&]:*?I?>,?.FVZ5$[Q!MW
M?B5;4CXP:->9"P_A`W-4KV$B][$&JJQUL0W"Y5?MO\8A+9#W)_W.0.<Y'Q&V
MGS!&@,<XYCQ2N1R,+T:I3`(8G.ZEN,`E)-&()][AO<8+7UM1O?M9Z*Z?DWN/
M<Y<A#L$>.^7:$G2N4;0LGI>DO;K(^);PUCXFQ[AG08.3CA1#N.?/APEB?X;'
M4/('L#I4*RV;CJ)L!X:]R></+<G"#<3E-"3&>8P9JR`HQ+"E^`LJ13+;23E5
M&F)6+,<29WCZD+=&I>B1FW..3J#+%DDDFC&8$(+WK`V3VU^S_>Y<J%<C(PWQ
M<-LR^9CRXPEPT)#9,!<'FQ"W:OI&ZV4WX7\[IG=]NPCGS(CQ)D+!(L;B26&>
M0#EP2HO&.60G2BG@S^B#<B];#X>N3L7SS"#CDY=B3(^'IGGZ&X3GTAP3F2.9
M.;X9+'9X0E.&.YZZQ`_MB#3)8VC46(),]'<1!G1'T@VUM[5[:.D.HER\#9GS
M,7?$V^;(QUS,9\?O*1J3S,77PG5/0+]E@ZW!!-L?J#I??]GVG)SV6+GXP031
MJZO-C&3XAGB'Q`3=+DV#\+WM?GW4\._+>$Q[@,DLY.,#L68GRDZ,KM`HUF".
MSC,6(H,^RU<R8W=LMP5&J52&)I'Q*%+T#EH^N%924(P(;B%T>7]E/M\V3J?:
M-CVOJA\B+JS<(%0S-C-%A39875)!%DV$)F47!C3T0ZLJD\">GZMZ*DP]YW%M
MA4-L^,S2)$7!R1BBPYYC/I&+]WK-FY;!RMM5M<NEK7TUY/-MR_Z]?1S$@<.)
MKSCCX>VN46E@!M;E\S7EK&12TAN:H7BVJN+L5DCAPJX!<$U,7;T5[^:'3ZUZ
MLN;FWBJVQ\%<]K:WTJBJ*A2E36MI?T5KZ?5M2E<EPZAM:WH>76_9^I]2E*_=
MC^CC_P#E\K_Z>LF_\3':_,;^]]_:PO\`-6-_^97T%[+_`.C1_C,G_P`-9.<0
M[89.-VI+8GQ<JP[%CWM2Q$Y5D.22,ANCO)X?'7-$K%CUE1Q1X;6UI:9:W%'(
MG):((U1:<R_4AZ5^E;Y_Z>WZ/:-7>N<Z`'EJFG2&(-F((-]/:/=KM<_#DS%"
M(;+X?='A'[-9=8OV]1C#>-WYIQ[!8$P3"3QE.F?FFRR1N4`7/25J,0DMHKNI
MBMY#$P7.$7U=@V,N1?2]KWK496=-FY(DRGD:(-<'T0P]ZUN/A]^LN.%8XM&D
M7(XBM'.T_@V;SMG1N\)FQ3N/V_VQ;O`:ILD=<1KH3D4,8Q6[2LIY2-K[!593
MU=8H/CC8]F([%J@]%6F**L.X+@M>N\W7K;9MV[C+E8^3WS"T^GK6[A2"001P
MN1VW-JYK;>G\C:Y)^3*#CSDG01\4GP@^Y[U9K&\*:/3K<5LAW;9=<(@JS/M%
MQ2YXX>FR&(7=+"<JK61I3-V)G]W]=#+NI7>0OLH6]0=VP&YQX;6O>Q)=:%.K
M)H-OS-GQ0YPLJ76"WQHP3=P/`2XX7X?#6Q?9H)<V#<9N.3`A6_@8$6X^\>-8
M@0_A";Q81E[?1E-ISCMY-3;^I='W7*T6-8,G(_6&#MDC4N\BQ_&G]M<4Z\()
MNRJS6M4X""$Y,0:,90>E>VFVGZQVG+P-NPI<>=7VZ,JA!0ZFL`KF][:2-5N/
MOBL2/9<J'*R<B*12,EKFX[`/!^R.%ZN=Q`>"3']TD`Q,TX!D;/@C*V,98Q3)
MAR](ICES(3M!5C&%,8%C@+.[R-6@2LZU4F*$(0[D#+LE*N$.NMJL=/=:R[5D
MROGH\^)*K!HP(T#ZKW+&QX_L'M/&J]VV"#<(D6(\J:-@R-<G21XAX1Y*]!RX
M96[F;<0#;%O[R3F3`#W,<!8F(Q%)8BU1.<I&W)"16A>FV22\Q6I6'W8GAR+?
MC3@([%G)0##T+BN`7)2G5.UP=.Y6P8L.0(YYS(I+(=`N+*.`-N%KW%_%4MM$
MK[G'NDCHTB0Z"".![;M[E[]EJ\W&W"4SWM7SAO-=]I&;L8LFUG>,QR6SIMMR
M+'I:-NQG-I<RK&YPET'<XZLNG3!0*W)1<I+<JP3DA@2#+VN24.US*ZPP]TP,
M%-V@E;<\)@1,I74X4W"M>WBM<WJF#9)</(G?#D'<YP;QVX*2+77Q>.UJIO:A
MPH]W^T[;!@W:]'<Q;<9@P85W/H-RY,M>XOD=O>)&K0NJEVO#3FY"M$D;$HSE
M0@V6`&8.P`VM<OGO5>[=6;/NVY3[BT.2LDV+R;:E:W9Z5^!\'9:W@J-OV2?;
M\"/`1U98YA)<CB>-[6\'OWK,'BB<+#&'$GQ0PD/"M)CC<9CCJG7$N:68@[MV
M/N/2`H<XF]FI^I<7>`/Q@!`/3W%8XG6QQ-PCZ5AZCI;JS,Z9RR(U,NVRW$D1
MMI8<+-X=+#QCM[#PK,W;9<;=HU,MUR(R"KCM!\7NCW/V:X.(:SG1V(<,B/J3
M"3E#%Q(MES,H.3V%9.:>UMLU0G&$6':P[$C,(O<-A<O1O;7EKF)'$LC2+\5F
M)^&MJ@*H%/:`*VTU155?+GXI)I1'$YXB9YP^@63N<>S#!\EK!`#&N,QBO<5[
MVTY+?5O7Z7_W4QJ]DB`=OWGE_ACKB-__`.X'_,7]NM;?C-8[WO;M1RO;FM?J
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M>.\A8"(;9:H?I),,C9AG$1B;P^#6LCA=(2V)C7`@TPH1>I8+!N*CIKI7J;$Z
M]V?=>C-@RNF)L7-BEW(G)$F)DQJBH8(<=219F!/,D`=%=6])A:LZ',PXX,^7
M*RSD;1+B.D./(EYA-*0(Y"W8G)TJSJ'])A:UB2:,RMFGAH[R,M0W>5GC=6\X
M6<U,`QFS;A]J1^&,F2G($O?,01=!&U;;A:?Q%"9"`L.36UJ++3G.BU">WF&C
MO?2X;7KIMLV[K[V.??O3VP;1)O&+N6=/E8&6DJ1I$V3^YRDD](<AR&/+#:U!
MX>"M&LF/O>U;;A9$RX&;@8RXLDCJ722&-F*31*@+<TJS`J1H#,HN0"346VKB
M98K7;9I#MMQWNNRCPH!Q#</DG,&&Y6U,$NRQ!I/B/(!U[DX@R@X15GDTY32:
M)C"6I1N):4\I49TPF7!K>]:CK3V7]3Y^[[/U[U!@1=1.NTIA[ABH!C.98R#'
MEXZL%C&KBK(2NA2Q%[J!EX6Z;=CY&X;;BQRP8F3-'+C2W#-$8XN6\<W:#'*+
M.=%RDI4#T5]*^&U7==$,Z\4[9E"6W=SN1WPM6,L?9U*GN:,M(T\6A*Z42'%D
MH-E";`T'<8XQ3!KC-F5H3ANK>C!J%BD`?X(D)?HN1WWI-=N]D_7'4<NQ0[!M
MTNU1QPHA:3),*9,9ODOJ:,N&8LB(H"AC=FU<*YLZ9MSZ;V^#-&3GGJ""1P`1
M`A*2+`!<!VE"EA,X]$@@*/1N==L7R'LAV0XLW3RO;ANH<]TV6=RF$9UMYPUC
M%/AF=XX68<AF6AA*FDJSW(9:A)BRV31F.B[32)8\<N2JG((A]8$KHWOZ9N`Z
M^]IW3'3_`+.\[96PL'$SL+,S<T3*\62,)Q)$N&@/-3FMQ=I[-&I%M;#C?3[I
MV[K.7K)Y#'-B/FC'Q=.J3GY*-'](W",QP,-5P3S+*&4:F`SOB&^?:;BR$[:G
MK`.]F+;/L78YQ=C-!E;;?BK9:.1;UI/DAC=#!Y,NR;FG*(*V92S9/=+A-6GG
M2$DL#(<>&R>X[!3CYWJ'HKK.;K;=H^L=ISM]?,SF;`E.8\.UKC&-!"F7BJ0S
M+C^D="Q.><(VN;:QH]M.))TIC8V+*N%O*02KD2R)SIFEYCL9L9S<H[0D1H+H
M+7#&S/6L_>)G[$&6N*UDS<ECR9E23#,FW&8TR,W3`++(6P'>XA*A:Q[,.9GA
MJ0OUCV,U"I).!9+TC#2!7*L,-PWO[)_=UZ5WWH_V33]-=0XSX^\PY.Y`QL5(
M8323M$P8&UI%92MC=`WIZ;&L7VE9\/4'T^UMS.9M6+'I:ZE95@C26.YX7BD5
ME)/HWOH)!%;&,>;^-ECKO2XECAG.8&R3:ID[/D>W@8$>4\:EII4HS;@61-3Y
M!&E(T"CQC^R@R4SC4-!ZA6D2EE)["L:(NPK7KPB+V8^T;;/8QL&=L>)+%[2-
MARL^(Q%XBPQ=PCR();D.$=(RZ3!0W%K,`=-CT>[[GM6Y=:2Q9$[?JONFT8N'
MEN+C0,=<>177]U=7B>*W[HE5L48BL5XYO987C8^Y+9#(R''=/*>*E$-YRZ!K
M6][O=>R-\?DCNX.ZM\(;AL"9"3(%J9$,CMH*FX1=(LJX+7O;M8?9CNFR]>='
M##QF;IG#Z7SL&>9&4\N3(,8"MJ;5K>-2P;21<<2";5J3NN/N0ZSDF;D'=UQA
MC*%L"L;QC2H)LH15X*S`"P5;\*RR<\J<-U;O0.XD;YNLD[>4XY!:]QCOLX)P
MGD-;G`S+C84@4G8_:I^D0!Q2JB:R6MH5)3B-Q*,LWBN$1=A!Z-^:VG!]HOL[
M]GV9[(]OV9\Z=AEP8V>LR+C<C+>1N9/$VJ99$25E*JK#4$/K5<W([7UI-C;C
MN$W<YDCQ5RXRNLZL5(U4XY!]+F<I3:0CB'MX+8D98W20;+6PA_AKT[$MN>\F
M<3'(>Z=RQL4W.YPF2`S:$2@-W$3Z6TE1T93>\O):/J;*`JA7MT[%=#45MQTW
M[.-[Z9Z]Z1>6!I=CVOI*;!EG!7_YCO,<JJ4O<:D&K@-*]EQV5ER[_BY\W5^5
M,3"NZ9F&^.C?&>*%85XZ1P*!""20Q*WX]M9*8MWDX`@VY'@]SMSF)ZB/[8MN
M2K'N>E2%AD1IN/WU^E.1TQX#B1-0!2`+6VRHA<?=LNLL(FUP@N(ST%7=]Z!Z
MEWCJ#VF100:8]^Q(QA.60K+RXU)4`,2MWCT#4`+DEN`-:<9T4/26TXB>EG8F
M^SY,L5P&$)R,616!/HW=8FTBXOIL3QJQ<_R1MR@.RW>/MJ@>X"/YMDV0=X&!
MLIXY>XW`LEQ1MF$2;!S!XE:E.FF<;;CFD^'FOA21398,GM@ZUQIK&EWM>M7L
M.Q=5;CN'L]RLS:YL1=AQLW#RR[PDH>3#'!(+/9EG,99``=`-GM6Z&9ML>^=6
M;GWA7AWG!A:"RFYD.3-(\1!%@5#"['T6OZ/N7JP%NLV_PE?P9"I5D$AK'M:S
M#N$F6>>G'Y4J!CZ/R_(J![C3DI,0LBH#W=T;B1&V+;;K3R[6N$P`1:6K>=:]
M'=2[E[0.M=QV_$=\'=>C4Q,20,@67(7&*/$`2&4A[`E]*W-P;7KEH)\8=(Q8
M3,%RQU3AY>GPB"-(>8]^RRZ&X?&L#;MJWO"UD\"RUNLW9;:\CW=G3;;NW8,T
MO\^<D1`BR8LSXPFCIG*&Y76)7,HFZ!&V(V`Q/<P\!(K>N(`7MTM`7GKK:,O8
M?[OW3_5<P,'5/2$NWY<`8V9I@%QI,8,+^G-S+>B3J"$$6)(WN];C%N7M6R6V
MDF;#WIY]O;@09,?+B(U`#TAR"#(I/\&H>3XP%:T]S^>U^ZO<EG'<2J)-2H,F
M3AQ4PQI,-L>&/XW8"RXYCF.IQ!L$-D;1$VQ*47:UK:Z:W]%>]Z]@]AO2DG2G
M0&)#G@??.2IFR&["9I3S)6/:>,C,2+W``4<!6CZPW'$RMZ;'P6/W3A1)C0+_
M`+&$")3;P&2QD:W`N[-87K*/>_N&A&0YML1EF"I^XG2[;IL@V^X]>9*PDR&-
MNV/LQ0(YP4N3>WN*]&UW/<F0\98K*T0CTAE[:!-';6U<E[-^B<[%]HO7N=U)
M@*VU;MOIGQC(%9)X'1E8Z1J.EP0+.`;-V5C;AG02=&;-M".K9..N8)D`(*\S
M):1+GL^*0_#P\>VKT[BYWLRWKONV#/,QRW#]LN=LDNO>%OR:B,?SA>VGAC)6
MB7<K'"(A$7%H<WV<,J89*YO+-`>8Y'E&"!T0FFWUO2NT]7>QGJ'>NF]GV[)W
M3V;S8[9>U!7A5X<FWI;<[O(-$3,?HI&NJ*K<27`%[.W,=1]-PON&0(NKL%EQ
MA*X+=Y@863(F(XAX/1#*"-::M%@JWK;<CO.VJ[VL.9%PR^H4FW^+;0``4<->
M6O#5,)$OET`8F9!%)?BS*)3.A=5B61Y@,9R']`XG$@(;UFB8\PHL/+QW3'0_
MM&Z3Z@P?;%-!]X=1;IEM'O6'&54<B:35%+`6;2&V]F,=@098BQ`)):MP,[8L
M>.7H#'DMTJL0:#*)8E,R*Y=Y%4!F@RN9(-/$Q>BUA<*M]-G^\[">%<?8<L'B
M42B#8+;XTSVW!["MQNWJ1;C[25Q97>TBF<?PBY((*L@#2QY%Z@)+0)4N0*VT
MX\83!AL&QM[WM4Z9W'==^SIL[I0YVYR^EMVY[=D=SD56B:*/OI>3FF6!F+.T
M9/,0+Z)(TUI^G9GBVZ),'<!M^<LI2=9%YF,P+I:2)0&;C$+,C?ZQ38V:XU,P
MW,F.&[>DRY\C<'M`L--VZ)OR?&(`>"QG>MC%%D=*^-C*>2"YE@";V`OI#*#<
M5BM.A:XK!MK[MT=L?5.1[)X.FNJ,II.J9=IEQY<C]TTLD3(K->WI<0-9L3;5
MP)KG^N)\#<]TS\G8XE^[Y&=TC8`"UE-PHX78J6`'9JM5^VQ=']N?%422?(TA
M`C@D$WC6R8[36Z5:XI5>/7B=#GK3-4J5K2*W!S;G6+/!"PFZ8DT9Q8O0!O>^
ME<9T@F5U+_=JFV/"QF&_CIC,V\XX(#+FQ8TV*\)OP#\]=)#<%)O<@WKI>L)X
M)^LGWB"0MM^5E8N9&[?NL>0QRAQXQI\':-)!XBN+9#N.C>WW<3G3,AL^78^5
M.6*-T"+%TR;4#N<Y@G4V3/E\>#;2$+6O6(%Z]<J)N68H(`20*]KG7!:U],7K
M_H[J+?/8!B='X6+)+OR8^UI)$&56'=Y<;O(9FL#RT1QV\;>B#PK'QLW;E]IV
M/O.8ZML*[IFSNY^+RY(<I$8@<2I>6,`#CJL>R]7$GV]V6;S-F;EAS=UN&F"C
M,6"90BR9A*42Q3(7)DS<@?3"FB48RR&W1)G4-HY?%@*?72//BX@("B"ST8QV
MZ18K8<WLFVSV>>T;:^NN@-JCGVB5>Y9V.`+XJN;Q[ECF1PRL`#%DQ+9G1@R\
M1:J,'J;,W':<_I_>LATBFC&1!(3:T\(`.-,5XM#,I9HA;3'.NIB%/&O-QVY+
M;MD_:$R;/(]EJ5*A;16B%2?%^5W9'+`QG=3*5)!R6?X]4QH3"4[QIFQL8_CO
M`E3Q8L@M,D6%F=1<\N]:?9ND.LL?VJ?UN9FSH,7<,^?$DP1RSD8F-94@W2_,
M*'(DY-LH)Z30R1J"S1D"[@9>WX_3QZ0;)#3S8ZY!FNW*BRQ(TK8:V`;NVA[*
MUBIS=4A`C(JVF1H,CE^W3:'AQ;,VN-S'$VVG<QNJD1+LUN[DH(89W-D,B@>/
MKC;"AA9%\ACD<NY)#%=P)2@KP7&+^%!:^]'4#[-[4^J^LX<9\G:,?[CV=EC=
M$UY(:3G2`N1K[OWM!(BW<E&4#T36%MF#WSIK:]JDDY4^Y;EN60A/Q4B3'C2.
M1@`2.\2XDJ7-E#Z7OHKQ-JDRQTOP=,,7O^_?+FQZ3WR<QY#2F)&O)#YAN>LY
M#$!FO=8DPPUFY!;,H,)][#3W5'&LZI#J`98#0:WZKVD;=DP=3[7U1'TQB=2;
M7CPRQO'>,9<,C'6K1]X/=WA<*0ZLO,#`$,5X#6[+.%BS<1\E\-L@0E)%!T.$
M+ETET@R"S%7C92`;NA4CTJMOO9SW#MQF[6:9@A/KRKB"WQ;,*65R1H3L4HR*
M=`(K'8L_Y5E#(DN:!K?<AN3.<Z'D7$8:"YUK#N(>M7O8GTQO7270KX.]PKBY
M$^?EY28BMK7#BR9B\>*K=A6!6"</1\5975V;#G-%C8<QRGQMOBQ6G>ZMD21Q
MD%['T@.-D+W<J!J))K,*5;K-OKGO0XFF84N0@G0C.&S[*F(\72CUAE@!RR9/
MN+(3'&6,I$@V4#NW%*W1L4D!-5$IT8.AK<RP+AO?PG%]FG5\?L=_5N7;BN^1
M]=0YSQEH_P#Y-=PDG:;5KTD"-E>P;7Q'HZKBNG@WK;4ZYV'<S,BX.-T_'C.]
MFLDZ;<D1%AQU"4%=7CXCA7E;>=X6#<*P?AEM[RXN3FMPPZ[R67-K-&&%>.2P
M"&;@&,$-9Y4S'KD2)E>'9$@=CW),F3+!F7&EZ`^J$*UZZ3KCV8]2]7]:]2P8
M<?=]LW;I+%QH9V9>6<C%R^\")@#K56**LC$6TN2+UH-FWJ#:.FX9&"R;AC=5
M)G&'C=X$QXH[KX!J9&5-78X#$@"]44OE&TO:GMMRW@7!>YJ^ZN7[D,HX'.7.
M4=Q5D;&\6Q+C7"N2"Y^JDLT%/FMO/>\COIMPI0DM@3R`EV.%8V^@0CN1XG6_
M6W4G2Z;IL;[+C]-RRS3.TD<IR)I(3CF.'E\5@`NY,EB05`!N2+V>=HQ,/J#<
M\?*[SE[KMTN-!"R,L@61N<7R'(Y;&,C1$%+`2'6;`<:U6;G\!JMZ?$^S(=.2
M5,!SQA#/4&Q9*3V"4'#F#[)HO$6R),Z9`:RB>$!:U4TF%%#6)TZ<FQ7HA`#T
M;US;^S;K&+V`1=+#;R.IX>H$GDA5XM0B7<VF#Z@Y0_1-J.DZB#PXBU;Q>H-M
M'M-VG>VF`VJ#;TC=[&RM]T-C6M\;A.2GBU>D/1-5MB3<5M>BLPX;6:WC/C<R
M2+">TG(VW?*F-C(#D0R2PA^"PY><&"8!DS6P+8\Z,KZXRI$D)*1''*R#S>F8
M$!=A"#G];]&]99$OM#V?"VR7)BZCPX)\'(62(([18^)`8)%9@RR'1*P8V32F
MF]V`//\`3.;@P;?TL<N=89MDWTM.A!(,$F?-E&>X[5C5U5E'I,Q)4<#6(>!\
MVXW@&QTS&BV?OT`RJHWP8#S$S'P^/K7&:L,/A[(YE2+(,=..*21\;W'%AX#"
M4JI>E-4G6L&WH;WO;M^H>C]^R^L^C-RPL$2[1A[5FP9.MEY9?)Q0BPRHI,AC
ME:\;,J,H%SV@5AXN?BQ8/5$4S(TN=!B"$&XYHBSGD=0P["L1#+J(`-K>D#67
MV^7<AM2R;MTES3(\I[?-W6Z9TFK$HPWE7#VU"<[<,KQ-D6214_3!PW`/:E!'
M<=27K6939/8AL1JU1[B,9AJLVP0F"X'I#IOK/8NML"+IW:MSV7IV&8'.Q,C,
MCS<"141HU3"4@SQL7(=9',:I$H`0$VKI9MRV_,VG,.[9,><[XUL8M%R\R/(<
MPZ6FD!T%%C1EE!+ZF*E3I!M3F#H+A3(O"JGT6SEG4C;TQG[\(0OCD\>(+*\A
M0\Z3-N(5YY3',6&$$+I.4A6-]S[I52=,HL4M+!8P%@#$,/3^US/S]J]N?2NX
M[;@G<IX=JSV[LCJDDB:HA)RF?T.8MU8*Q`9=7I`@`\_TDJR[#U'CR-RXW&VK
MS;<(WYF44+=A,9L4;3<@E;`W)KVEVZ/:?DV1Y1VQ+<G2Z%;;WC9!A[9U#]U+
MECZ0+USI*<+9,%E@J?23&Z(2F9),9RY\5GM8DY-CUY3<64;<GI"ZH/./[/\`
MKO=<7+]H"8$2[ZW6`WP;;S5"F`XG<GQN;I"=X$:+(#;0)B%O92QV.)O6T;#)
MM>R+*<K#@VG+PI\E%TD/FR-)S(8S8K!"Q":"`S+KT@!J\EIW&8$PHMV1;>\#
M[MI.8SX%R'G#+F0]X4.PJ_*85'9+F2)-43;(%%\0Y'):I#+<<DM[78N3@4IK
M7/+5*;$IU')86YFZ<ZF]H'4N]]8[KT]'#@S;'!MJ;9D9**V0L4S9$DDLL`9$
ME#,3C$:M+)&6*6-M8L^#L.P0[9#F')SLC>8\N26!64XPB40H8BY0F8@<R4&P
M9;)<U4&XS<SL_5SO9E+&)WP-F'<%CG/<2EV:L^;8-NT^V[PE5A^*'1T!2"5P
MV7I6=%(,CJE[>:JM=F:4*(@@'1`"XS+VMA>SS8.MXM_SL+#Q=RP.B)=KS(DQ
M=QR8LJ2/)R%98VQI4#-%$MRLG-D9G+`V`0$U]7R[=G]*Y$4V1BY.^OD0M"\,
M31,8HY&>1,@FR.SL4,)M9"C:B2Q-8ZESK`^/^)\GR]%<ULN2\*&;I"<WN.3F
M>$SF-H6IAE<X63!Q:E<>D;*DDZQTB*99VNK,3)3"E!P;W(Z0-*[[V;[-U'#[
M"I>BMUV^7$ZHP]LFPN4[Q-S7&/RXY$=&T\N4_$#$$6NUJU_M(R\;>.I,C?-M
ME27&S<J/(MQ!AODB1TDU6UNJ)J)7@0UAQO;([`^6MBA$)D\P6Y*V\86W$?E7
M9@GRC,>X+:UDK<K*5N)G:4&.L'.V^1](C6XXCCTI:#%A"U+*6VX#5"HLP(BA
M6ZP'CTW3OM0V?I[IK;9</<I^EL;IV#&EQ,+)BQ77-1;9$>5*2SF)O0"202`J
M$;3>]CU^X[ET_N?4O4.3#+CMD9.ZM+C33ACCB"1V8,(U!;FJ_IV=2K`JI6WH
MBL<T[G-H.X[<3Q(&%3N`*QIBK=OC/;SXN<\.N+)VZ1MHEF)1Q.0.;%-H''V$
MB9MACF<U').FA0GIR3PVL`0BKA'6NZ6]G'M`V3H3;<G)VR23<]AZTFW`X?-4
MR38LBO&&@D<Z2!K+@R$.5&IK&XJO/Z@V.?J3'DYQ?"RND1MKR"/08IRR2$N@
M`46:(!EC-EU@)<"N@W[JMH<#R!LV;\?YT<Y9#=OFS3=IB&69$78_G$5.4Y`G
M*>5EQ=0T,0V<]U3M4K<G0%VVX1G'$)AEC5B(,N,`<OJ#I#V@]9Q=>[HVS2X\
M^_;7M7=(.;&Y(QYF,D+R%E0S1QD&3AH+$B/4!<X^R9^S[`_2F*^8DK[;U5E9
M>2X5@%CFCC590+:C&S*P5;"7@2RBXJTNPG>'A#:WMXPZRS54Y*),U[S!S61Q
M.-LSD=*FS%,LVY2S%,AR`Q+S$A3`)RCKE(PF@2#6$JE(B[AL&UA=.W;^UKV7
M]2=:[U@8NSP\K;)^F,S#:9B`D.3))CSPQR(OTC)(8"&;3I&HL3P`//\`2^]X
MNR1;GER%9,J/<=LR88CVY`QI\@RK<^BNE9!I+<-6D_N35O8NT;'-LCQB$$&W
M@R[<=(Q;E<5S12DA..\D8PQ1C_&\.D/KD]3/,S--60*Z99((2*N@WD-`5!:?
M53<)X[""$?2;-N/774,V-L&;TO#@)B8&1'+D3R0RRM/)$RKW!E9>7$S"\CR^
MDPT#3QNNMZEPMGGV_=MPV_<I9)LX*L$(NLC%Y5E89;-=&1%OZ*,=<EG-M/'A
M1Y_PX$OB].JJ7!&9N?3R(K"ZLYDD2A7D!>JSVCE:`0!B:S%#89:/$64A,<K)
M`A"&P;WL*W1KB,;V>]58_LBZ"VJ+`D7=MGWC"ES8PR`Q1Q,1(_%K,`#;Z,L2
M+VN#77Y_4>TY7M4WKJ&.=6V;,VG<XHG%]+-D8\:11J"`06938D`#P^"M>0`7
MOI:W+?HAO>][V\RVNNG)K:OLSF:5%[$V_P`O">(\/N^+LKQMCH.ESQ'^5OV.
MRIA!N'37LZ_ZM2CHQ)2H0BUJD_8_UJN5-<P+<EK]G2]OU[WK';XQJT>VI[7T
MY;5345&VNMM.?F^O2E3:<]Q7O>P;WM>WZWF^;4WI7);7GOV>6WTNQ44K]V'Z
M.-_Y?*_^GK)O_$1VOS&_O??VLK_-6-_\=?07LO\`Z-'^-2?_``UOQZ-K]BOE
MBO1>--+>9^J_/4:$O>W&E-+<VE54II;Z]*5#HVUUTY=-.>_-0<!:E1Z-O,_5
M^J]4Z0.SA3M[::6J;>_46%+!M:E@.RIX&HZ4L*5#2W8Y/I5`11V<*5J[XG_-
MP\?G1=I/GSZJJ5M%I2OE,<9"1$HN)CQ"&(L\(%*_="['*[=D",..,9W"&_)S
MGCM^]M7Z=?W2HF;V2QN!P^\\O\,=</O[`;B;_5K^W6K4@T@?)UP`]'EOKK]:
MVMNQK7U)'CR3$K&"*Y]B+FU=P-R+VM;K@7OR\NO+:W8[%]:K.US$>"K+.UO2
MX#WC7*'J;<QP?JW_`-2J?NR9:I1_5XURVL5K:_7E:<G.+2_T>3ETY;4^[IB+
M$<*EI"PTGA^Q7/8L&EM3BM/I\FGTOI4^[I;WMQJPT@)OP!KF+**MI?KP<E]+
M:6UTYM;VTYN:AP)[6%0'L21VFNR$)%O^&#>_)RZ7M?0/+I?2K3;=,3<]M3S#
MX^VN4-B=+6L<5SWO:UPBO?6]]?KU2=NF;XW'WZ%RQU$\:G_D]K:B4E!UY[B%
MIKKYM[Z:ZZ5/<<C_`"`JV''9QM[U7=P7G+(^V_);'F##$M21+(L;2/J%D?S6
MED?RT2>2LB^./(;M+^B<6E1=2T.9Y5KFDCZNX^D'05K"MH^I>C<#K+I_+Z5Z
M@C,NR9T7+F0,R%DU*]@R$.#J53Z)%^P\":JAE[MFXVXPV[WB9"3Q-ZLD8;0Q
M'A`U'@01[AJV*(:-(2`KMLHRX;"U&(0.D,0Q7,$*_1TM;40N:UK6MS6M:UJW
MFS[3'M&!%M\`)CAC502#>RBPXGCV`?L^[3+R9LO)DRY+\^21F8B_%F8L6MX+
MDWL+#W!7>`K1W^R/*%II>WH[7T\^MB%>PN#P^"L6_'W:[`%B:U_^4E6Y=;Z&
M!MK?3S->7DJ&1[<`;U2Q!73X*[8%J6XKWNJ)#:^E_L[:<E]>3EYZM<J4\2IO
M5N_C\-53&GQ&E6V*&K*"2KMU=[W,#H$P/(4/7DMR7Y-/,K"S<1I8KLIN.(N/
M%_EPJH$GMXBKF!5)>E;4\F][:WUN(/)R7UO;EOI6BY+^%3?WJN\.SA:H=M)[
MW_W\J]_W8=?/H(Y!P"FWO5%Q7.%4EM;D4%Z<E[>BMR:6IRI;WTF]62HU7M4>
MVTGIY/[\-4\MQ^Y-./EJ?MI-?_ABNS_LPZ<W8UUMKI3E.WHD'R?_`(?AJDZ0
M.-B*N6DW/YSQWA;(&!L=9$30K%V7QGILFD,<7B)4SD3>K`W@7Q^V21LQD^;8
MP]$MA):UO2N!*-4$-[&%BZ0M>5W_`-G73W6FYX>X[_'*^3@2:T02.L+$,2&:
M(-RF92Q*,49E[5((K)PMRRMIDR,C!=5GR8U1F-BRVU#T&^,FH$ABA!*DJ38F
ML9$QJ),2400:0`HD`"@%V,#T0A`&P0VUY-=+6^O:O3X<<8\0BC%HQV#P#Q>3
ML'AK4L0[&0\6:UR>TV\)\7CM^W7HEK$@;6%=21KI?EL,.O+S\WFVM1D<GL-J
MQW>S$7^&N:ZM)>W_`"@GZ'HP_0TTY?H6J!&]^(-O>HK`-J)J(%B77E4%6Y-.
ME<5KZ:WY=.7LU=TM:UN`J&DC)N6!_9KG`K2W_P"<DZ6O_M@\M_-Y>:]ZI:-C
M;A<`W'O^/WZL2.I/`\/?KL65I+VTN>5I>VE]16O;333ZMM*MLDG$D$W[?=JM
M73@21>JB>YF]2Q2WJY1)ETB4,["TQ9H4/#B-8>WQM@(ND8V)(8:(1A;<T)?X
M,@%Q"L67H$/H;6M;`P]HP-MEG?;X5A?*FY\N@$!YBJAI">PNP`+MP+,+D7XF
MX^2988H)&!BA0J@)X(I9G*J3X-3,;=GI<.`L/*NK27M;125KK:^EC`WT^K:_
M8K,T2H;V)O?X>WR^'QUCR/&0`"+5REK$UM?Y25]#T5M=----=;<E5A78<0:Q
MW*D^#C7)=8EOI_#E7_W8=.?7LZVTU\WDJ0C`ZK>E_E^S52,@%C;3XJJ)\G#_
M`"AY=I#(Y<[OCZ^I$C<\N[D[*3ECFV-Z%(UM[4K,ZP%CFE$VMR<@I->W4%E$
M@#8.EK::?!V':MOQSB8F-&L#3M,1HX<UW:1I/2N2Y=BQ<DM<GB!:LF7)=]):
M0G1$(UMPM&H"JGN`+P(\/A\9\,*M-V#ROH:#M?3L=CFK<A6/8#PJR)5O>_$>
M[7)94GO:W\,#]]:H*N3Q!O5IBI:]QVWJ>RE+K:UE!=M;VZ6I@>3ZE^SRU2$/
MJGR4UCQURA6);7$*Z@NU[ZZ<MOI:_1J)(V*V()J-2WN2+U,!8DZ5[W4%=CEU
MM:]_I]FJ!$][D$&H:1#\8@W]V@UJ6_)8XK2W-Z*WF=CS*R44JM@+59#IXQ4M
MU2:_)UY=]+BOKTK<O)^SI57+;Q55=0/!:H65)[WY#B]?W5OI4T,+&W9V5&M/
M&*FLH3WO_OQ7T=1VM]'GYZ@(1Q`HSHP](@CW:JD<\DYD)!C.\S?"\<VEQ$^-
M@I;H:&+*9JD:QLJ23J6FVA![RF:CA$`.OZ,)5[AK0YO3&S;AO.+U%DXL;;U@
MJZQ3%1S$63XZ(>W2_P"Z`[?#:KL>?/C8T^)!);&R>7S4_<R"+4T8/ANA9M)'
M9J-4[90GUM;KRK?2&'SK7K?Z&/`BL#6/'\-<G;::U^4TNW+R>BMI?ZU`C*>`
ML:C4GC%3=M)K\QQ>E^?T5OUZG2_'AVTUKXQ4W;)'/UQ?[^W[?T:C0?%VU!D3
MPD7%+*4_IQ7[X/8YOK4*-8"WHCLJT[QWN"*C=4F[)Q7[ZU-+WO8WJ.8H%M0M
M[]+*TUKV_AR[6M?_`&]M.?EJ!&_@!JG7'<FZW/;Q''PU/VREUTL>5I_L=!6U
MM?ZG8IRW\1J1*@XAAY:CVRGOI>YI>MN;05M>S;Z=9&AM(U"YJP94N0K"WOU#
MMI/IIUP`_0YOJ\MOHU(5M.D+8>*H+H1Q87]^NU=:F"&UPG%W%R?[*U^7GO>^
ME8HAE9B6!N?'5BZ%B2P\M<0EA`O^%+M_NJR$A*#LJL&(?NAY14H5*>]].N!R
M_1U_5RU400.RJC(@["/+7/92GM:UNO+OI_Z5JLZ)&-[&K6M/"13MI-Z<7^^M
M4:'[+&FM/&/+4W;:?T\KGL+7I6YZGE2^J::T\8\M3]MI16]$>5;EY+=.U.5+
MZI\E-:'L(J-E::][WL<7II_MK<_^M3DR^J::T':17[M?T<0TLSA\+A`&$0?'
MWDVVMKZVUZF.:VK\PO[WX*^UM4;@WW5C?_F5]!^RTANFC;\YD_:K?M7RS7HU
M*4I2E*4I2E*4I2E*4I2E*4K5UQ/^;AX_.B[2O/GU*5M%I2M"NW=62GR;O\ZS
M`>*LDWOQ!,V!M(YE'F]T=_0P##8NTNV%+0L-ZA+<SH@MUFE@Z6TM6RQ=WW;!
MBY&%EY,,-[Z4D=5N>TV5@+GP\*H:.-C=E4GW0*RC]=4^G]D/;[]'2'-&GT?_
M`&=K)'4G4?Z1S1_OI?GU3R8?47R"EG9-;FVA[?OJ0YHM_P#IRH_63J+\_P`W
M[>7YU.1#ZB>05&[N3V-HFW^WTX>TW\Z.VJ?UDZB_2&;]O+\^@QX/"B?)%/7<
MCL[1-O\`]2'M'N=J/UDZB_/\W[>7YU.1!ZB>04]>"?BB;?\`Z?>@T^YRGZR=
M1?G^;]O+\ZH[OC_5I\D>:IO7DJW-M'P!]2(-7N=I^LG47Y_F_;R_.IW>'U$^
M2*AZ\E_%&P!X(-7N=I^LG4/AS\W[>7YU!CP>%$\@\U1L\EV_^4?`'U(@U6__
M`$[3]8^H?S_-^WD^=4]W@]1/(/-4HG<D=M![1-OXK>8*'M(K?2Y8Y0=2=1`\
M,_-'^_E^=4=VQ_JT^2/-4OKFD^*#M\\#6?W.55^LW4GZ1SOMY?GU'=L?ZN/Y
M(\U/7-);FV@[??`UG]SE/UFZD_2.=]O+\^G=L?ZM/DCS5'UT36YMH>WWP-:/
M<[3]9NI/TCG?;R_/J>[8OU:>0>:GKL1\43;[X'-/N<J!U-U+?CN&;]O+\^G=
ML7ZM/(/FU'UV(^*)M^\#FGW.5/ZS=2?I'.^WE^?0XV-]7'Y!YJC9W(M>U[;1
M=O\`:]N6VD/:;7M?S;7[W>2AZEZC(X[CG'_?R_/H,;&^K3R#S5-=\%>]]-IF
M`;6OV+Q!M%?E\V_K!;6K?ZQ=0_G^9]M)\^G=L7ZI/(OS:D]>Q?%+V_\`@<V]
MP:@=0]0C_P"OS/MI?GU/=L;ZM/(/-2[V/E_^$S;_`*^;WG-OZ_\`U#57ZQ=0
M_G^9]M+\^G=L7ZM/(/-4/7HSXINW_P`#6SN'4?K!OYXG/S+_`/C2?/IW?%^K
MC\@\U1]>S/BG8`\#6WN'5/ZP=0_G^9;_`,:7YU6^Z8GU2>1?FU*)Z,%;06TS
M;\*VNN@H:V7MK;FOIZQ<^M5#J#?QQ&?F7_\`&E^?3N>']4GR5^;7)9Z#;GVD
M8`^I$&NVOU.]V_9J?UEZE_2&;]O+\^I[IA_4Q^1?FT]>P?%(P#X(M?N=J?UF
MZE_2&;]O+\^I[IB?51C_`-T>:HV?`_%(P%]2)->OXNU'ZR]2_I#-^WE^?0XF
M)]7'\D>:HW?`W_\`E)P'?Z<2:O<]3]9>IOTAF?;R_/JGNF+]5'\D>:H>OEK<
MVTG`5O\`\I-?N>I^LO4OZ0S?MY?GT[IB_51_)'FJ/K[;XI.`_!)K]SU3^LO4
MOZ0S?MY?GU/=,7ZJ/Y(\U/7P/Q2<!Z?]DFOW/4_63J,=FX9M_P#QI?GU`Q,7
MZJ/Y(\U1L^VMS;2L!_4B37[GK4'4O4A^-N&;]O+\^I[IB_51_)7S5'U^Y/[)
M>!/I=Z;9[GJG]9.HOTAF_;2_/IW3$^JC^2OFIZ_W^*7@7P4;/<]3]9.HOTAF
M_;2_/JGN6']3%\E?-3O@%\4S`O@HV>Y^GZQ]1?I#-^VE^?4]RPO!#%?_`#5^
M;3U_O\4O`O@HV>YZGZR=1?I#-^VE^?4=RP_J8ODKYJ>OXOBEX$\%&SW/5!ZD
MZC\&X9OV\OSZD86%X8HOD+YJ>O\`?XI>!?!1L]SU3^LG47Z0S?MI?GU'<L/Z
MF+Y*^:HWD`K\^TS`M_IQ1L]SU/UDZB_2&;]M+\^I&%A_4Q?)7S5#U_O\4O`G
M@HV>YZGZQ]0_I#-^VE^?0X6&?]3$?_=7S4]?[_%+P+X)MGN?I^LG47Z0S?MI
M?GU'<L/ZF+Y*^:H]\(_BF8&\%6SW/U3^LO4OZ0S?MY?GT[EA_4Q?)7S4[X1_
M%-P-X*-GN?I^LO4OZ0S?MY?GU/<L+ZF+Y*^:G?"/XIN!O!1L]S]/UEZE_2&;
M]O+\^G<L+ZF+Y*^:G?"/XIN!O!5L]S]/UEZE_2&;]O+\^G<L+ZF+Y*^:HWD1
ME^2^TW`]_IQ5M]S]/UEZE_2&;]O+\^J>X8'U,7R%\U0[X1VYMIF!O!1L]S]/
MUEZE_2&;]O+\^I[A@_4Q?(7S4[X1_%-P-X*MGN?I^LO4OZ0S?MY?GT[A@_4Q
M?(7S4[X3/BFX%\%6WW/4_67J3](9OV\OSZGN&W_4Q?(7S4[X3/BFX%\%6WW/
M5/ZR]2?I#-^WE^?4]PV_ZF+Y"^:HVD)GQ3L#6^E%6WW/5'ZR]2_I#-^WE^?5
M)P,#P0Q?(7S4[XC/BG8'\%FWW/U4.I>I+<=QS?MY?GU'<,#ZB+Y"^:G?$/3^
MR;@?7_LJV_7_`,GZG]9NI/TCG?;R_/IW#![.1%;_`#5\U.^,WXIV!_!9M]S]
M/UEZC_2.=]O+\^GW?MX[((OD+YJ=\9OQ3L#^"S;[GZ?K+U'^D<W[>7Y]3W#`
M^IB^0OFIWQ&?%-P-X+-ON>I^LO4?Z1S?MY?GU'W?@?41?(7S4[XSOBG8'\%6
M[W/T_67J+](YWV\OSZ?=VW?40_(7S5#OC.^*?@;P5;NX%/UEZB_2.=]O+\^H
M^[MO\$$/R%\U1M(S>SM.P/\`4BS;[G[T_67J/](YOVTOSZ?=^W^&"'Y"^:H]
M\9GQ3L#^"S;[GJ?K+U'^D<W[:7Y]3]W[=]1%\A?-4.^,[XI^!_!9N]S]/UFZ
MD_2.=]O+\^GW=MWU$/R%\U.^,SXIV!_!9M]SU3^LW4GZ1SOMY?GT^[]O\$$/
MR%\U.^,WL;3L#^"S;[GZ?K-U'^D<[[>7Y]/N[;_J(?D+YJK5@S5DB*(?6R+8
M,QY&FRYYBJ[<P=MLR"ZDZP;&J;I&YM3)[GFV#:PA='I"TMK>^E:K,R\W/F[Q
MGSRY$P``:1F9K"]AJ9B;"_`5?CABA71"JJ@\"@`<>WLX?!7N?E)9M\ED8]EG
MGU+6/5RGY26;?)9&/99Y]2TI3\I+-ODLC'LL\^I:4I^4EFWR61CV6>?4M*4_
M*2S;Y+(Q[+//J6E*?E)9M\ED8]EGGU+2E/RDLV^2R,>RSSZEI2GY26;?)9&/
M99Y]2TI3\I+-ODLC'LL\^I:4I^4EFWR61CV6>?4M*5@?OAR[DB=27AZM,JA#
M-'VL/$YVHG]OH%[BH.[8+*R(:23U2H@LNX3;E:7OKK:U*5O=I2M:.P=D0N;U
MO]&I*`(0.(QGJ]A7`&][]*"X:!SWY=+!)M2E;!>]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#
M2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E.]!G](!]K#2E:S.)<R(6P7
M#T&E*``0^*-M'O<5@!M?T-LB`M;6W+IH=>E*VN4I6NCA[???B`?.+YW_`!'P
M_2E;%Z4I2E*4I2E*4I2E*4I2E8>X-W'2&;Y;W489R>S,$0EFWJ;-"UI-:E*F
MZ"3X,G<=#(,>3]4)P5*!)5YQB!T0.(0B"26J;AB"$`!6KH]UV3&Q.E-LZIPI
M'D@RCDQ9"L+&'*QG&N,<.,;0202HWAUL+^B;:N'.GDZER.GW2W_E\>?&87)E
MBFO&X-^',BR(Y$8+P"F,GBUJQ!D_$,S0GV>VW!0G$\0E63\U9OD&/MG>+;+G
M@DG)4#325S*C,PE*@*_MX)[MC^+N<@/$BZDDA+<CT&G2$+I4Z+VR'J;#V+<\
MB:+&@VD9V[2``'$5<?O,T2`@@R1AX,<!B=<[D#P*-4N_RS8&Y;KAJDN#'N(P
M\`@\,J1IH\2-W;B!$^49G#*!;&CU'B;U?W)N^UDB^Q)HWKP>,`F#=*XCCMVC
M4;<WU)%6=O?,D/C'%$I<XE;D59+%XS$)"]Z/2XTNUDR=*:+2U]--7^I66OM#
M7H"29$F?-,*S$%E,?+>99`B\6+Q*"B*;LSJMQQ(NX/4*2](2=59<3@XV&TL\
M"BT@DB81S0H&OI:.74'+`Z$5G(.FQZ&W[,F^DJ?HHUNMQ5MY=,<RR&NTMC>>
M-J$TF$A@4/4L)"9:9',DMF1TR%]L*5-BNZEH<VSKT(K)AE&Z"&`57]]VOHB+
M;,C(V3)W*#=,-QKQ\Z)%:=2Q5N0T5]+PD`R1R69E:Z?$8&SM>;U3-F8B9D&)
M/@9GHA\5V8Q/IUJ9-?HM%)Q17C)L]M0TL#5AFC=]Q%,QQA3N2VY[8,%O>UP!
MSBY0J!Y"R-+F;=+G*","Y0G4RZ`IFAJ4XQAQ\S3)S#&%N?#^O$$L(SQ6"H*M
M;:R=+]#]/2)L_66?G+U$\:&4XL228^$TRJT:9&LB2=H@P>?D`!03&MW1B;1W
M??=UFDGZ:AQ3M4+R1A\EG1LB2"21).4$!$<;-&8XGEX,;2FR'2*MS)NEWLON
MY.&8#VI0#;DS'.NV5FW#2R^[%=E".O[&8]3,Z)@B):/&H'8HIU;1A#=46<"]
M@&!%:QE[:5C;+TWTM#MFY[IU1D9DN-@[I%B(<`1.LO,BFD,@:;2-/T7HD=H(
MN+D5&X[YO!DVG%VO'BASMQPI\ATRM2F(0/`IC(COZ=YP#VBZGL`KP\I[B>))
MBYCV[8_71+8^Z[C-P6;Y5`6DUL?LYFX39X5'<?NTT`XN"XUO(FX90::S&E#`
M6F.26`(.FE];VN[7LG0.\[OD+BR[PFQ8>TS94Q=<83F2*>%%2,`E"C)*2=5F
MU#@;51G;EU1M>SC+S4P&SYMUQ,2$(93'IR(YV9I;^D&5X@%TW!4DD7M500[>
MWGC#4DSOC_?I#\)1J3XEV\+MTC!+=NLDF#S`Y5C5I=5<9>8^M19$0M\E9)JA
MDY*<A/8=KIG`*T-BK6$4/7%W'I?9=XV=-U]G\F=-+]Z0;<T.6D8;O.6COBE#
M`6#1D(PD[&2P/8>&5MVY[QC;_%M'5"XD>'DXF1E)/`7(BBPF@&4)5ET\56=)
M49?1*ZD/IJ35\]ANZ6=;H,2/+CF""MF*<\8YF*V$Y@QFU'KU2&*NRAN;I9%3
M$ASB8:M&F>X+(FY7>XQCM90,T%A:`TMA=>=,8/36=CR;'D/E[%EQ,8I6"@L\
M$LF-DJ``!99XGT$VU1M&;<>,=-=0Y&])DKF0C&RXFCD5#<_^6R8DR,64GA<O
M$^E[<!*DBBVFU8SY6WE;[,2/+KFF6;9\2QW9ZQYI8,2'L,BGDE2;K'B/R">M
MF-&W,+.T)F]1C.T==GQW)<$3*-0)V/;-+7N$P=KAV_3G2W1N\]QV&7<<K]<-
MRA+QF*)3AP2F-Y4QIRQYI<*A661`(XV8=NDBL;?M[W_;8,_=L+$B;9-LU-)S
M'99LB.,J'DQ@!H526M&)2->@GAK4#SLU;_MT,;E^XC(>&,(XHF>TO9I,TL$W
M`O4MF,B9\UR]W:&YH?LJ+<-L[>D-B!#=C!@D*8TVSR:$;F:4<6GT%;T-73_1
M_3,V#M7ZS9N5C[MU!*5PA#&KQ0HTS8L$F5JLY$V4I0+""R)Z;D`WK)WS=MXA
MS<S$Z>@@R/NO$3)R3([+S`T0RFQ\?0IM/'B@NQDLI=T503\:^VY3?:X8AF6W
MF%8WQ',\B$YIR1@QDDN35S.N9\28[@6990%B;'0Z5F]KDR.<NA9)MD#,WW4&
MD7N%0MZHGJ[':_ICH<[IFYV-O.5#BM@)FIRPRF>?)Q,67(Y<4?$\H:+RSM]&
M`O+0F1O1;SU,,+I9.HML@?(6?&BG0_N(HGEQX^9.1V#Z=55%.MG.H>@C&O'W
MO[H-U.#G@T6%H+MYC^,H9`SI]D7.F[/(;SC[&KJXFK5R5HP]C<V,6/<UV2ER
M9K-4B-6`LA``TDL-AF#TK%Z1V7I[<DDEWV7.DR6F2''P\&)9,N5BNMYB)"$$
M*+9;#TV>]N"M6PWG*W6$10;0D',9)'ER,ABF+CJC*BB4BS:I&<%2/0548N;L
MHJFMS&_7+V-M@N)-V^)\))%N2LKGX9,287R8J=$:EI*R.`"]Z95*EHNVK+OK
M<V`-LCN((`&G=#IEZ7Z-;/#Z,VI/:9+T3N>:S;/!/DK)DQ!;B.".20NJL2/1
MT>FMS8:N/"M7'U!G9G0<O56)"B[H,:-HXG8\MY),F+'C`8`-RY3*&C:P)5D)
M`XBNKO?XCSAM]VK80S[@V+1S)\ASRZ8_<XDPR-2XIF=-C5X;V^23Z9+A-:E&
MOM:)QE8&P06':UUIY(!6OKT;Y/2?L\&[>TF3HC?)7Q\+&R)(IY4TE@PD$$"I
M<%29IGC"D\"I+#@*Q]UZM.)[.9^ML.,/F+A"6.%^%Y=#2R1N!Z0$*13&0#BN
M@@\:RBR=OPVBX1R/"L.YDW$8PQSE6=HV96PPF1OP$3D>!\-`F;1K3.K,1L9#
M@JO<)`UYR:Q@?1!O</+7+;5T3U3U#'DY'3^#E9>)BR,C-&M_26Y"CUFL+E5N
M>SAQ%]QF]2;1M&+CY.]9$.,)XPRZS8<;7:_@4$VU&PX&YX&NMG3?_LVVRR`Z
M)Y[W'8UQ=)RB&%88P29U/)=PH).%R,8W`M"E1JE!K<N`TJ/Y0$-R";EZ&##<
M0+"IV#HSJGJJXZ?PLC*LY0F-1I#@(=)9B`&LZFQ/$$V[#;*W+>-MV9%?=9XX
M>9"94N?C1*YC+@"Y-G!!L+^'LXU8K/G$ZQ!B/-BG;JR.D5D.2W7:ID;<7!E!
MC^I.:GYTC+`LDL,AY2)L;30N1$S86Y4Y`6$N!0`HT@[!U$,%ZV.T]!;[N6R;
MAOSQ2IB[;EP02KH%[NY6>Y+`H<>\6I2I),R]EC6++U'M4&\;)MAD5HM[,ACD
M#>B$&@0LOHD.)V,JKQ7286O>XJ:%<3/!V2<$SQ\Q]E+$LOW*XSVNCSY-\+,K
M^I5V8GDC&Q,R5M!H0&65JV5`[GA2J;IE!RA,`5K&B`.LGJ3V?[QL.Z3.N/E'
MI9-X;"CRG3@X$[1`FU@&95+*;!&/Q215CI/J;;M_[EAY<T4>]96*LS0@V905
M!(4&YX7%U)+`=H\-9(8>W68TR+AY5DEZFL29W"`8VA,VSN@3J59*'%BN48V:
M,EJ273MXNZLEL+8'/MI.;>YO6)K:](0K7M6GZHZ7S=BWF3#QHYI-N?<<G%QI
M&`+3G'R#CD`+P+B32K``>D;"JNFM]3?-OAD<QC=6PL?(EC4FT2Y$1D1N/'2P
M5BI)[%-R""*Q_P!\6^F4;8(MM=GN+L>H\TQ3-N4F]HDZ5$:O3R,O$EH"_9"?
MIG!$UC$A:]]:XXS"6EI%)=^V"`#`$%C+AK9='](8V^=1YNP;_D';SB861(SM
M8K%-#)#$JRV!^CURZ9".(X$&P)IOF]38O3<.^["B9<T^;B111W(YR9`E;Z(F
MWTA$86+4+%F%P15YS=SX77<+MVQK"11B38QSO@[)N8TD\3*E1RDQ)$3X"*-F
M,9Q)]FPUI>6^8#-.$:&Y@>@#HW#Z*U:U>FYL;;]];=A+C[GLSXR-&VD#5+--
M%(')O\0176UAQ))(J])O44L&R9>V6GQ-WR9X]7$$)%B\]=([>86.AE;XMK6#
M<*[N)M].T3.N497A3#VXG&.0\J0KUT[X89''\M:ZIO6-88@>3$([DE(GTIM4
MEW"<)`:J"6&W3O>P/153F]&=5[?LL?4>=@9,6R2A")F2RZ9+F,MX4#`64N%O
MP\)%[J;]L\NZG8ERH3N_&T08:B5MK'B+*#=E%V%FN!I:U%E\2W8B-T>F>VZ;
M%5E\=4)T4@":ZJR4K*O5$R!0G;W-Q-0%MR!Q/*BKA<*<TT)U[IA6Z.MPV%=7
MH3K&3!3<DV_);$D0NC!;AT54<LH!NPTR(UP"`&'AJENH-ECS6VZ7)C&<K!"E
M[:6YI@XFUA]+Z!)(`(XFW&H-7$QV$OI6)CVG=AAU87G-Y71_%0"I,&QTL>6U
MT+8U;>40:F+/:3@.YEDX>WPI0FG7Z(+BO:]7S[.^N1/D8WW9EG(Q85FE`7XL
M;@LIOV-<`^BI+"UB`2*Q!U?TT<+[Q&;CC![R<?621:46NI!`(L&4EB`H#`ZK
M$&JERIQ`=F.#\K,^#LM;DL703+#X-E+0PE]?;E.A8Y&K"B9`NYI"<]OC]W$\
M8;E]OG)OX,83+Z%B"*^)LG1'5W4F"^Y;'@9.5@QZPSHO#4@+.J^NRCAI6YU>
MCQ;A6;NG4.R;)(L6[9,<$KJ&"L;'238,0+D*>T$VN.(X<:M;'-YLA=<FSV*R
M)PPY!8U`]VDPP591)5LP!(9E"HM@5MRV<LAY3<G<&Y1/4JE:<>I+573M]F9(
M:,%[GV#866W3>.NS8NY#O,DL^UY64XC"6B:#/;#4OJ((@TJ.81>02.H4:;D6
M\O='BW/*V^#E<N&3:@DCEM+_`'A&TCI=0?I>`&/;T6X\PC@:]_#_`!/]@N?I
MTWXRPYNHQA.YXZ-SV\H8VV+'5,L/:8TUJ7Q_<;FN;2A2%(FAH1FJ#S!F`"`L
M%[WO3<_9WUSLFUS;UNFW3P[5`JM)(VD!`[K&I/I$V,C*J\.TU8Q^K.G<G<8]
MIQ\N)]QEF:)(Q<L\BH[L@X?&"QNWO*:NE@3>MM6W1NDS9MO>>L=Y8=L>G!*F
M+;%'FRA6R!$<I(`K,)5$I1JVH9Z48++$]CDMQ6M;K/16UP-ZZ1ZGZ<P8MRWS
M"FQL">Y1Y%L#8`V-OB-:Y"OI)L>'`VSL+?-HW#<I-IP<F*7<8OC1@W;@P4Z0
M!Z=CPNI(X@'M%\9W;B<8.F&X3`F"MN64L19F<IMF^4XES(F9)`I<'O'Q$?QU
M+I84X,P$1A"-QN:^1L*0:JUE2'HC$&P^LZ-=!MGL[WQ]KR]WWO&RL7;TVB7,
MQY"H"RO')CA8V#<5#I*S<0&]'AX:TV[]6[;A2PX6#/!/NC;KBXLD0))6.83Z
MY%*FQ:-HD!`)"ZO2\%6^W3[@N)WAO,N/8MCF'[$WG&^=LUEXBPZOFK]GPB;-
MPE,/D,O3N>24[&VV8TU@I8JK*'ZV"4WZP96@=+BO;*Z/V3H'?,*:+=9=W3><
M3;I\R;E+C&%D@E1"D1=M98K+&?2`%P_&UJJZBS^I-L;O>W)A-M39&-`O-,G-
MUY#+%=@@TA1(3:Q)T`$C5PJ_J3?9BC"*_&.$=[NX#;-C/=K,T20UP@,#E,D[
MSCE+R\*T$>&SK)DA(=VE$YD%EV`)W$EN,[I7!J7<(KZL=&YW4;9.X^S["W+,
MZ=Q[*7E6/FB01AG2T9*LU[D*FHZ2`1J-JN2=01[%C(W6.1A8L\LC:-#/I*74
M*S%Q=0";,S`)P-FLK6Y4O$2P%^6!F#9\]2^,QJ4X:Q&T97D<C>I$%$B"F-+7
M.$K;5B98UI6]I(A4=`B<%:PU?<L92\%@@M<`KUC8_1.]971+]<0QN<`;BN(%
M`!8Z@`KBQ)-YB<<(%+%Q<<"*RLO?<;$ZHQ.E'9>^9.WMDEM0&E@QM$0>`U0`
MY&LD`)P/CJ1FXC>U_,6(]P$[VL9MQMF^3X*Q9+<AN4;:G%?:Y8V6/O#HT"=$
M9Z9K<S&)>N:^H-4IK"`"][!Z=A"#K1NW0O5O3W=9M_P<C%P\J=84=P`NMBMP
M2"=+`&X#$$@&P-C;.V'>]@W[=EVC"RXI,@L;A3=M(;2Q%Q8A6(%Q<<1XZH7/
MN[7<6P8*V82;`L2PPX9CW:3#&$3`@RVLFZ3&L:.G&,7B?NBBZF'"4RCJD)S3
M<DB_0/O<`O1AO?T5MYM_2.S-U[NW3FYS92[-M4&X2EXQ'SI%PF```;T+L+W[
M!>UB!7-GJ//;H;$ZEC2'[TR\C!A"'5R@V8Y2_`ZM*FWA)M?MJ7$^[3<9CS,<
MJPEOVCNWR%+R,(R/<1$\F;?I)/7>`@Q]`GE"Q9!031MR"UI)*T/#":\(U12D
MH`DJI.:,(`]84/2UN/3W3&Y=/R;[T5+N#-B9V/BSQ9BPH6?,$O=FA:)B"I,+
MI(KV*MI:^DU>QMTW_#WK&VKJ"/$,.=!D20OCF3T6PQ$^0LHD'$%)E=&7@`K*
MUR0:N.\<3S8(Q8\4Y8==UN*$>.DLX4XU%*Q.RTUM5S="@+=%[`TV(;353VH0
M(#@&J#$99Y!`3`=88&XPVOK8O9WUS+GP[2NVY/WG/`95CT@-RPV@N03Z*Z_1
M!?3<\!>QMG#J?I]X)\A<N+DXS(LC7("M)Z2K>W%BO$!;D+Q(`XU=#*N]7:KA
M'%L1S9E3/F.(?BF?B0A@\W6O@%C-+O7%&)>D''A-13@J=BKHP]88,DL8";7M
M8RX;WM:M;A=*]2;AO4G3F)@Y+[Y%?7"%.I0MKEKV"KQX$FS<+$W%\H[YM0VD
M;\<B'[G8+]*#Z-V-@!X2UP04MJ!#7'HFW+.MYNUK&.$H[N-GN>\;QW!\O*:#
MHIDE5("%$=DUGWE:R6$Q"6I5NJH^UA7&2048<18LRYH0=6/HHNE.I<CJ%NEH
M<.<]0QEM<`0ZU"\6+7X!0+'62$-Q8^DMT6][3-M`WZ#(B;:64,)2PT\>`7P'
M7<?$(UW!!4$$"E9%Q!MET3Q=!LUR'<KB]MQ3DI,YJ8+.!O0SV:3^L=DMWE*V
M#2)3SQ.K==:4$Y$,L"LL8NC<KI6O:V7'T)UC)O3].)M^2=]0(3#IL^F4A4?M
ML58L`&!TW(XUC#J?87VT;RF7"=J+NG,!)`>-79TM:X*JCD@\;*;#QT>V[_L`
M0R"O,YSSN$P%%F0V;9@0Q)ZCSO*$S2JB6,7EK0K$+L"4-25P,R%'$KZB`](T
MA1A5E1^B7K`6%>V1-T5O<V1!A;9A9LF8<:!YE8(?3FDDC5HM#&\+O&RQL3>Z
ML6L+&JTW_;SS\ALC'&")@(FNUPAQ4RK2W``D*%I!IX<LH/X0E:H^6\4S:RSY
M3VEXVBV3(--&_>`@EB_'\\:I*<:Q)"F8@:*-BNE1LRXQR-E<N`)IL0(Y(<C4
M%#ZZUKVZ-96+[->K9UWQ<G&EQ\O9,)9Y(W47)+`Z;ZA8"#F9&M=8*1$`785K
M\KK38<?'VO.BFCFP-SW'NJLK'4ME.J2Q7M64Q0%&"D/.A)L&JIC^(?MLQ%A/
M"^2=T>Y#`$'7Y?;#U$?>8F^2,V#2]2D4J25BZ#$OK9:7G1Y($H`352Y*4`L^
M]P"%;4.MA^A]^W+J#)V3IG`SI)<9(V9)50RH)%0@R:&Y8ULQY8#:F3C:X:V=
M)ON#M^VONF[Y$$>(N5/%K6^DF.1T"`$:FD0+:8*"%D#`'3IO=++^^/:5@./Q
M*59AW"XS@<=GL:4S"#O+J^@.;IC&4AS*G/>(RI;B5P'M,`<A1BT37,&(LZQE
M@W`$8@ZO"Z1ZGW+/FVS`PLB3<<60)-'HL\3'6`'!^)QC8$GT018GB+Y#[WM,
M6WP;J^3$-MR03%+<:9-*<UM!!-_H^/C\`X\*I>=\1C9#C#'N,,JSS<]BJ.X[
MS.C.<,6RM4^#4H)L@37+`L6-);>D5K+)D!YP25!AQ104Y^I9G1,M<-LW%Z`Z
MUS=ZR.GH-NR3O6-I,L=@#&&^)J+$*`X(*G59E.I;K<C$EZIV"'9EZA?+A^YV
M=D$O$@LNK4H506++H.H`<.P\2+W)SCN'8<6X1OEJ+J&B=*)6*)L&'D:%T(/9
MLB3?);@A9<;-J!V0C.),:7UU=2!F*2A7"%%89@;\FM:W:^G]PW'J.+IJ=6Q\
MOG,LVM2#`L(:3(=U-C]#%'([+P)*Z1:XMGONV!'LTN_+(LFW1XYF#*RVEU6$
M21L>%Y9&2-.!LSBX-C6O_<9N"XJ6'LJXDAL8B&P%ZC.>LI$8HQPX/[WN%2/[
M<\`@#]-ESG-4C:A.;T;=>\57%%!0F*S+=,BU]=1BMV_2VQ^SG?(,L9<N]1YF
M'A9&6X1<8H8(9TC54+$,9&26,G4JKJ#B]@+\]O.X=6;=%'E0)MYQI)\6`!S+
MK$LX"O?3=="S!P"#?1I-BQ(KW,F[C.(Y'\G[>MN,)B>R0W.L\PQD/*N5G:8/
MV;T^)6TZ&2UECZ1KQXM:4(Y:J"L1OI1AGKBD#>Q@!]$5@VMK9VG8^@<_[YW:
M27>!TYMQPA&`F/WESE<Y6U@GE`*T-Q9KZ3QXU&X[IU/M\.TXCQX!WK<LG-3X
MTO)6/%CAE0WMKUNLIU#BMP+'PU6^"-\4]9GK<YCW?(GP?C:7;7&S%TQF61L)
M2>52K#RJ$9?L[E1LQ:5(VVTQB;^RK648%Y2XJQ8DYQ:H'13ZCK&WCI3:,O;]
MLW;HE\^:'<<^?"6#*C1)N\0K&PY;HW*E2195`*FZ2*8W.M@HOXN\[KB;G/M?
M4*XJF/;QFK)CEV58`6642HPUHR%"X(!#QG4.`NV6<WSF@5(<K1+"#_#)]G3&
M^.VW(?B_/5K%B(2%_2JW*(I7M>SB"4UCFJ%M.LW_`,HZVX1EJ+E#(OJ+CDVW
M(Q(H]TWB&>+8!FG'ED"@.IC*G(5%>VJ2%&-QI*JXT,0UP.AARL?.R(]OPIHS
MGY.*9H/W2,K>A%(Q6P,)EL#9E++?2?"+09=WF][>S1'NQP]!'/*I4FBK(\1.
M+(U+:4O]=I(#M%L;%S>K=&=Q>UB64&E-AK>UW.<CU0^B25>P1"#NTZ5,'6OZ
MH[ID1PA<@J9;'0\:CF<Q2`VE7QPTP=[1HHU2$"L'!WE,W8SO(C<.L3%HK@,D
MJ,8Y(R6T@F.8<LC@7/",%F45D=@/*8\VX=Q]EB\>5Q8N>QQ#(TS*M<V)W4)D
MB\OK$Q@EL<<WAJ$%43H:$L*@9I(1V`;8!H1@#KNI=E/3N^Y6R-()7QI2A8`C
MB/!Q5;D>$@:6[5)4@TZ>W27>MGAW*>+DRRH"5N#8C@UK%K#4"-+'4MK,`;BK
MO5HJW5*4I2E*4I2E*4I2E*4I2E*4I2E:NN)_S</'YT7:5Y\^I2MHM*5KHX>W
MWWX@'SB^=_Q'P_2E;%Z4I2E*4I2E*4I2E*4I2E:D.(#@O/KGD2,9!VSQ!<_O
MN?,8OVS7.[@U+&AN'!\8S-Z2OC%F=6-R6H;KKXS"8]I[`)">KO9W#U0-`7KT
M3H+/V%H\G8.JI>5L/>,;<8[WLV1A%M>.=()_\[`W(]6\::N'&N<ZD7=,:/&Z
MAV&(3;]A=X@5-6EGAS%"JP;]R,+)2'+L""RB4"Y-C2^7-CV5LY;C,41"#Y*R
M]M(V_;(L*1Y@P5/<3$XY&_S7),X:U44E%F\J:L$U;BX_"L9,J5M,,,;2%`UC
MDHZLRX.EKM-JZTP<';=VZCW6'&W'J7?<]XI<>7F:(\2,IDL[:&0CGY3((U5_
MX/&%P.%]-E],R-%M'2VWM)!L^UP#(.2H36^6`V/"@!!!9(N=/*^GB^0!VW84
M9C;;AO0VT81W,;7,7H$6X!BBF1HWEK#\FW!H8,?'=QF,<JNIL@W![>I4%`C)
M8XO)+NUG4"=<)F*;@A=4]PE=78P(+VX=2=(]23;-U#O<1Q)(%DPLJ#$+B2&/
M'CT[=FXYD9B_)5HPT9EU'NVF]W!JYA;-OFRY&ZX&TY+32YT(S<;(G5=*9SR`
M94.1H"C3.4,BNJ$CG,[M<6JFML&"I7*]SS5/,2;!\B<.C#ZZ+Y!1;H6R:3*%
MMS7GE5*XA:.0>,Q'#^,)Q,X63:%N/37V?NK:3D8`73%$C"J,N'(ZCW#&3I'<
M-GWSJ"+?II8@FWJB2R28TIG627)DGGC1TO$#'R5>02%^)`B4UA[?!EGJ/;=R
MVO:GVV?'R`^5(718I(4B9!BK'&UI=<O+D$AC7EB+4#JD(JJ,7Y+X@>U'$#1L
MWCNQ259CGF-6P>-<([C8Y/\`'+9MO?X>0>:@QY-,J&O4A;LC0Q<PM'0N^-J-
MD<Q#,36N0=?MC0FQO6-TKUYN+=89.]0[;/DA),S'EBE:=9P@[QW4(K1SK(06
MA#O$-;<M[!2S9F#]Y=(Q'98L&7<,!'E;&>%E0%)97:.+(+D&)HM021U,@:,<
MU1<A:L1O)VPRN4[GL,S_`'3[$,C<1QI:-G,?Q[(W_"O>3#V-FSD3/U;U*7M.
MQ23+&.#$+6XMI@@IR0&JK`*$'6W2UO;:=([_`+?A86^8W2FZQ]/1Y&[P28PR
M2\C-BI!-&59DAE]/4T18V'80.`XZ[?=KW/-^Y9^H<5=RD@PLM<E(!H5)Y98'
MCT:G6Z(J2H+MJ((8W/9Z'Y(*+/,1V@8KQOLLW/;#,+8VW0S^3SF/H,FL\$R&
MP-C]B.0`#D&/SC&V59J^-30\R<Y.WGA(7A4&"%<%R0E"$*KJ]2S;3U!E[WN^
M][;O>9-TWDP1L8FDC$BY.,8L>2.6&)6+HLCK=632/2-["K,NUKE].#9]JVS)
MP(AU%M\\BEE!>/DY(FG1A(S+R+QJQNK!F70&XVNKG7A=MP&N*[?,$.>=DR/<
M=/&1UW3[LY_DI=F;+$8Q)A(@R6PK&S;+<L+Y$I"3(YZ>D+0-_:2IO`4!6,\N
M]^A6IV'VD3ON!WG>!APXVSQ/DX>)CPKC1Y&X3$0Q2,L`348(S([.S!E"QJA]
M)JV.Z=*Q0[9)A8`R<G-W4K@RR3RM+W;;VU2Y>@R$Z!+H6,(@M)))J>XC45>+
M;]M+S[M&WF#FELP9IW7XRW/X_51_-T\RO;&J=_QI/<1)4QN(GTPB$1Z"I%C"
M_P`:7N3,,1:%2I`H+3W-'U=P]#6[IU7L?4_1N3L<F#A[5E[?,,O#$'-(F,[<
MO,A)D>32Y`@F4756$3"X(]*]%T]N&S[WB;U!E9.<DJ'#R4E$=TA`:;&F0HB7
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MT47<2>]KBK#Z?FZ6W;!Z<S]ZW"/!R.FRBS1.CR/E0XV6^9CG'T`*TLNKD2*Y
MC$9`<,X-JV&[?>^T;CNF5LV(V5'NV*HBT.JM!E]T3"=YM=K0J%CG0J9"VET*
MKVC//=7A28.V'-K./L=,3C,!8LW)[3W=WND$C*/1P?&4J:>^"3*^W%24':K8
MUH>O."7<9M[:]``K\E<]L6_XLW6^7U!N++!#E0[JQO<@/E866L:<`2=4LJH.
M%KD7L+FJ\K9I\3V;9'36)>7-CV[#QT"\"YAR<,L5O:WH1._$C@#X>!M]OED^
M9$[Z/'[YP^&O?GMGFT/(NU,<<%CY;*8EF%$J<2>GD-BRQ(6F.DP52T*B1HGI
MI`:Z-JBQUKDF=(`K8_26!MF9!+.N]-LG544UXIGYJPF!T"OID@5IEG1[G3P2
M2,V!!4ZMGO&3FXCQE,/O^Q2(1D1+I,W,$BO'ICD(BDB95)8/;ERJA](-Z%N@
M[7\[139#L7PF_MJB?Y'Q/G[;O)LCI6QZL_HHO$H_/5[\]MY#[(%"96^QS&\?
M7%-9:@76*%"5&$5@"N+2NBR^IM@W+VFYF_1OIV:3!S(N:Z%>=(VURXW.9%%U
M;+G)?3;@TIU'M-<Q%L^Z0>SC+VE(>7N<LB218\;WY"'=8<J/'1R;$8T`T=MM
M,9"FVD'$'(6QW<4Y8CW58X)Q@^N[)@9H=<+;*&Q.[,JLR?XWRKFZ,YLE,G0E
M*W0D#:IB,?3H(H6%2),+J&4[H6N`P.N^V'K#98MSZ:WG*R%7<\G<=L?=78->
M*/:5?'0M8&XR2>^-;4=6CL(M5CJ79-TRL/J';<.!1M)VS=Y,*-#PDRMVA#-"
MJ\"O=Y!+%&6-M.0W&QO5P,X8OW%0&2;\,01[8FNW/(M]JE&XP/,B)_QPD@4/
M"[XI8,9AB^?3YD^H9<P-^,WIH,<D!C0B=2S"#ND38D[6]:S:,G8]ZV79L?(W
ML;//L65.TFI9BTJOFOF)D8?)1M4QC80E92A#(EV9"`-E(,S9=ZR-\^[WW&#.
MP<.%8ET:D,&,,:3'F,A`7&=R92R>"2?T-8NU_(+M`F3!DO<PHFL`2SL]9P]\
M!;=H?D9V;V1R'.Y%&83D5GR#'FP]Q/-<BR'5XNUG+"U(2B5`C";B$.X+W#I.
MJ>J(-TZ?S_NJ0P2YO5.9GB`$@A&AQ^ZNP'H7C<RJEC=6U$``B^SZ6V=]KWSI
MA=P"O!MNPQX\LA.J))5RU++Q]+^#!(;228S8FY(.,P]O6Y:)L&U8D>WV;RE<
MX<+++VU.8*&)5"KJL3955Q-M<HVEFH5TA0G>MCH:V7:DIS9=;T%@PV'T2M3*
MZC>MZV'==RZNY.?`BY>X[=F0%A((\H0R3#(5"JDB0F8.0X4,JM8W`%<QTMMF
M[[7A]'Y&9`>;MV7GIDIP+PIDF#DR=NDQIR6U6.I5(L"6(JKLK;/<J$XNV-,.
M-\'70N&--A^YK$<^0QU#%6PV,RV>;:(]'V6&KA@7);&GR/(*`1.A(C4XE@.L
M,,#:_67LY/5.WY/5'5^7/F"3;\_(@?'+%SSN3NL4L16X)'+Q];+JTZ4N!QX5
ML=AVC+PMHZ3ADAT3X6Y\S*O8M&C8.4CLQN;AIG4-8L2S#P<10^5\%Y)19.V<
M[?HW8AF!O4V]X6Q-N]BQBU&)ZB46VBML;FTC?%"5&8I%<4GBKDMA"LX5S"!]
MOIB["TTO6ZV[?=GS=WZDWK)83[;LN\3[Q@/Q"23Y#OBQ0BX'HO.,3+T\&MC2
MFW`VT&5MVZX?3.QXV/&8=ZS-L.S3@_&2&15F:3AP+8\(SA<'MG3C\6ME>[/$
MLWF>7]@3I!X<J>8OBG<DOD\\/;[-Q+?$(6+#D_C1"]<G4J4PA-OKDYID@2TX
M#AZFAMT.AK>WEG2&Y8N)E;Q+NLH4Y>P9T*EKMS)YGQV5#P-V?2YN;#AQ-=KU
M'M\LNR8.%ML?''WS;)0B6'+AQS+J<=GHQW0G]U8\`:PGMLKS[#MW[GC2$-`2
M]I!VV#=>@PED$E02F+P=,-P2V)@7857(2E);J=&V60-REY8#TY8NUD*HQ)<0
M>H*UZ1>IMKW+H+/GW!S^N0;;(&5V)[_CX<LDD<Q)!TS)$W=IRWQU6.0W+.*Q
M<C:\S#ZJV;)V];].KN67F3*IL<7(FQ.5)HCX+R9W`G4#XF3)-8!6%J7P/BS<
M9.)+L"PO(-CB_;4BV&/Y+G/\^.,@QPIA4M1Q3'3UCQ5'\""B#TNE\A9,Q.BP
MI>YB=T#5U24`1&A..M:X>DWK>.G5S.H>LL?=UR1O>#+%%@*D@F5\EE=$R`R"
M%$P`I5"CM<A0@1217.8&U;OC;/MO1LN$#-A9N-,^:&7DE<5R[S1DGG'(RP^E
MU9;#FY`=R0&;THEL\R63MZX=D)>,&C]=L>;^7[,F:V!4CC)XF>,&2K.[T@G,
MHM=<-*ZEW.?&=0`0!*5-A&E7Z%K@OT-;B]3[;%U+E9JY>C'7HH8<#`N+9/<,
M*$PKPN&+K,K6`4MJ.JQ!.^W'9S/M.[8JP:CE=3C)"D`\R#[S$IDXFVGDC58\
M2H^+?A7=S!LYGKKB7BN(8U@<A3+\\[AL;3'%@$#9%2G.?LD:9,,:OC2I,6$`
M3!:75J=QANI&F,">$\P-KB,Z0YZ9ZIV["W+H,Y69HP]JRIWR0VHKCB3-R&)(
M`)].$QWTAK(57P6&+U'LD^>_59AQTD;<=@CQX>`'.D3;Y4$9OP++.P`+6&K2
M;V`(PQW^[:-Y^6YAO1QZV;>MT>1DF3I0CE6&#\/Y!P=A[:F:Q-$/CI21^R>-
MM/9LSY2RL),TJ4"MJ?.VVAQ4`3%6&4"P3"MYT)OG2VW[7L>9+F;;CYN#D,<L
MY4>3D9`#9;LR840U8R0M&T;AQHGC?FR@ZETO@]5;=N^5EYL,<.5-B9FW+#CK
MCM'&G,7%TALZ9OI1RYN<H1=44D+1Q%1K+)ETUX(W&1/(#1DU/@B92$$9WTS'
M.I,<)6QE*XO,-ML4;X.U'!.4O5TJ8+QD1+=CM<=[B+57N(0.IMUE]!F[_LIC
MGAAR8F8[)N^.IL^DRY&^G(A'Q;VDQSSEX?$X&S<*RXMHSY\58Y(F34>EB0;7
M'<L8KEBU^V!O1;C:_P`74.-6*AT+W7[HXON,9LW;(-QN)MUNZ#"F2L9-6=):
M=@Y'M_VZQ$QE=W&+8:QSWNY'D4Y;(K)%B=.F>7<QH.7OCFH[86%EIBRB"=QN
M8Z8Z<Q<1.G]YV_+V';<S$RYH!S^][I/%-'K:37"(0(T+]VA+B*&('B\KNSV\
M&?=-PW9\K>-NRH,N:#*Q<>13&T6!'/#(O.4AUD,KOH>:0#66"1H%C2N?:-L^
MW63;)!2S)S9O2@`\<[8<OX':Y1N6EVU!/#H^[Y'B:"*(FC#K+MX@Y$MF4(0.
M30!<6J=5C2!&6C3&`2C..N$%[K;J?IK[BW,;5)M&1+NF5!+I@3/&1)RLCO&K
M*[Q+R8'"LT1:/F,QED062[5@])[/O&W[SLV/GKG+C[2S,YU8W=4)QWQP,<H@
MFEXL&4'E@!$9V+>B;BXAQ;N.?,E\-6$OVP!7A!!LBF+W"\C9C(?,;N,7=FE-
MA>40\MXQ0-B?U$J<L:3%]+3K5ASHE1K`KC4X>US!6..#:W#>.GY<[J+J>'>5
MDBWS:\@18C"421R/)!(D,XY?*!@&J/'*.P*J_P#!C2K8\>S[UA;%LW2APN=/
MM>[XDLF6"FF2)1.'FCU,9-<UTERU(!1]`U2GBNSO=UCB<SW)>QMXAL97R!LQ
MINO;IQ/%B(Q$`J,1$G$^46(Q]7V5JDQAB,#P])$]PD!--Z9X?0=&PKV\PZ)S
M\/;I]V?.D6-9^G<R".]_2FDEQ62,6!])@CD$V'HFY%>@]18\V9M4>/C*7F7=
M<"4@?5Q3AY&X\+*O$^'Q`FM;V>\3[BX3)=_V%8]L94[FT>_)_4/^/\Y)'_':
M/'T-327'C#CU/',['2]Z03)A28K=68QT;Q-*)T+-*.#<FQ)UQ7MV73V1LN[;
M%L*96\+LTVP9,C2JPE+RCO;9@R<7E(P>>1"("LI4ZHXPS,E@-5N'?-IZAS=Z
MCP&W+'W'$@B5%T!D,6.8'QYN8P"XSLW-U(2;2SG1K%VZF?=N&[&'2G.$5QEB
M1URTX9)X=N%L4L>7+(\;/D:%D'!SNN#-8\]-&15*@LR>SB/K#3XT-6W+6L3G
MU-U@P!#K;-VKJ/IS..1G[AD'$Q1UNFXF%3(DYQ)HPA:!H[`-!(%:0:D81AS&
M=1`K4KLF][:-GBQ(X<C,@Z3FVQG<DQ+EZFD1IP?2[LXM&6`=C<!E(UFK`X7V
MT;H7_-N?\I.FW?>&SMF0N'MG'"".6;K<L8JF>19EEL^S0H:D">#8U?10'%#%
M("3+$MJ9IL6B6J"3C3P)Q!M<>SZGWCI].E,G:,;-V9LEMVP<F.+!AR%C6)7G
MYNJ><<V:16.IA(3RT*\MSS"B8O2^#N$76FR;GD8^XC#PER8IILEH@!JCQ^7R
MH(3HCC`71K1%:1@5=?HQ(^?6X[:1D'.6W;AKX><&/)K$5C_(F%U.97+&<W/Q
M]/,:,L<PE)F)Y=DDS8'9&[LYS;(SR$AIK:::<+K;V#J"]Q6YW;^IMLP/:7O_
M`%%')COA3XF["`R)KBF>9U,*%&'I"4#@&`![&M60VS;C)[+]OV%HG&XKG;69
M$!"ND<4K<]PP/HF)3JU*=0-BMR*K:6\.G'.&-N.\`&%D67LM9SS%M\GN.D4P
MS'EN69BR<\(AQA[#&<>,4MR(]J3F:.F/K@(T",!Q"<2HZXS+\UP\[-USN>_9
M>W8.Y)A8NQP[E!-)'!!%CQ,1+&&EE6)1K9(@0I()5;A1<UUFP].;;M&Z'<S)
MDRY0QY(D>::28Q*RMJ$0<D(9&TER/CE4N;"U89;N-I>Y6+/6RO,>$V+<HVLF
M*-KI6"9="=G9NW1#F."2-P1Q5P[<;V//C2M@BV+.(F4Q"[&H%:5<4-.1I<\D
M5PA[O9.J=ARMZZIP=WEPY8=WW)<B*7-[PV-(D4L_H2-`PG%Q(LL7`J6!#+>Q
M7B'Z=W&#ICIM<))H9=JQ72:*+EK*#+!!&'C5PT;2*R-&XX$1LS*_QE>E))LR
MS9C7:1M.4HL,[O7C+&,,B9MG2&3X$S;@3\J;!]\RO1[R<@'%7^&1#;I/6.9I
MC1`?VL`0)6`\S^2=N7#UEKOZV;7E=9Y2#+VN/;I-IQL)^9CY+;?DC'M]&[M(
M^8B0V'=\BVN0QJK+&I!JN#9<Y^GFR,R#+?)?>'SU!EC3-A+Q<I)4$2"`R-J/
M><8MHTNS:Y"&6KAQO#N[S%6/-BFX.=[8UF?Y!MW=MPB-]P-$2,117-37$\V]
MIIL=9(6Q]"OC>$'+.3&WIKVF(6Y6E3B4.2L]*8(5AV%AR[OTI+O>\;+AYJX4
M>Z;/@XYRDY[X<>5B2\R>&%G#92;?,H$<)()41H'5E*@58VU[]+MD.9EQ&8X>
M_P"3FK%*(TR<C&EADCB><QWA?-AD<R7/"2Y(9'J_4)Q%FG)F<=D.8\C;3X3A
M%DC^4=W.29%`HLEBRHW&J#(./4#5C>0Y>.;5AK.Y9HEJRQPG52TA4DD*A]7U
MH^A<X>H;/V79-NW;:L7=6SLX[%BXZS7D$;3#.ADF@PPZAUQHXE.GF:=>ER%4
M$+6UDASMYCQLK)P.[J>H8\@*=/.,,>!DP\[)*L5+F5E554L4C,:DFQ-85R!@
MREM]W*[:WY[VL/N<I4FW)<4G+<6Q2W+(45.G"'2E[QZHC>0\<`E+PDBBJ0&-
M;E8:9.L7(#NTCS[]848&P!]'LN3@;IT[F8L.X#%C7I;9L6:8:]$,@S)BT,P4
M:^420)&0/8Z/18$VQ^HL3*7=Y,XPK+#/U6DL2$@"94V=AK7@?3C:(\L-H&M.
M-O187)QMMPW(8^R?MTW"N.UUX:6O(.Z7='/9/@N`.L$<7';1$=Q,"9HI%GB4
MB4/#0P'`(=&0U[DQ3&8KNE<7(RR<L\5A#%K\W=-AGVO-Z1CW2.22#I`8:9CB
M419&1#GC.[O$=)E"\LC&QVD4:M`U%4M:P,7<\C,AZJ;!EC4]5XV<V*3&9ACI
MMQV]IG&HQF9Y0N1*BO81Z>)DU"O'P?BG<ULZ)P5E9YV.S?<T)_V:1S;L_P`'
MA;MC&^1\.3&+9)GLO6H'U#/I.T1T>/)^V2A/=8J;5AYQ:A$6$U.:&X;VR]]W
M38>J8MWZ?AW:'!:?<\;,BGD$O=IXQMT&(T+M&C2Z\>5&=-2E6$DFDJ0=48^V
M[EM6?C=1-C29"8[;G$T*%>>G>=R?*CR(59EC(EB`5@&1P!$"2+A;[[5MEV4\
M99(X>9F4<5,%T>%<$;MCI*%I-:9%"\(3?,.0XE)(?CJ++E8@*S0QZ*.+@RHU
M21/U7:B4T(;EEC"&^MZ@ZJVO,BZD3!S7F?(QMFQ8Y6#1R9JX:/'DS.MO]:T<
M<C!R"P*E@6!K,QMIRS#M<LN,L49W_<\UH!I(Q(LJ*5H$-O1)#.`VFX$S-I]$
M`UA'*MHVX3'L/@TE8]N&[ICG,=R-O(CT?G.SB?X'09"CN-<H9TDLQ8X3+L-Y
MK`9BF38IF[.N+<T[B!28YMZD`2;)2[&7&'<[7U+MN9#'MV1G;6_/V+:HYX=Q
MCR),.;(Q(7C+33P6GAGQ]21JJ*R20O)=QITOC9^U9J[ME[IW?(*P]0[A+CR8
MLBQY$4.0,;2\"->.:"98G#B72\4BQL(VN&78!DZ'9DQ[LJV&R#-S%&&R6;=M
MP>V^<9O8<=M+4S1-AB3?(W*)J5X&:.@2,*(N&H92@7.06\`6\I2E/&2'J`AK
M0X6=L>?[4LU-CDD?!W+`S<2&25W8]ZGP"HLTEY"DDZM##K.KER(K>E5,6/NV
M)[-)4W2(?>&/+'DM&BQH6QX-R3)/,">AS!AKS<G1\:5)"IXUEQNQQS.9]EK8
MF_PV-+I`S8TW1&S:>.*$Q$%/&8D9AK*#`!]774JTYAR,;R]I$]K$!.,N,\-^
MCT;"O;D.B\_#VU]X&>XB,_3^7!'<'TIGGQ62,6!](K&YXV'HFY!M?J=_BDW#
M:,=<%>8?O7!FX6XQ1REGD!O8J%L>':.P&K`;MMBT&W>;X,#NN=\'ILL8#ANW
M;+#8O<7=P6H65BR,ZS.&J8^FN)D?VAZNY*VA,K$7>P#"+`"+I7L+HUL>C.JL
MKI7IK?9-LS&Q-\R.X+#I`+NJOE<_3J5E]$.A-R.T6OQK"ZJVD;UF[#CS0B?;
M(<G<'G'@35!C"!G.I39G1@H6_%3JL+59O`VWB>;!<7[QMK6+=I5\T8[7I%,S
MV_2I`1&BPYF198-4QA7B//#V\OB=T<W?$RM9?MIS/+ZI5$KZE![9*N4;N.HM
M]B]H^+LN?O6Z##WF&9</*5M0CBC4"0;ECI&ME,B+:9!9N]JA!*/>.SL^W1=%
M[]G2;7AM)LDV-WR+E#5*)DU*VWLTC7*LX5L4G4D<,L@DL5`:Y/#LP9D+8#"<
MT83S)'VYWB$89TN<4>YUF*`4T3=M71ZQ4IQS,#'9Y7R0IYPR:RC;F2YH1)3(
MF!%8-RS2S2[XOM-ZCVOK?!AW7;9)5S(7FQ&Q9.+RZB7BSHPBA3)F!AWL?'[V
M&*ET92*.BM@W+9MS;%GCA$6>L4VN.^G%E%EEP^)N,:"X.%IN!%S`VAA8Y)<-
M.(OT1V4X202AL4M#B](I7/D[$O*ZM2P,^1)[)YY&F<1(K:D7;6"0)@!!?T9=
MK6M?EM6J]I$R-U;)C(P>3$Q,3%D<?NI<;$AQY3]I&ZGWJR^D7[QMDVX(NC&S
M-QS,F-?%#/E2RPGWFC97'N,#6=H``+#8``A``/($(`V"$-O,L&UK6M7"DDFY
M[:Z<`#@.RIJBII2E*4I2E*4I2E*4I2E*4I2E*4K5UQ/^;AX_.B[2O/GU*5M%
MI2M='#V^^_$`^<7SO^(^'Z4K8O2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4
MJV.9IV=BW$^4,FD-93X=CS'<QFY3,:M&W%NQL5C[@^%MIJ\)"JZ$M<)%8JYU
MBC+EV'<71%II>YBP/E9^/A)\?(R(81PO_#2K%>WAL7O;PU<AC$D@4G2">)/$
M6`)[/\N%8BL^_*,W38]<Y7"W.,@></9"GN0V$"R[U+X%.X&]8F8`8P1L*!+8
M$C<I2ORHGNUJ0F$!6$#3'`!8M3TB^TRNB)5R\N#;ICE0Q9F+!C.%T+D#)?,3
M6P8CE&#N<G.!)"%7N;("W*8'4(GVO%SLJ(XTDIEYR,01!'%CG)$NH7U1S)I:
M(CBRL%`Y@9!5"C?UB!$D0C6Q',2-V!'<LRF91@^!A[X\7L^$R&E1/S\B(BW@
MQ.TC0ER!ONF"E.6]O=O$W(N985[AQ!T=N#%FCGQ&Q0<8)*)#RYFRY9((4B8J
M"S&6&5&4A2A1BWH^E6R7=X&EBQG29,V7(Y0B9;.#H276PO81F)UE#@D%;@>F
M--<L0WY8JETS:X3WBYNBZUQDS/$CW:7XZ&RL+.]2R.&2V`)G==9V5'$CR%'2
MKJ6L!1)QP=0EK`)#A@+%7D]$[OC8LF49,9^7%.Y1)-3L<5@N5&H"V:3'N"X!
MTLO&%Y;-;!Q^I\+)5)$BR1CR+"X=H]*B'(;EX\Y)(M%+(&C4VUJZGF(@L33#
MQOYAHUQK.Q0>:M;^SY!9HA+&+)+4;#'9JCTB@^3YBP3Q"V)!OJY8U.M\7K"`
M)%`$;B7>PNN(*&$(!T1]'9!@7-R)HCA28F1*K1'FVDQAB,\#]BZM.7'Q0NMP
M5!)!MF-NT?>I,-8Y%RXI<<6==*O'/E=UYD9/;H<$^D%X:2?1=6/O(=]./T)#
M$KFL(RA&6!TPUX[5&2S(JF/Q:"()HLSR1Q7$/`'L<F()ZUZ)0I;+6E*8I7#L
M2&W3Z6ES*Z/SHI<S&@E@;-P\T8IQR]LAY6R#CQ*BVY;-(REE"R6T*S&P!JWC
M[NDIQ3R9>5D@VE5?H@%B:5RY+:@(U6TC:2H9E%_36_1=]_\`BD./%,KC\.RG
M)9FF<)>T*<.M<51K\DL:^%1%#-WM7*6QM?%C2U,*"-/C6L.5%K5(NJ<TX"RS
M%`KD!M9/1NYXV08I9<880Q^<<G61CA1*T&G64U:C.CQ6"&Y1V!Y:EZOX6\8>
M8P1%FYC3Q1*@4&20RISHVB75I8-"KR#4R_$9&TR#0;(9;XBKI`%6,B4S=@",
M`G6VZ.[@AD9HS*]0!R?U+^YF-Q.-<9(T<$?12V6#,)"`D!MTHS5"D@NQ>H[Z
M;[!]GZRY6XXK]^R.X[HN$%Q8%F<DJ6,K@R*%B%NU2W83<#C6D7J43[7M^Y7Q
ML>'.BE<ODRM%'&L1BX%M!(8B4L5(%@C^*U9A8]W60#(&2KX80L,]:<I-K&&2
M2V*O,74(Q0I@5-#6Z,S_`"-Q&;VFG8I6I<AH6A0"XQ+UJ%86$`;I3NAS6=TO
MFX>W3;R)(9=GCG:$2A^#RK(R&)1V\P(HG9>P0/&Y;TU!V6+OL$SXV++%-%GY
M,8D6,K_J^6':6_U2R$0%C8\\Z-/`D6QD.^W%\&;;R:9M[T1'G65Y,;XF*-ED
M/;J?C_#3B7'LI99E")4I:2&*%Q22!,*,ZDU8M,)N4,H@P9G5AOX'1VX;E)#C
M0.J938\$T@D.F.)LPGN4.H:BTV4A#H-.@7)9E",1=RMWCPS.SAI($G:&(1C5
M)/)%%S<A8U[&Y1UI:X8LC)IUE%:NY'O-P_#\@.$%EB:;QU(EA<CG3=D%UBYA
M&/9.S1&*%S:2`BKL%88[O:ELC(Q*>F6@LD47*,+(.--`(%L.#IG<\G`DR\<1
MODQ3")L<-_Y@,V0F*EX[6&N=T1`6#'4&TZ#JJX=WP^?C1C4<;*"%)K?0`/$\
MRZI"0`#$C,6`*J1H<J_HU9M^XA4?CLI944AP5GR/1=3C^63R3KWV"7;Y-!V>
M+2"&MITGD$?$YC;S($)GEUEQKDC7JU!/4#(NEZ\)A9>XQNA9\LR0Q9V`<Q<G
M%@C`F!C>7+;)B6(O;T9.;`$"E=+"02:A&`YP9^HHX\>/*A@RGB=<AK"/TC%#
MCQY!EC!-G4HY#*2)`RA-&LV%_,W[L,4;?G&*M$Z-?U*B2-KA(U)T>;DC@GB<
M&9U3:A>LA2TQ6Y-XD$2:%3NG`:80%4L%<=^J3F=$71TNQ]-[CO\`++#A\M#$
MR1WD:P::5F6&!2`UY965@H("BQ+NB\:V&7N>-AX,><=4D<RLT8C&IG6.,2R,
M@X7"(0UKZC=50,Q`K%=XSSLIQ+N1R1F0>'Y.ERU(6!_@\HW&M.-C5[1.$N&&
MQ"KDT'9Y?=TN8>IAY9A2<\`$B8E4H3B+`:HN1?H=#M>R]8[GL$'3T&0D>U2Y
M"3KAO*(VU9$XQXYVC/QEDDD!4W-E8R%5#@G6Y<^S)NL6[2PF7-CQN4N2JZE1
M&@DS>5K!L"T,9EN!8ZE35JU(N1^2]XF-,;,<[?ET;R=)4&,ILHA,Y'#H=9V!
M'5"&#,&0W%_<%:MS;&TF.-\;DJ4=S;G]LGGW$2G(.,`*UN?V_IO.W*3%C5X(
MES$=HVD?2#R\ML/18`L7:9&LJJ3RP9&TJ"1LY=SBB63EI+++''"^A%NS+D1-
M-&5N0+:%-R2`'*H"790;))N(_C9N49*[\8-D!I10_++_``6,*6IL;'4<S@T6
MQY"LAR7+Y):EX;0H(='&J:)QK;"$)58H]-U))QIURB]ZO0.>8L18\C'Y\V,T
MLP=B!C-WV7!CB<A6),TL5HR`1J$FHJD9>M>W4.'(S/''(^,8L=H75>,S3P')
M"1W(NRQ*S,K:>*Z02[*K9)X\W0XURGD^7XMA266NRN&-J9<XS`#!>T"5J%+;
M'GFS.@?;*QJ+.MFB5(%)85*9,0J).O=,:?<HZQ>@SNG=RV[9OOG,"(G.:/E:
MOIB4:6-F"]A59(9$:S%U8`L@5D9LN'>L+(S8L/&+/SL=)ED`]#1(H=+GXP+(
M=0)71P*ZM8TUC[CKB%062,L=<9GC/*T'7NDKEK'(["C13PQ8W86S+LEP_#YC
MD)\1N8BF1CG4CC9I*41):HPI04?8T(""NV![I^@\W6HP<K%F1\3%D7Z0CF39
M.(F6<6$%1JECC93QTJ5>/TM<@2L?*W[&PY\N.>.8+BSY"&R7;DX[(LF0R@EN
M4I<$D`D:9+*1&Y%]=S&?7K`T;B;ZS8MD612Y#/8/$'A>WN30S1V$-<NFD:B"
MB1R9S7J;KAV3"D01)$B)(J.6G`ZN]R@:F6TG36R8_46[IM>3DQXJO',RLP9M
M310RRK&@7@6<QZ?3*JJEF)+`*<S>,^7:]HGW3'A;(DAC9N6I`)55+,Q9K`(J
M@WMJ8G2%4W)%GY]NYF^)IS-$61\5-#=`FJ$9=FL.LS303QE)W8L/M:=<MEDG
MB!3(%CC<*FR\VR)F4@=%*JZDXD*@@H1@@E[#;NF<;>-L5MMR&;?B^*C1LEH%
M?+R!CPP<W5?G@LLK@(4$:R$,VCC0^?)!N*0S(J;5),8^86^D(3';(FG5`".1
M%I="6=7)TMI&H"K@8[W(+0PC,S]G9@8<>R/`#B$G(Z.%O3O-HT)M<86PY!85
M\9<ET?CKTZ*%;#)2$YB<:`HRSB6867TR[EC%B;EL4"RX+;`TV5B[A/)#"'0)
M*T\62V*4T!W4!Y`&C.K^#D75I8,!3M>Y/FLZ9J+`RXL63J+DJ()HVD!<D#2\
M7+E28<0#&64LK*:\N1[W8+"XE'IG.,4;@X4TN[ZH97P,IQC=J-@))*MH2$OT
MS4FO8F@MC7W?$YB<3:J<E)A?6WZFUR#[%YV-T;FYNZ#:<+*V^;)<*(RDX99'
M9VC$:675KU*02RJ@!5R^AT9K$F_P18$NXOCY8AAN2.4=101"8R@7MH"'LN'U
MAH]',1E'`JWYX5;EV2"79IR8SL^-!902+)<YPDY-%)2]X;=_6;($=A3IV^,Q
MY=F92,`[7-*3)3B1W&`Z]BE'4XR=)[I)B8F0C0&?-7&:.'F`3:,MA'%(R&VE
M>81&]SJ1F2ZV="V6^ZXR9CXA#F.,>E*!]"&.-WP1Z_"YQ[R*`""%8!M2D#U0
M[V\0$L"M^>6K(D;NVX]CV2G5E?HB)*]MD?DV2E^*&TH].G<%:12OO*VXR]^U
MCSTQB*X%)1QA0PWOD)T7NTN4N+COC2%\M,96$EE,KXXR0/2"LMHS9M2JRR`H
M5!%6X-YQ9\9<K3(J-CY4UB!?EXFCFMZ)93<.I322&![0015!H.(!BIL#&TF0
M$+M'7I\E<\:'0MF"0]LL(C,7S7(L'QZ;39V6'LQ[<S3"4L=B4X4J=:>6>(RP
M@=22(^KF-T/N.>5^[G20-AXDPU$C7-E8:Y@QHK!M4B1DDZM"D!26!=5-G*W[
M&PGG&2&T0Y,Z+I`+-#!RN9D%;W"1\Y#):Y`)TJVEM.0&(=QD&S9(,BL$.:YD
M2'&S^KCC@^OD?NW1Q_7-SR\QUTO&74M6J"K]:WQ@5)U!"D"18#H`-ZFY!Q)I
MFFSMCS-OVW$W/):(19B!T35]($9%D1F6UM+HZE64L+W1BKJRC+AW7&R-TR-I
MB#G(QB`[6]#58$J&O\8!@>(&H'4A9;D4U+-W.*X9E%1BUY1S7ME`H0L[Q-D<
M8-4X[8YD[QE3,F+'[K).V@&$3!]C";MM,2!.8FZ)A8##RS3`%BJQMASLK9I-
M[0QKCHLSJC-:66/'($\D26.M(B2&-P24<(&T-:]+G0Q9D>#Q:5S$'*\5AY[F
M.$SD?P8E<!5)!`U(6TJZD^@U[H(,Y8#1;BC8WD5IAKRD:5<88':*V3SZ66DS
MDA:(4FC\6(<%)JE9.'!U2EMA9II(A]L@$=U(>E<-S,Z<S\/J%>F"T,FZF300
MC@HC*K/('<@*O*1'>4WLBHW&XM5C%W;$RMOFW5=:[?"KL792`RH!=E'%B"QT
M+P!9_14&ZDVC=>(3A=G*8KK(GF/MI8T2)]F;:7`@"<,0-4.F2"!S!5E4D3T`
MM@M&I&Y$EJ`I1KQF$BZXBQQ7HJVN-T+NN7-H@FPS`TN/'%)S2(YWRQ(<=825
MNQD,;I8JI1QI<+>L:;?8(,=YG@R3/&)R\0CU2JN.B22N5!(T"*1)58,0Z.I3
M43:KHPS=OB"=YD>\(L2QZO)VI7*VQM>%;>F(BLO>\?G(DN1&*)N07`U>O<H&
ML<2B7'KDB8GK;BL08?T!W#JGZ:W6/8AO[*.[%$<IQYBQ2LRPS,MM(CF*GED,
M6(TLRJKH6R6W?#3<%VZY,KD*&'%-9B$XC+`\',+"0"UBMP&+*RBTDEXB.'8V
M^/['>`9X?!L+CE)JLYQ_&@EK,]*\(.QK9EV[&O4/2,*I+`22[*U9YH223TY@
M0I!*%&I`=G@]$;GG8D6;S\***6+'E^DF"E(<HZ8)7`#65I/HB!=U;BR"/Z2J
M,O=TQ<]MM2#)GRUD6(")-0:=H5R%@5B5',,+<P7(CLK+KUC2:N<=\^$6QX>D
M1Y$],C;-''9Z\9":(*#\>.KPR8\ME=R@+,_!5]>LG:?'M[N5D=TP"!@`,H)]
MSPB*MB?JGN@@,C&$9/.*"$M],R+E##:=4`XP)DL(BU]1-V564%@AWB#(>%8(
MYW281^F$.A&EC:6))&OZ+NB\!V:FC4D-(@:P62>)8R1=K95L3P?EAU7JQ9(M
M(6*8M*.'.L2(B&!'[.\7>7@@IR>;A89RRM1823B^L4)R+G#,)L:38@>YPO9W
MERY$L69EXT:(J69&:0,YW+&V^:(`+;F0MDZN!TN>6JL5<LN/%U'BY44;XL<S
M\V;'5;K;7'DQS213I<C5&>2R^!@UPR@BU7VB^[IIED==IH"!3.)1S&R9^<<Y
MHYVVFLLOQXRH,:EY%C[ZVQUN&]!DS9*D)Y5DO0/*.L69<0RP&!$7;3[ETLVU
MR<J:>-^>QCQN601+.F6F,T+L2JQNK,2QN8^'!]!+!LV]/OBXZ8T+ID2)#(X>
M^D12PR.LL;?ZQ2Z<L<`Q(8%0P"FE)/N#V[KH3C'=]+,8SXV0Q]]?,:8H(<8>
M2#)J-VR+9,B>&>-)K2$,65():WQ\HT*P+D8B5$D`"2<(X02A9D>P=0;=ND_2
M>-/$&RH%?(T.>68X"TMI1IY@:%P2T80N"=0!7B+46[;;NVT#?'B?N>%()8]8
M"L7<+#&\7I%#S%R`@8N`-3!]#`@77'N^Q$2<8F46EZ501/XWC0].MBZM$I3R
MJ4X<\>3:E5)59A*E*25!]>V!&``(A=:Z<0>E:]ZUL_2^YX\+SL86B3'RYKK(
MK:H\/)[I,RZ;ZOI>,=OCH=0\5;*/<X)"%TR"0IB-8BQ'?9.5"#Q[=?!_`HXW
M(-ZMHDX@V(7*+LLA30/.MUDN=X*V0*&G8U,2S3("3);'(WV#R*+LREX))'&G
MTF)N!/;*P]'VJ>GT4A)`(`Q;&;H3=XLN7`>7$YL`GYY$MU@.,$:59&`-F".'
M4+JUA75+R*4K&CW[#DBEG5)N4@!4E+<X'(&+>($W;Z=D0Z@I`='(",&KN1'?
M'CF1S%R:5C<[,<.%'86\L4P<D:I.(EPD40R9,GN/S=N/(*[S'2/(,7KB+!-,
M.LH6%B)MT16!T\3+Z2S<7;SF1R)-*))R$B/,66*$895X&'&4S#,5D51?0C,.
MQK7TW17R\?&:*2)IBD;"0:3!,\\V.(YQQ$866$QN]RH>2-;W<7O!B3.*3*3]
M)6:T?<&'M*-P*?1@QQL(I4_0#(K,<M9'-8A&`!C2\(W-N6)5:74T!?0*%8P7
M6""#7[IL;[=!S#*KSQ94N/.JCA%/'9@H;L97C92";,&#K:P4EB[E'DSHJH1'
M-BB>%F%F>/6T3DKX`KKZ)_=HRL.-P+RR*,L<NC[U%9.U(7V.R-K7LCZS.1`5
M+>ZM+FF,1KT"P@=NB:G5)C1`%:_+I?GK4([PR":$E95<,""0592"K*1Q!4@$
M$<01<<:VBDJ;@WX$<;&X(L00>!!!((-P02#7996=!'VMM9&HBR1J9V]$U-B0
M)AQUDJ!O3EI$:>QJ@PT\P)*8D(;"&(0[Z:WO>_+5<\\^5D/EY+:LB1V9CV79
MB23PX7)-S8`58Q\>'$@3%QETX\:!57P!5```OX`!85ZM6ZO4I2J7FL+B^1(J
M]0F:LR21161).T'QC<.NN@=4-S2SAHEH"#21G)#A%6L87<70-!J`=KAO>U[V
M-D3X>3'F8S:,F&171K`Z71@RL`>%U8`CW15N6))X7QY1>*1&1A<BZNI5A<<1
M<$BX((\!O50IR`)RP$E%E%%%@`4442"Q99198+`++++!8(`%@`&U@VM:UK6M
MI:K),CN9)6+NQ))/$DDDDGQFYXGPU,<:1((T550```"P``L``.'```>X+5ST
MJNE*4I2E*4I2E*4I2E*4I2E*4I2E*5JZXG_-P\?G1=I7GSZE*VBTI6NCA[??
M?B`?.+YW_$?#]*5L7I2E*4I2E*4I2E*5QC'<(K6M;76U[Z=GZG+4$\0/'47X
M@>#]G]JI.M%K?4/):U[WOI>UK:<NG9[%4%R".'#P^+WO+0:CYO"13K!::Z6O
M;7_8VO?DOIR\E[\UJF[*?2%_@][_`-M1J'@!/&WBIUHK:Z@O_P"CI:]^E]+Z
M5JFY[;&@O[GA\=<@!=.U[Z7#I?32]KVOS6OKI>UKVYZD&X]WPU(-^/@_9_;J
M>IJ:4I2E*HG)$$:<GX^G6-WU2X)&3($0D<+>%34:00YIFN3-"MF7GMQRE.K3
M%+BDJP0BA&%&`".UKW"*W)>_B9#X>;CYT0!FQLB*9;WL6AD650;$&Q9!>Q!(
MO8CMJI&*-J''@1Y1;]NL8)GL0PW-)@*='N<X9)&9ABV&CU+"\-J5.I(1.\$>
MH]D%0C4LJM.;D>,+,<M@4JZ]NUQIR>I4)SBK`"'I\7K7><..:*'EZ9=SBSA<
M%N7+'W@-&@+6Y,PR9!-&P;4;,"K:F.A?I_;Y,?%Q9`Q@QL63'(N!SHGB$0$Q
M`&IH@"T3#2R,3Q*A5!!L<Q\!-(SG^=Y+ELIFN.LUX\G$U>E\5(?)45G8^)#E
MDC6)&6)-4>;GIK20I`E:RD*)*W)4X!6$E,$*XZIGZMRI(UQL;'QX,&*?"ECC
M3F%4.#+--&H9Y'=A)+/(TI=F<\`K(HM67!MW*R8\V>66;,CG:76^D$DP+CJM
MD55"1Q*`@4+Z5V8L2356..T7'3FXN+F<^S8E0Y3C%\^.ND=6U,(EXQ-`08ZC
MQ2,XMGLI2I5;*"QJJX1V/NJ]&484&U@5COU1GNH1TB*@9W@;_P!0N9OW7[F_
MT?B[&U"J(-HQH,=,5"YB3%Q,?B>U,+(;(B)X<69VM)X&4```W)L?!.&?AF"V
M7&%37);TX.*J''JW1>/'S:N6`@D8RC$6"[H9&H"QV?G4;/EE?V\ZK[*G9R4$
M$'*5)@[&W-VF=U[NF="L#PXZ1!,A2%$@7_S0Q1*54R%8@.Z1E(XE2-"7LG$6
MLP;'B0SMDZI&G:1&+$C41'E+EHKL%#26E!&J0LYC;06LJ::C;-@T52M,NACU
MF3+4NQ9.,<M&*Y%C.2(\2J&E1#8["T\,C;4EDZ+&"'("!*QA3W<222G8*<;D
M::8:68`T9=Z,SK;*RY#F#%QHMW&<^8LZ&;6N0^0,CF:#*87*V$2<R-PL("CB
M-54X^QC&R$DAR,CNJXX@:(Z&1H>6Z-'=D,D8D+F1^4Z%I/2O;A7(5L&AJ"!-
M$2C^5LEQ"1M2V:F&9(A;+AF(R%>RY#CS=%Y?&3XQ'L4M^,$S4[-+,A%UJ=A)
M7E+$@50%`3Q&#';R>L<C,R9),K%@EP)L80O`[Y#HVF1ID<N\[3ATD=RH64($
M8QE#&=-586R0[?&@Q)'2>*=)8I`L0:-HXS$.`C"/>-F#F579F(<MK1&6X!NS
M7%"M!ZVN*N5N22VWN/;<2[*W)ONI3Q6+.JA[8Y0D6E-)2M)/6]V/"H*7EC"6
M4>26,!(1!UOBY/5FZ3R33((XIYMV7<-2`C3,JZ0J@L1RK<"A!N"5)*FU5;=L
MF'MV+BX8U38^+BRXX$MGYD<W+YG,X#42(AZ0TGBQ[;$=W'.U5@QYDV^8O&3E
M279&<F<V-S%_E;TQ'ESN,IVYK11EBD;0TQQH9RTD*6-QJYL&A(1J"UCDN$:8
M<%4,%4[AU++G[;)LXQ<2';))#*(T1O0E,KR&1&9V8$H_(()*&%(ETZHU86L7
M88\?(Q\QY\B7-QHQ$LCLNIH1'HY4EE`=3)_Y@L1S.=<Z]!*&S$@V!0:<)F9J
ME#R)$F@4URDZ8V=6:.P5_=T<`S*^IYE.X*^(<EPN;QY*:;*PW&C=6Q.E=D1!
M)/:ZD@?6]//V_KC/VZ2/(B7F3MBX\,ZLSHLAPO0Q)`87BD'*ATQLFOEN"VM7
MU<*\W:$W`3PRZ5Q&RSDPD*K&.66/3D'3(KQL)7+R>FK>D^K@RBO4?.'=A>3Y
M1E.3I)()V\FRE#.&TR.*CH>!$U-N1,?!QQ)6IMDY$0*R'9C"RE@.;V\YY-0-
M2P-S4I)73'85&-UOO&'M7W9BB..3T")EUB35%EKF1N5U\IY$F0?2/&SF/Z-F
M*`"HFV'"R,R/)FN\$8B`A(4Q_10MCVXKK"21.XEB5UCD9BY37Z55`9LE8'MM
ME2;(F9\TY.=I=B>8876R"5.$#2+6^$3$V-&*"&5OBL"CK`WKV[O6(N4=9(+K
MC33C5-CS3.G:C];\B&5),#$P\94S\7,THKD-/B2S3(3S)'.AFF960$*J*BQZ
M+7-['VH0+&CS32Q0Q3QQJQ6RQSP+`R^BHU$(MP[7<M\<L``*GSIL^QKGF48^
MF4B7NC/(<?-JV.$+T#%CR1#>8BYK6ER<8ZJ+R%")F4R#.<&4@TMS9PMKRF%8
M74JP6%>U8VQ=49VPRY#XZK(F2R.REI4`DC+F-PT,D3G3S'!1F:-U:SHW"K>3
ML>+E;7C;6Q;1B*5B<A'90T:Q/=9%:,ED5?2*71E#(5-6<R;L&:,A9';W8K),
MO;\4.!F:5LHQ1<YE"TM4AS'&?6YZET"7%QH;TG>SY$&SB80ZK5S:08,SM9,7
M8P8+YVU]8Y&W8;)RHSNL<$,<&2+\R,09,.1'&P+&-D01:`0@<KI5G95`%>;M
M*Y31M'(XQ>\(\T-_HI0N'/AG4+:M1CE7@KJFI6D*F1BQA,N&_CS(49<X_-\O
M9BE"J32V62^;/CW;%CB;+G":8YBV,7D"V.+,9'0EJ&D8(@D,:U;<UI%[.I$<
M-$>38T0:KQ^MLG#R89\3$Q8H8(.6B(9UT_\`G),W6L@FYRN9I7#Z9`)(R(W#
M*`*L?<FJ$)+D323!\<ZV$1NN-#)!'&R<OE,G*DL04/IJDP(E&L]F3\-[#LD-
MNHO*YJD5%2D4F;CUK/BB8`:`N>/(7C>7L[>AG^-96VEI9@TX^:51RH9`W)O7
MI>L;E*,(S"Q7L?V@[M!.)S%"?0D1@K31:U;+DS45FAEC<"&::;1I9=<<K)-S
M!ITVCTU@]V3&1G$<4<"I?0X5L>)X$<JZ,C$POH975H[JL@02#55](9M?BD,S
M>[YS+E<N>WY9%%$+961W(AA;9&(^M%'3%C:C>6:(M,V?FX)T83"1I'EU<TC5
M<9UD1:>QQEKZ/(ZBRLG99-D>.,12Y`FD<&34[*TS*2I<Q!ASW!D6,2NJQJ[L
M$%9,>R8T.;#EQO(%@B"*ATD"R!.#%>8$T@GDJX@YC&7E<RS"UEMA$`+7@$ER
M7EE%'%S^XN<PAR5?"RV2>,!N4W[,K!")$KO"12$B/Q.=RAP-2G-ZU$Z*$BH2
M58K4DV`$.RQ^M,V!$U8^-)/"D'*=A)>*;'QEPTR%`D"&0X\<2.KJT):&.01B
M0%C5F[0F;/D9!FECDR3,'*:`>5D%&G@!*$B-V5FN#K3FRA'57L,HLJ8NC^78
M>="9&J=$34<_PN1#.9CTR9=99!IBQ39I*":I2+";)CW2/DEGVZOI"($,(1`%
M>PK<UM>=+M.YP;K`%;(QV=E#7*WDBDA8D`C]S*Q%B/2L?!8YV7BQY>#/M[DK
M#D0/$Q7M"N-)*WN`0.S@1[E8^I-FC&*9YRD<DRSDR;1S<(BD+9/X!*$.+E#3
M9G>FH+*WL#'*T..4&2FJ.1)!TK-3>%[$D(,-&:,!I@Q#ON5ZFFBV;$VK&QX8
M<C"D62+(1IEE$RR<WGLO-Y+S$V76T1(155;`5BKMQ3?7WU9I-;JJ&(B,QB)4
MT<E;IS$C8WD=5<%Y"68F]JJJ-[5(>V8LRAC*5R^=9(/S*:L/R)/Y8KCJ2;/B
M@R/M,59SRSHE'(U'FTV,1Y@0D(;IV\NUA)K&FV--&8,=K/ZCRLK.Q,W"BBPN
MXR"6!(=>A)>><EI`)'D)+S,68%BFFT:J$4*(P=IQL)9D<O/'-"L+"4AO_+I%
MR5@%@/0"%KDW=G=W9BS$U9/)'#RB^8DC&7EW/6=,D+FM(ZMRYRDU\1J1.2%>
MO8'-'9O:B<5IX_"'1H51M/U3E'TC4YG`,/`>H-`>9:^YVWKN;9<[OFT8.%C#
MF1R!4[P/I(WE=29.>92AYK*T)D,#(J*8SH4UAS[#WO%7$S,K)EB4.OI<L@QO
M$(64KR]);2-0G*]X1RSI*I-3PK8L<C7Y+=YGF>?K%,GGN?)3CYHCHXJ1'<6)
M\Y2I0[NRYF1O$.7*7Y\6LEB$JU,]F.[+>XE-B4@0*CK#Q9>K%.W8.'!B8_/Q
ML/%QY97#,TRXS!^41J"B%I%5C91*0B*9+(MKPV=N^32O/-W-I$9(PP%GCPH\
M)92P`<2+&)`H5A&-=RA;C4%G#DQ>?'8Y&$.2,JL#8WQD,3EQ4<%CAF)R&S$Y
M469G1(WEO28\`U19"WSUR5'$)(T0R(RT9XDEBNUP@`',Q^O]RQMP.X#'QWD$
MD$D8<S/RY,?&[JCZFF,DC&&P<S/)J90W:*M'I^#N8PUD=`3E!VC6*,NF6(Q+
M&%2-8XE^B0J84C8'4Q8L[$^TY\/;##A*X=,@.LE3O45=90L6JE+5C>1*)(TR
M?+#]F>\=4+I7`GYPBR1HFDE672K(\:T.MT9UR#E1P=+VQL'KC=L&!L95C;'.
M/CQA;R(%;&Q1B1R_1R(7<PJH=9"\3,JMRQ;C7F[!B9H;F$AFGFDN5C>PR.7S
MHP)$=0K<I2K6YB'5H<:C5<P[:YXL9U.,EPS(\E6R_)4HB:F7.$I:H*9TX'''
MU^>SH<4*.0IB5/ZU3:1J$P'EZ-<7X*0))/;]BB"PVP)>HQD;3C;+EX\?W=C<
MUP%:6YEDA6(26,A6.Q1)&6%8TDDU.Z.SFKXVI%S\C<HW;ODR!4N$(0<Q68:M
M/,D&E=$:RNXA2RPZ!>Z8[/X/.LF.F1'*8Y`1-3^[-4LD6-6Q='28,^Y"CT04
M02.3Y8(^.*986[LT:.`4%(2Z%-*@Y.2<H2&F@Z5[6#U)EX>RG9N5"UHYTCE8
M-S(8\I@^0D=G"6D?4;NCO&7DY;*&J_)A(^?'N$;O&P,!E5;`9`QGYD"S&Q<J
MC:>",FI416NJ@57;IMXB;C@B.X#*?)2V,</CT#9HI+4"IJ[\V%RQF<RK87*D
MJI6T*F0]^:G:/I50K'(3$9XP"`80(H0B[T2;_F2=2MU3IC&<^3),R@'EGG*Z
M2QD%BW+>*22,C5JTL;,&`841;7BQ[4^S-J?"DC9&N;&S-K!!6UF233(A\#JI
ML;59L.PW&:AIDR1[F^39"]S?'4WQ_-Y:Y.48+?)09D.=-N09/+EA3=%$+(AD
M:AZ:RBB"T:1,V)DENJ+26TL*VW3K7.@DA[GCXT.+C9F'D0QJ)"L9P1((DU/(
MTC*QD9I2[M([&^L5$6VJK-+/+++D2)E*[-I](9444#75551RHH8TA"J%4#T@
MU5CC39[C/%.9YEF>+*W(IQF+A)WPZ.&L>/RF]ND$X6)7*9/!4I00M'DMXN^.
M::Z@*1S?5R!",XVR0@@`K!#@Y75.?F[!'T_D*K8\:HBOJEU"*(L8XPG,Y("!
M@H<1"4JJ*SFW&RFR8D6X)N,?"554$:4.IDA6`.7*&0$QJ`R(ZQLUW*:B3744
M;,<9J;G7,?IO:YQVYLX5PN3/K86ZM8%;/PAN)B%>P&8T%K-%O^`#R']L<]4+
MU+G+BC$58@HP\+&!LU]&"_,B/QK:V/"0VL1\4*>-;5(UCS>_CC-WV/)X]FN+
M%[H!X]!C])A>Y?C<#A5'';`\:J+.+29D#*MX(NCCJ@*QR!TB9<8;YF]XIMA=
MSRBD/+B`9&9+SX)<95DYZXYD+5FC4@06.O85L\]:9[-SS!C=^$Y=9;2:TC.:
MN>V.OTFGE'(6^HJ90A:-9`K$5J\79X,.2$X\DJPQF)G2XTS/!&8XGD]'5J5=
M%PA16:&$LIY8KMY!V%XMR$I=%JV79&9ECS9,G7J&9QC-[F-8,&O>WY>U`+=8
MJYDEIG>$OIIIQE@]L`7@`:286"URQ1A]:;EA,#'%`R\V64@A[%Y,['W"_!P1
MHGQH](!`T:E8,3<1#LN/CQ01PO(&Q\;&A1K@D+C&;0QNMF9EGD5R1:Q!4*PO
M5ZFW;_&F4&71,LDF+2OS$VQIO>'="XMI3E'QQ."-L`:'",&B:!E)EH&MK*/,
M[:`K*,4]+4'57N56FRMXGS(8()HXC%!DS3`%;JYGGY[HZL2K1ZO1TVXH2&))
MO5[;MKQ]M$8@:2T>##BJ=1#".'FZ&5ETLLOTK'6I!#!6721>K.D['H2BP$MP
M"V3^:M;*\2]XFDA?4L>P^.[^XR!0>H>&Y;CY7C!3AQ+'%`CK"*0)(XG3HU!1
M:A/8M0"QM;7+ZMRL[>8-XR88V;&QQ#&G,R+JJWTMSN=WGF+<Z9!-J"DH#H]&
MK&+LL6+A38:2-JFE$A8)"H!`4`<I(UA9"%&M'C996)>0,_I5X[CL)@@'Q`^1
M[(.2FQO8S8Q(&J`J'..*X4MGL*PPLP3')=(E1T5.FSB=>!G$$*DP74"0PY,`
M\!(#;C$.K)ZQS\O#S,>6#&,^8F8ADLX:./.G3)GCC`?0`9EUJS(SKJ8!K$`(
M-DQ87Q?I)1!CIC*RC2.;W2=IX6<Z;@AF*E$*1E=*Z/16UH6[AYRUL@&#F=-N
M(G@\F8TDV&UKIE%45$U3LPP[$<,G#&VPS'#>;!A1XY"!^FJA2$V0M[HI6IQB
M*6G'6`2$&\R.O\;)WS-STP8%VW,3,U1#6#++E+%&))FUW73'&5M`8@K,TD>F
M1BQP,;IZ2/`;$FF=LD:1">%L=!G)F,J&VIRQC7C,9+E54^A=36<VV!Q-1"C\
M>PQS5F,LV>,)ILE.DQD#E=^*C6(9*]2M4^1%5'FQ*:9/)DXOJLI=VX<4W#)5
MF!L6$JW4#UF#UM+%GP9>7&B8^&V3-#'$@T:Y<>+&2!ED<@8RQPJ#:\H%R&9C
MJ7+W':'R]OR(%<R9V5"899)+#4LL\L\T]D``R%EEUQ!56,,JWT@`UE7"<9JX
MWDS)&1'!:A,M)VZ%PZ(LC4G,)11F"PE"L&C2G",`"YKHY/3TK--Z-KDE$%D`
M!?7IUS.1NHR=K3`2YR#E29,[$WYDL@5`1[BQH"3VL[-PL%OFIA"/+BE157$Q
ML-,>%1^YBU&1[F_&[V"``:5`N26-KXUKJV%*4I2E*4I2E*4I2E*4I2E*4I2E
M*4I2E*4I2E*4I2E*4K5UQ/\`FX>/SHNTKSY]2E;1:4K71P]OOOQ`/G%\[_B/
MA^E*V+TI2E*4I2E*4I2E*P<XA[&&3[9WR.*\IAPPR/4VQ>EDV0CH9-9VC:HT
M5/F):\('%C@BIN=RVN0)DMT"I4>K1MZ8A0(:H\HGI"KI.C91C=5X65W=<LHT
MC"$LJ"1U@E,0U2>@")"K"]RVG0BL[**UN^*S[!G1HS1O)CZ-:AF:-7DC5Y`J
M`N=*%B=/8!J8J@9AI9>I%FZ6%8&?%$)EF-Y:*!XJ2[1V#&Z*>1N'/,V;=X2]
M!DJ7M,>6+UI[0FR#A-*W/2YO>SU/:\<7F!L,15KC%[3MF/MN/NF8K31S%LW$
M?<AD&&26#!?:)6F@+A5#K!EEXB\:AA.D((#UYSN[3-M8BQT_D^'&WB/#>%71
M9MR3-QEV_(5;LZO(BLR*Q,;+SG4Z&:K[;JLE2?*^YY)*,1/.0'-<T#P'#-L1
MS$CFS"TVRS"]UKK'-V;28W'I6Y$L,00%&4!\&O*$G.CMK&DB$3>P[\]T%M\&
MV[.?O&.`)DSMD98DY9)VF?:)SB27](JIR]6@#Z1<H1JRJPM6XZPR5R7:*`R,
MV+@Y4"!`XT[U'G8>A%*V9G[N04;C"8><02.96-QOY0=D&:[,1F7[OQL<>_RW
MBB#YD*Z=6'?0DZ0VLH1ER$C@+;28[]2)GZ-Q1$(16OT;%WMN]M'3AQ]D&ZC%
M7I[F;0,,MRQ:8[9/WT3'XX4Y_=CDZ_1&1IX`L:UV[)O8R-W^Z!*W5$GW]JT$
M@C%)Q!MG+!O%<0F?NMAK/TMCK!K=;PY>^*V!9,%>9(#H(#/.<PX*-DASHH6#
MP-;(#K?&EV]0]B&['1JS5<5FH2@5QW;;$Z7Z/1KS+KWCE[?WD1C?/NC$&:$T
M@]Z"$-S-'H\XQB,RVXZRU_2O75].<KG[F,#4=A^\Y.Z$EBIAY<6OEZN/*[SS
M]`[`/B^C:LE,J2C(\3*0.<310=8U*GF)1TXN2*Y`F<`.,LEC5%R%)5VE(I37
M1HQ/!9P@BT,'8L0;:7O:N/PX\><F.8R"6SD6M:RJ6]SQ&NCD9E%Q:H]//_I&
M'OYU-O45/Y/\<WD7ST^E_%IT\_\`I&'OYU-O45/Y/\<WD7ST^E_%IT\_^D8>
M_G4V]14_D_QS>1?/3Z7\6G3S_P"D8>_G4V]14_D_QS>1?/3Z7\6G3S_Z1A[^
M=3;U%3^3_'-Y%\]/I?Q:=//_`*1A[^=3;U%3^3_'-Y%\]/I?Q:=//_I&'OYU
M-O45/Y/\<WD7ST^E_%IT\_\`I&'OYU-O45/Y/\<WD7ST^E_%IT\_^D8>_G4V
M]14_D_QS>1?/3Z7\6G3S_P"D8>_G4V]14_D_QS>1?/3Z7\6G3S_Z1A[^=3;U
M%3^3_'-Y%\]/I?Q:EM?/MN9/AVW_`*S-?45+;=XYO(OGI:7\7RU-T\_^D8>_
MG4V]14_D_P`<WD7ST^E_%IT\_P#I&'OYU-O45/Y/\<WD7ST^E_%IT\_^D8>_
MG4V]14_D_P`<WD7ST^E_%J6U\^VOK9/AVU_-LIFWJ*EMO`M>:WO+YZ6D[;+4
MW3S_`.D8>_G4V]14_D_QS>1?/3Z7\6G3S_Z1A[^=3;U%3^3_`!S>1?/3Z7\6
MG3S_`.D8>_G4V]14_D_QS>1?/3Z7\6G3S_Z1A[^=3;U%3^3_`!S>1?/3Z7\6
MG3S_`.D8>_G4V]14_D_QS>1?/3Z7\6G3S_Z1A[^=3;U%3^3_`!S>1?/3Z7\6
MG3S_`.D8>_G4V]14_D_QS>1?/3Z7\6H7'GZ]M+D8>O;_`*5-O45+;>?#-Y%\
M]/I?Q:A86?0\R?#UOI*9MZBH!MP[#-Y%\]/I?Q?+4W3S_P"D8>_G4V]14_D_
MQS>1?/3Z7\6G3S_Z1A[^=3;U%3^3_'-Y%\]/I?Q:A<6?K\Y&'K_^M3;U%3^3
M_'-Y%\]")"+'3:EA9^MR63X>M;Z"F:V_^I4`VX"P,UO>7ST^E_%J/3S_`.D8
M>_G4V]14_D_QS>1?/3Z7\6G3S_Z1A[^=3;U%3^3_`!S>1?/3Z7\6G3S_`.D8
M>_G4V]14_D_QS>1?/3Z7\6G3S_Z1A[^=3;U%3^3_`!S>1?/3Z7\6G3S_`.D8
M>_G4V]14_D_QS>1?/3Z7\6G3S_Z1A[^=3;U%3^3_`!S>1?/3Z7\6G3S_`.D8
M>_G4V]14_D_QS>1?/3Z7\6G3S_Z1A[^=3;U%3^3_`!S>1?/3Z7\6G3S_`.D8
M>_G4V]14_D_QS>1?/3Z7\6I=<^_<V'?YS-?45+;=XYOWOGI:3C\7C[M-<^\G
M\GP]R<W\IFW)_P#V5+;?>]YK^\OGI]+^+37/O+?M?#O+S_RF:\NG_J5+;=XY
MO(OGI:3\6INGG_TC#W\ZFWJ*G\G^.;R+YZ?2_B^6G3S_`.D8>_G4V]14_D_Q
MS>1?/3Z7\6G3S_Z1A[^=3;U%3^3_`!S>1?/3Z7\6G3S_`.D8>_G4V]14_D_Q
MS>1?/3Z7\6H7'G_L$8>U_P"E3:W_`-2J0-NOQ,UO_=\]/I/Q:NDU7<[H$MWF
MR$+IVN5V_9L$I$WV5=&W7=IB5A`HNGZ?V/3M86G/6*VG6=%]'@O:]5\;<:]&
MHI2E*4I2E*4I2E*4I2E*4I2E*4I2E*U=<3_FX>/SHNTKSY]2E;1:4K71P]OO
MOQ`/G%\[_B/A^E*V+TI2E*4I2E*4I2E*4I2E*\)BCS/&DEVU@:D#,W76+W`:
M1M3EI$YB]T6'.#BM&65:UC%*Y:H,--&+40S!WO>]5233S,IE8L$14%S\55%E
M4>)0.`'@JVD4<;.R`!Y'+L?69N+,?&Q/&]>[5-7*4I5ILR_Y(M7])V&OZVH3
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M4I2E:NN)_P`W#Q^=%VE>?/J4K:+2E:Z.'M]]^(!\XOG?\1\/TI6Q>E*4I2E*
M4I2E*4I4@S`@TU^K]"WF_1IQN`!^"AX>]_[+U)8X-]>2_)V.S]6U[6TY:I+6
M%['C47\8J/6]FX=.73G\V^ENQR5`?UN`\OO>6FI1VGW*AUP>76U[:<^O['FT
MUKV^"ESXO'X1X*Y`#L.VH>;73SK_`+-5#B+T!O[U6HS+_DBU?TG8:_K:A-9F
M'_#?[N3\FU42?$_9_;J[-8E7*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*
M4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*QUW<3&38YVM[C<A0MU&R2^$81
MRA+(N\%IDBLQJD#!#'AT:'$"5>0J0J1HUR4LRP#BS"A]'0016UM6EZBRI\+8
M<[,Q3IRH<65E/B(C)!_8(KLO9WM6!OG7VR[-ND?-VS,W7%BF2Y77'),B.NI2
M"NI21<<1X*_$`#C)\2FX0WON:<];AM>_^;S$_/>UO_<:OE,>TWK:W_SS?9Q?
M,K]73_=C]AE_^PQ_\SE_\>I_EDN)3\9IS][W%'N&UJH>TSK8_P#US=H_U<?A
M_P#<JD_W9/8;^@4_YC+[?!_KZS:B6[7BO/\`LJGN]UXW>JHQ`(G/XY!6!B4X
MBQBM<)KZZ/K<P/KZ@7EQ1,6A01M8X]&X;D'W5&$F`"(%PUU\F_\`7F+TK@]6
M[ANIAV_.S^0HY",RQ#6&R39?24-'(H1;EBA](<*\IR_9U_=[C]JT?LDP.F5R
M=\;;I<F1QFY*K$R1-*D#`S&[R*H)8LH0.I(8&KIO>ZS=P?MARWN<QEQ9C,A,
M.)#8^RKF1RV>,^.P2*<281?K5"(^_P`H8^UG%X&7<9AETY!]B2@V&98(1:VR
M-XW_`*FV_IL]48'4!RMO.8,:.^(L)EDX%M&L7(CCN[\+*%()O6AVOV?>S:7V
MA;?[/-_]G0P,_.ADG,B;R^7R,>/XTTJ0R74%K(H9E+,>%_#CWM>X@7$%SZKF
MJ^><0R.X$@D#21RSK*)-BS&DJ>W=^F+Z5'8O'8C!&6)I'Z3*E;B9<2LTB_5(
M$P+FFWTN&U['3/4/66_JSY.]KAJ<S'Q80T*.\T^2^F,*BJ"(@+&24^BFI01Q
M)'7>T3V0>QWHJ+&CVCHG(WG<\I)Y1'%EY4,44.-'S9I9LB25HX[+PC0^E*WH
MKQ!J^#/N*XEK3G?/6'<W\1J%X59\`O\`%XP\SE?BS'4K5S-\G[BC;X&C@<!;
M8@@DSZ%X`N`>L,!H!K)L(1U^2VN1L6[];[GE9&#NF^18.7#N4>WHIBCE:7+D
MD,850JJ1$.#-,1I4.FH"[:>8W3HKV%CI/9NJ.E.B,K=SO6#/F)$F7D0K!C8J
M%\A\B=IGCC=;%8XSZ4Q'H<*C']Q?$O;,K;M,?YRX@9.'8OL_0-:Z?Y(0X"A6
M26UV#(9"VL4;`RQQCB;8^C$\%.A:FUK!,,*#801`]#<5L3;^I.L6PMQS=_WL
M8$>VYT>));'7(O/(90%'+0<+1,P-NPB^DW`N;GT+[#7VKIK-Z/Z-^]=PZH21
M\;';<9\1HTBB,DC2R23/&-)&CM`)X@FX!P@R9Q<M^,6F[ZPXXWNN65H6WFD`
M9)_;"$`@W?"48E*-/.[U7^%GNS1VLJ&,GHG#N(?5].WH;VKELCVE=8Q9,L,&
MXM+CI*523E1KS$'Q9-)2ZZO5;TAX:]5V3^[?['\[:H,O>NEH]OW:1+R8W?LF
M<Q&_Q>:DP1^%C=1;C;MJ@_EDN)1?37<TZ<_D]Q1;7Z>D'JR?:;UO8VSW!M]7
M%[WAC-;7_#'[##Z/W#'QX?\`S.7PO_OZ_:YL:R!+\K[/=MF3,@/(Y%.)WAR#
M2>6/QJ1"A,=WUV9$RIP7F(VQ,C;DPE!YEQ7`2466'70(;6Y*^I^ELS(W#IS"
MSLQM>5+C1L[6`NQ6Y/``5^67M7V;:^G?:5OFP[)%R-HP]SR(H8]3/HC20A5U
M,2S6`[22?&:RKK?UY]2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*4I6KKB?\W#Q^=%VE>?/J4K:+2E:Z.'M]]^(!\XOG?\`$?#]*5L7I2E*4I2E
M*4I2E*5B+O>SO(-O6W^3S2&L[H[SMX4-\(@QJ*,265MD<DTJ&:A1S67((JU/
M+DGA\,(L:Y+C>IZ`@)K$]*PC0UM-DVH;UNJ8$DBQ0:))'<NB'1$C22(AD*IS
M9%7EP@L+R.O@!JB6>/#@?.D0RB,*!&-1+N\B1QJ=(9M`=PTI4$K$KL`2*T_0
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MWAPDR%2UQ\TO:TJ3;ZVW;CVQ#0@9`'LA:+&3R=:Y;QV__P!:(`KK^@L85?H]
MJZ0Z<W`;5MTT`2`-M#"<,X;..;MF3FSQ,;Z#?(@01:5!CC=HR3=6&HWC?=WV
MU=TW/'+ODJ^_1)CE=4<";<<2/$G""TFK3D/)*VHI(=+`!18[AMA61IUD/$4X
M)GLF7SI5CC<#G/$4;G[L2A+>9Q"\<SUR8(Q('H]J2(&IR>;MY-DJI8E())5'
M)A&6`&XKVKS3K+"PL>7;LW$QUQ9<[:,7)FA6X5)I%(?2K$LBOH$JH2=(>PX6
MKK-DEG&9NFVR3/D8^#N3PQ2-8LR<J&72S*`',;RO%J`%P@!](-5S]P<BDK4S
M,J)JQ^]2="9/<2*QNZ!\B3:E)6D94B1A#2).^/C>X#4K1D`+`8$JZ<(C@W&,
M(0BO;GMM2*21B\BHP206(8W]!N/`5NY38=EQ>JG\8>2?(%-/#+%'NXJWW;'_
M`#A/DR?,JK4WJGX//3QAY)\@4T\,L4>[BG=L?\X3Y,GS*:F]4_!YZ>,/)/D"
MFGAEBCW<4[MC_G"?)D^934WJGX//3QAY)\@4T\,L4>[BG=L?\X3Y,GS*:F]4
M_!YZ>,/)/D"FGAEBCW<4[MC_`)PGR9/F4U-ZI^#ST\8>2?(%-/#+%'NXIW;'
M_.$^3)\RFIO5/P>>GC#R3Y`IIX98H]W%.[8_YPGR9/F4U-ZI^#ST\8>2?(%-
M/#+%'NXIW;'_`#A/DR?,IJ;U3\'GIXP\D^0*:>&6*/=Q3NV/^<)\F3YE-3>J
M?@\]/&'DGR!33PRQ1[N*=VQ_SA/DR?,IJ;U3\'GIXP\D^0*:>&6*/=Q3NV/^
M<)\F3YE-3>J?@\]/&'DGR!33PRQ1[N*=VQ_SA/DR?,IJ;U3\'GIXP\D^0*:>
M&6*/=Q3NV/\`G"?)D^934WJGX//3QAY)\@4T\,L4>[BG=L?\X3Y,GS*:F]4_
M!YZ>,/)/D"FGAEBCW<4[MC_G"?)D^934WJGX//3QAY)\@4T\,L4>[BG=L?\`
M.$^3)\RFIO5/P>>GC#R3Y`IIX98H]W%.[8_YPGR9/F4U-ZI^#ST\8>2?(%-/
M#+%'NXIW;'_.$^3)\RFIO5/P>>GC#R3Y`IIX98H]W%.[8_YPGR9/F4U-ZI^#
MST\8>2?(%-/#+%'NXIW;'_.$^3)\RFIO5/P>>GC#R3Y`IIX98H]W%.[8_P"<
M)\F3YE-3>J?@\]/&'DGR!33PRQ1[N*=VQ_SA/DR?,IJ;U3\'GIXP\D^0*:>&
M6*/=Q3NV/^<)\F3YE-3>J?@\]/&'DGR!33PRQ1[N*=VQ_P`X3Y,GS*:F]4_!
MYZ>,/)/D"FGAEBCW<4[MC_G"?)D^934WJGX//3QAY)\@4T\,L4>[BG=L?\X3
MY,GS*:F]4_!YZ>,/)/D"FGAEBCW<4[MC_G"?)D^934WJGX//3QAY)\@4T\,L
M4>[BG=L?\X3Y,GS*:F]4_!YZ>,/)/D"FGAEBCW<4[MC_`)PGR9/F4U-ZI^#S
MUB]O;G60%NSC=4D782EK0C4[>LP)U+HJEF,E"9O3G0!]`<N/3H)BJ7'$I`"N
M,0"2QFCL&]@!%>]K5SG5^/CITIN3+D(6[C/^YD\$3?B5Z'[)&)]J73=Q_P"N
M87B_.(Z^>(#[`'[D/G6KX3'97[CGM/OUVDA:8U6D+6'FI41BI,6L4D@ZTU.C
M,/+`K4%%:7L8<0GN(8`_[(5K!Y=:RL-<=\J),MVCQ&E19'4^DL98:V46-R%N
M5'A:P\-JMS'(7'E;%4/D<I]"DV5GTG0I/@#.`+^`$FXK]0F5YSM9RKPRMUS-
MAK/CF'#&,T&W&&PR*J,-RIB-A+]$P$+BV522N7)S)(\9<FARA4Y/1)))*09X
M1&@,L7K?W#K_`#=CW?H3(W+:<HR8*;LBXL0A:,!,?%,<.(%8W0%=4K3L+%W8
M$=EO@CH;9O:!TW[?>G6ZKV>,=59N-N<N5-WV&7GB=V#Y&H+9$Q(0D46.Q9W5
M+(RZJU?[L>GBC81P_<$-0[)[9,:)]N@GQ1!EA^NTAD[YWO1$:JY8M+^M<>!8
M!0;^B`(T5];:Z6XOV@1"`=/=,8A5\7$V:'(LND:LG<B)V9@;*2$TH"0#I'$D
MDFO>/96?UC]I_7'7&41S(,^':,>X)T08D>J72>'!YM3$WX@"X)%4UM>V:[IF
MC-C@XQ6$X\*W#X`3P+*K!MWS$F;7*0Y#8).?_('Z*Q]4<.-/R9B1#"X'A.7$
M&IP!+/!:XB[6K-Z,Z>ZFV[>GW+`BQ9-]VS/B@GQ)C]+$DI0&?TCH18U<L9$)
MDC.EEN2`;WM#]J'LYW#I*'$W++S?U%WN+(@^\\)I!%"T`!:&20`S1M._T2KR
MBLGIQDA2:S,RI@:4Y"XEVX'+.T)[Q/ES*.%9;C_(R_$>174J<K)C.)*D2I,B
MDP$MY&%DDS+BYZ,$8,)J\L;6$LJY5A7("$.RV#:,F#KK<.H.B6QL_`Q=\:()
M.RF0XN0X8YBR-P,<;<WZ<,70K<*3I+><[=UE@;9[!MAZ4]J\>X[5M>[[5-!W
MK&5H8X4QR>[19'+]..3*0+Z`C*SAG#D!VO=EX%N/1[R=_P`3PY<I8^?I0\2C
M$;]DJ'O"MKF.3I6Y&+!*)VBQ&^2XI;'G*'P>1KSR'8)I@C248B@%:=6'3)V,
M=0P;CNJ>S[(AR^GQU(A=9-#3R0!Y.7/(TGHR8GIS([JQD(TG5:Q;GG_4G(]F
MO14GMXP,W&9-FRX\6:,/%A0$!1"F3'#:6/)GB2-X!;EEM9-RQK5;Q/@8L*WP
M9K+Q$3%DT<`LC?K^3"NI#%`Y+O&&OQF>LH48A(+$WF0EG3L1?JNMZ>G^RKS3
MJT[0>K-T7I\WV09\O(X"PC!-B".!0\>7[EAV`5]&^PJ7J2;V/[$W5SY,F\C%
M:_/)YHA,K]UUWXEN1RPU[GLOV5@-^W;D\WEMV;Z6M7/#3V.;#_+QUZPOQA_G
M#\-?0.X=TWGJ#8KM+1MV%Y6^(DV!L=$IG='*<;I$KB27'T@"U:=,Z2]&X$E*
M`6L,(3BBS`VOH(-KZVK[AZ$AQY.C=L<Y"`G"B/Q7]4>)2*_$CVXEA[8>I>!/
M\M97B^M;W:S+\8>2?(%-/#+%'NXKK.[8_P"<)\F3YE>5ZF]4_!YZ>,/)/D"F
MGAEBCW<4[MC_`)PGR9/F4U-ZI^#ST\8>2?(%-/#+%'NXIW;'_.$^3)\RFIO5
M/P>>GC#R3Y`IIX98H]W%.[8_YPGR9/F4U-ZI^#ST\8>2?(%-/#+%'NXIW;'_
M`#A/DR?,IJ;U3\'GJ%\AY*T_[@9I?Z'?EBCW<4&-C$\<E`/\V3YE-3>J?@\]
M75:E:M<WI%:YM/9U:A.4:I:E1Z)4I0'##:YB4Y0W*%:$XPD5^C<11AA=[\PK
MUB-8.54AE'A%^/[!%5UZ-12E*4I2E*4I2E*4I2E*4I2E*4I2E*5JZXG_`#</
M'YT7:5Y\^I2MHM*5KHX>WWWX@'SB^=_Q'P_2E;%Z4I2E*4I2E*4I2E2#+`:`
M99@`F%F`$686,-A`&`=KA$`816N$01!O>U[7Y+VJ&574JP!4BQ!["#52,T;A
MT)#@@@C@01V$'QBK4F8$P::XP1W-PUBLQUQ<58C&;D/'T3$OQZ2$WM@),(5W
M:;GQ4H"B_66"A$1:P_16Y>6MJN^;TAG9,S*#92!)B)7O*BC2JR>EZ:A?1`:X
M"\.SA6"=NV]HTA:"$Q1.SHNA;([L'=E%K*S.`S$6+,`QN0#7@1+;9@^(&L"E
MOQA#ECO%9;-9S&9&]QQE>)%&Y7D)Z5/\O>8\\JT`E;"L>W%8(1PD8B.G:P;"
MUO;6IDZ@WIP(ER9DA.%%B,J.RAX(!:**0`C6BW)`:X!)L`#:K?W9@O))++$C
MO)F/E'4`ULB2VJ5;WTO956XL;*O$D7JKR<-8A3FSX]/BS'1!^5@C#E`XF%1L
MLW(P3"#DHPSHP#:$<L"-.I,!>R^Y^H3!6OR"OKCON.X/CP8;SS'$QFU0H78I
M$UP=4:WLANH-U`-P#X!64N/`F4^<B(,V1`C2`#6R`6"LWQBH!L`3:W#LJJHO
M%8Q!X^U1*%QQBB,684@$#)&XRTH&)A9T)=Q7+1MC0V$)4"!,`0KWL`HL(=;W
MOIRU;R\S+W#);,SY9)LMS=GD8N[6%A=F))L``+GL`%1C8N-A0C'PXTBQUO94
M4*HN238``<223XR23QJA<S?Y)-7])V&OZVH356'_``W^[D_)M5<A.G]G]NKL
MUB6%7*5%A2E+"E*6%*4L*4I84I2PI2EA2E+"E*6%*4L*4I84I2PI2EA2E+"E
M*6%*4L*4I84I2PI2EA2E+"E*6%*4L*4I84I2PI2EA2E+"E*6%*4L*5BAONM;
M\B?=QR6_LWYH_J\D%<[U6!^K&Y?Q*;\DU>A>R4__`.TNG/Y[PO\`J(Z^;:#[
M`'[@/G6KX?'97[BMVGWZFJ;V[*CPW\-<EC30EC*"<<$HRX1&$A-,"28('V`C
M"K"L68('8O>U[V[%3J:P%S85&E;WL-7CL+^/M]_C01IIG5V-,,."5:P2@'&F
M&`+!:^O5@",0K%E7[(0Z6JI7*N'/$BW;Q!`X@'QCW.RU2`%^+POXN!]_W_=J
MOLCY0F>59:.;2YP($]!:66/H`LJ4#&W,L?CK8G961@96Y"(`&YI;FU*``"PB
M%>]];BO<0A7K*S<[)W#/R-SR7+9N3)JD(]$7L`%4"PY:HJ)&B@*B*%\%:?8^
MGMIZ=VE-FVV*V$A9OI#K9F9V=G=FN7D=V+,QM?M\54`6::298XDXX@ZW3T/)
M.-)/_A;WN;_#%B"9_"WOZ+E]%V:PU9E&E20+6X&W#Q</![E;AK.+.`P]T7_#
M[YJ)1IQ!G6D'GD'>CMUQ!QI)VAE]3+=:4,!E^LORBY>6_/0,PO8D7%C[WB][
MW*$!ETL`5X<"+CAV<#PX>#Q5Q^;]'6][]F][WN*][WY[WN*^M]>>]1<]G@JI
MF9C=B2:C2Y'9[GX:A?C#WQ^&OHQ<-?\`L!;/O[OV-?Q<1U]L]$@?JCMO\3B_
MT17XE^W#^V#J7^>LK\JU9N5U%A7EE*6%*4L*4I84I2PI2IM2E*4I2E*4I2E*
M4I2E*4I2E*4I2E*4I2E*5JZXG_-P\?G1=I7GSZE*VBTI6NCA[???B`?.+YW_
M`!'P_2E;%Z4I2E*4I2E*4I2E2W%8//?36HOQMQJ+@=O^7AJ'6`TM?I6TORVO
MYMO-^E2X/94]O9?R5#K`_1\SF_5K0&YL;@\>WW*7MP/"HV,!?72_-S_0^G].
ME_#X*@&X!%['W#4UKVOS7UJ1QXU-6GS+_DBU?TG8:_K:A-9>'_#?[N3\FU6Y
M/B?L_MU=FL2KE*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4
MI2E*4I2E*4I2E*4I2E*4I2E8H;[O[$^[C^[?FC^KR05SG5?]&-R_B4WY)J]"
M]DO]J/3G\]X7_41U\VT'V`/W`?.M7P^.ROW%;M/OU-4U%*4I2E*4I2E*4I2E
M1MST/F_"*E?C#WQ^&OHQ<-?^P%L^_N^XT_%Q%7VUT3_1';OXG'_HBOQ+]N']
ML'4O\]97Y5JS<KJ*\LI2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2
ME*4K5UQ/^;AX_.B[2O/GU*5M%I2M='#V^^_$`^<7SO\`B/A^E*V+TI2E*4I2
ME*4I2E*QOW6[@F/;/AF1Y-<R4KH^6&CC&/(JI7)6X4XR7)CKML)B)*I6>G+)
M"Z.XPB4&]*W:Z(HXZ_H2[UG[5MF9O.X)MV%<2E6=FLQ$<42-)-*P7B5BB1G(
MMQL%'%A4/+!CQ/E9988<8&K3;42[K'&B7X:Y9'6)+\-3B]A<UJD9.)YG9ZQ[
MA?()<9Q`(A-@[`F9,_-*-,_+@OI^;\Z"PVJB^+'<B4W)CQ\,*0JEW7+2G7MT
M_JR+A)M>YE>NR^S;IZ#J#+VCFYCP/N4&#B.="N&FVULWO$P*<8]>B,1KH8*9
M/3U(`?,XNK]VGZ>@W4ICIEKM^Z9\P.IEY.W9L>*,="K>C+(A=M9++J"632S6
MR7W4;W<F82SLY0Z),,-78]Q5&]NDKRDFD3>['2N8H-Q&;UF($J.#.B)Z0H(^
MKA:1`-RN-2C<`N)XK)M"+6ZV_+=&](;=O^`<C<GE6?)W";"Q^65TQR0[=)G<
MV4%6+([".&P*:5+2`FVD])U+NN7M6D8(C]#:IMR<R*3KBARX,8PH`5*.0\K\
MPAPI$:Z>+$8VJ>)_F]O;WEV51#&BI+E1F7N6`2"6R0D*(*>1NV;MKR8C+`Q2
M8TJ6D72/R1^&-#ZSWZ\HU#:V@@J+;W;_`&<[3N)PMO265-Q!VY\MSH,;IGX$
M^>W(4J&5H>[F`$L_,UK)Z)!0ZK=.K,C:EW#<Y41MLA?>(8(S=9#+M;8\8>20
MDIR\E\C45"JT80"Y+7&S?9YFV79OQQ,5L_0L":<8RS3EK"<H7Q1*N;XS)'+%
M\L5Q\N4LC4Y+W9>S)'YO+(/&C-5JKI3Q&%V.,L&PK\+U-M.W[:V!E[691@;A
MMF/EJDA#/$905>,LH4,%D1]+!5U*02`;UTFTY>7)E;AMF<8VRMOSF@+H"JN#
M%%.C:26*-HF5774PU*2#8BJIS_-69@8V9K7II,<I-G^(W(`VB&2]_163),JQ
M$\T!CFQL;@W%+1`2CZM,(VR@T5PA``0AAM?4;=$\TA9"E@D@-W4?N&\!(-;6
M5E46-^VJN\<\._!V2/>;RY[B:M=RG\<7VD?SZJYB^[3QSP[\'9)]YO+GN)IW
M*?QQ?:1_/IS%]VGCGAWX.R3[S>7/<33N4_CB^TC^?3F+[M/'/#OP=DGWF\N>
MXFG<I_'%]I'\^G,7W:>.>'?@[)/O-Y<]Q-.Y3^.+[2/Y].8ONT\<\._!V2?>
M;RY[B:=RG\<7VD?SZ<Q?=IXYX=^#LD^\WESW$T[E/XXOM(_GTYB^[3QSP[\'
M9)]YO+GN)IW*?QQ?:1_/IS%]VGCGAWX.R3[S>7/<33N4_CB^TC^?3F+[M/'/
M#OP=DGWF\N>XFG<I_'%]I'\^G,7W:>.>'?@[)/O-Y<]Q-.Y3^.+[2/Y].8ON
MT\<\._!V2?>;RY[B:=RG\<7VD?SZ<Q?=IXYX=^#LD^\WESW$T[E/XXOM(_GT
MYB^[3QSP[\'9)]YO+GN)IW*?QQ?:1_/IS%]VGCGAWX.R3[S>7/<33N4_CB^T
MC^?3F+[M/'/#OP=DGWF\N>XFG<I_'%]I'\^G,7W:>.>'?@[)/O-Y<]Q-.Y3^
M.+[2/Y].8ONT\<\._!V2?>;RY[B:=RG\<7VD?SZ<Q?=IXYX=^#LD^\WESW$T
M[E/XXOM(_GTYB^[3QSP[\'9)]YO+GN)IW*?QQ?:1_/IS%]VGCGAWX.R3[S>7
M/<33N4_CB^TC^?3F+[M/'/#OP=DGWF\N>XFG<I_'%]I'\^G,7W:>.>'?@[)/
MO-Y<]Q-.Y3^.+[2/Y].8ONT\<\._!V2?>;RY[B:=RG\<7VD?SZ<Q?=IXYX=^
M#LD^\WESW$T[E/XXOM(_GTYB^[3QSP[\'9)]YO+GN)IW*?QQ?:1_/IS%]VGC
MGAWX.R3[S>7/<33N4_CB^TC^?3F+[M/'/#OP=DGWF\N>XFG<I_'%]I'\^G,7
MW:>.>'?@[)/O-Y<]Q-.Y3^.+[2/Y].8ONUBWO>RU%'/9MNL;DR"?@4+=O.84
M9(EN*,H-J0)RF`/Q10E+@XQ!*@1)["%J,XXP!18=;C$&UKWKG.KL.=.E=R<F
M.W<9S_"1^")OQJ]#]DCJ?:ETYV\=\PA__D1U\[H'V`/W(?.M7PJ.ROW';M/O
MU-4U%*4I2E*4I2E*4I2E1YN7Z7T^>W-;GO>]2%+<`0/_`&54OQA[X_#7T&>'
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M*O1G6M?T19Q8#`WY+AM6,P*L5-KCQ$$?L$$@U7<'LKO5%*4I2E*4I2E*4I2E
M*4I2E*4I2E*4I6KKB?\`-P\?G1=I7GSZE*VBTI6NCA[???B`?.+YW_$?#]*5
ML7I2E*4I2E*4I2E*52LP@T,R$S&QV=Q2.S%B.'8T;1)V5N?6ZQX2S2@*0(W1
M,J3EJBBSA6`;8-A@Z5]+VUJY'--`W,QW>.721J1F1@&%C9E(87'#@:>CPUJK
M)=3I8!E)4AA=6!!`(!L01PK%UNX?NTYG0XG:VC%B=I:,,MK8RP]G;7^2H6E6
MSL<I)G+$U3-N3.Q:2?(&2:$!=DA;R%:$E?J<'T0A:]:_7W54F5E9TN3KRLO1
MK9D0D-'"^.DD=U^BD$$CQ\R/2VEC<WXCGDZ6V*/`CVR*`)A1M,0JEA<9$JS3
MQL0;O%+)'&SQ,2AT*--A:O.8=AN""'EFDTO0O\[EC/,WV8@=WN3R@M*Z"79*
M<<K1J/21EL^*$4KC6.YDX76L*-TNM);%5KFIPE6O8%L>+K3><2!,/;S'!`N%
M#!943MB@;%,ZG3]'D20.\4DJ:7>(A69R"QKGZ?P<R6>7-#2"?+FFMJ(LL[Q2
MMC\""<8R0Q2&$WCYB:M"W(KWP;$-KH19-Z>-^O+RNE5HI"G4R24*$S,D73,S
M)*PB`IS7@1..BS\CF=\%[,MD/_7``*K:&`!<-M.K^HHL?"QH<@HNWR1/"RJJ
MNIQXS%!J<#7((8F:*,.6"QNZ6TLP.6^S[;+E3Y<T2NV2DRR*UVC89`09!Y9.
M@-/RXS,X4,Y1"3<`U?;%.)H+A6')H+CUI-:F(EQ>'M4-:Y.3V\/4AD;DI>9%
M))"_/*I<\/T@?G=8:I5K%1QIYYH[W$+FTUFZ[OG;SDKE9S*62)(T555$CCC7
M2D<:(`J(H'!5`':>TDU>PL#'V]'6#47EE:21F9G=Y'^,[NQ+,QL!<G@H"BP`
M%>=F;_))IOYF3\,_UM0FK&&!SC_X<G^@U9,A]']FKLUB6JY2HM2E+4I2U*4M
M2E+4I2U*4M2E+4I2U*4M2E+4I2U*4M2E+4I2U*4M2E+4I2U*4M2E+4I2U*4M
M2E+4I2U*4M2E+4I2U*4M2L4-]W]BC=QS_P!F_-'9OY/)!7.]6"_2^Y`]G<IO
MR35Z%[)?[4NG/Y\PO^HCKYMH/L`?N`^=:OA\=E?N*W:??J:IJ*4I2E*4I2E*
M4I2E*C4$`CB+U*_&'OC\-?1BX:_]@+9]_=]QI^+B.OMGHA0O2&V@=@PXO]$5
M^)?MP_M@ZE_GG*_*M6;E=3:O+*4M2E+4I2U*4M2E32FE184I4TI2E*4I2E*4
MI2E*4I2E*4I2E*4I2E:NN)_S</'YT7:5Y\^I2MHM*5KHX>WWWX@'SB^=_P`1
M\/TI6Q>E*4I2E*4I2E*4I2E*4I2E*4I2E*M-F7_)%J_I.PU_6U":R\/^&_W<
MGY-JMR?$_9_;J[-8E7*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4
MI2E*4I2E*4I2E*4I2E*4I2E*4I2E*Q0WW?V)]W']V_-']7D@KG.J_P"C&Y?Q
M*;\DU>A>R7^U'IS^>\+_`*B.OFV@^P!^X#YUJ^'QV5^XK=I]^IJFHI2E*4I2
ME*4I2E*4J-N>A\WX14K\8>^/PU]&+AK_`-@+9]_=]QI^+B*OMKHG^B.W?Q./
M_1%?B7[</[8.I?YZRORK5FY745Y92E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*4I2E*4I2E*4I6KKB?\`-P\?G1=I7GSZE*VBTI6NCA[???B`?.+YW_$?#]*5
ML7I2E*4I2E*4I2E*5;7+>2+8H@SK-N\V83V[68B+[W(0F9CGDX*Q64E,7GJI
M(]1R.,S(TEF74KW!P7I$:)(4,TTP(0UD8D"Y.4F.\D<,;7O)(2$4!2Q)L&8F
MRV545G=RJ(I9@*MSR&''>=5>1D6X1!J=S<`*@\))([2`!=F(`)K$QCXB&)92
M_;=XM&XC.E<DW(05=D6+,C\NQI`G)BC+9*D,-6F/"2?Y"C)SVY7>5@KI4C`%
MY/<$A`U"0)Q-P#'VLOL]W;'FW-)Y8!#M30K*ZB:129XI)D`$<3NFE(SS>:L?
M)9E272UP.;?JK"&+B9$<<K29LV5'&EXDXXDB12,9'D6(H[2*8661N<GII=;$
MUSF7>WB7!^56;%,J;)FO6'HX`Y3*5,+8U*XKC!KRM.S,9XW<IN>K>D#N!+*I
MJ2-*&[>C7B2%AN>I"21>QE]5T_TEN74>+-E831((Y&BC$A*F>9,=\MX8K*1K
M6",OZ916)5%8NVFMCO.]8VR<OO*NY>"2=P@!,6/%-#`\[@E?HQ+,J^AK?T)&
MTZ4)JU/RG>`"P9".5,.2T:6)MZMTA2L]C8;I\WHT>7O$*,6*S"9,;VR:9E<P
MAL`6[V:#+EJB5>ED@KG!SX>@-[R8,&3':!\G-?&'*U$20+EX[96/)/J4(J/C
MI)(2K.4T,C`2:5;$R.I]LPY<P99:/#PTS"TQMRG?;]`RXH[$L9(WECC`*A7=
MK*Q`8C++`V<XIN"@I\VBK>_L0VF62Z`RN*RM(C126(3F"/JN.2N,/13:O=6H
MQ6V.B(5@G)%2E*H)$`THT8!VO6AWO9,C8\B**62*;'R,:+(AEC+%)895U(ZZ
ME5QX596565E92.%;+;]P3.,\1C>'+Q9VAFC?3JCD4*UB59E(9'1U96(*L#>]
MP/,SS,(DR1]G;7N4QQF<3,AX@<"T+L^-;:L,;TV5X>:I7%I5BLD\:-.4G,$8
M;8/0`$L5[WM8-[VQ<"*:24M&CLHCD%P">.AO<K+D("V)%[U6_C>Q/Y3\>>&L
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M>Z]O;\BP1<N6;=LQI4B)'+X\I5JE1^/WXLA,F3$N(SCU!Y@K!```;B&*]K6M
M>][5SG5N+E)TMN3M%(%[C.?BGP1-[E>A^R4J?:ETYQ''?,+_`*B.OG3@^P!^
MY#YUJ^%QV5^XS=I]^IJFHI2E*4I2E*4I2E*4J/ZOUZ`%N"]O^7CJ5^,/?'X:
M^A5PYLFXV:MAVT=N=,A0=M<$>`\<)UB!?+&%&M2*"H\D`:0J2J'`L].>4.UP
MB`,(1!%:]KVM>U?<'0^-E/T?MKK%)I.'%^Y/JBOQ*]N#*/;!U+<C_O65^5:L
MT/&]B?RGX\\-8UW3KJNZ9?U4GR3YJ\KU+XQ3QO8G\I^//#6-=TZ=TR_JI/DG
MS4U+XQ3QO8G\I^//#6-=TZ=TR_JI/DGS4U+XQ3QO8G\I^//#6-=TZ=TR_JI/
MDGS4U+XQ3QO8G\I^//#6-=TZ=TR_JI/DGS4U+XQ3QO8G\I^//#6-=TZ##S";
M+#*3_FGS4U+XQ5<H5Z)S2IU[<K3+T*LD"A(M1*"521409;I%G)E)`S"3RAAY
M;"#>X;VYKU88%6*,"'':""+557;J*4I2E*4I2E*4I2E*4I2E*4I2E*4I2M77
M$_YN'C\Z+M*\^?4I6T6E*UT</;[[\0#YQ?._XCX?I2MB]*4I2E*4I2E*4I2K
M89<8\DR"'*4&)I=%(9-.W6P]*YSB''3R)K6U.M*->6%\CB1]C2\Y"^-H3$XC
MDRY.>1<=A@O?3HWO8DF)'EQON"-+@<0Z*VEB""`RL58!D8AUNK*2+,I4FK.2
MLSXTBXSB++*^A)IU:6!#<5N-2L`58`@@-J4A@#6MU3PTWHW'6)L36R;CU=%(
MZ<P.6398ZX93*<QN3HS9O59X-(Q)D0F4$*,<Q<<E7&H$34I3NR=L06L(C^'N
M,8O1H/:#C0[[+O:XN5S$6'NT8R2$8X^&<%#FJ4MDLZ6>1[QNQ+("(V"CE,CI
MK(RMLGP99H3)G#,$[<G4(US9EF=<,%KP+&05C%V0FTCJ9!>NS*=B.6,X3I;D
M/+^3(XRF3A[BK!E:+,T0ZU7(<5X)SV\Y=P,BCKHBDPVZ,2@U&K+;Y`H/`Z%J
MT8K")`E4VO>UK:>LMIZ?PX,3"QWF>%4RU+/81[E+M[864UBFIL<:UDC0:&66
M.VMXB=5W==FW#>99S-+'&A7)PD.G43MDN3#DHIM:V2'B<<TDCES&Z!E6U/&\
M*P*U+*FYPS"4)NCC4O;=N(4L/-`IQWVWN'1[F23L@&FR(XJ=C1S=I1M@0H@-
M`1L91@+_`,I'90&[A>TMMNCP<G&Q5.X1MA#*9F^CGCP<2;!C5$5`8^;#D2-*
M2S#FA&0*H*FWF])0[E)EXF7(?N?)^\I$0#Z2.;=3`^0W,-U*1OCJ8$T?%9@Y
M:P-9];7<$J<`X^?F!XDI$OE\[R9D/+\^D"!J-8F5;-LF2%1(GPF.,BEQ>%K3
M'&X9P$J(E0L5*`DDVN8:,=[WKD^H=[CWF3%BQHVBV_!P8<6%78,YCB!]*1@J
M@N[,S&RJ!<`#A6[VS`FQ)<O,RW5\_.RVGE*J50,4CB545BQ"K'$@XL23<^&P
MJG-C:W*HNT*%*!$I/#DK#A(3E"1.>98DS+,,"8389Q8Q6*,",5A!YKVO?S:U
M6#=)B$)`,<A/R&K8R`%;D>&KF=[<=_`++[%H?XBL?F2^LWEJO2OB%.]N._@%
ME]BT/\13F2^LWEII7Q"G>W'?P"R^Q:'^(IS)?6;RTTKXA3O;COX!9?8M#_$4
MYDOK-Y::5\0IWMQW\`LOL6A_B*<R7UF\M-*^(4[VX[^`67V+0_Q%.9+ZS>6F
ME?$*=[<=_`++[%H?XBG,E]9O+32OB%.]N._@%E]BT/\`$4YDOK-Y::5\0IWM
MQW\`LOL6A_B*<R7UF\M-*^(4[VX[^`67V+0_Q%.9+ZS>6FE?$*=[<=_`++[%
MH?XBG,E]9O+32OB%.]N._@%E]BT/\13F2^LWEII7Q"G>W'?P"R^Q:'^(IS)?
M6;RTTKXA3O;COX!9?8M#_$4YDOK-Y::5\0IWMQW\`LOL6A_B*<R7UF\M-*^(
M4[VX[^`67V+0_P`13F2^LWEII7Q"G>W'?P"R^Q:'^(IS)?6;RTTKXA3O;COX
M!9?8M#_$4YDOK-Y::5\0IWMQW\`LOL6A_B*<R7UF\M-*^(4[VX[^`67V+0_Q
M%.9+ZS>6FE?$*=[<=_`++[%H?XBG,E]9O+32OB%.]N._@%E]BT/\13F2^LWE
MII7Q"G>W'?P"R^Q:'^(IS)?6;RTTKXA3O;COX!9?8M#_`!%.9+ZS>6FE?$*=
M[<=_`++[%H?XBG,E]9O+32OB%.]N._@%E]BT/\13F2^LWEII7Q"G>W'?P"R^
MQ:'^(IS)?6;RTTKXA3O;COX!9?8M#_$4YDOK-Y::5\0IWMQW\`LOL6A_B*<R
M7UF\M-*^(5BIOI8&(C99NT/(96@DXK;CF8PLTML0@,+,!CV07`,`PD6$$8+\
MMKVY;7YJYSJV25NEMR5F;3W&<=I\,35Z'[)`H]J73G`?]\PO^HCKYP8/L`?N
M`^=:OAP=E?N*>T^_4U344I2E*4I2E*4I2E*4Y_U:_2OI?DOI>GE_8J5^,/?'
MX:^B=PW6)C4[!]H)Y[*TG'&X`QL,PTUN1F&&#%'$=Q#,,&2(8QBORWO>][WO
M7VUT,7CZ/VU%9K##B';^**_$KVX`'VP=2W'_`*SE?E6K-?O;COX!9?8M#_$5
MU?,E]9O+7EFE?$*=[<=_`++[%H?XBG,E]9O+32OB%.]N._@%E]BT/\13F2^L
MWEII7Q"G>W'?P"R^Q:'^(IS)?6;RTTKXA3O;COX!9?8M#_$4YDOK-Y::5\0I
MWMQW\`LOL4A_B*<R3PLWEII7Q"O5))*3EA*(+`24`-@EE%``66`-K:!"```A
M"$(;6TM:U4>&]37+2E*4I2E*4I2E*4I2E*4I2E*4I2E*4K5UQ/\`FX>/SHNT
MKSY]2E;1:4K71P]OOOQ`/G%\[_B/A^E*V+TI2E*4I5K\IYAQEA5H9Y%E>=QW
M'L>?I4R0IL?94X`:60R32(1Q;*U*70\-D+<-P,3C"`U282185M!#M<0;7S-M
MVS<MYSAMVTPR9&>T;NL<:ZG98QJD(7M)5>-A=F[%!/"K&5D08>,^9E.$QH].
MIC\50SJ@+'P#4P!8^BH-V(%R.I`\XXERC*Y_#,<Y%BTWD>*G%J:,BML9<BGD
M,1=GI*H6M[0[+T-C6TIV&F3#N:G"<,Y/</1-"`5[6O5/M&[8>WX^Z9D$L6!E
M,XA=E*B7EZ=92_%E&H`N!I)OI-P;64W'"ES&VZ*5&SHXUD=`;E5<E5+$<`25
M-E-F[&(TD$W;K!K-J%PVOSVUTIVBW@I87OX:AT`<GH;<G-2PIP[.%.@#_:V[
M/8\WGY:BP/;2G0#YEN;3ZE+#RT(![:C:UK<WTZ``"P[*5:?,O^2+5_2=AK^M
MJ$UF8?\`#?[N3\FU6Y/B?L_MU=FL2KE*4I2E*4I2E*4I2E*4I2E*4I2E*4I2
ME*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E8H;[O[$^[C^[?FC^KR0
M5SG5?]&-R_B4WY)J]"]DO]J/3G\]X7_41U\VT'V`/W`?.M7P^.ROW%;M/OU-
M4U%*4I2E*4I2E*4I2E1MST/F_"*E?C#WQ^&OHQ<-?^P%L^_N^XT_%Q%7VUT3
M_1';OXG'_HBOQ+]N']L'4O\`/65^5:LW*ZBO+*4I2E*4I2E*4I2E*4I2E*4I
M2E*4I2E*4I2E*4I2E*4I2E*U=<3_`)N'C\Z+M*\^?4I6T6E*UT</;[[\0#YQ
M?._XCX?I2MB]*4I2E*5J%XM&5,2!QVQ;<<IP/<3DF*Y&;'[*V78SMY7P]E6$
M[>\-J&E;DMUR([3!6B--QT2:](K+T+(.S^K#:UDMPWL+7T3V:;?E/OIZ@AEP
M8(]N:(+)F+(T(RLIS'AV2(%VE$J%X[CDJ4)F!7T3H^ILB6+9SMV/%/D9VYF3
M&BB@*+,ZB/F9`5I/HT#0@Q,6-R);)9K,(\)YFP\VQK-3AM6Q7G#%6T"23-CD
M>"T>534S?!Y48[(7!1,YC@R(.:2V08[CYY7W3WL:^J3KKC`]8D`4G"&PMI[3
M9>H.3M^'UGE8F1U?C":*98Q?)BB1EY4>7(IY+-J,CHJ+K0,>83=0.<Z178^^
M9&1TI%+'T[(D;:^S'FG(4,T"MZ9(15BD>XC)0:`3J(V\UY/7?U0&3,H0;#\3
M53?(CV)BC:1:U-@E1+4]/RY4Z/C@G:69J:V*.-SN_/+HZ.2HLDA,D3'GFF#M
M8(+UD8F+D9V2F'BKJR'O87`%E4NQ9F(55559F9B%5068@"]6IYHL7&DR\A@N
M/$NIF/@%P.SM))(``!+$@`$FU65_+<VK7MBD8<RQPPG-B1"OQPJ)12$Y"[)'
M.0EQ!M.=UY3,-'#`KY>9ZT$V>S&ZYKJ$2,-KJ0#*#T"]%]4-E9>$N&YR<(*9
MEU)PUQ-.FCTK2EX$:9!$7+1#F*"EC6K?J'9H\:++>=1!+),BDAKAL>589]:V
MU1B&9UCD:0*J.P5B#PJMY[N4P=C#($0Q=/,A-<<G4Z$VVCC(J1O)X#;/;U>-
ML`W=V0MJIDC!,BD=KM[:-T4HP."ZUTZ>YIMK@MKMKV'=]Z@R,G:X&FAQ@3(0
M5%K1M*P4$@NRQ(TK)&&98U+L`O&LO<-RP=K$39\@C68L$)!/Q6B1F;2#H0/-
M$A=]*:G5=5S:J,*WK;6SC,IE`S`PV'AA.H69"L:W2,BS<D2R95"3U3((]E+#
M-TY<T1&,UQL=W(/KL&R.U^V1!*ODCI;J!L3#SDQ9&Q\^2..`KI8NTJ"2(:`2
MZ<R,\R,NJAX@TBDHK,*#NVW+EY&"\JKDXD4LDH-PJ)`H:<ER`A,(9>8JL60L
MH8`L`;S8QRE`<R0YOGV-)(EE,4<E#DB(<4Z=>A.(<F5P4M+RTNC4[)$#PRO3
M.Z(S4ZM$L3D*DQY8@&%A%:]JP-TVG<-FRNY;E&8\C0CCBK*R2*'1T="R.CJ0
M596*D'@:O86?B[A$TN(VI5=D8$,K*ZFS*Z,%9&'A5@#8@VL0:\3,U[6B33KV
M<GX9_7RU":LX9'._W<GY-JOR#T?V?VZNU6'<5<I2XI2EQ2E+BE*7%*4N*4I<
M4I2XI2EQ2E+BE*7%*4N*4I<4I2XI2EQ2E+BE*7%*4N*4I<4I2XI2EQ2E+BE*
M7%*4N*4I<4I2XI2EQ2E+BE*7%*Q/WW7M^11NXM__`,WYH_J\D%<[U7_1?<CX
M.Y3?DFKT/V2B_M2Z<_GO"_ZB.OFW`^P!^X#YUJ^'QV5^XC=I]^IJFHI2E*4I
M2E*4I2E*4J-0;6XV%2OQA[X_#7T8N&O_`&`MGW]W[&OXN(Z^V>B&4](;:0>!
MPXO]$5^)?MP_M@ZE_GG*_*M6;E=3<5Y92EQ2E+BE*7%*4N*4I<4J&MK\UZFE
M1I2E*4I2E*4I2E*4I2E*4I2E*4I2E*5JZXG_`#</'YT7:5Y\^I2MHM*5KHX>
MWWWX@'SB^=_Q'P_2E;%Z4I2E*4K1GQ2&?:3*MP>#H5N8W2Y4V?F3'`6?(ZER
ME$LMXLQ1`Y-!'9YQXAF^*YHMR-''TYW5RL*A.:G(2B*#U"0_IZWZ-[>K>S1N
MH8]NWG(V#!Q=S:*3;W?&DAFF<LKY)AGB$+H5,#ABS-<`NEO#7,=6RXL,>V/F
MSS8:=[R.7DQLB<E^[C4KO(&`$R<%`%[H:RHX=*+`C9$9LS8"W]2_?3'&-3%&
MDY3*\QXRRX3B5*WLYR1EC+(?C6.1].P(W-N(L9U*NQIAO:X1`O:P;ZX'M#FZ
MAR7QLKJ'88MFR)7F?FKCS0ME.S!I"YF=@Y0^H!;4;W)%8/2>/L^(QQ-GW23-
MABQXT6(RQR+%&MU0J(U4B]M-R2+*`!PK9)7G%=K5I,V"GUH`ZE8Z@T=R2]+1
MI&URA<EF2N`I'J+.2@"*4$H)4D:W>[<^%LIQHD?6%@*&=:P1&E:].U_$CQ)<
MR.+/=H\)KAG5=94Z3H;1==2A]/,%[E+Z06LIM3OD10/+AA6S54%%9M*,0RZE
M+`,5+)J"MI(#Z=5EU&M,97#BW*$QN!Q9<Z8^=BIMCG%V/,D.(7P24.$F;%^Z
M!USVRML-3!8B3IXF1PQY#'B3M4JDQP0`6'#&`R]Z]CBZ_P"G5W:;/8Y![OGX
MV;&XC`;,FQ]L?!EYBJYY7.GM,O:L<3N@4-P/`Y?3FYS;<Z0B.(Y&#NN"L.H%
M<2#<<N+(C82VU2M`BLK@\9)"I#$7-5]E+:[N2W-Y0E&0E\,C$!C^6%F(\;RF
M[M*%WKW!(CM6W//F3(W/F-L6QY"N?A9;B0P!(26"D$VN%[&B$<GN$P6NZ=ZA
MV#IK;\;'EFDDGBD7<P(U%CD9.UOB28,A#D`02LCF3B&B9T*K)Z(S=^P=RWJ;
M)6"%5TXF7M*EVTA\9\W'R4S?"26"3(80+%A$P<J6(MRKX:6X)R;G1G/509$5
MA]B<V_$*V\B/-OF4X_>(U;I4G?@26U!,AJ>[*P$LIW776"]=%(U0?X$%["S=
MM]H.Q[<<#<&2:3)8[8F1'8`0)@;?D8$C0R%O2:4SB:+@"BQZ&-V%L/=ND\G=
MES]H9D3`G?>YXY?W3/NSXLL<;Q"QT8[8[+(^KT]89!VBMH^S/#4SPUC><%9!
M`TH9=E+.68<WNT=8W#UX:X??*4O5R%'$R'FR5$4\J&5`84!2J+)+*/57,$`/
M1O;7@>J-UPMQ.WX>WEGQMNVO'Q.85T<UH@Q:0(22JEG(4$DZ5%ZZC:<;)7+W
M'=,L*DVX9[3\L,'Y:B*&!5+``%BL(=B!:[6XVN:PS_#4KXRLSH<_3-L,*GV(
MVT*6/RUY8V\9:K*L1*$J-0(5!:8QQ)LHO<H^X>L+&``@WU!:M-MTAAD956,Z
MDD/%03_!MX:VLJAA<W[:JGQ-M?MYR_[ZDR[IU;[[)ZD/V:^:J]`\9\IIXFVO
MV\Y?]]29=TZ=]D]2'[-?-30/&?*:>)MK]O.7_?4F7=.G?9/4A^S7S4T#QGRF
MGB;:_;SE_P!]29=TZ=]D]2'[-?-30/&?*:>)MK]O.7_?4F7=.G?9/4A^S7S4
MT#QGRFGB;:_;SE_WU)EW3IWV3U(?LU\U-`\9\IIXFVOV\Y?]]29=TZ=]D]2'
M[-?-30/&?*:>)MK]O.7_`'U)EW3IWV3U(?LU\U-`\9\IIXFVOV\Y?]]29=TZ
M=]D]2'[-?-30/&?*:>)MK]O.7_?4F7=.G?9/4A^S7S4T#QGRFGB;:_;SE_WU
M)EW3IWV3U(?LU\U-`\9\IIXFVOV\Y?\`?4F7=.G?9/4A^S7S4T#QGRFGB;:_
M;SE_WU)EW3IWV3U(?LU\U-`\9\IIXFVOV\Y?]]29=TZ=]D]2'[-?-30/&?*:
M>)MK]O.7_?4F7=.G?9/4A^S7S4T#QGRFGB;:_;SE_P!]29=TZ=]D]2'[-?-3
M0/&?*:>)MK]O.7_?4F7=.G?9/4A^S7S4T#QGRFGB;:_;SE_WU)EW3IWV3U(?
MLU\U-`\9\IIXFVOV\Y?]]29=TZ=]D]2'[-?-30/&?*:>)MK]O.7_`'U)EW3I
MWV3U(?LU\U-`\9\IIXFVOV\Y?]]29=TZ=]D]2'[-?-30/&?*:>)MK]O.7_?4
MF7=.G?9/4A^S7S4T#QGRFGB;:_;SE_WU)EW3IWV3U(?LU\U-`\9\IIXFVOV\
MY?\`?4F7=.G?9/4A^S7S4T#QGRFGB;:_;SE_WU)EW3IWV3U(?LU\U-`\9\II
MXFVOV\Y?]]29=TZ=]D]2'[-?-30/&?*:>)MK]O.7_?4F7=.G?9/4A^S7S4T#
MQGRFGB;:_;SE_P!]29=TZ=]D]2'[-?-30/&?*:>)MK]O.7_?4F7=.G?9/4A^
MS7S4T#QGRFL7M[F*6YKV<;JW$N9Y45&(MO.8584SADN6+D!XD^/WXP)"Q"I<
M#$ZM&=T>B:4.UP&`O<-[:7KG.K\QY.E=S0I"/_(SC^#7PQ-[E>A>R10/:ETY
MQ/\`WS"/;_\`J(Z^=\#[`'[D/G6KX4'8*_<=NT^_4U344I2E*4I2E*4I2E*5
M'G^O;E[-N6W+:]M+VO:I!T\;7JI?C#_.'X:^@IP[<6-SOL4VE.9LPR>C,6X%
MQRH&E:LC2EL;DXC8\D'<I$WI'`M,C3%WOH`L`;!`'2UN2U?<'0F2\71NV)HA
MX840^(I_<^Z*_$GVXJ#[8>I3Q_[UE>'_`&K5F7XFVOV\Y?\`?4F7=.NL[[)Z
MD/V:^:O*]`\9\IIXFVOV\Y?]]29=TZ=]D]2'[-?-30/&?*:>)MK]O.7_`'U)
MEW3IWV3U(?LU\U-`\9\IIXFVOV\Y?]]29=TZ=]D]2'[-?-30/&?*:>)MK]O.
M7_?4F7=.G?9/4A^S7S4T#QGRFE\--5__`&ZR_P"^K,K><YU(SI`;\N`_[M?-
M30/&?+5T&Q`!K0)6\M2N5EI""DX%+DL4.+@?8H-@V-6+E0S%"I0.UM1#&*XA
M7Y[UB,=3E^`OX``!57"N_44I2E*4I2E*4I2E*4I2E*4I2E*4I2E:NN)_S</'
MYT7:5Y\^I2MHM*5KHX>WWWX@'SB^=_Q'P_2E;%Z4I2E*4K77NU<]@6.\WXCS
M#O'R]AR!2MFQYD6%8YBN<)1C]MB$B89&[Q!TE;TE8)JB-.<'AD5L2(LM4F.+
MLG+4#`,(NMMIVO28ZPR<#<=IZ2QLG(&0<5\AH$D:6(1-/R@&C/H+(9)-08'4
M4%K:3?2;ZNTZ<3,WJ1(\?&FEY8D8"-Y)8@K!@PLQ5%NMN*W)\-JO-M@R_LTR
MP@EBK9Y-]ODU:6=>V)YP=@1;"%J)"XJTQXV@N1BA00DEJSDI1ER.V-17`$71
MY-:U_4>T]:;6L#=60;A#%(7Y)RA*`;%0XCY@[02-6GQB]4[3G].Y<SILTF(^
M0$!81%-06Y`)T\;7X"_#MK*ZN:K>U+<-KWM>^O)YEZ@@,.-*EZL/F7^O^O\`
M3J-(O?PT%U[.RH=4#77EUY>6]]>6_9^G0JIX^&H``X>`U&Q0;>;IIIIKR<^N
MO):W+32MK>"I_:J<(;!MI;FUUJ0+"U223Q/;5I\R_P"2+5_2=AK^MJ$UF8?\
M-_NY/R;5:D^)^S^W5V:Q*N4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2
ME*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*5BAON_L3[N/[M^:/ZO)!7.=5_P!&
M-R_B4WY)J]"]DO\`:CTY_/>%_P!1'7S;0?8`_<!\ZU?#X[*_<5NT^_4U344I
M2E*4I2E*4I2E*5&W/0^;\(J5^,/?'X:^C%PU_P"P%L^_N^XT_%Q%7VUT3_1'
M;OXG'_HBOQ+]N']L'4O\]97Y5JS<KJ*\LI2E*4I2E*4I2E*4I2E*4I2E*4I2
ME*4I2E*4I2E*4I2E*4K5UQ/^;AX_.B[2O/GU*5M%I2M='#V^^_$`^<7SO^(^
M'Z4K8O2E*4I2E:WN*%#,:O6W'OWG>1(AB5XQ3.X/D&`S>7XK\=#8MF,;>BG!
MD@3ABYM3'2W([5,%I02S&)G$!Q6&EEC)]&5:NOZ#S]PP.J85V^&3(.1'-$\2
M2&(F.2&2.2027"Q&&-WD69SRX;%GX7-:W?<:#,V#.Q\HHL)@!ULJN(W6:)X_
M08$/S952$Q@:I1)RU#%@IMKPMFJ++",[9/)S?CS+N1\IO.+7V=-N)L$O&VZ`
M1%G)QXE'CHYHQC)SE<HNKDT76V.6.:M2HNH5$C3AN"Z410.G]I7?<+#V_86P
M\G&V_$GS`KSY29CO.947(0216C1(RB%4"C4)!,2PE5CR/1^7C[IFR;KWJ&7*
M;`QE5(L=\91C,TLT,CK)Z4DC/+*C-<",1\E@'1A6VNO*:]`KQW^0L$4:%T@E
M#XSQMA;">V')[?W-$SM#<1T@@Z]<Y.)Z9$D)Z8K6Z1@PAUO:VM5Q123RK!"K
M/,[!5502S,>P*!Q)/@`XU#,J(TCD!%4DD\``.TD^`#PD\!5++\M8K:@14QTR
M9CYM+G5B!0@:^9QQ&"8A5"("F%%1*'(L,ALH$J*L"Z3KNG<P.FO2MKFIM.ZR
MS2XT>-D-D0?PBB-RT?;\=0+IV'XP'8?%6*^?@QP+E/-$,9R0KEU"L1P(5KV)
M!(!`/"]>^YS"),KTQ1MYE$=:9%*1JRXRPN;VV('J1&("['+@,36J4E+G<:(D
M5AFV3EF7+#?46EJQH<7)R$DDQXY'CA4-(54L$4FP9R`0H)!`+6!/"K\LT,&C
MGNJ<QM*:B!K86]%;_&;B.`N>(\==`O(F/SKRT),ZAQHH!<5IV$N3L@[PJX$Y
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M'IS^>\+_`*B.OFV@^P!^X#YUJ^'QV5^XK=I]^IJFHI2E*4I2E*4I2E*4J-J6
M)[/<_#4K\8>^/PU]&+AK_P!@+9]_=^QK^+B.OMKHDC]4=M_B<7^B*_$OVX?V
MP=2_SUE?E6K-RNGN*\LI2XI2EQ2E+BE*7%*5-Z4I2E*4I2E*4I2E*4I2E*4I
M2E*4I2E*4I2M77$_YN'C\Z+M*\^?4I6T6E*UT</;[[\0#YQ?._XCX?I2MB]*
M4I2E*5K3XIK]#6C;W$&F78AR3F57.<\XK@\%9<,3\O&.8HKD)Y5.AL;G^+9B
M:(D+=.HS=$:)`7UZ:RDPWJA&A`,6O8^SW&R,KJU$Q\B/$6/"S)I9)(N?$<>*
M`MD130C^%AFBU)(EC=;V4L!6LWQUBV',=XQ*&&.BQZN66EDR\>.`B7_5/'D/
M%*DG[AD%^%ZLGPF'S;&2MW%XOVXL6>A#Q@X8I0SZ:;FY'+'7,ZMW=XT\*&_'
M$D8)HTM3Q#$N+BDAR9,C+L8B.`KNI3C&4;8P?6>TU>I)]OV_=]Z?;>Z3SY"0
M#!5!CR"-,?5E!T)UO*&2$APKQB`1NJE=(Y#I.+:,'<Y-HP5S1F18:-(,IF,N
M.&R)QW4(PLJ,VK*#1L4D.1K4L+&MS%>15Z%6&6_J2R2)[9)R\PG;>?NLGA)[
M`"!X?[UB9@U+)D)X3"CTKDK*<2JN;&H.X!`ZK!%%&J>@FL$D-SA`K>]+8_>N
MI,.!L_[JB9V#Y=])QT*$.ZGMYA0LD:CXS,`Q"WK$W*6*#:LJ:;&;-C2&_=E`
M+9!U+IBX^C9FL6)%E168]E:DF';9E3&\;V=NV-FS<A-<]1*$MD7:E\JV\1)G
MP22KGFX\&0\^E9&:IRTKY;A]K);#3K,0`%LW:K4B1=H*3CKC)KV.3J'9\SJ#
M=<2?[OBZ4D?##DYCME=TPMOFQ\9H98F"Y&27(>="[L9I"KQF,:E\W^[MQDV.
M+,D2=NHOY3FC1(`F.F?FSX\FF2.4,4QQI55=4".B32<Q)#H-8;AX?D_<_G];
MD?'&),CK$<D58)QCB&=.;"G`1AZ8[9]VKY(<V2=P>D*]R3PF/RB'D!5MKAUQ
M=Y`0'M*]NMM<@.JZ-R,'IK:XXL_*@A>27[QF6_'(P<O9YH(<8J5!:99VT/!Z
M1CY@F'H+JK:=4B7>9)H\6&67N^'F;:`%!";AW_#G&4A)LD1A3ADW5AW<Q6!*
M*UCE&T'<DL09(1MV'Y>B=H;&7A#G->8V=I`W/'&;ZV_.I:>*+!B`'*1B["Z)
M>,([7-Z(UUFB][#-N5;:;7U3TYB1[1/G9*-MHDVD10CTFPGQ=KR,3*FDB`(3
M3E/`;D?3*IG%PFJL#=]EWC.;=<+;P\>ZSG?W[Q?2LT&>V(V!`)R/C<N.:,QB
MZP<4.D,"=R?#YQ_+,?86F1,EBCK`6J8[@,Z9'QS`7M")G=87B^<S]S?86R+H
MV/0<3470*+J;M5PEW;^V.JN`%PW#;S7K;.Q\R?;H5F3)S\7:,6#)E5N8'R(U
M.JTO'FZ%*1\P$ZM':;5UNQ0NN5N>:D30;?E[D\L$;+RRL?*AC)Y=AR^9+'))
MIL/CZB`6-7:W!LDS<&=E5L4[+C;6">8D2F-0XBUOUSG([*L2`D=++5JU.:79
M&::69U'1N`SJNC>]K#O>W-;<T*2,)(];E)#?418:&X=E;V4$@$-87JHN\C,W
MER3^]='>ZM6^?A_F_P"_-56;UO@IWD9F\N2?WKH[W5IS\/\`-_WYI9O6^"G>
M1F;RY)_>NCO=6G/P_P`W_?FEF];X*=Y&9O+DG]ZZ.]U:<_#_`#?]^:6;UO@I
MWD9F\N2?WKH[W5IS\/\`-_WYI9O6^"G>1F;RY)_>NCO=6G/P_P`W_?FEF];X
M*=Y&9O+DG]ZZ.]U:<_#_`#?]^:6;UO@IWD9F\N2?WKH[W5IS\/\`-_WYI9O6
M^"G>1F;RY)_>NCO=6G/P_P`W_?FEF];X*=Y&9O+DG]ZZ.]U:<_#_`#?]^:6;
MUO@IWD9F\N2?WKH[W5IS\/\`-_WYI9O6^"G>1F;RY)_>NCO=6G/P_P`W_?FE
MF];X*=Y&9O+DG]ZZ.]U:<_#_`#?]^:6;UO@IWD9F\N2?WKH[W5IS\/\`-_WY
MI9O6^"G>1F;RY)_>NCO=6G/P_P`W_?FEF];X*=Y&9O+DG]ZZ.]U:<_#_`#?]
M^:6;UO@IWD9F\N2?WKH[W5IS\/\`-_WYI9O6^"G>1F;RY)_>NCO=6G/P_P`W
M_?FEF];X*=Y&9O+DG]ZZ.]U:<_#_`#?]^:6;UO@IWD9F\N2?WKH[W5IS\/\`
M-_WYI9O6^"G>1F;RY)_>NCO=6G/P_P`W_?FEF];X*=Y&9O+DG]ZZ.]U:<_#_
M`#?]^:6;UO@IWD9F\N2?WKH[W5IS\/\`-_WYI9O6^"G>1F;RY)_>NCO=6G/P
M_P`W_?FEF];X*=Y&9O+DG]ZZ.]U:<_#_`#?]^:6;UO@IWD9F\N2?WKH[W5IS
M\/\`-_WYI9O6^"G>1F;RY)_>NCO=6G/P_P`W_?FEF];X*=Y&9O+DG]ZZ.]U:
M<_#_`#?]^:6;UO@IWD9F\N2?WKH[W5IS\/\`-_WYI9O6^"L7][,/RPDV=;JE
M3GF,AU;B-O683EK;;&T?1W7I"X`_"4(K+"G,9J2ZHNUP=:$(A%:](-KWM:U<
MYU?-AMTIN:K!9NXS_NV^J:O0_9(&'M2Z;]+_`-<PO^HCKYY0/L`?N0^=:OA,
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MDCW'(_:J-+>M\%7::4R](WHTSHX6=G`E,46L<[(R6^RY2`-K&J;(B!F%);'"
MY>@$5[!\VL-M)<L@TH>P7O:J_P!FO2J*4I2E*4I2E*4I2E*4I2E*4I2E*4I2
MM77$_P";AX_.B[2O/GU*5M%I2M='#V^^_$`^<7SO^(^'Z4K8O2E*4I2E:I>)
M$[;@6]TQ<1A-/OU-(.12)0]';,8/M/EZ!$O2JV<38IFYFY>_7MSK8H1UF^[5
M;HW+N=<V]A6+KON@HMHDGRSN[;0JJL6CO\F7&#?FJPB.)Q;A;F"3A\0+>["M
M#U,V4FVQM@KDM,9F##'6)I+:059A-Z`5&6ZD<=1]P$>QPVG;-#B@R[;-IF],
M4@"\Q,UO_+0B.UB)R8:`;:X$7-B!>V45T[DTB&18"@UZU.`8`(4]^A8=K9?M
M!BV6+%P/N<[(1JE#_=\F:_&Z%><,NR@FYT<KBW'7X*T_3+[D^;)W_P"\=)A!
M0Y*8Z@V=@V@Q>DQ%P#?T`"MO2K:%7FU=M7&,'3O;ETT^O;Z-KZ\EZ@B_#P5%
MN/\`E_E[GO5+U/+K<8KWUM?6_8^M?2HT\+7X\?AX4M;B.W]KQ5Q%(R2`6+(`
M604&X[@*)+"24$1@[F"O8LOHAMTC!7O?DY;WO?GH0Q-R3>P'D`'P``#Q`6H`
M/V2?P_\`MN??KEZKS1=C3EMK]/G['T*C3PTW-O?-ZGPZA\8"U<@`V!;2WFZ_
MZ]5#LX]M.'@%JM1F7_)%J_I.PU_6U":S,/\`AO\`=R?DVJW)\3]G]NKLUB5<
MI2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4
MI2E*4I2E*4K%#?=_8GW<?W;\T?U>2"N<ZK_HQN7\2F_)-7H7LE_M1Z<_GO"_
MZB.OFV@^P!^X#YUJ^'QV5^XK=I]^IJFHI2E*4I2E*4I2E*4J-N>A\WX14K\8
M>^/PU]&+AK_V`MGW]WW&GXN(J^VNB?Z([=_$X_\`1%?B7[</[8.I?YZRORK5
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M%AVXIOPQF?!>6V7OT@K>;?!T8RDQ$(D3''7%`S2C(*K+"!*[*<B3I';MAS3M
MHS&5,<GN),$'6C#7I?MGS=^SL7:I=]P\W$R&,[GGO"T>ME@#Q8PA)/)C9=:M
M-](3*5)(45P'0V'M.)O>=]TSX\T')C5`JR"7EB6=UDG+C3S+2"*T-E98D9EU
M$FM^U>$UZE2E*4I2E*4I2E*M-F7_`"1:OZ3L-?UM0FLO#_AO]W)^3:K<GQ/V
M?VZNS6)5RE*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*4I2E*4I2E*4I2E*4I2L4-]W]B?=Q_=OS1_5Y(*YSJO^C&Y?Q*;\DU>A>R7^
MU'IS^>\+_J(Z^;:#[`'[@/G6KX?'97[BMVGWZFJ:BE*4I2E*4I2E*4I2HVYZ
M'S?A%2OQA[X_#7T8N&O_`&`MGW]WW&GXN(J^VNB?Z([=_$X_]$5^)?MP_M@Z
ME_GK*_*M6;E=17EE*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2
ME:NN)_S</'YT7:5Y\^I2MHM*5KHX>WWWX@'SB^=_Q'P_2E;%Z4I2E*4K5;Q>
M>^R^VB$`A'?I:2BW*8-$V&XPDF)8?EDE04_J3RA8HE.:5R6$LV033B@EH+C+
M4G*KC&FL0,L\P0>Z]F/)/6\'/TF+N><"&65XSJQ)4M,D*M+)`=0YJ*`-%W+*
M5!K2]4@GH_=.('T,#7U!+:,W%<D.WH(X"$H[64/I!![#['#9;\ZH&+*ELX(-
M]B%8:^QR\>MOAFNVR9/)J4+:NLMOCT[;FC1H$#4$ZX.W@.EA'#.Z%R?0V%6Q
M]H#["T&$-E;8BWTO,^[HLR-NU-)R.]$AO#HY?9Z6KP5INF4W1,J;OPW3E<E+
M=Y?'9-6IKZ1$`P>UM1/HE=-N.JMG5>:5V=80\0_+6*L);5<A9$S)?("R(,YL
M>LFBV,9/)(=+I]*3GM):+0%-)(JL;G9J:I8\A*2N)W;*=.6@$<,\P)(1UO\`
MI3`W;=.IL+;]C&.=VED81F=5:",Z&O+*K^@4A6\A#7%U6P+$5A;I-@XVT9F3
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MKC\!1EIWPM<G4DHV2W;1-P`OU]^3Z#V>#&V=FW*"%ADSF7),H5BNTR[3-+BY
M",=1C5\JYC=2C'(6.,W)"UT76.<7;1CRLO=<++B7074C>4SL("`Z;<QUQB-,
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M'IRBAUZXU`5)"@C:10J^FQ)`)-=9T\Z-/N2X;%]D7<G&(Q8N##RH2VAV+%XQ
MD&95))L!8'2!5[=P!\]`R,H(VUQ!8T=_^(Q''OK\^-CB%UME6(]ID%I6Z-NJ
M8QN,/L58TVY]C``$.X2Q7"&PN4VX0\QN>7#Z)+64$6T-^,*Z"75;T;6O56=N
MYW]K&)/#N9?!W5NV!ZTWR5^?55Y/Q:=NYW]K&)/#N9_!W2V!ZTWR5^?2\OXM
M.W<[^UC$GAW,_@[I;`]:;Y*_/I>7\6G;N=_:QB3P[F?P=TM@>M-\E?GTO+^+
M3MW._M8Q)X=S/X.Z6P/6F^2OSZ7E_%IV[G?VL8D\.YG\'=+8'K3?)7Y]+R_B
MT[=SO[6,2>'<S^#NEL#UIODK\^EY?Q:=NYW]K&)/#N9_!W2V!ZTWR5^?2\OX
MM.W<[^UC$GAW,_@[I;`]:;Y*_/I>7\6G;N=_:QB3P[F?P=TM@>M-\E?GTO+^
M+3MW._M8Q)X=S/X.Z6P/6F^2OSZ7E_%IV[G?VL8D\.YG\'=+8'K3?)7Y]+R_
MBT[=SO[6,2>'<S^#NEL#UIODK\^EY?Q:=NYW]K&)/#N9_!W2V!ZTWR5^?2\O
MXM.W<[^UC$GAW,_@[I;`]:;Y*_/I>7\6G;N=_:QB3P[F?P=TM@>M-\E?GTO+
M^+3MW._M8Q)X=S/X.Z6P/6F^2OSZ7E_%IV[G?VL8D\.YG\'=+8'K3?)7Y]+R
M_BT[=SO[6,2>'<S^#NEL#UIODK\^EY?Q:=NYW]K&)/#N9_!W2V!ZTWR5^?2\
MOXM.W<[^UC$GAW,_@[I;`]:;Y*_/I>7\6G;N=_:QB3P[F?P=TM@>M-\E?GTO
M+^+3MW._M8Q)X=S/X.Z6P/6F^2OSZ7E_%IV[G?VL8D\.YG\'=+8'K3?)7Y]+
MR_BT[=SO[6,2>'<S^#NEL#UIODK\^EY?Q:=NYW]K&)/#N9_!W2V!ZTWR5^?2
M\OXM.W<[^UC$GAW,_@[I;`]:;Y*_/I>7\6G;N=_:QB3P[F?P=TM@>M-\E?GT
MO+^+3MW._M8Q)X=S/X.Z6P/6F^2OSZ7E_%K%S>ZKS0+9ONL"[1W%Y#6+;QF$
M*\YOF<N5KRD5X`_65&I$RB"HDZA6`K6Y8!FE`$*UK"&&U[WMS?5ZX'ZJ;GRV
MFU]QG_<KV\IOQJ]$]DFO^M+IN]O^^X7D[Q'7SO0?8`_<A\ZU?"H[*_<9NT^_
M4U344I2E*4I2E*4I2E*5']7Z_+;6U[7MK;DUJ18]ITC_`"]PU*_&'^</PU]!
M;AVJ\QAV*;2@LL?QFI:0X%QS9O/=)A*D+B:EM'TG4C6I$<'7I4ZD1>EQ@+.-
M`$6MK"O;2]?;_0:X?ZF[9S&FU]RBOZ(]7W7_`/;7XD^W$O\`UP=2Z;6^^<K\
MJU9F=NYW]K&)/#N9_!W76VP/6F^2OSZ\KO+^+3MW._M8Q)X=S/X.Z6P/6F^2
MOSZ7E_%IV[G?VL8D\.YG\'=+8'K3?)7Y]+R_BT[=SO[6,2>'<S^#NEL#UIOD
MK\^EY?Q:=NYW]K&)/#N9_!W2V!ZTWR5^?2\OXM0NMSQV(SB37Z,ZF=__``[I
M;;_"\P'^8I^#6*?2?BU<UL$Y"0I1/!*(AS$07=<2W*5"M`4IN&W7%I%2I*B4
M*"`C^Q&,DL5[<X;5BMI#'1<IX";#X+FWEJOC;C7H5%*4I2E*4I2E*4I2E*4I
M2E*4I2E*4I6KKB?\W#Q^=%VE>?/J4K:+2E:Z.'M]]^(!\XOG?\1\/TI6Q>E*
M4I2E*UG<5ILQ(][86]ARWCE9E(N0YEQ4PXVBQ67)!@9GME]V>S4./WJ79AC2
MM(ZP&*,KF>(Y4N+ZX8;A``HHP\90;]I[.3O(ZSQGV2=,?,2')8R-$)M,*0.^
M1HA(/.E:)62.("[LUKA=1&HZA&(O36Y29ZB3;QCQ\V/4$Y@;)@C0:R0(P)7C
M9I"0%52;^`VMX4;;$HB'<7C(G'KWCO*T`E\$)RHW)]V^3-XV-UMY%%CW^'*H
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MS3#3!7N(8A\M].2LG(R,G)96G=GT1)&M_P!RD:A45?$J@6`MXR>)O5F/'BB9
MWC55>21I&('QG<W9SXV-^)[;6'8!7O6)O:][Z`M<0=!7M;2XN:V@M/LM+>;6
M/9M.F_8?<_`1PJ[:QU+XK?Y?Y&N4L/0MI]'D\S32UK6M;FM:UK54+]I[3VU-
M@.`[*M3F7_)%J_I.PU_6U":S,/\`AO\`=R?DVJW)\3]G]NKLUB5<I2E*4I2E
M*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*4K%#?=_8GW<?W;\T?U>2"N<ZK_HQN7\2F_)-7H7LE_M1Z<_GO"_ZB.OFV@^
MP!^X#YUJ^'QV5^XK=I]^IJFHI2E*4I2E*4I2E*4J-N>A\WX14K\8>^/PU]&+
MAK_V`MGW]WW&GXN(J^VNB?Z([=_$X_\`1%?B7[</[8.I?YZRORK5FY745Y92
ME*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I6KKB?\W#Q^=%VE>?
M/J4K:+2E:Z.'M]]^(!\XOG?\1\/TI6Q>E*4I2E*TY<7W-KUB3&#"S+,G[/F+
M'N3$3_$9!A?<SAJ>YTD^>7H^S>)CB&,8)!YM%!N*DP0AEG]M`$04><08-0F"
M&XZ]"]F>SP[WOS8Z8FZ96YPM#+"^%-'CG&LS!IIYI$81QCT2&NILKJ`Y8(='
MU/F_=VS#*;)Q,3%:4I*^4K/$\;+;EI&AUR2$D,5`8Z03I`!8<W!OCV;HO@23
MM^7<-[/=O;6KE9#M`L0;36I.S&1]L<TYYJYWRT@;YI.VM!,)$,LDXI(6N-.2
M$!ZHX5C`W`#<^UV79)]SQ/NW-W7<<R.-TEFRW+Q<-)"8[&*(NJ$MK?2%<V*$
MJ03RO0,>>!DS9.-@X>'*042)=$[D%EUS+K?1J55THS%U!(;2UQ6X>O)*]&I2
ME*4I2E*4I2E6FS+_`)(M7])V&OZVH367A_PW^[D_)M5N3XG[/[=79K$JY2E*
M4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*
M4I2E*4I6*&^[^Q/NX_NWYH_J\D%<YU7_`$8W+^)3?DFKT+V2_P!J/3G\]X7_
M`%$=?-M!]@#]P'SK5\/CLK]Q6[3[]35-12E*4I2E*4I2E*4I4;<]#YOPBI7X
MP]\?AKZ,7#7_`+`6S[^[[C3\7$5?;71/]$=N_B<?^B*_$OVX?VP=2_SUE?E6
MK-RNHKRRE*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2M77$_YN
M'C\Z+M*\^?4I6T6E*UT</;[[\0#YQ?._XCX?I2MB]*4I2E*5CKG3:+M@W.*8
M\LW#8$Q9F=5$D[BEC*C(T.9Y2:PIG<Q*:YD-8W1,HNC*7F(B;FV!I8=RPZ\U
M;O9>I=_Z<:1MAS,C#:8*).4[)K"WTAM)%PMS8'LN?'6'N&W8.[8ZXFYQ1SXJ
MOK".`RAK6U`'A>W"_;:NW@G:KMMVP(Y$W;=L'8RPJ@ERQ`X2='C:)-,33OZY
MK(.3-RIU*:4Z<"T]$G4#`6(=KW`$=[6YZKWKJGJ/J-8DW[.RLQ8-7+$LC/HU
M6U:;DVU:5OX[#Q5CX.R;1MDC3;?C0PR,H!**%N`20#;P`DGWS?MJ_P#6AK:5
MC3O`DF9X?MMS%*L!.<*8\GQN!R*0,4@GZ!>[QR/DLC6K='1Y,9&\19KVYH&U
M&8-$D-,*3'*NA8\=BNE:^?M0V]MUQDW82G;&F42"(@2,#P5$9O174Y4,Y!T*
M2P4D`57''+-(((`O>9/10M?0&/!3(%](H#Q(4@D"P(O>M8#INIW,-T'V2YPD
MTF?5V$W3;C@*7;@%>/I=A:-Y`D65,TR^!QIK>;X]D4"EC^^Q!.-P4V5(VOO<
M+-LL%9(K,.(ZBWL4G3'3$?5W4'34$2)G_?+X>WK*F1+#&B1Y4C"22.6/EN=,
M0#R/)IT%C$49G7RZ#>=\EZ1V[>)9M;18&7E9K)RHI9%@>!%,22*][?2G0D8!
M+(C2JQ4&LMVV\#,D+W#/*#%&041$,Q%'=KSP5"FEMB\@:\S/.;=S#CAC(<>>
MG)0VN3VG.BK(WV3HBVI6B/0NXKC4]=;0FVBZ&Z8VO<-MYN[P-++F;C+B@EF0
MXT2;5+G)DJ`5#:I%#$N'1X8W50I)>M]U9NN5A$#;I5C[OM&3FL1I/,GBSL3&
M7%E#7T@1R-J5=$VN=#>RH#C`LWY[K&UKD+J#(IBP>78\[.!:$^)Q&P=LBQ-O
MJ:]LUCV0PI@*,5)$<`?!7$&0^N7_`%VA[9N+J1&)ZZ+:^B>GMQ^[=NEATLK[
M2SS+(P;-[]M>1G2PCBT:WFQ@L31JI6)V0ZG*N--O'4>[[;'N>YX_TK1MO\,<
M!`TP_=;8D>/D$A1(;C(:26Y:-V"@!4'I;<]C&49_D_%D^!D>0#F3UC+<%G+#
M3;.3VUM:ETUC6-)XXQ^/R!U2LB-N8QO1C>2%.M.1)DZ8]4G&8`HOI7!;SCJ_
M`P,5]MSL")8%W#:,;*>)2S)')*K!PA<LX1BO,569BH<#40`:ZS:)\@YNY[;-
M(TT6#N+01R,%#NG)AE]/2JJ61I6C)50#H%QJO5R,_P`D=VMC9D*&#RB1)AY`
MQ&L&Z,RB)EH2E!&58D84UF`>I,T.';RP9(0%B"0(BPC0],P-NE<//[<BR2,S
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M3J=O.84YSDN7XT,1H2CH`^@,6J@-^0%RX29*$72'8HDTVX;7Z(!7TM?G.K\>
M%>E=S99XRW<9S:S_`%3?B5Z'[)&/]:73=U_]<PO^HCKYW0/L`?N0^=:OA4=E
M?N.W:??J:IJ*4I2E*4I2E*4I2E*?ZGT^?L:\FOTZD`MP!`]__P#$54OQA_G#
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MQHC%J(8PV$),I&W*UR$1Q5[Z"N4<:7>_,*]8I`#%00P'A%[?"!^`57QMV5WZ
M4I2E*4I2E*4I2E*4I2E*4I2E*4I2E:NN)_S</'YT7:5Y\^I2MHM*5KHX>WWW
MX@'SB^=_Q'P_2E;%Z4I2E*4I2E*4I2E>4]-#<_-J]E>&]([,[N@6-3LU."8E
M8WN38X)S4B]O7I%`1D*D2U*<(HTH=K@&`5[7M>UZBY!#+\=2".-N(-QQ'B(O
M^P*E6D1UDC)5E8&X-C<'A5I%.W'`:UQQX[+,*8N4NN)&]M:<7N1T&CIJO'S6
MSB)$SMD04#;[F,+>T&)P#2DI[@+3C!81=@BM:];9-^WZ-\J1,W*$F:#W@B1@
M9B0P)D-_3)#,I+`D@D$V)K6G:=M:"'';'@,./?EC0I$=R&.D'LN0";=I4&W`
M5X<6VJX#B9[`O1XJAKF]Q2836>1J2/\`'65UD,?E,_D*R3RAU8W$QO+$SFN+
MPN&=HF"4&PPV'I<S4=[K]2;ZT:PQY$L<"X,.'I1V4-!`FB.-Q?TP%+`W)X,5
M%DLHH.S[?(\LLT2R--G299#^D.\2Z=<@!X*3H3L'[A6)+"]521@'"2<W(AY&
M(,;E'Y<*,)RB8"&L`19"*.N?<TN8"[0MZ_`.&I,&.RCIV$88(=_17O>L,[ON
M[8N/A')G[OAOJ@36^F)@00T8#64CP$6MX+=E98P\5<U]Q$:=\ECT2/8:V4@*
M59NTJ0`&'8P`O>PJNH7"XGCV--<.@T98H=%60FZ5GCD::D;*R-B>XQ&"*1-R
M`DA,0$PT8ABT#J(8KBOK>][U:R\[-W'(;,W"62;*>UV=BS<``!<D\`!8"_`5
M.-B8V%%W?$1(X`2;*`HN3<FP\))N3VD]M4?F7_))J_I.PU_6U":JP_X;_=R?
MDVJY)\7]G]NKLUB5<I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*4I2E*4I2E*4I2E*4I2E*4I2E*4K%#?=_8GW<?W;\T?U>2"N<ZK_`*,;E_$I
MOR35Z%[)?[4>G/Y[PO\`J(Z^;:#[`'[@/G6KX?'97[BMVGWZFJ:BE*4I2E*4
MI2E*4I2HVYZ@\1Q]S\-2OQA[X_#7T8N&O_8"V??W?L:_BXCK[;Z)`'2.VV_,
MXO\`1%?B7[</[8.I?YZRORK5FY745Y92E*4I2E*4I2E*4I2E*4I2E*4I2E*4
MI2E*4I2E*4I2E*4I6KKB?\W#Q^=%VE>?/J4K:+2E:Z.'M]]^(!\XOG?\1\/T
MI6Q>E*4I2E*4I2E*4I2E*4I2E*4I2E*M-F7_`"1:OZ3L-?UM0FLO#_AO]W)^
M3:K<GQ/V?VZNS6)5RE*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4
MI2E*4I2E*4I2E*4I2E*4I2E*4I2L4-]W]B?=Q_=OS1_5Y(*YSJO^C&Y?Q*;\
MDU>A>R7^U'IS^>\+_J(Z^;:#[`'[@/G6KX?'97[BMVGWZFJ:BE*4I2E*4I2E
M*4I2HVYZ'S?A%2OQA[X_#7T8N&O_`&`MGW]WW&GXN(J^VNB?Z([=_$X_]$5^
M)?MP_M@ZE_GK*_*M6;E=17EE*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*
M4I2E*4I2E:NN)_S</'YT7:5Y\^I2MHM*5KHX>WWWX@'SB^=_Q'P_2E;%Z4I2
ME*4I2E*4I2E8];J<M3W!V`\FY2QEC$>7IM#8JZ/C)"12!MBK>L,0)35*AQ?'
M]S&$IOC[(D)&K6W*":J,(*$`@L1H@VK/VK%QL[=,?"S9QC8<L@#RE2_+7CV1
MKZ3LQLB*+`NPU,JW(D!F.B)3).19$!"F1_W*:SZ*:CPUMP7M-[6K6X^<2S+R
M./X0F#9!,;F,BG;KM>W`YZ;U=I+ZY*D6Y7(#/C\B/XH6%OA9#,HB!BA6X#-=
M"'3MT`"DU@DBN(ZO5%]G>R+U%N>R2Y&3RXM^DVK$8!+\U<>>=9LBZV9&T1(4
M30PUNX8Z0I\['5F[-TYA;MR<<9;[-F;GD+J9D$.'/#"\,5C<.Q>4B5BR`H@*
M6<D7EW1;Z<@8/SHLA47B4.=\>XOCNWZ59@-?0/=Y>^MNX?-"O$#*FQVK0.J1
MI:%<."A&Z*A+D;B!QM>R4NR85NNOSO2'2.#OV`V3N$LL<V1G286-R[%5GBP9
M,TO,"I+1M9(0%*%=1DU-;16^ZDWG*VGEC"16*;9-N$NL$AH(LJ#%$494C3*V
MN636P=!IC73=B1CF?Q3<OMZ"0.JW'N-ST>2F=<Y[;RTH).4I8CB-U2#:ZG1Y
MEL8^G@?@C.?$<@$8U^LW\&`YOL'K.@JK>8/LYP-Q7!PX9YTW/5M[9C$*8Q'G
M8$V?:!+*_,B7'DA])G$A990%"F-M5N?5TVU+G[A-$)-L@;>(846XE:?:3!&3
M(VHIRYWR%8`*KQHI!+,WH[*-HF<Y3G?',K<IVTL#5.\:9ARIA.9#B=G`J*O3
M[BZ5*X\;)(XC=5CDZ-;6_I"R5(4:A4K-2#,$4(\WH=._$]4;-A[5+A9.VF4[
M=N&W09<:RE3)&)00T;L@57*NC`.%4,NDZ0;BNBVO-RI\G.V[.Y9S-OS6QV>,
M%4D^CBF5U5F9D]"9592S6=6L;$5[.X3(,6C+,RLSRJ="%QT\Q([@"DB\K>$U
MT*+*D2/4#$O961Q0@4!*2#Z)`C+'F7M:P`"$(-KZC;8)IY&>,#2$D'%E'^K;
MP$@ULY655L;WO52_E`XQ^[Y5[V.4/<;5ON&5^)\M/G57K3W?(:?E`XQ^[Y5[
MV64/<;3N&5_L_EI\ZFM/=\AI^4#C'[OE7O990]QM.X97^S^6GSJ:T]WR&GY0
M.,?N^5>]EE#W&T[AE?[/Y:?.IK3W?(:?E`XQ^[Y5[V64/<;3N&5_L_EI\ZFM
M/=\AI^4#C'[OE7O990]QM.X97^S^6GSJ:T]WR&L>]U6^^![<<`Y'S4T1V0Y`
M<8(@:5J6'JX[/8,0]B<Y$SL0R3)6]092UM'4%N@CK#-+%8RY75V]$.U<]U7G
MY'3'3^3OSQI*N.JG2)$!-V5?!K/AO\6NZ]F71G]8W7>W]%)D]T.>[KS3&9-&
MB*20GEZDU7T6MJ';>]:3/\2X'XFYWOZ$_!57BO\`7FOZ-_\`Y_\`_1K[./\`
M<3<&PZF%OX@?_P!U3_$N!^)N?[^A-]/J>*JW9JEO;H`+C;?+/;WN/)\=J@_W
M$WL3^LZCA^8'_P#=_@JX+Q^D"Y&C^.H=EIZV#OK9CC(3N]L,'EZO."$+7*7:
M-V(N^(V@`,9B7G]H74!L(RY(2ABO>P!CN$5@[/*]KFYX,6)D9FRRQX^<A;'8
MS@B90YC)2T9-M8TBXN3X+6)TF)_<WV3<-WS=@P>L8)=YVY8CD1+@F\(FU&,R
M$Y8`U!2;`DCP@7%ZTRMQO]P>#(Y"Y=F#AMS?'L;R(B+70QWD69T!*5X+-1D.
M("1V38V5'M3A=`J+.[46@3*^@+7JM+"TKWGVK[OT]DIA[ULDF/D2@E0TX-U!
ML3=8F7T21J&K4MQ<"XOJNF?[J?1O6>3E8G2W7&)FSX3E)A%A,3&0Q6Y!R1J0
ML"!)&7C)[&JWF//TAJ;99FT<QQC;8B\3*<RY>%KCD99\Y(A.+JON4:?<DD2K
M&*5(2$))!@A&&F%E`"'I"&$/+5G:_:_N.]9B[=M>S23YK*S!5G%RJ`ESQB``
M4<22;>Z*W._?W,MGZ8VB??\`?^L(<79<>Q>5\!]*@MI[!DEB2QL`H)/BJ\6+
M^,QN@S3()[%L5\,J=3=]Q>XJF>?HFC-[*`J,/")<<W*F=:Y.&/D+6I=P+$Q@
M`I$YQR@SH7$``@>BK*V[VH[[O&%+N&T[%-D84!L[I,--PI<A08@SL%%RJ!F`
MM>UQ?G.H?[L70'2<6)-U+UYAX4>>BOC\S!<M)&PU"32F2S)&1;TW"KQL2#5K
MX'Q_\G9/R0W8@@/#_DLER>ZN;@RHH.DS2G2OPW9I`K,=41Y+GC!`0@-;0(3K
MG]L#*"3U8K"O:]M*QMI]KVX[YFKM^T[/)/F%6;2DPOI12SD$QJ+*`2Q)]P>D
M0*WN^_W.MAZ8V1^I.H.LL?$V%$1C.^"S):32([<O*<MS&9=.D'@;]E48\?I(
MSA'W=V8'K98K;WEB<W!E=V\[.J:YR!U:E9R!Q1'7*Q885<U(L3C+%T1"#T@W
MTO>W+6M3VZJRAONWM'UY_P"#6YA_N,#(A3(AZH5H9$5U(P&L5=0RD?\`FNP@
M@BO*._28+%$FF6V;'"N66,=@^/4FW2Z`;BTUOBJUK:Z5+>W554M]V]@^O_\`
MZ-75_N(NS:?UG47_`/T#?_NJ_0W$]S>-I)%XU(CS).WFO\>97PUO+QYDQ>!"
M8[-J9>-(!>1#`D+0)[J.A8T%K!,M;I6M:UZ^A<7'RLK%BR0(U$D:O;F)PU`'
MU@?#XJ^`]RQUV[<\G;BQ<X\\D5])%S&Q4FW&U[7M?AXS50?E`XQ^[Y5[V64/
M<;61W#*_V?RT^=6'K3W?(:?E`XQ^[Y5[V64/<;3N&5_L_EI\ZFM/=\AI^4#C
M'[OE7O990]QM.X97^S^6GSJ:T]WR&GY0.,?N^5>]EE#W&T[AE?[/Y:?.IK3W
M?(:?E`XQ^[Y5[V64/<;3N&5_L_EI\ZFM/=\AI^4#C'[OE7O990]QM.X97^S^
M6GSJ:T]WR&GY0.,?N^5>]EE#W&T[AE?[/Y:?.IK3W?(:?E`XQ^[Y5[V64/<;
M3N&5_L_EI\ZFM/=\AI^4#C'[OE7O990]QM.X97^S^6GSJ:T]WR&GY0.,?N^5
M>]EE#W&T[AE?[/Y:?.IK3W?(:?E`XQ^[Y5[V64/<;3N&5_L_EI\ZFM/=\AI^
M4#C'[OE7O990]QM.X97^S^6GSJ:T]WR&L7M[6<,=/&SG=4U(5TD$L<=O>8$"
M4*C'61T)`E*J`/I1`35JV)IT28L1@[6N::8`H&NHQ!M:][<YU?@94?2FYN0E
MNXSGXZ>")OQJ]"]DCJ?:ETYV\=\PAV'\XCKYY`/L`?N0^=:OA,=E?N.W:??J
M:IJ*4I2E*4I2E*4I2E*C_J=B]].6UM=+<M[6^AK4@$\`+G_+W#4K\8?YP_#7
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MR@<86_Y_*_>QRA[C:E=NRV-@$O\`Y\?SJC6ON^0U=AJ=$CTWHW5`(X:)>G*5
M)1*$BQ`>(DX-AEW-1."=*M3#N&_*`TL`PWY+AM6&RLCE&MJ'N@_@JNX/97HU
M%*4I2E*4I2E*4I2E*4I2E*4I2E*4I6KKB?\`-P\?G1=I7GSZE*VBTI6NCA[?
M??B`?.+YW_$?#]*5L7I2E*4I2E*4I2E*52TUBS1.8I)H5(235$?F,=>HL^ID
MZ@Y(>H9I`VJFES))5I[A/2FF(E8[!-!>PRQ7L*U];5`;2ZR#X\;!QV'BK`C@
M?=`JN*62"9)HK!D8-<B_81^WY:Q36["=MZ\O"R<Z,2"R+!L.A&/XTWERY]*0
M26%XT=&M_@$=R2E"IZN?MD1D;.0XHP+^GU:RPC+W%TQ6OUJ]=]2+F[AGF2/O
M>Y9#9$C&-#IR'26/GQ"WT4W+E=-:$$*UAV+;FQTQM7W;C[7I<8V-')&HUD,T
M,SI)+`[+Q>*5XHV>,^BQ47_=7\)OV"8=5O[',<@.$VR#+F:8/$I5.3K+I&6U
MR9%?)KCEB"Q&8,ZIV<;2F*8KER^RN/I%AQI;>>&]RK`*O8D-4'6VZ8&.N+MB
M100C"AA-D1B98\9L1\H,%&C)G@DDCDE`U-&0&);TS5D]/XV?)/)GM+(LV7-+
M8,5TQ3212G$%N)QA)#%)R;A.8I(50Q4^D7P_-L=O&E8V(O:LG*B%8@6)%<K?
M#TD&2KYV/*2LK%1%U/0QX$[)X@R+5!T+A=B2C@Z=6$-K$?6W44.-@P8\HC?;
MY(7C=542L<:-H<<2O:\@A@=X8U:X$3NO'435Z38=LER\C*R(PZ94<ZR1M<Q$
MY83O3"*VD29!CC:9_C%D#"QN3D7AK#T)P9""('`TC@2U!=WR1.;@]NJQ^D<D
ME$H<U#W)I5)WYP&8N>Y%('=88H5*3;](PP?-:UK6MJMTW?,WK(3)R]`6.&.*
M-$4)'%%&H5(XT'!44=@\=R>)-9>#M\&WI(L1=I996DD=V+O)(U@7=C8DV"J/
M`%4`<`*DS)>X8DU7#>X;WR?AKFO>W^EN$7\^VOTZL88'._W<GY-JRI"=/[/[
M=78K$M5RE1:E*6I2EJ4I:E*6I6L?C)7O;AJ[IM+WM_\`AB&<U[V_TI0:N%]I
M?#H?/MZJ?E$KWC^[)_;MT_\`^-/_`-)/7S^?K?6M7QSQ\9\IK]C^-=A(>6F5
MI%)R1,O*3*DZDU`LL.Z1<4G.`<8C5A*&4<)*J`"Y9E@""/H"OI>U^6KF/((L
MF.5U$@1PVAB=+Z>)1N-RK`%2`02";$5:FC:>"2!7:-WC90ZD:D+*1K34"-:W
MNMP1>UQ:M]N:,JN.=MK/"GF>0FZ*,S>OW=3-B!&(DQ)(S"8W$F60PMJ:HVRL
MB2PBDC.WHR;!O8=S#3A"&,T8A#$*_P!"]X3=>I/9_N>YB,OEP2O)I`5`PSIE
M1%065%C1$1$`&E44=M?&W2FPQ](]0^U;9]@:=Y,?8L5A)+(9)WD?%GDDEDE)
MU-([.S$^`FP``%5GOM/NX8$XJ=Y*H5*#&;B68T##K.1AA@$2R\,*1&E-?;`[
MA3@[T;"M<)6G\GL'DZ-[5Q'5C%^B"^<YYR]>[PJ$DDB,]Y++_F$JI([+JM^P
M55[(HA!U]T-'MJJD4WLS'."``,.\!@6M\8M)IXGC<GC4.!C@MT;'A-NK:8LB
MG3ZYY7:,'QQ-9W820XZ@RU`H=LKY2<4+BY(W!2ILG)2-#<!(6>;<2DT75B!H
M(/<>R+:9=NPL??(D$DNYRSQ-)=;8^-CJQ?T=0?F9.0J1C2"`BEC<,16E_O<=
M709\<OL_GG?#Q,3;6SV!20][S&D$>)C(RJT81$,L\NHJ+J@N&%C>;#\,18BO
MG--N@2S5HB#IQ<L;KL6,6*W)L#,$V6'5X4O;$^3ES*5K6E7C-9''1M,,0D:N
MEA=98OJC=`U;Z$@CVO;^FL+?C,NZ+U3E1X*QFZ19'=9%E7-*WUQ,3<!#93Q9
MBA(72]?;I+U/DQY70;XDDJ>RN89TF8K:),*/2I7#&E73*619E#N.58(3<7)O
M)L*VZ9"@N\W<'N0ED:BL]R=+]V60<,K%D5<&9%'L7P0A,ND\\R(2T.SJ0^"/
MDAY[8SHBR`*5`-5`C0Z"Z=KGLHV+*VK`;,FC1]PW3*W),F160I!%C2Y`M&E]
M0;+SE.G3_!P(FNX+5S7MRZXV3?.@-LZ,VW(GP^G]OZ=P<R*.9',N9E2F&."`
MR*ACMC8W.FE9BB/(4$?Q0#^8;='#9)`=R.=(K+FP3*_H<KSQ4J;S%2%8(E.Z
MR9R=6\=U#:I6)!64(%A1F@1B$&PM!6L*U[6^<HXFQBV#*&3*QW>.12;Z9([*
MZW!((4D$$$@^,U^@G2&YX6\]*[9N.V/S,&7;\<HUF74!"BDV8`CB".(%8^KK
M_P`B5]C^3'\W)?\`WH79MRU42;'B>P^&NEA_A5_SA^&OI]X6Y</8HUO>^N-(
M'?G_`/=9JK[SVS_MN-_%X_\`1%?@EU3QZGW(GM^\,C\JU7-K.M6AI2U*4M2E
M+4I2U*4M2E+4I2U*4M2E+4I2U*4M2L4=]W)LGW<?W;LTV^I?'D@U^O7.]6<>
ME]R![.Y3?DFKT+V2_P!J73G\]X7_`%,=?-L!]@#]P'SK5\/CLK]Q6[3[]35-
M12E*4I2E*4I2E*4I4;?M>?3WK_Y&I7XP]\?AKZ,7#7_L!;/O[ON-/Q;1:?6K
M[9Z(4#I#;0.SN<7^B*_$OVX?VP=2_P`\Y7Y5JS<KJ+5Y92EJ4I:E*6I2EJ4I
M:E0TMS]FII4:4I2E*4I2E*4I2E*4I2E*4I2E*4I2E:NN)_S</'YT7:5Y\^I2
MMHM*5KHX>WWWX@'SB^=_Q'P_2E;%Z4I2E*4I2E*4I2E*4I2E*4I2E*4JTV9?
M\D6K^D[#7];4)K+P_P"&_P!W)^3:K<GQ/V?VZNS6)5RE*4I2E*4I2E*5K&XR
M7_EJ[IO^S,+_`*TH-7">TO\`H/G_`.:GY1*]W_NR?V[=/_\`CS_]+/7S^:^.
M#VU^Q]+_`*OU<M2#8ZO%0@$<1<>+QU>!_P`[9-D^)<:8/=WQ,9CG$4BDDK@+
M8D:4"!T:'V6#3F/:PU^3%E.B\1HTH+DV-,O8@5M0Z5N<O?\`=\V#`QYI5"[5
M$4QBJA2@,G.%FL26$K%PQ'#LKF]NZ0Z?VKJ'=>I\.)_O7>DB7+9W9EE6%=,:
M<LW10.-[?&'`^"KQY#WR;A<W7Q:TYHFX)/$\<2^-R\Q"V0^'(%LH>6`IK;`R
MB;@LVDH,D3.T?:[)0+'VRGK0"$`V]P&&6OMI>L-PW7>\+=]_;F18LYDY44<*
MJ2[H\S&-E,3RS:=+M(K!C;5<5RFS^R/HWI3#W-.D,8X^=N6'+CAWGG^A1Q(R
MPQ,&:3&QDE<L(L<KH]%D])1:FY)N>DB;=>Z;K,1,K'B^2)I^*<P1C1L;&>QQ
M8].B`V-Y8X^F1)HV,=T@;F'DE)@I>V#!7`&UM+6UNW=2;EM._/U%MG+AS'FR
M'5=(9(UR&>\05A\54?0"`+``@#P;2'V?[5E^SF+V<]32S[AMIPHX,AR[I)-R
M[,6Y@;6"746.HM;XQ-S52XDWZ[H<(O>1'Z`SAH).RE,S\CRQJD<)BTNC?C!-
M<CG8N<L,<D+>N;(W*T*P^]TRU$`DXD%K`#>U@ATR=GZPZ@V+;?NC;)PF&)&D
M74BNT4C*49X'<%HW8%KLI!X@VO>L'J7V1=`=7QX?W]AR/)AX8Q4:.>:*1L95
MTKC3/&ZF6$V!:-[JQN3\8U:*`;@\N8SS>W;CHU+#E&96V2NTP*F$C2I9,<KD
M;X2N(=7-U1NY:A&Y'+`N1VMC`7"&XK=&UK6MI@;'OFX=.[A]Y[2XCRRLBZF4
M2$"4%9/C#B9`S$D\;F_;71=1]&=.]4]*R=%[MCH>FY8HHS#$6@"QPLC1)&4X
MH(]"CAV@6-^VK7R!]<I0_OTG>C@*7F2O;M(7A2626G+4.KVX*'-Q/+3E6L4G
M`:L5#%8`+6""U]+6M:UJTJ+H4*.P5T4$$.)!'B8X(QXHU1`3<A44*H)/$V``
MN>VJ>7?\B5_]&/\`^*%4GL/O'\%94/\`"K_G#\-?3\PK_P!SN)_Z,X'^*S57
MWIMG_;<;^+Q_Z(K\$>J?Z3[E_.&1^5:KFUGUHJ4I2E*4I2E*4I2E*4I2E*4I
M2E*4I6*&^[^Q/NX_NWYH_J\D%<YU7_1C<OXE-^2:O0O9+_:CTY_/>%_U$=?-
MM!]@#]P'SK5\/CLK]Q6[3[]35-12E*4I2E*4I2E*4I4;<]#YOPBI7XP]\?AK
MZ,7#7_L!;/O[ON-/Q<15]M=$_P!$=N_B<?\`HBOQ+]N']L'4O\]97Y5JS<KJ
M*\LI2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4K5UQ/^;AX_.B
M[2O/GU*5M%I2M='#V^^_$`^<7SO^(^'Z4K8O2E*4I2E*4I2E*4I2E829OWK1
M7#>X_$.VHYLC"F5Y5CA\J`[2[);'CUJ;&T,L:8B@;&X+FVN9TCECZN<#1(&X
M':W;5DA@0F].]K5U_3G263U!M6X;Q&THQ<`QJPCB:9V>2.:3XJLNE$2*\CW.
MD.ITD7MH]\WN/9'Q(G56?+,UBSB-%6$P`EG(/QFG"J+6NIN17FYYWVQ'!&7T
M.,'&"R&1M;0V8L>\KS9M<FQ&AQDS9KR2=BG'"TUG5ANNDUUTK3&#7EIAE"0(
M+6/_`(6]^KM/372&1U'ARY231P'O#X\"N">?D1XKYCQ`@^A]"EE9KAI'5+`'
M53?=[CV/EAXVE<XLN5*`0#'BQ3PXS2B_QR99C:-;,5B=O5#68%Q4\?IR)NK7
MXIF*5"4V+'7!ZL+TQG@SFG29V+VY6*1`#8!D*5'Y*6HQ!`ML?;UH5!6:ZA$3
M;9X_L[S\R#![KD0MGY+8G.B(8=VCS<5LR&1Y.*L!!'*9`+%)$$?I:@U8.9U;
M@[>^;-FJR;7B+N`$U[\V7;.4N3$J6#`\R:-(W/HO<MP4<<V-N.>6[<-`7*6I
MXTYPM]BT\G6+IU#G96D<E,9GF.I`KCDE;"7=!8*)Z;>VDMCDBPL)85*8T`[@
M!>]P6YKJ#8SLD^.(YER,'+Q(LF"0*4UQ3+<:D;BCJP9'4DV938D6-;?;MP;-
M?)QIX^3GX>2T$R:@X5PJ2`JXL&5HY$<&P^-8@$&NYG*0,+;&V=$XOC,WK!Y&
MP\K"E7NJ!$H$D(RQ#1G*@DJE!)@DY("1B&.UNB$(17O?2UZUN`KR2ED5B!'(
M.`/;H:LZ4J%L3QO5P?&#`O;O$/"5F]6U9[OD_5OY#YJN:E\8IXP8%[=XAX2L
MWJVG=\GZM_(?-34OC%/&#`O;O$/"5F]6T[OD_5OY#YJ:E\8IXP8%[=XAX2LW
MJVG=\GZM_(?-34OC%/&#`O;O$/"5F]6T[OD_5OY#YJ:E\8IXP8%[=XAX2LWJ
MVG=\GZM_(?-34OC%:TN,',8BZ<-_=`A;95&W!:HC4."G1H7UK5JCQ`R="#1!
M)3D*C#C1!+#<5[6M>]@VO?FM7`^T^*:/H3<'9'L$3P'PRQBO>/[L97^O7I\W
M_P!?/_TD]?@<KXV/;7['TJ*4I2E*4I2E*4I2E*5UEO*C5]G^3'\W_P#3%5+$
MA20">!X#B>RKD/"5?\X?AKZ9^&I[!B<18J*-FD3+,+QM!2S"QR1F",`RXPU@
M&`0;K>D$0!6TO;L7K[[VK'R#MF,0CV[O'X#Z@]ROP1ZI9?UGW+B/^X9'Y5JN
M5XP8%[=XAX2LWJVL_N^3]6_D/FK1:E\8IXP8%[=XAX2LWJVG=\GZM_(?-34O
MC%/&#`O;O$/"5F]6T[OD_5OY#YJ:E\8IXP8%[=XAX2LWJVG=\GZM_(?-34OC
M%/&#`O;O$/"5F]6T[OD_5OY#YJ:E\8IXP8%[=XAX2LWJVG=\GZM_(?-34OC%
M/&#`O;O$/"5F]6T[OD_5OY#YJ:E\8IXP8%[=XAX2LWJVG=\GZM_(?-34OC%/
M&#`O;O$/"5F]6T[OD_5OY#YJ:E\8IXP8%[=XAX2LWJVG=\GZM_(?-34OC%/&
M#`O;O$/"5F]6T[OD_5OY#YJ:E\8IXP8%[=XAX2LWJVG=\GZM_(?-34OC%8K;
MY9Q"ENS#=DC1S"*JE2C;GF4E.F3R)G-///-QZ_A*)))`LN,PXT5]`!M:XA7O
MI:U[WKG.KL?(3I;<G:-]/<9S\4^")O<KT+V2%3[4NG.(_P"^80__`,B.OG+`
M^P!^Y#YUJ^&1V5^XS=I]^IJFHI2E*4I2E*4I2E*4IS?7M]#GOI;EOR6UOYM/
M+_EQJ5^,/?'X:^AYPXIM#$&PO:(C72Z+HU:;`.-RE"54_M*=2G-!'481E'D&
MJPFE&EBMH((K6N&]M+\M?;O0T4\O1^VNB/I.%$>P^K[E?B5[<"![8.I;G_UG
M*_*M6:GC!@7MWB'A*S>K:ZON^3]6_D/FKRS4OC%/&#`O;O$/"5F]6T[OD_5O
MY#YJ:E\8IXP8%[=XAX2LWJVG=\GZM_(?-34OC%/&#`O;O$/"5F]6T[OD_5OY
M#YJ:E\8IXP8%[=XAX2LWJVG=\GZM_(?-34OC%/&%`K?^V\0\)67U;3NV3]6_
MD/FIJ7QBJG2JTRX@I4C4$*TIX`FD*4QQ9Y!Y0[=(!A)Q0AEF%C#?6PK7O:]6
M3<&Q!!J:[%*4I2E*4I2E*4I2E*4I2E*4I2E*4I2M77$_YN'C\Z+M*\^?4I6T
M6E*UT</;[[\0#YQ?._XCX?I2MB]*4I2E*4I2E*4I2E*5ASN1VKKMQ3RTHW;*
MKA&L8'GP<[(&.4$%AK@KFGB^G;=D%@NWY"4ID\OB@S'9M+)4A`:L(NGM>Y!2
M<\0CK])TYU%'T[-WL8RS[C')SL9S(Z"&4121:F1;QRK9]6EUO<`:]!9#J-ZV
MY]VQFPUF:+&FQ9L:=0J,989RA<!F]*-K*5!5@MF):-G5&6P;OL!?<J3(S(&:
M<QNCD[2*0,J7(S`S1Y@L@G.,\49N=LP8#B!KHC2,W>^MABE:!&XK2$IQKHAO
MU!E[&VNH%O-NZWQMCQ(L/;<53RHHY@79AHW%L%L+*R4%VNCH^I(KJ%EC61?1
M]"M=N.QY.[/.<K(*1,<C'CTA21MLL\.0N*;V&M9(2><0[Z)72Y.EE\T?"UQV
MH(F:-=DZ6J6Z[8N;L))RF=I3F82`MSH1N,L:0?VP,4X.2Y-0).KNK"E#9H3]
MIWUN,1U58OM)W'"CP9L6"(9^.^&9I#J89*X6-+AP(Z"P0''GE64@DNY$GHZ0
MM,KI;"SILF/+9CMF4-P<1`VY<NY\ELJ59;E[EX(VA6P6,:E.H$6S7VXX*;]O
MT#=8L1(5\O?97/ISE*=2UP0IFHR23S(K^ID<G=$S*C-4)6-L$L4V*2HP&FV3
MIR@`ZP=[7%?F-\WMMZEQPD8AP</#BQ8$#%RL40.G4Y`U.69F9K"Y/8*VNW;>
MV$^3DSN9<[,R6GF>P4%RJ1@*H+!56.-%`N3Z-R;DUV\YQR/.D<:%SHP,CHM!
MD;#Z,M6Y-#>O4EHS\L0T!Z0!ZI,::%,<`X81@M?HB",5KVT%>U\+!DD24JC,
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M_#_73_\`23U^""OC0]M?LA2HI2E*4I2E*4I2E*4I766WO9&KO:][7LF/TO;G
MM_!"Y;5#<5([.!_!5R'C*M_6'X:^F9AK'L!/Q%BLXZ#0\TTW&T%,,-,C+*,P
MP8XNUB&,8Q(KB$(0KZWO>^M[U]][7DY/W9C+S)+#'C_='U![M?@CU2J_K/N7
M`?\`<,C\JU7)\7&/?:'#/!=C]0UG=XR/K'^4:T6E?$*>+C'OM#AG@NQ^H:=X
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M]\D"@R'9ANQ6(X7$DBM-MTS*>F4IHVS$J$YY6/G\91Y!Q:()I1Y0PVN`8;V$
M&]K7M>U[6O7.=6SSMTMN:M(Y'<9QVGPQ-7H7LE`'M2Z<X#AOF%_U$=?.9!]@
M#]R'SK5\,CLK]QF[3[]35-12E*4I2E*4I2E*4I4;<_UOJ\O-2Y'%38_L?MU*
M_&'OC\-?0XX<<%A#CL+VB+5\-BJU8IP#C<U0K5QYH4J5!HXZC$,T]0<C&:<:
M8*][B$*]Q"O?6][WO7V]T/-.G1^VJ)'L,.+PGU17XE>W``^V#J6X'_>LK\JU
M9I^+C'OM#AG@NQ^H:ZKO&1]8_P`HUY9I7Q"GBXQ[[0X9X+L?J&G>,CZQ_E&F
ME?$*>+C'OM#AG@NQ^H:=XR/K'^4::5\0IXN,>^T.&>"['ZAIWC(^L?Y1II7Q
M"GBXQ[[0X9X+L?J&G>,CZQ_E&FE?$*>+C'GM#AG@NQ^H:#)R0;B60'_.--*^
M(55:5(E0IR4B),0C2)RPDITJ4DM.F(*!;0!1)!(0%E%@M;2P0VM:UJM,2S%F
MN6/:34UV*BE*4I2E*4I2E*4I2E*4I2E*4I2E*4K5UQ/^;AX_.B[2O/GU*5M%
MI2M='#V^^_$`^<7SO^(^'Z4K8O2E*4I2E*4I2E*4I2E0N$-[ZWM:]_-TI3W/
M!3HA\RWUK=GGI84IT0^9;S.;L5%AV^&AX\#V5'2UN:VE3V<!V4JTV9?\D6K^
MD[#7];4)K+P_X;_=R?DVJW)\3]G]NKLUB5<I2E*4I2E*4I2E:QN,E_Y:NZ;_
M`+,PO^M*#5PGM+_H/G_YJ?E$KW?^[)_;MT__`.//_P!+/7S^:^.#VU^Q]*4I
M2E*4I2E*4I2E*4KJKO\`D2O_`*,?_P`4*H/8?>/X*NP_PJ_YP_#7T_,*_P#<
M[B?^C.!_BLU5]Z;9_P!MQOXO'_HBOP1ZI_I/N7\X9'Y5JN;6?6BI2E*4I2E*
M4I2E*4I2E*4I2E*4I2E8H;[O[$^[C^[?FC^KR05SG5?]&-R_B4WY)J]"]DO]
MJ/3G\]X7_41U\VT'V`/W`?.M7P^.ROW%;M/OU-4U%*4I2E*4I2E*4I2E1MST
M/F_"*E?C#WQ^&OHQ<-?^P%L^_N^XT_%Q%7VUT3_1';OXG'_HBOQ+]N']L'4O
M\]97Y5JS<KJ*\LI2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4K
M5UQ/^;AX_.B[2O/GU*5M%I2M='#V^^_$`^<7SO\`B/A^E*V+TI2E*4I2E*4I
M2E*4I2E*A>]K6O>_-;EO2H)`%SV5+8P%^S^K37SJB_&W^0H2!V]EZFM>U^:^
MM3>]35I\RVO>)--K6O>]\G89TM:U[_Z6X3YEKUEX1!F/N1R?DVJW)\7]FKLU
MB7JY2HO2E+TI2]*4O2E+TK6-QDO_`"U-T]^:UHS#-;WY+6_SI0:_/S5PGM,8
M#H?/OZL?PRQC\->\?W8P3[=NG@/KY_\`I)Z^?SK;S;?O@_MU\<:E/&X\HK]D
M`CD7`-J:V\VW[X/[=+KXQY130_JFFMO-M^^#^W2Z^,>44T/ZIIK;S;?O@_MT
MNOC'E%-#^J::V\VW[X/[=+KXQY130_JFFMO-M^^#^W2Z^,>44T/ZIIK;S;?O
M@_MTNOC'E%-#^J::V\VW[X/[=+KXQY130_JFNHNO;M)7J(-OY,?SB#Z4+Z-0
M2MCQ'8?"/%5V%'YR7!^,/PU]/W"W)A[$^ODS@?XK-5?>FU,&VS&8=AQX_P#0
M%?@?U1_2;<OX_D?E6JYM9]ZT5*7I2EZ4I>E*7I2II4-=?-^M>HN+VI4:7I2E
MZ4I>E*7I2EZ5BAONO_\`!/NX_NWYH^EIXO)!RZ\VEJYWJSATON1/9W*;\DU>
MA>R3C[4NG!X?OS"_ZF.OFV`O;H`Y;?8!_P!D'S+?1KX>!6W:/**_<=D>Y]$]
MM3ZV\VW[X/[=3=?&/**C0_JFFMO-M^^#^W2Z^,>44T/ZIIK;S;?O@_MTNOC'
ME%-#^J::V\VW[X/[=+KXQY130_JFFMO-M^^#^W2Z^,>44T/ZIIK;S;?O@_MT
MNOC'E%-#^J::V\VW[X/[=+KXQY130_JFH=*UN6][?7M?]:U]:%EMVCRCQU4J
M/>Y!`!O\-?1DX:_]@+9]_=]QI^+:*OMKHDWZ0VT^/#B_T17XD^W$$>V'J4']
M,Y7Y5JS<KJ+UY72EZ4I>E*7I2EZ4J:5#6VNG9J+TJ-32E*4I2E*4I2E*4I2E
M*4I2E*4I2E*5JZXG_-P\?G1=I7GSZE*VBTI6NCA[???B`?.+YW_$?#]*5L7I
M2E*4I2E*4I2E*4I2E*5`5ND&]M=-;::Z:Z?4[-01<6IX*H0Z,2H<[1R0C(3D
MFAZ=C,;5.-PQZ+F-*UV&88,N0F2(UL%+"%1)8P@LG+5A2WL"U[@O>]]<N.7%
M7"DQY(%?+:1664LX*`6NH4-H;5XV!(OP/"L=X9#E1312%($4AT`4\PDFQ+,"
MRVN+!2!PX]IJN0`Z`>CKKRZZZ:?K5B*".WQU?`L+#LJS&6<.,64"6\Q8)P*<
MT#Y#E@3B93,&=$)I89>TR!S2>M[`]($)K@L0HCRB%`RKG%&&`%88>@$0<W#S
M),,GEZ=)#7NJGBRE;W*D^&]O<JEXU?MKD\0.,_N28>^GE3W:4[_E>-/LT^;3
MEIXOA-/$#C/[DF'OIY4]VE._Y7C3[-/FTY:>+X33Q`XS^Y)A[Z>5/=I3O^5X
MT^S3YM.6GB^$T\0.,_N28>^GE3W:4[_E>-/LT^;3EIXOA-/$#C/[DF'OIY4]
MVE._Y7C3[-/FTY:>+X33Q`XS^Y)A[Z>5/=I3O^5XT^S3YM.6GB^$U3,LVL8*
MG#$XQ.:PYQF,7=RRB7:-RB=Y$?V)T+)4$JR"G!H=96K;U@"%2<LT%C"Q6"8`
M(K:"#:]6,C).3"V/EI#+`UM2O%&RFW$<&0CM%_V*R]OSLW:<Z/<-JR)\7<(B
M=$L4DD4B$J02CH0P)!()!!L:LI\F/P_^7_X4L46TM^"E5N7S-/7#DYJU2[=L
MQ6XP=NM_%,?P</JKUU(]H_M$'#[_`-\X?_\`0RSY?IJF!PQN'^.^EMJ>*;:V
MUMJT+.6W-]WU4-LV?\QVZ_\`%,?_`(53_6-[1?#O^^7_`)PR_P#C5$?#%X?X
M-/\`X4\47U_^R5EN2W/_`,_O0[9LX[<#;[?Q3'_X5#[1_:(!?[_WW_G\O_C5
M)\F1P_\`37\E/$_8YFM7>W+SZ7[>Y;6\WFJG[NV?PX&!VV_^3Q[^3E5)]HWM
M$#:3O^^W_C^7_P`:N6_##X?]@W%?:IBC2UM?O2L_87U4VV;.!?N.W?\`*8__
M``J?UC>T3_[@WS_G\O\`XU2@X8O#_'>X?R4\46O;_P"R5?U[?R_FI]V[,388
M.W?\IC?\.H'M']HOZ?WS_G\NWY:@N&+P_P`-]/R4\4<UN7UI5VMK>^FG_+]:
M?=FSC_Z#;^S\TQ_^%3^L?VA__<&^?_Q#+_XU2_)C\/\`Z71_)2Q1KKI]ZE?U
M?^?]BJ?N[9[A1@;<2>/#$Q^SQGZ*G]8_M$_^X-\[?S_+_P"+X:E%PQN'\*UP
MWVHXG%85KAO;UI5WL*VO1$&_\OTTTYZ';=F`).!M]A_^DQ[?DJG^L;VC+Q_6
M#?`;@C^4,OW_`*[_`-AK(=#MYQ2C2IT2%KE"-$B3D)$:-)DW*"9*D2)R@DID
MJ9.5,@$D)TY(`@``%K!`&UK6M:UJW2Y^0`$01JJBP`CC``'```*`+6M7%/\`
M3.TTI=I&8DEF)))-R222223<GPFNWX@<9_<DP]]/*GNTJKO^5XT^S3YM1RT\
M7PFGB!QG]R3#WT\J>[2G?\KQI]FGS:<M/%\)IX@<9_<DP]]/*GNTIW_*\:?9
MI\VG+3Q?":>('&?W),/?3RI[M*=_RO&GV:?-IRT\7PFGB!QG]R3#WT\J>[2G
M?\KQI]FGS:<M/%\)JG9=MTB+E&'Y!%U,L9)$L;%:=E=S<H95&6VN)A5PIE@P
M6F!UQ!(,O:^G0%]*]7(MRG217?04!!(T)Q_>U!B4@@<#7O`P'C,7HNTYA;DT
MM_G4RIK:W/:W)-;VUY?J<U6_O#,[+QZ;_5I\VJBB$6KD\0.,_N28>^GE3W:4
M[_E>-/LT^;4<M/%\)IX@<9_<DP]]/*GNTIW_`"O&GV:?-IRT\7PFGB!QG]R3
M#WT\J>[2G?\`*\:?9I\VG+3Q?":>('&?W),/?3RI[M*=_P`KQI]FGS:<M/%\
M)IX@<9_<DP]]/*GNTIW_`"O&GV:?-IRT\7PFO+>=L^')"TN;"_L#\^,3V@5-
M3TRO.1<ENC2[M:\@29<W.3<MF!R-<A6)AB+-*-`,LP`KA%:]KWM5,N9/-$T$
MHB:%P0P:*,@J18CBO80:O8TDV%DIF8<DL.7$ZNCH[HZ.AU*R,I!5E(N"I!!X
MU8CY,'A__%3Q1[$+/5]:C[KV?\PV[_E,?_AUU_\`6-[1/_N#?/\`G\O_`(U/
MDPM@'Q5,4>Q*SU?3[KV?\PV[_E,?_AT_K&]HG_W!OG_/Y?\`QJXQ\,;A_@OI
M?:GB?3DT_P"JEFM]==>3M[DM:H.V;1X,#;C_`/VN-_PZ?UC^T,FWZP;Y_P#Q
M#+_XU0OPQ^'_`&_^5+%&FFNOK4K[.FG_`#_LU'W=LU[=QV[_`)3'_P"%5/\`
M63[0R+_K!O?_`/$,K_C5#Y,?8!KI;:EBCFU^]2OFUO;[O^A4#;=G-].!MY%[
M?_*8_P#PJ'VD>T0"_P"L&]@<>W<,OP>YSKTMPR.'^+73:EBCDOV6I7;D\W7M
M^AVW9QVX.W#C^:X__"JK^L?VAB]^H-\X?_K\O_C5&W#'X?\`KI^2EBC7ETMZ
MTK+\W9OHNY+<M/NW:3\7`V[W^ZXW_"O\%#[1_:(!?]8-\/\`_?Y?_&KE^3"V
M`7_^53%'L2L]7U7]U[/^8;=_RF/_`,.G]8WM$_\`N#?/^?R_^-3Y,+8!V-JF
M*/8A9W0I]U[/^8;=_P`IC_\`"I_6-[1?!U!OG_/Y?_&J^C!MBPO%61JC48C3
MU'(ZQ(2&QD86'(.2&AF:&U*'H)F]L:V^7)T2!$F+MT2RB@```-M+6M:MK%E2
MP1+#`(TA0`!1'&``.```7@`*Y++R,G<,F3-SY99\V9R[R2.SN[-Q9G=B68D]
MI)->OX@<9_<DP]]/*GNTJYW_`"O&GV:?-K'Y:>+X33Q`XS^Y)A[Z>5/=I3O^
M5XT^S3YM.6GB^$T\0.,_N28>^GE3W:4[_E>-/LT^;3EIXOA-/$#C/[DF'OIY
M4]VE._Y7C3[-/FTY:>+X33Q`XS^Y)A[Z>5/=I3O^5XT^S3YM.6GB^$U"^`<9
M:7U23#3L_P"=/*GNTJ#G9)%CRR/=CC/_`,-!&@XVJK<:1MWB$&C<8?G<Q^=F
M5O[15.YJE8M,76+/.N08-8XB&O4F%IA``(9PA&"N'6][WY:MY,HGR'F`"AF)
ML``!?P`"PX>Y5=5U5BE*4I2E*4I2E*4I2E*4I2E*4I2E*4K5UQ/^;AX_.B[2
MO/GU*5M%I2M='#V^^_$`^<7SO^(^'Z4K8O2E*4I2E*4I2E*4I2E*4I2E*4I2
ME0TMKKV:4J-*4I2E*4I2E*4I2L$=^;[D)NB.%6/&ZJ>A>)QN"B41<6G&L_:\
M72V1LBB'3QZ5,:"=/)9B!D),4LI*@Z][@&<6FN2$5KF6KJ>BH<3(WZ89ZQ-B
M1;5ERWD0R(CH8=#M$IN]M9`'8-5S6IWZ2:+9II,4L,CG8J>B=+:9<F.-PKG@
MI*L0&_<WOVU8$K<IFG$68<7;?$4&E:]O2L^)G?(-\KRAHR+.7([-<[>XPJ1)
MLQ*\BQ%H1WQ>2VW4Z)6>3">!&%(2K(AB+-'O_N/9]\V_/WN2>)0DD\$#8Z-`
MB=VP>\B9L<0RL_/:T04M!HTRSF1PO+K1Y6?N6R8T&-%#/)D-$\["219B53(C
MBY?,+QB,LK%PY+Z6,2&/2Y<>QL(W*Y8GY3!#,DS:!Y9N\XNEN26U^AI:[OWB
MMX]E9[@_>GD<9[PO:WIZ<B"@73J2D[/8D]*<E[7."7VR*.M-@VO!QY,O`Q\C
M&FA&"K7TG'F.3B"8G'-@P*LNI@7D#K(LOT=]%;5,O)7?6Q'FQWQ9LS<8U1=1
MDA&+DB-6=KV:)E?3;EJ8V4(&D'I57F\/*&7GO;4TOF'PY(P9DAYSKB*(LI,H
M;6!IE*PE1D5D*6,YB,EPDC8-CG20`FZX^MZRY"D8M`"#:M1TUA[;B=5XPW40
M9VV+AY4\BHS,NF/"R9"'&E&UQ:.8%!L75!J-R*G<YI\OIW<^[\[%S5C$<4C6
M4I(T\*)*I!8<N[V)(N5UBU[5C`Q[UYK(<B9HRW&<G-R#%LOQ'@=NP3&)3'U\
MNBC9.'/)DUQW*W1JBT>71A\?Y/)Y@C4LY:58[M2/MEH!8]8C)Z9MNHGZ.Q<3
M:X-FF@Y^\KO<YD=&"RG#[FN1$H=KQ(HAC.5K`?Z.<%!(UD.G3>Y)\R+-U\C#
MCVJ=9HW4A5S(I<;6S@:G)1LE8-%E8.'C?2P8K[<(W_YWG./C9\F;<3,R*-X;
M02.3)GB/2(L:J;R#<3DG;V@?C#D60%R&)0.,C@=GYT2"/=CQ%",2@7@#:RRU
M.5T/L\.X#!YF1;)W##@A*NK<N.?;<;<)22T*<Z0\XP8]EAU.R,Z@C0\KO^XQ
MH>:B238\>XO(H0HT@PIDC0*O,<1EEE1I3KE":'TZ@05]5TW);CX9EN7N1F7,
M"Y*B>.XQMX03]GAD?D(XW(E.2L_33&BI7#;`R"YWQE-4[4J2#<BEJN3$",0E
M%`"#K!#+L[=T_L.X;?#$V)N&//F;G/#"TK*73E[;'D7+\E>=!S$.G3'$2TDE
MWM&NJ-XW+=L!EDCGQ7?'VW+R7TJVB1(9H"%=.82DW+9U$FMP`4)C(8Z;][S9
M(^HY/CF.PK-TIB&4WMN>#L6XJBKRSQ5N?I*A=F;MC)N6GUT$<G6XB@C<;<"Y
MI/`$IT-4V((N:J,)+MI.BH%DRI9,K#BR-MBEQ^\RR*SK#C,9!+'%&INV5D@:
M,9U].)T+<$UNFUZBE$6'"SRRPO+WA(5C;2\^0T(,(+V81Q0'5),Q4J`RL^K2
ML4MJX+E#+#QNF,:T>3W8]XF<_P!TN-WC&KS<+U!<=QC$+<T>*.=)8*F/:G%J
M&Z*CR%*Q3=:1=\+<^B`T`>JN#9MM6V_J8TBP@@;?BY8R`/I!D391CFQC)V$1
MKJC6(@\LPEF!)<FW)D31;M#WB<C(7+B@Y"LH7(@?!6>68+Q-Q):17!)19.6;
MC2!;%\G^4R]J&0WV:[D9P[YCQEF+=2G8PQ&;8\PBX9)!C?([HT(U04#J0>-1
M#\9-80'!CJ%2(:Y/8M,>-2:,`A9HQ]J/4&UMMNWPQ;;F;3MS.)(Y<M8#/&-4
MKA=/,EG>R%RJJ'8M$L8!MC2ODPP;G#N.66GQ\UC'RRL+2!<6*7N\;,6Y:J)&
ME-V9B([NS`F^WS'B]Q=8+#'1W6%N+LY1*-.#HX%-IS,4N<5K,B4K5A;.HN)0
MT@4J3!#LF'>XR+"Z`N4-Z\[WG'@Q-ZS,;&4I!'E2JJE@^E5=E5=8X-8``L#Q
M/'PUMMARYL[9,/,R&USRXL3L2-)+/&K$E;#223>UA;LL.RJRK75MJ4I2E*4I
M2E*4I33]7Z]/=I2E*4I2E*4I2E*4I2E*XC1W`&U[<FM]+WTU^M;LWJ#?L'AJ
MEF`'$VK4#G'.:J+/6<\BR;<J]8PR5BS,37CG"^#Q2%I9(3+6X;%$WYB:)%"G
M!)<R>.67$C@Y"3KS#K"3`M8"(19B,S7TWIG:1FQ;/@XVVQYT6XK*V7(`S.BK
ME2XS<N0?P!QHN3/8"[,X9]2,`.7WK*2/*W%LW+.#!@P1MCG4%5V?%$ZS2?6I
M+DB3%"-9%,6CA)("UZ=ODGDLIW(3U3&LX2++$$;$T_;,HW>7IE[QV[)!,L:N
M]"!86B",P]6V)L41T2MLDKH288C<G`973&)4`XLC6;CBXN+TA'S\189I#C'#
MD"MS9D"3#*RIWX`19,@C;&A8+H56T7CM)),>3D3[Z`9CWE-9R8@0(H0\4308
MR+=M>0BV>:0-=;OS!>98X<?9-E/(C0/<E+,7;@)CDB-,*)UBL]F#F[LO>O%Y
M^ZYGB,:/3X/AA5E2J,-N#,<.CH0\O%A'-BET`28,1AZ538O;[9MFWYN)M6)O
M&)'B1Y63B&`@'GRQ<F=IYIY?B\K.G6!<6(V=4,G+&@I)(R<G(BW/.DP)GESL
M2'.::(\(8BL"OB0HC7US0*.;D.I](JRR#5,(X.:1Y"SNV;<)NY0+/CQ:/8<W
MA1W&Z.>O+:AG$\RIBT[*^*61,Q^,)6L3MQ5^OE3@W.#J!"N4K4Q74EF)S`B-
MK-PL'9<CJK9EW3`CU[EMT[28ZEH(HY@F:(Y3&`6("01RK&&12Y#MJ4Z3CYDD
M^/M6\)MF:S]S02).^F5D_P#+)-+CJ;A=0D<`2-J*(Y33J"LN0+5*GQ!OC98Y
M'<NRR;Q"9QK+*V6M*^=Q*50J/O4-/8DB7'K!CN.)TKOC=YAIRLLT]W<+"NY6
M4#3&C,/$#H<SCXN//T3DY&5B113XW(>&70ZR.9I`O/,[>A)&XUQKCK;B!*J@
M1L3E;CE21=184>-,[<^1XY8[C1&L>,[:&BMJUNRI-SR>&KEDD.@&Q0/V(?I6
M\ZN(KIA8#AV5&E32E*4I2E*4I2E*4I2E*A:UK6TMR6J`+"PI4:FE*4I2E*4I
M2E*4I2E*4I2E*4I2E*4K5UQ/^;AX_.B[2O/GU*5M%I2M='#V^^_$`^<7SO\`
MB/A^E*V+TI2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*Z"UJ:W,
M:`QR;4#@8U+BW1L,6HTZL;<YE$GIBG%`(\LP2-<6G5&EA.+Z)E@&"#:^@KVO
M7'+)$2T3,I9"IL2+J;74V[5-A<=AL+]E4NJR+H<!EN#8\1=3<'WP0"#X"+CC
M7AN\$@[_`"&.RU]AL4>Y7$+K+Q*3.\>:'*0Q>[B6$EPO'7I8C.<F2ZXH-@G=
MK&E=:&UK"UM5V#+R\6*:'&EDCAR$"2JK%5E4$D+(`0'4$D@-<`DV'&J9H8<@
M(N0BNL;AUU`-I<=CK>]F'@8<?=KK13&^.X&>\JH/`H7#%,C4DK)"HBD68XZ>
M_*TX1@(5/)K0A1F.BD@!@K`&?<8@V%>UKVUO5>3GYV9%'CY<TLL$5]"N[,J7
MM?2&)"WL+VM>PO5(Q\<3OE"-!E2?'?2-3?YS6NW[)-5(X-+4[%IRG5L;W,I(
MN1N:4IP1IEI:9R;CPJ6]P3@4EF!)7(5(`F$G!M8PH=K"#>U[:UC1N\+:H25:
MQ%P;&S`JPX>`J2"/""0>!JXZK(ACD`9&[0>(-B"+@]MB`??`-4@X8HQ:[,ZR
M.NN-8`YQ]Q1`;7!C<(='5K.N;BW54_%MZQL4MQB)4B`^+CEMBA@$796<,ZUN
ML&(5\E,_.C97CFE5T964AV!5D01JRF_`K&H12.(0!18`"J&@@;5J1#KYFJX'
MI<UM<NKQ\U_2DO\`';TFN>-=U)CK'R!M6,Z&"PU$T.#,='%[4DC#(F;5T>4*
M'!6>PK$)*$"92S'JG94:-*,(B!&*317#>Y@[WIGS<S*;5DRRR-K#W9F8ZU"J
MK\2?2554!NT!5`-@*100PE3"BH472ND`:5(`*BW8I"J+#A91XA729<3XLC32
M!@CF-8`P,11"!*6RLL-CK4TEIFIT.?&M.!M0MQ",!#:]*#%B<%@=$E4,1H+6
M,%<5[\V[;KDS]ZR,G(DR0U];2.S7T<N^HDF_+]"][Z/1[.%68L#!AB,$,,20
ME7&E44+:0WD%@+6<@%QV,1<WKKS;#F(LEKFQTR-BO'$_<F4NY3,XS:#QF5+F
MDH1X%0BVQ6^M:]0@+$I+"9>Q0@6N8&PN>UKU&#NFY[6S-MF3/CLQ!8Q2/&25
MOIOH(OIN;7[+FW;5>3B8N:BQYD4<L:WL'4,!JMJL&!`OI%[=MA?L%>\B@T);
M92ZSENA\6039];D30]S!%'VE+*7AI;;!LW-CK("$A;LX-R"P`V))..&65I;H
MAMI5DYF6<08!ED[B)#((]3<OF-\9]%].L^%K:CX350QL=9%E6-!*B:%.D75/
M5!M<+^*.'N5Y;WBK%\E3(T4CQO`I`C;I"?+F](]P^/.J9!+%2D:U3)T9"]N/
M*2R%0L-$:-:"P5(S17%<=Q7O>KF/N6XXDJSXL\T4ZQ\L,CLK"/@-`(((2P`T
MCT>`X5&1BXV7$^/E1QRP2,&=74,K,!8,P((8@<`2"0.`JO-+>9:L*K]@.RHT
MI2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*A>UK\]K7^G;6E+D=E6XE^&\09!
M=$[Y/L58WF[VD;CV=*\2^#1B2NB9I5=9VTUIW!Y:UJLEN4]:/K"`CL4/I7U#
M?6]9V#NFY;9J^[<B?'U.KGE2/'=D^*QTD79;#23Q%N%JL9.+C9BA,N-)5564
M!U#`*_QE&H&P;]T.P^&]<44PIAJ"2!;+(/B3&4-E+D0I2N,EBD"BL=D"]*L/
M*5*TRUY:&I&XJB%2DD!A@!F"",P`1"M>]K7JN?>-WRL48&3E9,F"""(VE=D!
M4$*0A8J"H)`-N`)`[:M)M^!%/WF."%<FY.L(H:Y%B=0%^(X'CQ%<++@S"4;<
MI"\QW#N+&!XER%R:Y6[,N/HDUN4G;'D[MAX;I"N0M!"IZ0NJB_34DJ1FEGC]
M$.PK\M1+NVZ38B8$V3D/@QE"D;2.8U,8LA5"=*E`2$(`T@\+5<7$Q$RCG)%&
M,TL6,@4!]3$EFUVU78DDF]R2;U4K;C^!LT6009HA,1:H2U62V:X<VQMF0Q9M
MLB7`<T5D$?2HBFE'9(Y%A4%=62'JSPV,#H.UKU:FW#/R,LY\\\SYQ[9&=C(?
M1T_')+?%]'M^+P[*F/&QH83C0QHF.P(*A0%(;MNH%C?P\./AJ+9`((RR=\FS
M/"HDTS.4$)TTEES9&V9!)Y"F1]#M1.^/Z5$4ZNQ"7JP]6!0:8$'1MI:VE4G,
MS#B#;S+(<!7+B/4W+#&]V"7TAC<W(%S<\>-5-CP/DC-9$.8(^6)"!K"7!T:O
MC:+@'3>UP.'`55M8U7:4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4
MI2E*4I2E*4I6KKB?\W#Q^=%VE>?/J4K:+2E:Z.'M]]^(!\XOG?\`$?#]*5L7
MOR6U\RG9Q/92N/K`]F^GZN3Z]4ZAI#CXII>WQN!J'7`UZ/HM?I>;?37E[%3X
M>/"G@O\`N?'7):]KVUM^K2@-Q<=E*C4TJ%[Z6UY?J6UJ"0HN>RE0L*U_-_6\
M[76@.H7'90\*EZP.NG+YG-]#7]?6EQXQ47\7[7^7&N2IJ:@(5@VUO^M4$@>_
M3W?!4`BL*VMN;Z/)?ZW8J:`@\14U*5+<5K<^OZOUJB_&U+@<30(K"YJ`@]E.
MWB.(J:II4EQVM?2^NOZN7Z51[MC:GX*!&$5]+>9K]3S[4XWX@VI8^$5$0[!T
MUUY:GLXGLI<#MI8=KVUMKI^KL4[>RE2]:'45N7T//R?L\U02`;'A>HOY;_LU
M'K+7Y>73Z5"0!<\!4^&WAI<=K=@5^73L<^FO9OR4!!X^"G#PU-:^MM:FH!N+
MCLJ-[Z6UI4UQ]8'L:WT\RU[_`*K5&I?'2XN1X13K0Z:\OUOJ:>9KK5(=2+@W
M7Q^"G;V<0*=:'Z-N73F[/T-+\M57'8.)IV\1Q'N4ZT&M[:WY/H?K:^;R5`=2
M-0/"]JB_D%3!'86NG8J>/A!%3^&IJFE+\EM:4KCL:&^O)?D\VW^KIS4\%[4\
M-JC<P-K:\OUJIU#MH2!VD"IK7M>VMJJI4MS`VOII>]^7DMIV.?GO:HU#P_MU
M3J%[#B:!'85[VMKR?2_;H"&%QV55<>`U->]K?5H2!VTX5+U@;<G+KYGF?3Y=
M*7_R\=/!>EQVTUTO];]NI\%Z@D"H6-#?FU^K;3ZE^7GJDN@-KBJK>2HV&&_-
MKYWGU4.-4DJ#8D7J>E37&$P(KZ6_8['8Y^>E1<7L#QKDI4U((=@ZZZ\EM?\`
M4Y^>H)`X>&GA`\)J'6!YN7FO?F\S]NEQ>U.)%P#:H7.!;77I6T\VVEOU?KTU
M#P\/_P`;=O947%[?NO%4X1V%KIKR<^OF^9ST#`]E34U32E*4I2E*4I2E*4I2
ME*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2M77$_P";AX_.B[2O/GU*
M5M%I2M='#V^^_$`^<7SO^(^'Z4K8L+FO]*_G4I:_"M:4BS9N>G9$,?(ZT.>U
M8ETW*OVWE3#\P8O:,@O$M86QVD1#+F>,N+?.(V!%'9BW,Q9[>F,+.U),Z8A"
MTM>_=[=M/3\,T<.:Z[CS]E;//(E,9QI%0.V)*#&^J1";2$6L./`\*YW<LS<@
ML\>*&QSCY\>.LCJKID)*85$T:AP54%W`!-V86('&UMV+=+NB_*)3016TI7:&
M..8<OXX9#GZ%P:"8^DK5BJ/NBQ0G8<I)<OR::%9'7+V\L9;>MB*9&:1VX,!M
MRDG6"SEV#IN3I@[FVJ/.&T#-TK*TDREYUC2T9@6$P`.`\AGUJ-+,JEK5B2[A
MND.YKCGCC+FPXVL1IRBSQ(["1S)KC=AS#&J1N"X2,%KDC)6&;T$4\P$KSI&,
M=+#TBV>,F+X1&'"6-*)=(YR[2MIQX<C?'0")6AAS*BGJXY.!<<%394V$`7DE
M"`I(*%ILWI&7!W[$V&7(0RY,33%PC!4@$,F4&TGTFD.-&6:$#4DWT!.L,5V,
M6]H^#G9TD95<`Z)`&5B<CF+"8E(-B@GDCCYYLFEFF($2%SP'[QG]ME<:C+YA
M8Y!8"S'S#E1:AR9%G\>/Y3E.6/<(A38P(V=$HMD1O.?V07;ZHDUO-;DYMA&)
M[G`.3EV1T_A2XD^;C9A>$)D'&O"Z<\XN%W^</=K0!8>"->5)9#9"8P9!<.XY
M492.;'`R`Z\Y1(I$:/EIAJZ&P:0ZWUF,JCJBV8"1DC:E"]^:Z1DXP;L=837R
MV894CT$D+/'W#(++&D+01-HGDN7Z/[Y=F>!(R&E!C-0`1I:0VYYB@%@`T"*L
MC(Z13#R=R3/RE3!VM9&EE6-GU+&N.QT+=068Y"*JE@-7QF53>L>'?A/B8<\<
M+#(S'*+&39E/>I,2[FW!0T9=K`L$O92PL:#+X@,[2IYI.U.%"EF*6U+@5S1N
M_?:>E-@+!DW';[-9A*,IKFN)R4MECL65-1:0M<`H2,1AY=U!J4H0C0;=>@L)
M<B';7S-.YRYN="2(QHD..^,D$<(:1=4\W/)Y99;Z2%+-I5L1.HLV3'DRX\1B
M(\.&4QA]3AY)9XY`=".3'$(=1D0,VDDF,`$K<#+NZ3*\'W#Q*'16$1J7XTD$
M%Q<H;"B)0C;7N2SC,T_=HA'CU+RI0K$S%$8VW1\]48:G)7'++BM8(;:ATUVQ
M=-[=N.V93YTTL.XPY<L?%"5BBQL4Y4[E;AFD;A&B$J`W$L.-9.[[ID8R8&3@
MK')!D)*S#4+R,7QHH(T8BP77D!C(1Q7L`T^ESN6^\YLM-%)N&G,]M1I'59C!
M2FG+(8JR$7',T1G!$A+?$)C85?')R::RQ(8E"I,6]MH+&&7ZHP%R;VL3I#OD
M&,8LE1ER]V,J,A"PIF8^1E8[!P3S;Q8SF554&-BJ@R'5IRYMSDQ\N2&6(]UC
MCS#K5@69\%(WG3EV#`'F6B=B%<KZ6@/&7]C'F[:8Y88<PHV[%;9`IS`\;*)E
M$2I1D!H=HH_NEY/E''9*9X>24+&2QMR:=XM6!L:<,-E#>:2>*Z<0A%EVMUZ6
MQ]O@P\Q<IIL;)S(HF5(BLR)+!B92LBL2K2F#*%H[D<T!-3!M558.YS2YAQLR
M`1HL<I+<P,-4&@S`D+=(U$L166QN#*=`Y8UVNB^]*8XM2+&//;5('N7&N1+2
MF:%^/6W%,L9YC(&8Q3CV`KD#--\F0"66RBZMZM.Q.S&^JT]CB#2%00&EWM;;
M9'2F%NLJ'ITH(G=E0B8S)((W@[PYUQ0RPG$AR$GG#Q%3#Z<;-QK2XV]YN`LC
M[^=.B*.5UT*K1I*F3RRA225)TGEQ7AA`991->.15)0&MCM]3P1E`<"%@U?ZQ
MIY]:%JIA;(;)<1:5+FN.8#=WTJ.A9A+#K)9W*T=TZ6YP!J4(3SA#)$6`LW!Q
M^D(I]K7<3F*C/C\U4,3$G5AY.9$A8-8%X\234>(35&;L694V&;O&5A/(C8VH
M0*ID^D`M:"+*F"@K=M$,HT=G-E!3T%M(:+-WX3V1QYN-C6%B6.4R)XQ6[P1E
M<YTS/Q$U@,OSDEPX^7='%$A0)X%(`+Q#&2$VS@`LDP)O\(84:FMF)T1CQ9$*
MSY6N'3*LP"E#"YVV?/@8-=^:@$5I0H!N+)J5E>IS]WGQ!EE83RX@_*?4I:5H
M<J+'E4Q$AH[Z[QLQT&X#LC>C5;*]]2EO01E2=AIQNM3)'5RS(@#.&H8L;-K'
MF`W"3D;&C[,MO&@L#,DQQA1)`&SIH`!,$(!I@"!8F!T5'FY!6',5<29,7N[M
M&099,S&[U"DD88\A>78.]W`<V4,`Q%&7OL^)C222X_\`YN"3+$J"10@3#91(
MZ2,`K,ZNKQQV5F!LV@V!)M]+N6LDJE^P8Z,L0;`YA<6"1@GS(X+'J,X%RTUX
MMR=(W1A"T)AQQ(W@=;.Z(%U*H2M$0;8RZ<80].A.DH7PH,COJ#(D3;FD0QM:
M/[TADEQEYFJSM=`CV`4<Q&#'T@MS(WB6+,D@B@,F.C9:*X:Q:3$C25UT%=0#
MQLVD\6$B-&R"ZL??DFZZ5&MFW::X[Q1*I]&\TSB?-26,1H^'"F#_``=BB<P>
MHM-F%9,I?`XPWML@!'TSF$)ZT1HFU4`(0B,%Z&SC]+(N?F[;NTJ8^7A[:D[E
MM>B"9I\5##+H5W8HLYC<*A*SBQ]%22DWE)=O7.P%>6)\\0Q@6#2H%FUNFHA0
M-<1*%F`:/T@;,!5F8+Q#)"9;%[5+L'S=>]S!5.G.?KF1&!.@Q+%D>;)]BR(6
MDIS9WTQ(QT)%#1!=1FOZ)&"Y0SDYRCI!*MM,CH;$'>)<7-QQCP8>,\;LUER9
MY<%,V1(^9RI%5@3R_HV<DJIC`#,*,S?)\-D5L3(:67->(16!DCCC;%C+MRS(
MA]+*1[Z@FC5>16THU&._$@G<MA3[)L;8L;V!^BH,QDJHQ.7)P&E?+1C!S#F'
M'DB:Y'=E9K`9GMJDB<\P1*16E5EAZ*56:48!3?.@]GV/#EP8^YY!:/(?%6\=
M@8I&W>/;<F.1+E@\9+A0_+=6(,D2E3&<23J-I&GCQT`:$.ZF^I)8NZ9,\3JP
M`&F1X-)*%UTW97:XK(W!.ZG(DRR4JQUDS&K;'TKS/,X1:$S%BE*-R2*5&'G)
M%ZZ,+HP]HDJR"TS8X=$IUZ^UEYR<R]TB4(@6%IMUZ8P8-B&[;;DL\Z;?C9,D
M<D96ZY#M$'#7(6[A3RO2THP/,)!47<3>LY]P3$R8!R9<@Q:E<,(F&,F0%((!
M<6+)K%CJ%B@%F-MVC=-FR"O\D#EQJ2N;C(U`TF),=HHFT1^+2Y:Z9!8H5&%<
M(S^PSR?QIWBX#),C]=AO[:RO20(['@;Q@U#?(3IW:]PQ((-J+#,'*,[L[:X0
MT,DLAEQ6B'"T4AB.-+.&(5'96D2]&1N^1@;A--E,!M@7(,*A5;F\DK81S+)Z
M+^DHE&1'"%+,RDK#(PJ)GWN/"N>1!N>($%I:Y"7&(0^1DET3N3G&<H.NXUQP
M&]J2):$I*VR.'-"YO$>086D(-6%Z"M8L0NK#9CZ.Q9\$Y&/D&0..=%*R%08#
MM4NY@21@MHE=8Q';40I:]V7B;N1O61AZQ/#IDQY'BD0-J!<9V)B71](N`,GF
MM=5*A2C!7#`4Q%=^$@D$Z=E;S"4['B-.M1>L;DT/"*229Q3M^)\TY`DQ+F@"
MG1%);7'B^UT9B8XX0KC"6(-@C$,%/ZH1+L(S]9;=F@DEY;*44`R;5'"`W$:@
M^XV<L`M@7)&D`Y4VYSC?3M2IIQX\H0-)?B)%GS8G]"Q)6V)K!4EKMHTDU6*3
M>].5Q+3'FW;L-5E!XEC:RI8C?++(&,DQY]Q$^9G8Y.MGY,64)BAJ(TQ&IU"(
MM`:-.M&`(3#216.O1E])X6`9I9<[^3<7&R7F?DL'$F)D8^/-%'&SCF`MDQF.
M0L@8!@XC(JUB;U)F)&(8+2Y#X@@4R+Z:9@FY3N5#<LJ86,J6<A+.G,'"K@8U
MW?EY#RC`8`KQLZ0ABR?BR/9&@<NE+V)->9+G:+)I8]1>(-Y+`8RR)5"D1_5.
MPB7>RM,9T1]J7(%UUK>Z=)-MV'N4RY"39.W9CPO&BW81K((TR)`6#)'*Q(C]
M%E)&EG5B!48N^G(&`[0M'#FQ$EF8:4F!8''!`(9_1)](QW7B@:QMA2W;S-TY
M#*Y9`0L3ID6/%RZ5L+K'0[?'_'+''2&O.J'&\7;X+E>73-NAV5)%)T)@D8"@
M'ITX%)@E1AI)1`P7Z6/I3IUY</`G98I\B'%<.,I&ED>;"&3(AQ@A>*-+M)S6
M[$C"+K:45K<_==SA?-?%(>.";)2Q@?E)'`9%5N?J`=G=8UT@'TG8'2$+5<;)
MF_R50-DRF9)(F3AR4-.8(M!<>Q3+*5I<7:S`EQ)%,L317(Q8KE>0&=2<\IE*
MM$UFDK`=2>M2V.!T@""/6;?T;A9,NW<B8YN,^/E39+8^L62+(?'1(^>D.F0,
M8B=0*L%<*U9^7O,\0GCDB.-)R,<0G(T,K33RY"&1A$[,8HTB)(7TM8%P$?4*
MU4;D,L2R?1&21&2MT5V^9)*Q\UXYF8\6H,D1Y6ZY&C;88W(9Q(&#)B.9X[R"
M3)'L!2=`XQPIA&`M,4<XV.5W`6CZ7P,-,C9LZ,R]38[Y>I!,8M28HD?7C:HC
M%/%RH6>0M,DQO*(HWY:LV$W4+9$6+O>-]'LCPXS2DH',<N3,(>7,`ZRQ'5+%
M'&T<4D9>QD=%<A:[Q!D#.H</9_R-D;(T2G;IC]VSA'8DC:<7V@R%&JQ`\2QF
M2.;L$F:R4]W]??68DXX@(TX217&`%[VTO6FZ@QMG1-LCV_'G@?-QL2=V,O.L
M,I48HJ\M/B:CI-RSV`]RMKL_WC+N&2F;*DD4&0T(54T$Z0IUEM1OJU6M8`=M
M62P9NUW$K'+&J*5PIXR>S9DMC]MC4ID.*'[:R5'Y:^1*5SJ8MJ1NFBJ3+)U&
M&.(Q@2LAP0D=$Y4<!-88NG<P'4;YTITYCRYL./,F+)@=YE8+,N6SXL#P1:V2
M,*8I6FG11&Y!MK8@!>.@Q-^WDQQ931&>">.(`-&T`7(F9M$:R/=9$T*6+*IL
MBAP6U:*]A%Q*%CK#WN>M^VS(R2%MDG:`$3.4'/D:B!6+W0$KZ>59([FP):J8
MF9"=%;E'73I7%J*&L(N8YE@ZT96"G0-LG%P\C/QUR\A+-&I5W6<K"T<"#F`.
M\HF&C682Q1@BMZ.K;Y>_2P96X8L&-+,<+5I8:@LW+G>"4@Z";1LC,V@2D)Q8
M*0P6Z,QWL.D>*R@_,>&S)9`\?O@(*UR8C)T19W*6Y&$"%&V8TL6<DX5Z6-FD
MS8D13L2:M&(!!AHTA9%RSAX&!T><QL'%GR.3N6<S,(VB<A($FE@:21P;+('A
M>\+`#38<SF,L9F;J&)&FEA3F8.,B\QPUCS&Q^]!(E95$RF(I:1&L7:P&E)7C
MIV2;UI-"37TE7B,Z3J(P=F]_G=D\YC[`EA<,P5;&`IGZQ'*VT9T[=BB<AW&W
ME6*;QKKHQ!,$GZ8+U7A](8.X-`5RQ'!,,14?EL[229V5EXT`,:L>6->,IDLS
M!5>XU.-#UONN=%%*!`)-Q24+RN8J(#W+O;@3.%6P`*!G"KJ.IVCC#,ODM6]:
M9H7O)89A!$0TT==LJI,>M,>>D8`S!$P9.Q1C6#6D+R[)4HH@X.+QDDH*T8RE
M"9.1TSQWU+"6.XO1T&5@X1Q)2<S)[DLNL$)&TXW!Y-%K\Q5CPBX%@Y8JD>HO
M5)WPIE3M(A7;(89958<6D2/'QIC="`4;5D<L>E86+.5`-NT^[^I&QH1"!M[<
M5[K$HSEV5Y@1%9*9B6Z#M^%)TQ0>7IXR\FQWH9`7K3GT*EL#8EL+4@*&`T:<
M=M*N8'1&)G9$2Q9X&!DS[=%CR-"VN1MR,RPZX]9Y8C:%N:2[64ADUWL63O67
M!CRZ<4ON$)R]4?,`73BPI.6$A''F)(BHND$2GER:+%AP9NW=Y!Q;FO+D)2MT
M:61U)@J(.6&[*VY79R6Y]F"B7A8XU(5Y;D%.>Q/I+6FZ@HLLDX-R%%^LN&][
M@P]LZ8Q]QZ<[Y=UW+[SE1O2&CN>/#C/D2JEM1:#G-)(0?X("PO:LAMS,>Z8K
M.I^YY<16<W57YTLD@QXU8FVJ?E&&-`"#*1<@6O)!]]3Z7'8JOF&-K/:,4+(1
M2F>1U^1M8'#,+?@=1G=UCK+CE4G7NS?$%\9;S`)W8YP,"6L,`3<H8+"/K*W3
MI3$6;(?"F>,`O)CP,-;-C)DPXK,\_HH)A+.H$>GTD4N2@:,-K]JWC-DCQ(,]
M4DRV:**>12$2.6?O!CT*;LZ'D$L0?0#W&H1S&.E93OOS(<P-)[)@YBATDZDB
M02!ND.04TF)1PB4[=\F9FACDA.;&%J"KD9*V#=4Y-H^K++L5<LI4.Q]CBLE^
MB=NQLR:&?-::&+O$?T<6F^1C9NW8SBSN+QLF=Z#\"&XLH"6>J'?LJ>**48XB
M,[8C)JD!O%D#)))"J2LD?=^*C4"'!#7%JJ]%O(RD>*$-[IB%&RS4EY-!,(0D
MDJ.2&RF/KMN$US5&5,1D"5(@3,CTZ+XQ=.<C/3J@D"!<H)IMC`GAQLSI/:\6
M3+G7+U;7%%D$2$%3&^/N&#BR%P>,D2197-U*%+$<54BQC!WG.S$QX.3ISIVQ
M-'I+:1,F+(8*0/X)N;`$()8+J#!G6]KD->[=-DEOQNY8S;0$L&3,@S&.QF7.
MUBW)LD$8QQC]UF\I?FM,E-3=$I6XLQ[,FN(P=[*"3#KA$$-@WU>Y=+Y&SQYW
MWBR\W"VN7*D0$AEODIBP*21VNTL>00`?H&!!);AE86_8VYC'7#U`Y6=C8R,5
M)57>(Y61>WU4,<D:M>S9`Y;!2"*Q[Q;NWW`1K;RFS[F:"3B8+IL1BELQQCUM
MQG#8D7)I1DP\':XXFZ8RR?GB7ND;3%GAU&X,:)PL5T!V2B$(P)73;[TKL2=1
M+TQM4T2RI-.)9&ED=H8\:-GD,RR000JYTFPCF=-2E=04ACK]KW3<Y\7)W;+0
M]T2(LJA$".S3<I`CB1I3QTAN9"A(8$`L-%5MC#?)+)5E-2R2C%*B/XY?Y7B:
M&,+DJ>D2*;0J79'Q`5/K1Z60LP@:]W0D.+:OZQS`8BZA/<FUDIEPGW*P\SHK
M#Q-K,\&6DF<J9LI(75#-%BR+=DD4E4;E21^B#('D#^DJF-I,A=]GFC@F7&*0
MR0P\U'95>%Y<O)Q%(5K-(I>`&WH2!#JY98.J90Q+=OMRG5Y#WK9:BSD7$T29
MQDJ@8G)N2LJ!6Z)V1,K7*W5O0I2R3G=461:_3OZ,=M>3EKFY^E>HL=()),27
M3D3)#':S%Y9.*(H4DDM^YX<3PK9??.V!IT,R!L9)'EO<"-(03*S$@`*BJ2QO
M8`$]E8_,V]HUG6REGF<4LX.3(MF;BD<6E<E9F\U@;MS"+;]'VP1#@-4<:ZV]
M>$ZTX\(K%'W`(``!$,-K9WZJ&7;,/<<5R.<NWJRV+$RYN)-DLPT]B1\AAI/&
MQ!O936"-ZDBW',Q)D9H89-U9&`L!'MKQ)RV/&\L@E!!X``&X`KQB^(.Y(X-(
M9K(]OTG;+FQ2)RS&$?9I45,'V?IIME0K#\?0.+8P1<]RB[DJE*U*;<E.G>#+
M(3^G:PC07(OGMT0&RHL''S(GRSD)%,"A18M6&<UF#EM+B.)'5_B?2*`"58/5
M9WU4EF,D1&%%CYD@<,"7.%)RI%T<"!(Q!B:Y#*;L%8:37>0,\9.D^W&'97QZ
M-OPK-Y*I6(B('DB"N\\ECW,";O#.R8SCL82ND/7'.,EEB$L`EAY9)J9KZQ08
MG(N$SJM?#LN#B=3_`'5D6S\(Q*ZM%(D:Z&$4AEDE^D1(X86<RE6=1)I".X/I
M51Y^3G[+)F.C84B2NDA=#(T?+=XSRXFY32R22*@AC<(SJQ!57L!1,2W";A7:
M?^MR]/C,X^1/F3L9,N+PI7!"=$)UBO'['*W*4OLZ3N;HK=(NY/*Q0F/(+;"[
MIRCT/5'#&=<5[N=M73\&SR94#9#A,5\T3DC2T*9[82X_*T<9&CTS!]:\4D73
M8<+>+E[D<R),Q%6,9F/ARQ*H),D^VON)F$A;T5#QF`(5(XZRQ8!3Y2;<EG4Z
M!;3<OK'6`$Q7)K)A-)EZ.LD3&X"CS[ETT3<;)5;HJFI<E8(L)X4ITC`G1LSL
M:K67'9:<G3A$>7M)NF-F3J+<^G(>\&1),I<21W"DG'AYJ1D*FAYV%VD#O%&D
M0U`ERJM8S]TS<7!;-D:`+BY$@G1`6U1G-;&5SK8,L"A-+2*KRM,P`C*JQ7-G
M!T]<,B0,#P]$IR7]HD4NA4BNA*$0WJGR#R9UB[@XMQ(CU-R$3J-KLI`5UIER
M>MZNXQ7!>]^+W+$AQI(9L74,3)Q89T![5$J:F0FP)T/K4,0-:A7MZ5;S%DEY
MV3A9%N\XF0T+$"RM94=&47-KQNFH>!]0'`"KOUKJS*4I2E*4I2E*4I2E*4I2
ME*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*U=<3_FX>/SHNTKSY]2E;1:4
MK71P]OOOQ`/G%\[_`(CX?I2MBPOL1?2OYU0>RH)(%QQ-8E94W(X,CKM%VIV:
M9+EIQ2+I)*6\.*<?/>900IQQNXHX_)7MY4PU$\E11SBCC(`I3K'"+5$#-,!T
M;7L*UN@VC8]XG:7)@9<2%88U+S2+CH\>4)#'I9RO,2987/"X95N3:U8&?E8T
M`2"5&GF>4J(XT,CAX@DO%%N5(UQLI8`W9;5T,A3C9@'&S^Z9!>,).>/TL>,W
M$/#2Y'QI>:8QO)0U0LIBC)QGKO?U[]=1`LO[7L(\Q1<'3N(=PWN8N!U7]YQ8
M>.F2-QBF7`2VH!&<B-<<L+JH.KXI.G2=5K<:M1YFTRP\U6BY<Z-E`-8%U@LQ
MFTO9[P\KTFL#&T=CI*FK@M<9VU3=%D+'3*U8=E"22-<<OE"#LHXH\!<&<4>;
M6Z)&3"/MQIXP(Q1E`D+;S%!0+72DE=5?HA!IB961U%`8<_,;+5(<J4QR/K`3
M(YADF*L;`2<W4TH#:M=R_&]1B':)5Y&"<=A+AHI12MVQ70K&&6_I1-&Y5;@J
MRL5!(JCFN(;*T+UB=Y9&W;FF?H,ZN6-,+N+>J@('%@D!(!&.<'@AQ"OKN^%/
MV^,PY`EZ:LL9UQB`$0[BOF/G]8N<MI&W`G,QUFR+B4\V!00)7X>E$%!`?XFD
M%=5@15D8NP)C0PE<48^-D`1CT+).Y610MS82.VAPM]3'2X!-C7-!H[LRB8)I
M,L=I-NS(3$'];*,@RF++H$0FB,A6M[H6M=Y:\MZOJ8VM-:GA980E9A&A"D[3
M0)@M<?-EZHEQHL'/.:<:>+N\2.)-$L895,*!A9P&5%*@,;JHMP%98AVP[A-(
MBPG<4D$LI!7F*Y+.'8?&4EBSW-KDLU[W-6ZRVR\/2-QMGGF56O;>!A/CL1<(
MTYN0H8>!ZB3`?=MAJV.DE*M7Z-LO?`("4Q.$Y*02H%I>P!7K:;4W7<VYG;]N
M^\!NO>V5E^D!3(FT*W,N`4D?E1@ZM+$H@[0*P<P].R;><C).,VW)&SZM2D:$
MYLKE2#Q"D2N0#PL_B-7Z=W?;@J=']_?7W#)SSBQ'%%4K=G)\AO;F-T#6H4OL
M)/D:H];8R)(TBEQ.5MHE5R`!$<(PJ_HKWK1Q'J&"%#",I8<J655L'"S3.!#,
MBD<'D<?1N!=B/1(\%;`G;I-..Y@8Q1+(%]&Z1>BXD`)]&/T$8/\`%]%2#P%6
MZC:;9LKC[WG%O:,*L;#FR2H4S]/7U#&(P1D>31B6J4[)VZZO?:13^O!+F2ZA
MOO88[J3RP'D].]PCK92_KABRXW39.9SL=.;#CH69HA-%S/0C6[*3'(=8L"@9
ME('I"L99-EEY^^DP:+202Y!TA3'<1,K2'@4;0%OJ*R*%M<`5ZT3EFU!X7Y=C
M+&HQ*A<H8CDL/S%'7$N.,J]OC+([/#S(A2IH<KIE(X"%ZF+DJ$N/+];#3UZ@
MRQE[F&7OBYN+U)'@8V3DC(.VS-$\378H)"B0Q`,+A9M$"(B`APD:!18+6P67
M'CW$P'0-T"Z]/#65E1'9@+W9&4+K-M)T:3Q4@>!'<+;3RF'':K&AV.XUCN+R
MMLS(R,N.7N'(X!+7Y5UT<B,N>C41:R[XC0.P_P#JHXA640)Q`&UKFB!8%LZ?
M>>K$SY?O/O,F[&%L4<Y9#+")@694!L5DDBYB^DI+1.]A8ZAI(=KV`X1@V]<=
M,"619GY6@+*,5D;TCZ5TAD$3L05T/&EV`)#7+3M6W!R<)>Y)2<.KW."NQYV0
M%J91$E*R'/@Y.BR,J',#B3QF1QS%+FDAZ'V[U)G;R<"F_HP6%;3"7?H\3'Y9
MREPIUTPD:]+J$?&`B(]%],4TD/H7`61D[&L=RYP\J:7#D,<F1PYB&S-Z<:QC
M6M[^G&BHNH<44`<`*LYAZ";&\30^0%8Y=L$W96<;!D"=2XR6P-V77,:WU6ZQ
M:<3F3%K;`+];GZQHT"Y4(LLM07?JQ=,-[UO=WW/K/<9H'S5RT56,,*!)$17E
MA5&BB0CXTL#KJ5;ETD[-+5KT789\O)RT.,^9DJ\LS:D9FC29V9FXWY4<T9N3
MZ*/'8G4AM=97C[;)-UD)>U<9PW*5T/EHI-`G.Y,5<SF.:3,T4ON[1U068=U3
MY*#A7=`B*O<U9?\`E(;#TZ=:F'-ZCVN26&-\S'E>`XSKZ:DQ0+;D$</1ACX:
M#_!J>(`-7W3:=Q@+2C'G@>1)S\1E+2D!9K\03(P`#?NR`H)(M5".U]L&2_&M
MAYODT2A<IAK5D2,SA,PKHS$\@1*.30+'+LIN[=9W2*%**,2@;XD/='8"820U
M0;TA'6/!80;T2;[C8F-O,\+3;9,<>P;4\,BXSRP8\$P6PLG+E2*(LK&.X0!6
MJ](^+'G=T1Q%NS!ID86$H>86,T08$&3T;L^EA=0'!L15X&E5A%/`8=.FMYQR
M=C?'C%=1")Z4^1]5$(LPH6@V+GN+/+^W#&="A*:+&(S5(%%@=5TBQ"TUM6'F
M'>SNDZYRSIO&4Q$R,K+(_-=9M+*?3(=PC@6.HA2`;"K>#!@';X<?!,3[?C@<
MO20RKRE*7N#:Z#4"1\4:KVXU0RF%;4GKO1FPXUA%_O!B7"705]3)HB[F,Y.1
M5SBY+'R+J$PE%A!F[KVX<6:3TK."NQMR[C,Z5[7VR^H\,9&-(V9&)XQCS):0
M%E@CNL,BFQ/+A866UUB;@-)XF^ZMT,4S-!,!()XWNA766$7-5M5OX14C+WMK
M4*3J4`6NQ,R;$)1$8^9A^"X3<XAD5J?6H1<4C<9&@3(W''X5DCCTU2D6N.-+
MU&/W0*=8@7@*4@2&V),`$&EJW&\OUMBRSQ[W-E"3&(D)=V(/*R$57C8G3)R\
MF)6#HQ7F1A@=2U:Q(]H?)EDPHXCF1Y!1U%M:R%I@0R<"IU//8$#@S6%F-7;C
MSUM2C;;CYZB\BP*T-3D]R!LQ<[M$D@J=O=I(\``CE;?!W(AQL0[/C@6D"6O)
M1#-4&=7:QEKZ5J\Q>K,F;(CS$SGE[L'F5DE)[NIYB-(MKB($ZE)&@7N#QJF`
M['C1(<8XR0IDA%LR`"<CE<L6-A,1]&%^-^Y`JR\<#P^UL>:)-'(Y@P4>WA2E
MSQHF5)&./A1Y=DMKR-T<XVN)L#J%APE<=6",+%:U[JP@#IUHR[7V<N/UNDJ[
M3,<P2;7BIFJNHVAA18V693>X"K+&5*DV4DCT58U8U]/*\V\`0<^:=L260@7:
M5W:-X'/A9W5E93\8]MZNNU8_VA3'&3NS,4>P+)\21IA-QT]@9KPQXA$?C\2<
MP253$79:WGGM;4ECCU8*\U,>:4)*J_AAV"._2K79>X]4XV:F=G29<>;/(F2C
M.75I'`,<4R7`U</HU<7&FZ@D<*R\7$VDI)MV)'`8D$L<D:!2$YOIRI(HOI+_
M`!W#<6/I'CQJE'9PV18@98EEFQ."&!O<6ML8L=26-$Q!8KDC6B]=&%O:L?%L
MXSSI.2@33->1<MM"HN2G7GVO:P#!ZY&/C]9;UDR=.+WR3(FOS87U@7D6.YEU
M6"(RP1`F32IY4?&RBV.9-@Q<1-VC;'&-"SE)%*FS*SR-RRI-Y.87;2I+ERW#
M435;XWA&V*%-_K3CR%8N@:1BF,C<0,R%JCT=4-\L=7!WQL[/I*"PBCB%$D-0
MJVLE1:UKK"K")+O>VH*P]RS>HMP1'W.:?(CFQ4A747<-"RID+!QN"+:)#'X"
MH8]EZR88MMQ9I.2D4<HE6=B-*^FJA5F\'Q!)H#]BEBHL38T0TO&QR%9"A4OC
M:_`3;/Y>-[Q7#I;&W&('JQ>+Z,'.+[#DSVW+#4K5:,1EIZLY/TRQ$%V"4*UN
MG8-\[1UKG8>1A,,Z3",/?)4(D"R(\L:<[2WQPTKKQXW/&_HDU8<;'!E)E-W<
M9<<ZXJM=;I(0Y6$\?1D(5R$/I<#87-7.9I/MK?(NX1>/2G";Q$(ZE/GCHQ,\
MFA;@P,B%!)CGY5,7!&A<#T;:WH9<F-5&+C;`*+7E"'<=C`WTU<L6_13Q[AD)
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MNTJX[R8DL@>9M/T<D<CK)J8\%9)"U]1!!;W15ZVY_P`&!=G7$35(,6^O\G+D
M,@>,9(7Z+B?7XB36&[2=[6Q`A:)S7IWL+L)2L4"3B`<%3U@A7L/6^C?&W:3&
M[_-%D=TQ%5.85;3"(B8T0OQ5!&5"JI(TLNFP8$#/&5AI*$62(2Y)+J-8URDH
M'U*+W:Z$-Z-_1(;L(JG8SDC;M-#W)%&)#CI];]O1C0><]-ZYD5Q?&ZE:R/3$
MF"V28HXQD:EK>Q$K4*D!1X#$9(A$FV!8>E\S)PNH<8+N&0F0K[F7C!.H/D7>
M*9^!&IU9C&X-B'900=2\*89=OFE.UXYC=\?0Q1>/+(UQH"!<*Z@.+?&4&Y`#
M"]IS\=</M^:)@]F,NUIT82']!E2>NY+ACLYG2/;GVVF:IO*W`A?VFD$XW,/`
MG4JA@*.N(RP+BO<6N<F?UGA=TB1MPC*#NV.OTHL"$?DQ"WQBO*8(O'3H(X::
MP9(>GLULEINZ2S3()IB"EV5#(@DD-[Z5?FKK/#7KN=6JUT[XOVO225KL@=YN
M%WZ92A*PQ9?*BD$3<7=[)3IF^1QQE,7EW--6&6;VQ*L2%!O<P2<@HP&I80WM
MB+N74^#%]W+)F0P)/)-R[R"TJW$KZ3;TU);F>J;EK&K\F)LN84S)$QI2,=8U
M8A6`BDN(U#<1HD!(3P-<A;WM5&3K$6T&<Y7;5<\1XC><AXS;Y!,APA\=HD:<
MS&SM]@SDMR3(X:K,NN*<U+K#&L"9U4E@!R]"PA7,#I?VK=^J=MP))]J;*CPY
M7AQQ.BOZ+1]X*0)(O!23DRLT0-V:S`7IN.'M&<AV[<5@99&Y[1-I/,"1/$7=
M3\=%BU*200%4@FRD56+[#=K;8ODQLE9<)-KIEUZ=8%*+O@H@C69#D4H2,P'F
M'KK+CBS'Y]?DC(@N<WZ&*3PIB17!?H`O;#@R>HLC'BQ,=\M\?&43HBASH$#N
MXE4"^E8GDD;6+!'=^()-9,RX&/*^?D<I)F"HSG2#:5%15+,1_"QA5`_=J`!J
M%J\5E;MG3(VLV-V(6WEN;3D$DPZQPQ`Z0(LI6B-5D/4NQLW,Q:ZYBTRZP)2M
MQ;``&9UG0,.!KI>LK(S.K<J5MTR6SY)2(LPR$2&XAU"'(U6M:+TA'+?2OI!6
M'&L>*+9<:/DQ]V2+F/!I!0>GD@%XSQ^/,+$I\:06-B*\PG*^SB?,J'*IDFPJ
M_IW%F<YXUNKDLBRB0KV?#Y$J:5\B;FY6?=Y4EP-,XNY'6E%B[2`J/#T@=:*U
MV1MW56U228,D>5'I0:P`^A5STB%G*\`,F-85-^$@55-]/"J&?:<QHX4:%Y.=
MRD6Z@\W#F+Z$4DDMCRKS`%%XV&L6O>N:$1[9M.Y'%)E"V/!;S.)3A9O[U36X
MB(F35?@Q^;@IT!:9J+&)ZM"%;:J[6O\`P7:U@"$1<5K:@JO,'5^U19NUY39D
M>'#G!<A?3Y8RH](&L@Z#(`BE+G40BL+@`UC8TFQ99PLV'D,QB=\9@5U%/3#F
M$7N0#(X8K\4NX-BS`^](([M/?%LGC\F18+<'+'*6*ODT9757#!N$&0,#(Z,\
M,=I6@/4V4QIO;8X\+$R`U8$@H*-2:`N_5C%:^/!E=3HJ;C`^9R9Y9ECE`DTR
M2SM&<A5?L>21XXS(JDL2B$BX%9DL&V*_<95A$@AC.@Z0PBC;5$=/:(T9KH;:
M03P/&J@5,F#W,('5J7P!G>%3*RNS!-HZMAY;^U(75@<8'$99&W12!P3`")E<
MU#<U*[E')S"S!D`L8$0@7QI9-['-Q\GO-FD>.9&#@,SLD\T<@X'5(T222J;,
M="MPTAA$7W8RQO'W=E$2NG%3Z$99$9+&VE#(P5KZ59R.UB#;:-M6U9'C"),<
M:R9CXR$;9%;4>&3-^28@K#"%B1N5-JR\ZD)"PUN;3)8V.ZHMT"L[7[=`M-Y`
M].U[;'.EW^?<Y,_,Q)!+N"/"L9B81NC*J<B*-AQ6(!%C52W+T1D<0*L01X"X
M[[;',"\<@R)&#J)5FYIR3.^@`(SR:Y'.D(P9^&DVKW43_M6RQBN'P%0IQ2[X
MHR*F<XM!,?2$4?0,LR;\?.:AJ5((A%W0U.)[;6!2R=81="486`@LLX%[%W`*
M]B:#J7`W:7<YAE+O$"QY4DH+%XA/&)%DE<<4)5_2UV()*DW#"JXY]J?`$$;0
M_=LKMC@77E2'404CXZ7U$$KIN&%F'@-4\TMNQN,2UDR7';;;&V=M4+=BXS*8
M^X8^[Z"X+`FF[$\ACRAN5W7J66(,C1=$<)/80$))`BA7!:P@U?R\[K:3"RH,
MM]P[DY62=")=-Y7+K)*.P<UR&!X:SV$\+4QXFRR38F.B8YFC<Q8P]#4&6YT1
M"_QEYA8J+E>86-M1)J&6;CMK#]A]^E<OR9C!_P`7.^(A9+D+4Z/C"[>N6(GM
M$`(WQRBABHYP4,+@6JLFO<:>X!'BZG7K/0U8_5KJ.#>?NH8N0FZ1;A%B\`UE
MRF=>4I<"R.6*LIN.%I`=/&KT.[;=/`N5%/$T,F/+*MF7TXHPW,<"_I(@5Q(>
M(%F#6L17$U8HV>219#8>RPW`S^Y818T3O"XPW)X<ZNF,X](`D.C:Z-S.F-4+
M(\SO%A%*R#Q``2>+H'`%<71%4Y.Y=4PG(W;*ES$[RYAFE;F*)&C/I1._9JCT
MV*7NMB"!Q%8T./L>5CP;?"L#P,O/CB&DW$G`S*M^(?59G`LU[$GA7,Y7V@N\
M%*]=%^WQ?CB3)Q893*E3W`S8>]%&.IBN^,D:T2^[4N4>O@1&!:BC+G!56N*Q
M=AVUM1&.J>\KCQ+G?>&I<E542:R8@%CG50`QT)91(."KPO:KQGVB/'ER`^,N
M-$TD,C%DT*9N,D;F]E,G$LC$%K7L:H]OC6QS<#CUEAI$=P5/,=XBD[[$XY%5
M:2,'-$"DD;?7/&SHG:6@PP-V4XQW)4-Y1H`@NLL;H"XPG6Z>;/E=9;7N2[XT
MF9'NV=CI(L]WU21SJDR*6'%BRJC:+\#&.`*<+"P[%-C2["$QSA8TK%X38JKP
MW+.5\!C,AO)X"YNUSQJZ._DK-.344G@K=BQ9DZ<+U>&E$N@R)B?'LQ;"HRK?
M%D$D[^PW5F,YK/'HM?I)EAA1EK)2BA6O<)8:QI7ZFR]JEP<I\K[I,9SC'(66
M.16E2)ID#^C)])D*"5O\=F\)-5"/9\;,255@[[BE,,%;&2&X=EA(!+1@!&(!
MMV6\-JB="]HZN;L2?UMP1;)N"8R(4<3D'PD,TQ)$VPH)(%2-!UPW.)LC(%<&
MY9II):=*(VU[='I<MM<[J=<*?.$F:,#/8)++])HF:34H5G["[`,O;J:Q7C8@
M9&7'M4F3%%F+"TZ2/-&LFC5J+&1Y%!-R+WD8V-C=N!XU5..95@N"QJ)P6'Y-
M@2A$;%G28L=C)]%W)WDT>`M<'"39`N:2X6&]MY[K=6I<'0D%T@3[FW$(%K7L
M&SND.\9,TV9E8\L:P<F%_HW1(`%1((3<'E_1Z%C5SJ8:3=BUS7BMAQ.F/#(K
MSY,LI7TE9Y9=;-+I`L796OJ"CT/BV`%A5H,RXE.:XB\D95QN<SS]R"RP-W*G
M$6,;9N\B$(`6F(+@NETDE<Q&%B#8A$(XV][7MT:LMM&[]XDQ1BY(R(8C(Z<M
M]:1@7,CC3=4`XEB-(!N34KN.`<=<DSPG&:01A^8N@R$D",->Q=B"`HXD@BUZ
MZ/CQQ2)4[)P9$APDC`C7JY!(`25A'&H^)L=F]C7-SX_!<+MK0\$.;H06)*H&
M6:&Y@;7M:][6O`VK<^4,@Q.(V*Z`5(:0.LCHZ+:[IIB<EEX>C[]5IF0.YC1E
M,@!+`,#I"Z2;D'AP93Q\!O:O"'N4PMWTQJ&(,BQM_D<QB;7.XJAC;JW/H)!#
M7B6M\(0R9H5MRDY*Y,XY"YEE"/(&8"P+"'RA"+3*CZ=WQHYI7QY8TQIA#+S%
M*&.4PR3A'5N*EHX7(O;]R.TBK$FZ[<BQN)D=)5=D*LIUB)D632;V8JTBW`XB
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MM*5KHX>WWWX@'SB^=_Q'P_2E;%K\U].?2^E0>(MVTK`@>SA5BJ5!D6T4>*L,
M)7Q-F4Z=LLIA4NFJ-YEF;9C&IO+IZUB;\@1X:.0*7M@$8(D_KT0NNM8!18`]
M&_6P]2#.V\[3U.<G*P4Q\*"#E21QM%%A)DI'%Z43J5TY+>D1JNHN6O6HFVTP
MYPW?:%ACW1\J6:5I`S+*\J0IJ9592&`@4$@@$$DC5QK'N1<,!V<I2X.[7EME
M"U6PT]X?:27V#.JUR,;WW%K+!3U,E2MLT:8@]!229CL]$F>M9:^P51B/MJQ!
M2:Q/1[=[18L.!$[F>:N;!/99`%`QLQ,J%0S1M("(T&,UG".H$SHTI8MJLKIF
M7+FA>?(OI#F1E0(S&:/(3(`TG1HE>=I;2+(4(6)2(A:K^X,V<2C%&Y7(6X=Y
MG\<>C<@1>01APC<>BL@CR?J764-DH:5@B%4S=HZD.C=DAK>5VBVI!K$ERS50
MSE5C#C-#N_5,&?T9^J$$$BQ\V.02.ZLP9$EC)N(PYY@EUNO,T(ZVB5$)6LG'
MV6:+>(MYE>/FHC(5C4JI1DB`6VNUHVA&ABK.P<\QF*J1;1\X;+2X@VZE$2IB
M,!A="O:7LA8RS-L;7PMQGK;/U4G8VJ$9$B*$F:FK&P*41SV%[0B*,N.Z:Y@;
M7OM$]H>3'E[AFI#(KY,,"Q:'C+QG'A>)$U312`0OJN514=2!I<5:W/IM-RV5
M=G9D"]ZR)G-GLW>6]*X1T8L@MINY1N(92M@/*Q?L1R21C01,T?L8QF;D,..4
M,9C3!`!J(8$_'>2UF4$969DJ:4W*RJ<ZNIX42HU,8V`[2N.X`V-&(=7-SZTP
MAN$38"3S8R2ZG:1^-CA'"(QQR[P,%9I%<Z]$JQLH"*%K)DVF;(R<V25HUAF;
M+$6F,<PB?*[P&F8DB1+JHY.D+I:0-=F)JN2]@HRX0^,YLLAJV6/&.A1=,YK,
M<V4QI@D:[.$DSFZ&L;$;(1KD$#$[R+UM3M):P!A*%,7JH$*UM,6+K88^;!)#
M%+W*#.PY;&;Z62'#PHL)5D<(`TS+&9>:5*B1CZ!';COL,F3'/WN2/G3Q9ZV2
M,+&CYTW,NB7-EC%D87O-9G8AG-4>GX;ZIKF.3)TU36(&R"43M/D6,FR&-3^2
MMZIV,R/?)SC',DL+OE)3%WF%$.8NT$*1D;V(TM$64,TTT\OIBK@ZZ,.UX6U\
MES%CQB*3C$+HL$V.LD3<GG)D&.8N7>65!,"Z(H<@,CIT9&ZS[H[1B2:`*+*_
MHO;$N-/,Y9@+8BZHP@=UD*NY"+7JY9X?4BR?MIQQM]'DV,-`HF\9'=GYZ105
MX;6Q8HR!WXJDJF*-L=FK(]Q<R(.LH+-2D>N9Z)64FZE82<4.X+4[;UM#MG5`
MZA@QI&6/$PX8U>0,P[IW2QD+1M'*)5QBKAH[IS=<161$:K\FS2S;5+M\SQ$Y
M&9--*!&0A$[3%D4:]:Z.=J1@]V,8635&\BMY;WP[Y7)I%+W=YR;`RTSG.9/E
M>.#:\5JD[XHG4D0Q!&)@R4ZGS`\,[Q82**7ZUIZM(H4%*>K&HM8D%ZR,;KS'
MPH<=,3%E+01K!IDFU1\D9,F075!&"F3Z>F.8-:-@)0I<UC-T_-/"F'/.O([K
M$CNJ%9S+%A=S5DEU72-OX22*S%U+P,W+<FKEQC8V8VK<6O3S.&L+C',CS/(F
M3F2*Q`31"YV3))>3DIC@S"S.#X[*8I$85DAK;G1$`9ZPZ_:HP7%:QYEZP)NL
MU5I(L."48WW;%BPF277*DD,<D"Y4CA%#RF#(R8K`*H$JD<8UJ1T\\T3=ZD3O
M4F:\S<M-"<J0Q&3'`N3:0X\#2,3>1E9G!+<*(A'#F2PZ([F(@7-&I5X^XU((
MDBDJAKG#L^I6N02)^DRA7-"9/DA]C[JN)4OMTX"&1"PHKDE:B*Z8Q7K*?KTR
M+L^O']#;LG$F:,<I8V;$"*O+"0K*NL(2W-EF"N;KPX5G1;0B=2Y74!TE\E)E
MX:M0$S:R#=]!52`%T1JS#X[$@&NQ*>'GZX$SKO8E\08[S7U_)6-YD"4)FU8V
MOF?B,R":7-3&9+'G\HE(R%792%+>L1+DM^BH3'$7#8NL:#K1E@QL;)CEDBQS
M%Q,ESJCPI\76H974%I)A.5=71]!CE61'-6SL^F%EA,:2Z0H*QJ!I&/B0Z"!^
MY<XS%BMF3FEHRLBAZY-O&S&48@RAB<MZ<3WZ"X.P5'XBD?AW;TB#(^56H]^C
MT<G`F`UX?Y,WN\&QF\K6LP]<HN!2-QZ173ZJP@YF^=9Q;S@[IF*JQ;EN&<&$
M?I$PQ-%"<LJRJD6G+FA@.@+K3D&Y"OZ6OQ>GI,.?!A1F;%Q1.[$&R/JGD?%B
M(+-(3BB68^D2A#Q:3KCLO%E3A^/.5Y=F-:ZY#B;1$LG2*43EO]9(`O;,EMTH
M?L5LV+4['(,B-TN1*WO'R=$WGJS41!"%68<84$M258D(KX6T=8IM6VX4$<#O
MF8:A!JD^@=#G]^=FAT_PP8+$CAK6U,R,;`;7<=KDS\]I2\:X<JQZ_HP9E:*"
M>!#%)>P!Y^M@RMZ*M%\25ZNG&=H-HYM,D6VVX<?NIDH.?%KF6K195!`;K'R0
M`>QEEDFY86Y5`4BN07<L^TH"K[9!UMC`V]!6%NO5!W#J;%WZ,3QIB\O0;P\X
M:-1U#3`L`:[D`-`RVOK5B2:M;-LHVK;\C$/*>3(+DBTA2[1K%9N9([L&5;L%
M=;$VCT!5`MJ1L9R2`Z&=NYM97@),9QJR9(<7;'@C'U_/Q/-YU,HE:*JFZ1MC
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M>WR(NX'>`(<F96F#NQSQ/:(%!&L7K7!$9<VU[)06)+M6OW/KB#<SD0R1YBXL
MBQE"L\<<JO&V2^AGB@0-"3D&X"K+=%?FZ[UIL+I.?;\95@FB.6I9=3H\J,CP
M00<QT>4WG`@1E(*Q*KRQ",1N:O+;:`YF8FPEC(R61<@S#V19-)BWINA:A%9Q
MB\F9<DQ8Y*VI?7\9K#-D;+D"QY;H`TPCUQ26,[6ZL?5ATF1U)#/N65G-%-IR
MMH&(1S`2KA<8AP='&+7BJ&A8<8G9"][-70Q[<8H#CJ5]'<AE(=/@$[2E'X\6
MTR.%==-G"/:P(-,Q39;+V'#><\?*)[`T<IRS$(G!6MUB6,SF.$L[)`F$;"Q.
M3Y#5,H<S'B42!.<9=Z6D*T8C=2^UNH$46*VPW#K#&S=UP=P&/-R,;<&RY4><
MLS-(T1>*%U1&AA41#E*-11F8DM>L/`V.7",X$R+JPABQ,L2:E5><5EE#:DGE
MU3'5J719;6LS5:!)PVI6S8_C\&:\G0A6G0I9.R.9DCQY(I6:U1AZS8/."`C'
M*N29'7NT?DC>ZJSFHQ>O6.-U2$"<PP-CR>F+:P^T6&/=4W23&F;E##8<MXX9
M)9,/'?&42E(E3E2QE&>-$0+*)"I"2:1KSTK*V#-AQS1QG(ER+AEDDBB3+2`2
MZ$>1F+H\3-&[,QTOI8$J"?>C>S3+,C5DS=R>XWC!7+)@\2*=X_?F$F?.Q+:P
M[GLEYYQ^WMTGCDL;X\C4.J6;!2O5@EN`0@M_)C0&6$*^LDZDV[%PH-H429<.
M-CXA1U+1*<A-KBV^8,&4N8DT:H])0EE.JZ,!69/M63N&7/N%N[23I-C$$AF.
M,TF.ZN"C:5E+0,RF[@)(@8!T(KB1\/"6%X\4P0S)$'0H+O&4+1YB10)_=(S`
M(GDW#<EQ8XL\.5R:;.TY&N(<'X+N$US=UY10@"2D`)(ZH)64>N,,YT6;)CY$
MDB8J1RNTJK).T>=C9B:]$8CT*,;D$!`SJ^MV9P2V5A;7/B9?>;PA!N,64$56
MT719%DX,S%7<2E@5(1'4%4`)6O>D?#E97ELR&VMTM:8\1.HUDQA$2Q1$YAZO
MOUD>%9*R)7%=&Y`S.QS$RG8@$E/)2J$AYJ9T,Z@Y,8'IBQL;KS)@&.)(VD;'
MR,28ZW)#-CRY\CD`@^E(,VP)OH:-6(<'2+<&P0P8Y@C8*3CB$L%%[=Q?#9N/
MC+";2;@D6-SZ528]X<S%#&L^Q[S$!/RHW!JDM<UQ"0JB&`S$F;I/F)T1QUPG
M,XFLO)0RF\DNAU4.9QY8BQ'&"."*Q0;F?U[-/*IB27EJ^422T:M(,C;%VY0Z
MPQ11'E6:1;1@$$H;-=SA1=,!<=XI6C,AC8`:7959LI,K6#))(Y-XT7BUP1J7
M38"JER+LA?IYM9C^VNTWB+8G9)>_.:AX3PU]0('2,NZN8C1I+I6"9,DB:).V
M%R<E0)>A=$Y:E6CZ)I5TIYJ<6O@ZJCBZFCZB,4I9<*.$KK4D21Q0)K4LC+H)
MB-HI$D72_&[HC#;';I.XY&$IBY<V6TMBILT;3&9HY/2U7;45,D;(X`&DK=JY
M(=L*;X^TLI+G+FU;*$<E9'9YF[5$PMDH<FQHVPD[;[MR1X/=5[BA/.`5Z[A'
M<TTH!E^JN6*_\+5>Z]:S9^1.T$&C$FBSEY1;5&&S=S&XEF4K9A&0(K$7=`.*
MCA6NVSIM,$0--()<B!L+2Y6Q"X2R(@!#&Q99&LPXI<CB+`=:*[')`BQ+G3&<
MFF\"&/,$-QQ`DJR%XR/C+.V,>-6HUD1N+\R*)4Z7D4@D2(=AKS0GIBKFZV`"
MQ>@;969UO%/NFW[G'CRZL+<Y,UU>74&:1H7,45D7EQJ8?0%F(OQO:LS;-IDV
M^69M:LCX0QD(72^D">TDIN>9(3.=1X`Z>`!8U3DOX=UW9%.$L9F428BIL8N`
MXM@X&L2-JQN<-PDJS28W+U<6E,<D">Z5FDH69.J;UB%:F$E"<2:6`5R+6<;K
M/3C8N)F12R10*@U<R[`IMQPM:AU=-7-/>+2*Z-_!RJZF]4OLP6"1(#$L[7L3
M&"+&/"30UK'2W=&N00R<XM$4D76?4VY;.I3B+*F/#GY>>]0K">`8+`FAZ,$V
M)$.2<L,;<OA9>3O6`#J^2!I=8_BSHLYHERC128L&,H-[%V,OE=0=8IO&'N.7
M%Z&Y;GN#R<LZB8(7$4F0H<*L93)R4CD5576G*;4;26K!Q>GWP\C"@#,^)AQ2
MG5P59"9I6Q4(U&0MBQSSJ2UXVUP%#JB]&K7K9*5*<N3:5RB11QPQS+AY-=3&
M5)$52+)JAVRO`D6/7UE?<B@D`R'*#,C<G&K:D0&XD]*LL0+KKV3EUJ8>JY\3
MIY-MPQ+%NT4:QQRAU,*<O,3-CG$)3CDI*BJ9"Y5HP05)-;;(VP9&[KF2B&3"
M,J221NFIG"8LF(81)?A!+'(QDC(-R67XCL*ME,>'&;,H[A!'(<E)9;*,>N$U
M<<@2.2L\Q;DT]=<AR:-2613%*S0#(L++2R]#:*IT;>%R.=&LI*,76)1BL&]M
MOA]>IA;KDYN#BMC8$D$"0Q*\<C0G'+LJAIHI5,4DDLCR642<4TN"ESJ]QZ:;
M<=E;:)9N9))DO([N'`=&@?%56$<B->.%D("NL;.K$II<J*M2;%G)A7;?#XC+
M(;'E>&I#*'=XF2*'/),SD;3+\DVGTDBZ5$&5]X@VV3)TY"):>ZM3FO+&7VRC
M/3&Z5BGK*.8YXR8)GQ,O`AQA#S5T`PXC8Z.S&,R*(W8RH(7B_=1N9%:U9&1L
MLK8Z18[HLR9LN1S-)#AI)=?H`$`D+Z!YFM&LGHKI!%JC>&G*%DNQV_J\J0HE
MMQPROD>:4#3CE]:C3V5[19@8UR-P3I)\4PO(G-GRD4<H,<42TPI>V6NDNF(4
MG%7SCU[CC`R\5<67GYD"HS&52-2Q8*AK&(E0DN'J0(R,R2LDK.4C9;$O3TSY
M,,B2QK!#F&9;*0XOE-.XU*P!:1':)BP**%1HT4M+KNCAS8:HQEG>&YM=)3%'
MU;&X!%(ZI(;V.?-2LI[C6*6;$H@1=O,R:K@3%$%[4S=OB3FL:MS"L/-MV[<N
MX;!L[IUT-QV[/VZ&&6./+S,B52SQ-Z&1DKE,)6Y',9TD4(C1R1)RM*LA*<:(
MNFN7EX$Y>,C"BC10`XMRADHA4+($NR9)YA='(9+QZ=1K@D&PA?)I)D@]RG$4
MM%I0GRJ".DDX_.[[E`\T3N-3R6I<I2`R2C1S]HCRF.V1,)`4B.Z1&=T31&]"
MVN-MG6B;9@X,(QW;+Q9<$M]):$IM[3-$T<80F.>7FWR)`Q#R*9`H:1JR]PV1
M\_<)LKFA8)8LBP*WD5\C&BQB!(3_``*",L(@`+%%)(AC(N%FK:5(<D912S:)
MSF.0Z..D0QM"YE'%L*4/2TQKQ1D-?D:-!AZ]'(65O8;+UKB-&L">D5A"G"$1
M'5F6UOK]IZDBP=NDP<Z&3(D[X^5&P<(1-)C'%;F$HQ=`MI%])6UBS$HQ%7]R
MVA<HI+B%(9QB/BL=`93`TT4X"J"MG5XR`>(TO\7T15OT6P(B,Q..,L+DD+;G
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M2H8H:Z@D616-NCC\U'LSFWKI0L@#?'UCV^F.=CB6BSX4;TBK.%R33`"QLSJZ
M//@WI,J*5VW6:22-#(#'`[\L)+\42%XDC"!0Z1,EM49*@B[!LSXC[:V.R:\%
M]3.01(UW+N%(;3:2XU<Q9&#7=64FQL:NX8<Q=W7UW<LMP,"@K!;EA1.0V8SD
M2)L&W.&)(_C<HQ>PVR(*/KT;<\QHEX+,-2#=1"4G)A+>H+3!)Z%/:5BQ3RSQ
MX<S-+N<>8=<JL=<>X+G#T^7K'HWQ[(RH4"R%#+K9M:W2\DBX\,DL8AQXVC4K
M&5;0T,^.ZDA]+<Q91*S.K$2@JMHCI%]8!L750K,&9LM6E\>$ZY5BTW:T:U*Q
MS14[L#SD)&R@=0^M\BR*]X\'#X\N:/\`JQ`E8$B@26X"E2@^X+B'S6X=6KE=
M.1]/11R"&*1#Z1CLZ12RR)K9(EG,S"33(PF"EAK5%8BV?C[&T>^0;U*8R\4*
MK90PTL((8&Y8+\L1D0\STHVDU,5UE0!5J<:<.*;8P8FY,UY*Q;('9/*Y:^'M
MDXQ1(YQCXA'D*"8_ALN.;8O*LENJLB0$*\?%+VTP:P2!,%<I1W2W2W+`#>[A
M[0L+<,@%\7)CQ3!R]4<J)D`)F2YD(658A8!IY(I6=6DE1(9&<S(SMK8^E\J%
M9)4FB.871U!1N06$#X\CRPAPKLZ&-U":$A82I&HCE"K5*/8'-&E].4LN48.V
M,;U(E*N3D)\5'%NZJ.H,^.&?HVE:1II<G8V^0!>G@]M7*3$AZ8:$)-TZ<@8+
M]+6/UCBSXT<.3CS.\2XS)>;4!/!AG"U'4A=HS'IETZ@QF#%G9&*UGR['(9I,
MB)X];PY$)!0J#%E&"23@C`AQ+$VAE(58G5-.I-1[VV_8)(,%9!%.W/)S-(NO
MG[=D!<T-$6D+2F5NZ#%\[QDI4$V>9M(DC,:^$RXIP4)T)*5N3GIQE)4Q!(P!
M+O;QUS#N6UKMJ8TD:QXD\"'F!PJ3SX.05_@U9Q&V(51I&>5A)Z;L5XT1=/R+
MN+YTDRZY)XI#I0C5RFR6#.`VD.PR-+!%5!RU(6[-?S5>R*>SW(&?GF5NT"AT
M5FDTS>Z0LUFB`7&>O1>6,+,^)@KII*"I"42XP]`F&L4A9+I"%`U:=,(9]BRP
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M$>%'CPO`K123Z4*/)`L>0JJX$3N2SIRU,3R.^A7FB(9)6JGIAL0D3/CID8\>
MND+?9"SL<=BUT#_#DJ:-NYJC=3!<Z/DMD*/UX)"YDMC1'SBSD-S+'.`P>A."
M(5@UE8G7$4F[1S9D3Q8JRPR`JY)08VUY>$J(0NI3*\RD,#>*^H7M>LS(V0=Q
MGBC(,KXVY*`%`+OFV95)-P`I4(Q/`J;C3:U5*Q[%GUND$&D:R<POMUI4W>)<
MF9L=*6MON\"W$L&X`+=C@B\H4F0^(D*6L]L+1GB7#"6:`[K.F$81XS=8P]WE
MPUBR6@T1)&6F761'MV9MY:9A&-;E<D2`J$T\O1Q5N%J?8YLC5)*\(R96F+!8
M_H@)9,>0:%+$AQW9>8[$F9G9V])J\V/\/D:<^Z64S"'OC`SR3$YT>0(\>&H%
M<@BN,<T#S-KE8Y1)%Z&;3UW7CLANZ@3I2"RK",$G,&8.U[B==")87A@D7)5)
M-=G`C1VVZ7;T.,H0&&->9SF34]V545E`%IR=A.3-DDNIQIU=;,I9RLV9%E2"
M5R;RVY?+CN!IN9#=C50MNR-\CV2,33*+S2)QU-CB99!?UKBUQ%Y)E+Q$9UEB
M4Y2.Q>F0FRL_'B2*V/D($PE0V4QU3B)N:B4I;#$5?$AZO3N>1B9L,TT<NW8V
M-H,@*-)C8:8J9#L4,O,4H'41RHK#T)A*.(JS-D,TRR8C1QVSY\D,5)9.?('=
M4L0K:K'7S%<%CK4*PO6Q.N)'9714I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2
ME*4I2E*4I2M77$_YN'C\Z+M*\^?4I6T6E*T?X:W0NFTC*.]F"9"VC;\)<;--
MZ64<JQ&6X=VEY/REC^2PF6P_&J5F=F291A"H:5]C%+(I+,`$72*,*N$5NS=2
ML@?E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N5
M2E/E28C\27B?_F#YO[E4I3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4
MI3Y4F(_$EXG_`.8/F_N52E/E28C\27B?_F#YO[E4I6*^Y+<P^;PI[L:Q_C/9
M_OUC"J$;^-O.7YA*LN;2,H8P@,8@$$[[A25]?9A)D*=J;R4070G0(A=(=Q:6
MMSWLI6^>E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*
M4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*
M4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*
..4I2E*4I2E*4I2E*__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g579867logo_amarin.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g579867logo_amarin.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`0P$Y`P$1``(1`0,1`?_$`.0```("`@(#`0``````
M```````*"0L'"`(#`00&!0$``@(#`0$```````````````<$!@$%"`,"$```
M!@$"`P,&!@</$`L!```!`@,$!08'``@1$@DA,1-!D3)2%`I1@2(S%19A<2,T
M-388H;'!<H)#E+35EA>W6'@9\/%"@Y.S1'1%=95VMI<X.>%B)"55M<4F)U=W
M&A$``0($`P0$"0<("`4%`````0(#`!$$!2$Q!D%181)Q@2(RD:&QP=&R$Q0'
M\$)R,W,5->%28B-#)#06@I+"4X.31'3QTE0E1:+B\F-5_]H`#`,!``(1`Q$`
M/P!_<P\H"/P:((Z?'#U1\X:((/'#U1\X:((/'#U1\X:((/'#U1\__1H)`$SE
M!EB8CXZD'4JP!TS<"269\SOOIBP/_'C,68BAI-FVO.6;80A3$A8!%P18&,6S
M`X*24JLD9I'-_E'`ZADDE-[I[3UPU'6BCH4]F>*SW$B4YDX>"-7=+M2VJG+S
MY'-L23*>,B<B0!T'AC&QVU[<ACS=KM[Q'N0Q4]!_1<OTJ)M\.!EB*NHM9XD*
M4O79,2%*4DS69I!Q'O"<`Y'+<X<.&M=<J&HM=>Y;ZD2>;64GC+(]"AB#$JCJ
MVJVF35-?5*$^C>#T'",\^.'JCYPU#SRB5!XX>J/G#1!!XX>J/G#1!!XX>J/G
M#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G
M#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G
M#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G
M#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G
M#1!!XX>J/G#1!!XX>J/G#1!!XX>J/G#1!'DJP&$`X#VC\.B".[1!'!3T#?:T
M01Z6B"#1!!H@C&&;;'D.G8=RC;,2U6#O.3JS0K3/T*FV697K\#:+5$P[M_#P
M<K--V[I:.9R+M`J9E`)V<>`F(`B<LBC;8=JVVZA12RI0"B!,A),B0#$>J4ZU
M3K>:2"XE)(GD2!MBG@WC;Q=Q.^+-]CSAN8NSVW7J067CV48`BUJ]#A&[I44*
M;2(%-99E`5^,5XE`B0F474`55E%53&./6]FL=MLM$BCH$`,\HYMZB0#-1WY0
MA;K<:NXU:W*M1*@2);!T>;TSAK;W2[J'E@;'?NG)DB:`D9:U)G+VW-60<\"-
M[(V;D5R?CQB*@<"A+QS<DXS1`P%\9N^$`$RH:5OQ3T]V&[]2)R/*[+=\T]6_
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M*29VSE,?DJMUCD'L,(:LERHF;E2O6^H`#3K9&../IC3T=0JCJ45+9(4A0RSP
MEYXN(=E.ZZ@[W=KF'-SV.%4@@LI5%E+/X@JP+.*K;&P"PM]0D.`B8CVM6)LX
M:FY@`5"IE4`.4Y1'D>[VUVSW-VWO@]A1D=Z9X'K$/RW5K=QHT539$E#'A+,=
M,;2ZUO1E$Z`-842`2,X/%$;EYZP73#QI=K;C>^[U\'U:]T2PRM3N%7E9]XE+
M5ZR03M5A,0\B@2-4*F]CWJ)TU"@(@4Q1[=;]C2VH:AI+[-*XII8FDID0?'&I
M=OEIIU%+SZ4J'`]&[R1\Q_3;])G^7G@+]\,@'_I6I!T;J@"9HGO%Z8\OYDL1
M_P!2CP'T1NCMXW1;>=V=*?9&VV9=IF9:/&3SNKR-DI,D,BP8V%BV:/740[\1
M)!=N\2:/D5>4Q`YB*E$!$!UIKC;:^TO!BXM*:=(G(RRZHV5+64M<CVE*M*T#
M"8GYXSSJ%CGLB3!H@C6'<GO2VI;/&E3>[G\\8^PDWO3F3:5`UXEC,%+"O"I-
MEY4L:@B@Y75)'IO$A5/R@0HJ%#CQ$`UL;=9[I=E*%N9<>*1B$C*>6,0ZNX45
M"![VXELG*<:I_P!-MTFOY>>`OWPR'[E:VG\FZG_Z)_#@/3$$:BLG_4M^/T1F
MG;_U*]A6ZG((8GV[;I\49=R0:$D[&6G4^8<O9H8.&,V+*R@-UF+<OLK$SQ(%
M!YNSG#4&OL%ZM;`J:^G6U3S[RI>2<2Z:Z6^L<]E3.I6LC"4_1+QQO#K41/@_
MK?'Y`^,=&6,&.S$Q@#&.Z;;WF?*69\+8MRQ4KME#;W*0T-F&G0CTSB3I,C/-
M#NXY!\84R-G?8D=%<S918K5T0R"PD6*)-3JFVU]'3M5=2TI-*^F;:C\Z6?1P
MB,S64M0ZMEEP*<1F!LV'QQG_`%!B3!K(SE!LXQJEGO?3LYVM6R`HNXW<CB7"
MMNM4"K:*Y!9&M;*LNYFOHOUHM658&?BD@NU)(('1$>?B!RB'#6QHK+=;DVIV
M@96ZVDR44["<A*(55<:*C(34N);)RGMC"COJ\]+YDB*[C?AMD\,./S.4(%T?
MT1-V(M5UEC!RE'N+WZFHTIJ->":-\GZ,1?OZRYFI1&/)/KF=(V'.)'V_/!G,
M`\O!G(S\D''B(?)-'03HIN'#MX"(!KW_`),U1RR]S="CD3(>4Q\_S!9R)H?2
MKH"CY!'Z=8ZV?2=N#M)C!;\,!F<KF`B9):POZXF)Q'@`"XL,7%MB`(^4QP#A
MKY<T=JAL$FC<(&Z1\A,93?[.3RE]`4=\QY1$A6.\K8NR]!IV;%&1Z)DRO*E(
M<DY0;9!6Z+$IPYB@9Y!/GR*9A#R&$!UHGZ6JI5\E4A;:_P`U22/&91LFJABH
M3S4ZDK'Z)!C[[\_4<DC*/;/$=V-0=R6_[9?L]GZU5MS^XW&V$[%<H=W/U>(O
M$JO'O)N&8O0CG<DQ31:.04;-WQO",(B`@;R:VEOLMUNJ2Y;V5O-`R)$I`[L2
M(A5-QHJ-7+4N)1AMGYAP,:Y_TVW2:_EYX"_?"_\`W*ULSHS5*3RJHGN;H'IB
M%_,-E&=2UX3Z(\#UM^DP4.)M^F`2@'>(V%^`!]L1BP`-85HW5"1,T;PZAZ8R
M-164X)J&B>D^B.!>MYTE#B`$W\;?C"/D"R/1'S?1G'6!H[5!$_<W1X#/QQ]&
M_P!G3WGT#P^B.S^FWZ3/\O/`7[X)#]RM?7\FZH/^B>\1\\8_F&R;:AOPGT1L
MCMOW[[,]W\S8ZYMDW(8OS18*C'-9>QP=+G?;):*BGJYVK>37CW*+5T=@9T3P
MS*IE.0AQ*!A*)B\=;<;'>+2A*[C3N-(49`JP'BB537.@KE%-&XEQ2<2`=D;<
MZU>&R)HRSG'PF3LH8[PM0;1E/+-R@,>XYI,=]+VVZ6F02BZ_7HSQT6OMTI(+
MB"39N+EP0G,/]D<`\NO5AA^K?134Z%*J%G`#&<?#KK3*%/.JY6TC&8EXXT+6
MZRO2L0`IC[]=MQRGX\HM[^R=!\D`X@;V9-7DX<?+PUO1I'4Q'.FB?*.*91JS
M?[/@/>&YGB3YO+'TN..K-TV,M9)IN(\9[R\)7?)60)EM7Z73:_8U7TQ8YMX1
M4[6,C4R,@24=K%0.)2B<.[7E4Z7U#1LJJ*JE=;90)J*@!(;\YQZ,WJUU+@:I
MWDK<)V`G/#.4A$C6M%&TC@H`B0P!VCPU@Y01ZOAG]4W]7Q!K`G/TCT&,X#.#
MD,'?P#X.(E#\P1XZR0O9(^'TQ@J3T?+C*.DZJ*7-XBZ"8$`3'%19(H$*4.8Q
MC<3_`"2E*'$1'R:SRK/H$X^>9(Q)PD=H$H33P`]4ZT?7\N.?W!#3^SGIGM?H
M'&":_%>`LF0X>6>L:])HI*)G;.5;#>F[^=$>WF8P[(IAX&*&FU7MC2.B4T:3
M*[UY!60<0DB>8EARX$93BC4ROOS41?/\)2Y"6>[K)[6>S=$_75[V#1W45V-9
M8P2BT:!DV+9_PBX/FG)$P/%96J#=R[@F?M1BB=M'VQL=>'>"`@`(/A./$2%U
M2-*7I=@OC5=/]V)Y5C]!6!PX9[XL5]MJ;G;ET^)=`*DG#,;-N<5&$U$2]<F)
MBNS\<ZAYZORLC!SL0_1,@^B9J'>+1TK&/4%`!1%W'OVRB*A![2G((:ZQ:6T^
MVEUH\S2@"#O&P_+.$.ZVIITH6"%@RD8;[]T_ZB`8PS'<NGYDB;!"DYQ7=Y`P
M>L_<<K:(R[$QY0M-4:BHH":1;Y6F)7"1`])]&\I0YUQXJ+XI:?#],F^4P)J&
M^RX`/V>Q72#XHO\`HFZA#OW:^>PX>SP(R\.7@BP)TB(:4&B"(5NLAL8VBY(V
M";T,C6#;AB-3*%:PODC*$%DF&H5<A<B,[Y7(9Y8F5B^M\1'-9YT\6D&O,Z\9
M90KI,QRJ@8##JW:4O5UI[U24[;[GNZGDI*"H\I22`1(X9'JBO7RV4*[<^][)
M`>#:B%`2((QV15OV[#]YI&.\/Y3GXCP*3G&)MTMCZ<2$RC64^H5OD*1;(Y4W
M(4B$G#S3`IE$N(C[.Z04[E`#73[-;3U%0[2-*YE,\O,#F.83'_&$L]3NM-)?
M4#[-<Y'B"089$]U?WY%V[;RIS:C=YDC+&&[IHV8UT'2WALHC.=5:N%ZDL03?
M<D1N4$+N*/W"JZ*S+Y`TN?B?8?O"UB[M)_>6#C(8E&1\&<7#1%U-/6>XND^Q
M<R''?YL]L60W#R<.T.P?M_U]<[@`8"&UM.T3CQV``B82@4`$3"80`"@':)C#
MQ#@4`#M'X-?1G+LB:I9<=D8)`Q/=&9W"*OGKT;AL@;_MR>:-S574]KVC;7<G
M0NS+%4P*R@Q\]<%&5DLUKF8(G)X#M2<D:\Y=.%@$!(P!@4>/,'#I/0ENI[);
MV:)<OO.J075#:@9`&$WJBJ>N54JI0#[HVKD2=F$SXP)[L08@-JT>UE+15XIX
M05&4I9J_&O$RF,F91H_EV31RF50@@=,3H+&`#%'B7O#5\JU*12N+'>"2>L#T
MQ6*8!=2E*@"DQ<S8*V?[5]ML=`HX(V\X>Q4ZA:ZVK[*;IE`K4-9S1)FS<B[5
M[:FL>2PR?MG@%,X.X<J'<'#F4$QNW7(-?=[E<%J%:\ZXGG)DI1*<]B<AT`2$
M/ZCM]%2!*J9I"%\H$P`#EOC9+6MXG*)T+0>\M=1G=!L.V^8HK.V][6:6YW'2
METI<_E?Z5!3)5+;PD4P>K-Z!73I`BU7E&,@H52<$RIXXX$*FF151-4&'\.]/
M6^^W%Q5PYN5GE(3(\BB<IGS14M6W:HMM*E%,9*<S5MEYL\^H0D+TG>H9:^GG
MODH.XA_*S$O0K1(KTS<+'JNW+YY;L<7&215L<N].NHHM)6"NRH)S3=503JJ.
M6QBB/W4W%V:JT\S?+*Y1)"4N($V\)24,I`9`Y$98PM[%=W;?<DU*R2E2NUQ!
MS](XRBV_K=C@KC78&W5:593U8M,+&6*NSD<L5S'S$'-,D)&*DV3@GR%FK]BY
M(HF8.P2F#7*;C3C#JF700XDD$'.8,B#T>>'DVM+J`XB7(1,<0<B(_:U\@RC[
M&&,89RKMMV\YZ,V-F[!F(\NJM(]S#LG62,>52Y/8^*>F,9U'Q[V?BW[M@T64
M4$XD1.0O./-Z7;J525]=1$BD><;&?940"1OEGUQ$J*.EJL*AM*\-HGF?%U13
ML;PJ96,>;MMS]#ID0U@JC2]P.8*M5H1J!S-8:OP=^GHZ(BVHK&45!LP8MR))
M@8QA`A`#CKKFRNN5%GI7GSS.J8023F20"?'"%N:0W7O--X-AQ0`&X*('BAFS
MW2G`^%\X9/WLM\S8FQIEF.@,>X=^AH[)-&K=V:12\M8KP5\YC$+'&R*3!9TB
MP(14R0%,H4I0$1`.&EM\5[A64+-&*-YUHDKGRJ4D8#<#O,6_0M+35+[XJ&T+
M`0)<P!V\89JWD^[\]-C=I1)Z(AL#5#;SDQRS<FJ^5L'PS6E/H.8%(_L*\Q5H
MOV:JVB'!P(>T-7+4#G2X@FJD?@<%I:-=:@M50E2GEO4WSDK,R1^B3,SZ^J+K
M7Z9M-8TH-MI;>E@1ACT#.*W*3E=UG3`W:Y+H-!RI;\/9NP'D>=IDS.8^GGT7
M&RSRO/A30=.8T%!B[%79^/%)R1L_0<(+-UP`Y1UT2VW9]46ENI?:2Y3O-I4`
MI()&_'.?7T0I'7:ZRUJFVUJ2ZA<L\3*8GX1^2+$;H+]8J1ZH6);O3LPQ$-7M
MSN"FT"I>SUU#V&N9&J<Z+AI$Y$A8GF/]".S2+%1M*LB&%!!R=,Z'!)8J:?/^
MM]*?RS5-O4RBJVO=V>:3^;OENAJZ9OIO%,IMZ0J6Y3EMV3\.[>,HF;RKMUP!
MG<K5+-F$<3Y<!HR<Q;%7(^/ZM<G,?'/S`9XRCG4_%OG+!NX.`&,5$Q`$X`;O
M#CJH4M=6T((HW7&TDS(2H@$]`,HW[]%25?\`$MH7(;4@GPYQ3U[VZ+5<8;R=
MUV.*-$HP-+HFXG,52J4&W.HHWAJ[`WV=C8>+;'6,=46[!BW(DGS"(@0H!QUU
MU9'G7[33/NJ)=6T@J._LSA!W)"&J]QML`("R)2V3,,0>ZE;2-M^Y;/6Z*T9_
MQ!3,ON\04+&SO'T;D"(;V6MP4E;9^SMYF7&M21%X60DS-81%-%1RBM[.43B0
M"F-S`O/BG=J^@I:9%$ZMKVBU\Q29$@`2$\QGLE%LT30T=8\\:IM"^1*93&4S
M#L^7.F7T^,N4ZRUR[;-=N;EG+0,G'*R$-B>FUFP,DUF2Q"N(BQ5Z)C9F)?M1
M`#HKH+$424*!BCQTF:345[9>;6U5/\P5M65#P&8AA5%HMCC2T*8:Y0@Y)`\8
ME%3Q#;2<RW;#&>]QN.J<]M&'MNF1HBBY3D8PYGTK2&UL5F_JK9)J.3(+D]85
M&%.U<OR@*;5P9/QN4J@&UU(N\4-/5,6^J<"*IYH*3/`*WCIG"7-MJ5LKJFDS
MIT*[1&8GPW3CYO;)N8S)M!S;1=P>`[>[I>2*#*)R$8^0$RD=+L#F(65K%ECP
M.5&;J]@:`+=ZS5XD52-Q#E.!3%][I:J2\T:Z"L2%)4,)XR/`[.J(U#7U%OJ4
MU%.2%I/1/JRBU3Z4O5-POU1L!M\@4P[2HYBIS>/C,X8;</`6E:18EDA*65B!
M5$KB8HE@42.I'/@*/``%!;E63,`\NZGTU6Z:K_=W@54R\6U["-QXCQYP[K+>
M6;O3^T;E[=([2?./EP,256FJU>\5Z7J%UK<#;ZG8&:D=/5BSQ#">K\TP5$HJ
M,I:'DT'4?(-3F*`BFJF<HB`#P[-5YEUUA8=:4I#J3,$$@@\#&W6A#B2A?;;.
M_;"=WO0731VB8ZV7M=X6&L.T7"^5L<Y&H]1E_P"#&LQ-/K]\J-U<+PQX^QU^
M$;,HA63A'I$7#1Z1$C@I`42.8Y#E`K9^&^I;L[>/NRK=<?IE(49*43)2<<#G
MEQBBZMLM#[DFH80EMP.`'E$I@SW<?#$S/1YZ;FTW:]LUVKV^L8;QS.YEMN*,
M>9;M>:YZF0LID:0N=^K#"V.G4=991L]EH!G#A,^QLD&:R":+=$O`.<QS&J&J
M=176Z7>J2Z\Z*0.*2$<QY9),B"!@=^,;RQ6NAI*!E:4)-0I(5S2QF=Q.(E$T
MVJE%@C4S?5&U*7VE9N87K'^;,J5-2K-59G'VW*1FHG-UI0:3\.\1CL=R%=G*
MW,MYL':":AO`?-S&;IJ%$PE$Q1V5H+HN319<;:=F9*<D4#`]Z8(X99Q"N(0:
M)P.)6M$A,([QQ&4OE*%6GU(V6*HB=_TP?>`544.*GW2_9U5`G9P$Q2DW`&.(
M\!X=@".F,A=WGV;C:YR_,1_R13%"WR,Z6X8'>KTQ\>_QSL&D#D66Z7_7^*9-
M,2!PM6<5>SB)N/,[S:X/QX^0!X?8U(147E(_$+0KI2GS)$>)3;%9TMP\*O3$
M>O4!L73XP_M]M9:!LIZM6#L^9!04K&%;;N@R)EFJ4$;1X[(95Z=.0R9++6EY
M#0RQU","-E2K*'3*<2D$>-AL+=YJZY*WZNVN4;?:6&D`KE(R`F,)[XUMR=MK
M-,0S3U:*DX)*R9<3CG^6-A-A>T+;QA_;S16.>NE1UB;KGB7C_IW)&0<4%O%!
MJ$[+/W;MQ&H5R)J>7J2;Z&B(59!%%9VV]K6,!SF$.<"A`O\`=;C55Z_=+C;F
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M47O3MWPMBG!,5-K.;N!Q+S`')0)M3M+Q#CQY.&MUIW\=I/\`<M^M&MO'X54?
M8K\AA-K%FPX=Z7NM]!M=2ACRF9MK.3=PN;L=E:HBM)2E=CL@SI,J5%L4O$ZI
M9JGH&>)I%XBH]BVX`''39JKX+/\`$A0694E0VVA7"8[)Z03ATQ1&[9]XZ2"D
MC]<RMPCHF9^8]4*(5&V6"CV>LWJG2KB%M5/GX6UU>:9G,DZBIV`D&TM#23=0
MHE,55J_;)G#X>'#3>J&FJNG<8<Q9=!!^B1(#KE%`9<73/)<22%I/6"-D7!O3
M8WG5O?YLNPEN:@U6B<O;ZTC%Y&AFI@X5G*5:`L/>X(Z8=J*:<VW.NV`>TS-P
MB?N,&N2=16ARQWAZWK'92KLG>@D\I\W2(?5HKTW*WMU2>\1)7TMOIC4KKN;X
MI'93L.N1<?.%U-P.XU^3;Y@6)C0,K-JVJ\H&CYF?BVR?W=5:M0#A4Z)B=I7R
M[8.\P`.QT39A=;R%OR]RIQ[59.4DX@'A/SQ#U%7^Y6]3:/KWNR-_'Q9;S"TW
M66V3L^GST*MAFWCPR%N[C<*QR!FA^4`,K,Y=M^-+1+6E9PL("HL$(HJG&(F$
M>U!D33'T==3>]:UE8#^H#!2CZ*5`#PYQ3M0T)M^GJ9I7UBG"I724G#J&`A0J
MC?CS1_\`7.I_[0Q_YNFU7DFA=)_,5ZL4&C/[RCY;(NYT/O=O_B[?^\DUQFHD
MJ,]Y\L=%-]Q)X".8B4H"8YBD(4!,<YQ`I2$*`F,8QA$`*4I0XB(]P:Q*>$?1
ME+M90D%=\#+^\=]3#=O)N+/+P^S+9+B^SX$PC9HEPHC'3F<)E.3;Q-J:G!)5
M%^R=6]DO*OBE#BO$1[!(1`%N.G+3W#^0=/4[:0#<ZQ8<=2<PV/R9<87C]&K5
M5Q>))%(RDI3TXR\)Q/"4)79=Q7=\&92R)AK)<.K`Y`Q;<9ZC6^(<)G(9I.5V
M07C7OA>(!3*LW!T?%04`.55`Y#@/`P:=%%5,W*E;JF%!3+K8*>(EGX87-53N
M4=0NG=$E))3+HV]/&']/=7.I&&<<!3>P[*$\"^4=M\<,UB-Q(.`]MM6"WSP$
MOH9`RI_$=/<9S3H&O*',)8MTU``X)&'2%^)VG305Z;O2C]VJ,%RV+W])\T-'
M1EY%72^X._6MCL\4C/P3\$-MZ5:2",,1OB\QS)Z1?TP?GZR<!QGYC&#\O"(I
MEM^P"&^3>0!@$!#=#G8!`0$!#_Y,LG8(#P$-=?Z<)-BI)_W"/5$<^W@2N;_V
MJ_6,-0^YL)G_`(3=^2O(;P_J'@E/GX#R\_T_D8W)S=W-R]O#X-*_XP?5T72Y
MY$Q=_A\/UKY_1'EAZZQ6&OU"!F+5:YJ*K58KT>ZEYVP3C]K%PT-%,4C+O9"2
MDGJJ+1FT:H$$QU#G*4H!VCI(M-N/+2RTGG<4J0`SGLPWPR%.I;05N*"6TB9)
MRBG^ZIVX6E[K>H?NVS_CA<'>/L@Y:DU:5)>`+89JLUR,BJC$SP(&`#D+/-H`
M'A.;Y7(N7CVZZUTG0U%ML-+2/R#R&@"-Q49RZH1%]JT5EU>J&<6U+P/69'P2
M/7#,/N>VW7)K?(FZ7==)0,C%XDD,=0F$:K//6ZS9E<+<:VL;9/A!**E*62;5
M5E#(I.EDN9--=X"?-S@8`6OQ:N-(XU36]M255@65J'YB9&23X<(N>@J)Y"G*
MM0(9,Y=)EA+JA[@OID_3E_/#23AE)V]$4VG47_Y@.]S^=9GG^,FQ:Z_L'X'2
M?8H]6.>KSA<7OM%>L8:,]S9;$'(>_!X(F\4*9@YL`<?D>&:<R`MQY>'I<P=_
MP:5_Q>(+-"G])SR)B[:`^NJ/H)]94/9O_P`'2/\`F][^UE=).G[R>D>6&6YW
M3T'R0E[[I)`0=JI/4ZK%FB(VP5RQ91Q["ST%,,T)")F(>4B\FLY&,DF+E-1N
M\8OFBQTU4SE$IR&$!#3=^)[BVW+<ZT2EX-$@C#$$2QB@Z,0VXU4(<3S!0`(V
M$=K.(D^O1T-IS8'<)'<KML@Y2=V:W:8$[^+0*O)2&WNSRK@QTZS,*!XKE;'D
M@N;A$2*O$6HF!FX-S`DHK:M#:W3=V!;;BH)NK8`!V+3(8G>H;8T6I],JH'%5
ME("JE4<0/FGY9;^G.$S9GO(SEL0S[3MQ&`+*I!6^L+@C*Q#HZRE:O5774(:9
MI5PCDU"%DH"91)RB'8JW5`JR)BJIE,%UO=EHK[0KH:Q)6DCLD#$'\[H&<5JV
M7*JME0FJ8/:!R&T>?CO\<6LW3:ZCN"^I=M[B,TXB?IQ=CCBM(?+.+)!TBI:L
M7W46X*.X>3;E$%'4,^,4ZL9(E*"#YKP,'*<JB9.7M1:=K=.5YI*D<S./LW!W
M5#TCRP[;5=:>[4HJ&#^L'>&X^B(SO>J%2)](3(Q#CP%QF?"**0</24"SKK"7
M['W-(P]OP:L'PSPU0W+^Z<\D:_58_P"V3V^U1YXFEV5($;;.MI#=/CX:&V;`
MZ*?,/$W(EBZK$+S#W"/`NJA=I?>E00/]0YZQC<6P#[N8(_ND^01M%J!$V-7=
MZ5JA*3M>S!:K'N&EMJ,)"P#%U([A(.!C+/+8R0-889`)AC`S$//QTDL^45*P
MY%6:_`'8F*7F`!#8VEM3MQ:;0R*A14?U9,@K`X3V;^J(=P6&Z-:RX6@!WP)E
M.(V'P0LX\W@8!3.(D]Y^S&Q2(4`.1WMXQ>H<AO*)U3X90`O'CV`)>S5^%LJ_
M_P`!L_XBO2(J"JUJ7XHZG^@F/F'N\'!2_,E__5+D9J!AYD0_)TQF@L01X@F"
MBB..6YU"<1[>`%`?L:]T6^I3B=/-$_:G'J)CY]Z;6F8N[LMX;'F$01Y&S?1-
M[/4:AJ)NGZO-_G]J.V3Z7L&']VMZQE%-I*4N#0D"_35Q[C:LUMY">)-6YFB"
M3V4;F,>.CN8P=I$M7ABD=LFGE/VVV)3<WR.=D*&6T%1W`G**X]4IN%T#%96+
M51MDR<*<CGD-Y$3HPVZG;F@[;HD]Z*W*/@,)B`DZP35U!4Y^8P`*[O#ZY2&*
M/<8Q1[`X!JC.6^L&/\OL)'V@],63WRG4J0NKL^",/'.)QNE_.1V1HK(V3Z7U
M-\E]0W'X.6-%`EVQ_2J3&X^MD85.9>K,5*]2:;+OI&1BY%`J@+E60!/@)1`W
M'5.U"GV2T,NT"*)T=J25<Q5+R19+.0ZA3J:I52CB)2,9QZENR:K]0;9CF7;-
M/D9-YRT0)YS&%A>I\P5'+%:(K)42Q)J<0,BB25(#5WR]IV#I=/\`LM1=.WEV
MQ7=JXM*)2DR4#M2K-/5G'K=Z%%RH%TRY%Q0[)XCTY'A%0#=Z5:\;7.VX\O4*
M]K=UHMDFZC;*_()&1?0UBKT@O%S$<Y3,`&!1J];'+Q[C``&#L$-=<4=2S5TZ
M:ELS:4D$'801G"#?953O%I>:3(]1AI/W5WJ'$P!N=L&R[(LY[+B_=(N@\Q\H
M_<`1A7<ZPC(Q(YJD*@\C8F0X%$S`P!R^*_;-"]HFTK?B=IXUUO%X83^],9RV
MH_\`;%VT5=O=ZGW!X_J7<N"MGH\$6+?Z'8/V]<_PV8TJZD?_`"^-[?\`-9SA
M_%Y/<?S-;>P?C=)_N&_6$:V\_A51]D?)$8_NP[!N;HX8+;N$R.VLE=\[F=M7
M"::J"R+G*%D07:JI'*8BJ"J8"!BF`0,!A`>S5B^(A*=5.*!Y2&T&?&0E&JTF
M$FRI2K(N.#_U&$6>M9L26Z?O4`R[BF%C%F.);T\/F#!RXIJ>RCCR[OGCKZOM
ME3%*50](L";R),`=H)MDS#PYPT\=%7O[\L#;JE3JFY(7]).1\'EA::FMJK=<
MEIE)E1FGHQE\N$3`^Z?[^2X>W&WC8Y?9KV:B;DB#;<6^W.`(TB<TU>,,#V):
M^*;E2-?*DU%,"%X"J\CD2AQ,?MJ7Q3LGO=$B^4X_6,'E<^@9>0^"9C?:&NA;
M?-O=/ZM8[/TAZ9^2)<*HH3J]=>F9N!Q^L&SCI*,AA:W_`(36;KN1?/U"*ODQ
M`%F+Y1C:(U9;B/$?9J^AY%=4]P_RIHQ+7<N]QQ6=H:(RX8;MIBP@&]:@*L#0
M4OC/GFKK'+QC\KWP+C^0YMQ^'\IQ'C_NYM^O?X2_C+T\#[`>L(\M>?AK<]CA
M\ABOKHWX\T?_`%SJ?^T,?I\5_P#!._15Y#"KI/XI'2?/%W.A\PW_`,7;_P!Y
M)KC0]X])CHE'<3T"(2^O?OIEMF>QV<J^,'#EQN3W52I=ON!X6'^ZV`LM<$P8
M6BT1K5,#+F5@8)V9)L<H?)DGK4./$VK=HFSMW6\I>J?PZG3[19.4QC(^"-#J
M*X&CHRTU/WA[L)EG+:?,.)C8[I*;$(?IW[',1X"*V;&R&YC@OV:YM$I16G,L
M6YNV>V3Q'``)W#6O)D1BFHB(A[.R*8.TPZ@:IO!OEW=K)DTJ24-C]!/=\)B7
M9+>BWT":=?>[R_I'9T#`=4*O>]E=.TM5N5$ZBN-(($X._+16*]PJ<<W^YL[F
MT9G)CV_/2HD`B25@B&1XEVL;O<M6O$>9;M:'PKU$5-KL56KE<3VF]LA\Y`Z#
MCT12=;V8I6+DV!(]^6_9X?*(59V6;K\A;(-T&'MT.-%536'%EJ:RK^((L=%O
M;J@\YHVZ4M^8IB@+*T5IRX:F$>()J'(H`<Q`TT+[:&+S;7;>^F:5I/*K<K9X
MXH]JN#ENK$/M&1"AT2XQ<)X!SCCS<OA3&&?<43"4YCS+5-AKI5WZ9R&4*REF
MI55HYZ4@F!O*PST%6;Q$1YD72"A![2CKDFMHG[=5N4%0)/-J(/F/1*4/VFJ6
MJQA-2T9H6,///KC,*?IE^/\`0U%/=_I"/?9X/+%-7U$O^/O>Q_.JSS_&58]=
M?Z=_`:/_`&Z/)'/MX_$W_M5^L8FO]V[VT[J=QD]NV:;7]\MPV5R-6@,5N+0]
MJF-*MD<F00E'US3A6TJE9GC08A*O*-%S$,VYCJ^U&`>``&J1\1;C;+>*;[TI
M$U25%?+-?*42`GA+;G%DTE1UU6IT4=0I@@#)(,^N<89ZYS3JQ;<<K1NVW>[N
M_P`B[A,36Z");L;6*+=.:CC#(<2V="T?IRE,AV\9&EM%<?%(1ZS=B\\'Q$E4
MSF34(;4O1'\KW.F5<+32-,UZ#)23CR#\Z9Q,]D>6I3>J-X4M:^XXR1,$83'1
MAY,/!&".C"3ID6W<]3,4]1/$\U/QM]G6L-0,C/<F2D!BJ'MCQ9)"!KF3Z=&-
MHM4\!.O#>SA)C*@W17.F5P@"1C*DG:S&H6;:NHL+@D@36GEFN6]*L>K"(FG#
M:%U26KD@C'O\TO"-W7Y(M4*!CVBXIIE=QWC.H5RA42I1J$16:A4HEE!UV#C4
M`^Y-(R+CT46K=,1,)C"`<5#F$QA$PB(\Q5%145+Y?J5N.5"S,D^<F'2RRTPC
MV+".1D92C[`OID_3E_/#7G'NG;T13:=1?_F`[W/YUF>/XR;%KK^P?@=)]BCU
M8YZO/XB]]HKUC#2GN:_X\;\O]5<&_P#FV0-+'XN_5T'TG/(F+MH#ZZH^@GUE
M0]6__!TC_F][^UE-)"G^L'TAY1#+<[IZ#Y(34]T%_`_4A_\`V/%W[5R1IM_%
M/_Q_V*O-%#T3W*CH']J'#[M2:CDFG6;']_K</<*1=(.1K=KJT^R1D8:?@I9L
MHSD8R19KE,FNV=-E3%$.'$.\!`0`=*5MYZG>2]3J*7DR(.7++;^2+XXVAY):
M=2%-*$CX(K)NN;T2K=TV\A+YCPVRF+;LRR).JIUF7$B\C*X7L+]0ZR6.;R[*
M4X_1*@F$L)*JB4KM,O@*B#@G%7I'0VMF;^P*&M4$71"9$##VB?SANZ/-">U-
MIU=K=]YIP54:SUI/'Y8],1D]/_?SG7IS;AJYG_!\J)E$/`BL@T&1<KDJ>4:0
MHY36DJE9FR0F`.<I!49/"E%=@Z`JJ8]ABFLFH-/T>H;<:&L3RJ3BA8V&-+:;
MM46FJ#[*NSS=H;%"'*>N!OKP1U#>@.]W!X(G`<Q<IF_"$=<*;(+MOK;C2Z(2
M3\\O3+<Q0.<6T@R4/S(+<`1>MC$72$2GX`F](66NT_K;W*M24J2RX4G8H88I
MX[QLAD7NXT]TL2:FF/9]JB8V@XY^G(PT5L^;^R;3-K+7F`_LVW3""'/PY>?P
M<:5I/FX=O`#<O'AI<W4SN=1_N'/6,6JWB5"S]BGR"-D]08EQAW<`QR])8;O[
M'`C/%K_,+B&*6@L\UH33G%B\V5\S.!;HA74UIM2**T*J(`V**GC`0>[CJ70F
MF35H-67$TT^T6Y<XP/=GAG+JB/5)>53J2P$%XC#G[N>WY9Q#.\QSUT'!ERJX
MFZ,[XIC#Q.O#9U-[2`=H&.1:".(";@'I"/#5K]YTH,#477PH],5\TNH`.RW0
M_P!4^B(M^J/N@ZHFP?;7*WS<+A[I&P#?)KE[BFGEQ76<@3N5U9BP0LB5Y/4Z
M(M<(PAESU"-`SQ99P<Z#<WA<Q#B<I#6+2UOL-^N8:H:BXGV?;/.1R=DY**3M
M,:2]5%VM](552*,>T[*>5,U8C9,"6&V/C^D+TT^K/MLVLPEVPS5NG(BTW*-H
M#,D@3=!4\G6;,$9'3$*@-8A9E>%ASP\8T1BE0>$:(&/X:KTXJ&YQ$"R=4:CT
MO7W$LOJK0&)H!:4$H5(XF15.?&"R6B]T](%LIIN5SM2<!)$^HRPQB75MB7KM
M-RI"-=Z-IUT@^^"T;.2!S#Q'Y102B."?R>SLU6#6Z.5^TNG]9)'3WHW7NNH`
M9\M`?Z)]$2^;<8?,4+AZHM]P<5AN)S6HW>*Y!1P&RFV.+59/Z0=%8*UI.R(-
MY\Y!ABMP6%T'."X'`H\G+JGUZZ9RJ+E.M];">[[215XL(W](V\AJ3X;2]MY`
M0F6S/;&<@^'43+`YF)71%>=[U=TZ5\,[@(#?QCF)`F-MQSUK5LN(,D#%2K6;
M8B+$&,XY$A1(1ID>MQ_.)AX?]XQZPCVKET_/A?J%-51FR52OUS!['%!R2.(/
MBA5ZWLY9J/O%L297F,<%;STYC+;"F=;LD]3K%`V^JRKN"M-5FXJR5N;CUCMW
MT//0;Y"2B9)FNF)3I.&3YLFH00'O+IKOLH?973NB:'`9^"*&RZIEU#J,"F+>
MCI6;ZJ]U$-D^(]P[!9HE=7$86FYB@6QB<U<RQ54&[.V-#(%X&09RJIDY)GQ`
M.9F\3^`=<F:HLJ[!=W:$X-<W,GBE60ZLC#YLMP1=*!NH!'.!)7TM_7G'O]6"
MP)U;IG;ZYI93PBM]L&6VP'YQ3X*R=5?12!0.`AP$Z[TH?'KYTR@KO]&@9FH1
MXC./N\K2BU/J)``;,:#^[%EY>COM^+V_)NF<0\V5K-K>?$@)_FEYLD8MH\0$
MXUFDIFRH)VK7XU9QA7WH787^4[L>2W'TJ$!]EK9^[>W-86;459.<PQ-@W;9(
MAB@D0R[@(`Z+6;3+W)ILG'#M..I_PWOQM=\%$Z?W2J(&Z2]GR)W1'UE;#6V[
MWE'US/C!P\1QZ)Q6\4>X7"@W"K7C'<W,UV]5:=C)^G3];<+-K!$V..=).8=]
M"N&WW=.12>%(*0EXB)^`<!X\-=#U+33K"VWDI533(4%9$C/PPHF5.-/)4T2E
MP$2/'CT1;`]$W8V?8EL+QK3;4T#^&S+0JYPSS*KASR;S(E_11DQB)!R</'6/
M5(0[:/-S"/\`VA)8_><>/+&L;O\`?5[=4SA2M?JT#8$ISEPG/A#QL%O]QMP2
MLGWIP<RR>.7@$1'^^"+I$V1;:T#"(*+;F0,D``(@((8XM8J")NX.`'#[>K9\
M)\+T\#L9'K"*]KW\.9'_`-I]4B*_"C?CS1^';_[UJ8_%]8([MT^*_"B=G^8K
MR&%?1`^\H^6^+N=$2@V0,<Q2$!JB8QSB!2%(5`@F.8P]@%*`<1'R!KC7%2CO
MF8Z)1]6#^B/)")^;FV_OK+]5&][H.GVWQ`\Q'TV[:RQ5@VW9X6.MBJ6OL>N^
M6LEK@HL(.:96FP/K$@:11.8@)M6+6-5,?F,F4731&QZ1TRFVWLN>^5R>98;[
MP2=I((.1ETSA>5(NE\NYJK>$^[TY`23*1QPS!VXRQ$I1)"YJ7O9R)@*EE/I^
MO`,`F$Z$/$)E(/'T#`YI*)A-P[>(`(?9U7.?X9`XHK>N?_-&XY=8;%,RZ4_\
MD8.W#[5O>?-U.%L@[?<WV+I_VW%V3H)2O6N$%G#,7"C4RZ+ML]C9%M4/:8N7
MC'S9)RU<I?=$%TRG+VAJ9;[E\/+77-UU&*M+S:I@]KH([QV<(C5E'JNMIU4S
MY9+:N*=\Q\T>(PC%N4VY9;VD9PR%MWSC6S57)^,9L8:PQQ%Q>1[H%$$GD=-P
M4GX:2<Q7IR/73=,W:90(N@H`\`'B4'K;;E27:F:KJ(^TIW4`B>'+*>"AL,*Z
MNHG[?4*IJI,EI,N$-Z>Z==2$L/-V[IN92G>2.L)YK*&V=U).BE3;3B28O\F8
MQ:'5,`A]+-R#/1R)1X>*C(``<QR`*?\`BGILR;O].!SIDAV73@KHV3]$,#0U
MXG.U5!Q.*3YO!Y.,/9)^F7[?;]L=)4F8/!?BAD'*<\SYQ%-5U$O^/S>Q_.JS
MS_&58M=?Z;QL5)+8PCU1'/MX_$W_`+5?K&&L_<UDRA,;]%O#^5]'8*3\7D[>
M7VG(IA3Y^'=Q'CPXZ5WQA,Q1R(_:>1,7G0(Q?^BGRF&->L]TX(;J5;,;?C&+
M9L$,X8]]JR-M^LCHI$U&5[BV2OM%5</!*8Z$'?XPAHUT''D(J=!<0$4"Z7>D
M=1.Z=O**A9/NRSRN#84G)0XISBV7^T)NE`IH@>W2)H.V>T'@=G&45-$_`3=6
MFYNKV:(?P-BKLM(P%@@Y1!1G*0LY#NU6$K%OVY^55J^CWS<Z:A1X&*<@ZZK9
M=8JF$O-XMK2"#O!$X1SK;E.\4+$G$&1ZHL?_`':OJPJ;Q\"J;2LXV@7^Y;;G
M`-4X&7F'A3RV6<+-#(QL).^*L<5I.S4,QD8V5-Q%59`S5R;F,=8P<Y_$32AL
MM>;G2#_MKQQEDA>WH!Q\?"&WI*]BX4PI*A1-6@83^<GSE/DEQAH,OI$_3E_/
MTM]LML75.T[)139]1CLZ@.]P!_E5YY_C)L6NO]/$&R4DO[I'JQSW>/Q%[[0^
ML8:7]S834^NN_%7D-X7U8P:3Q.'R>?Z5R`;EX^MR]O#X-+#XND%%"-H4Y/A@
MF+KH#%ZH.SD3ZRH>H?B`1TEQ'@/T>]X?L=320:P>3/\`/\\,I?=/0?)":GN@
MWX'ZD7P?PR8N_:N2._3=^*?_`(^7]RKS11=$@ANHGP_M0YMI0S!`(RD(ONV>
MS\D?!92Q?CS->.[AB?+%1A;YCF_0;VN6ZHV)F1]$3<._)X:[9PB<.*:A!X'2
M5()54%2E43,4Y2F#VIJJHH:A%52K+=0A0(4,YCS;(\7V&:ELLU">9E0D1QWQ
M5Z=:KHS9$Z8>6#VRFH3%VV@Y(FW(8OR$HDL[>T:2=&.Y)B_(KDB8)-9MBGS!
M&O3""<LT3YODKD53#I;1>LF-14X9=DBZ)`"TD@`I&U.^$WJ/3K]GJ"ZB:J16
M((&SR1"^QR)>J_1+UCN%M4U'4/(9H!W>*@U?*DK]G?T]VO)560E8TPF;+R$"
M\<J&;+@`*I@H<H&Y3"`W&HI:=3GO*TCVR`4H7\Y(4,>K?&AIJEY'ZA!(94I,
MQUQ<Y;4D3MML&VALIP\1O@'#:*G*/$`.ECJND/P'@'$.8O8.N/[I^)/_`.X<
M]94/^B_@FOLT^J(V&U"B3'!3T#?:U@Y;>K.#;$.74FZS.">FQ987'=UP]N#S
M'E"TT52^5FO8HH2KZL+1YY%_#L6T[?'RZ<7#N',C&J`H1%%XN@EP4,D/,0#6
M>P:6J]0(]LV\RU3I,B5GM=0_*(TMTO#-N5[(MK<<EL,NC;,\9`RPWQ7G=23?
M#O2ZG&?H_->6<1WV!JM0(6-Q%B""H]Y?TV@5OVU%\X0]H7A4U9^=L*S8AY22
M4(F=R)2ID(DBFFF5^Z>M%BTU0&EIJA'O"QVG"4S)V@\-L*^[UMUNU4*AULAM
M)P3LEX8=JV>^\9[6\F5?#^.\I;?MUV$\LRQ:7CYW7VV!K9;L?-I]Q]'5U!U$
M6N`;"JVJIWARG*=XS;*-&WS@<""84O>M$7&GJ':NEJ*9VF*E*F%I!Q).(.<A
MN,,2VZAIG&&VWVEMNA(&PY#IGT80R08.`\.P?M:HDR<]D6:<\1E'C1!&(L^9
MNI.VW#>0,Z9'2LZ](QK!C/V-&F5:7NMI58^UM6)20E5@&[J8FGAG#P@`D@F8
MW+Q,/`I1$)%)3.UE4FD9Q<69#FD$SZ8\GWT4[1><$T#=\AOVX`0F-UQNLQBG
M?-L]G]INVO:QNJM\A=[53+!*Y'R-@JXTF#I;>F3S:?37KL4JS?STM89([;V4
MICI-FZ+9941,<PE)IM:+TH[9KJFYW&HID!"5#E0N:B3XL/+%#U)=D5]"JBI6
M5JYE`\TQYB831_@+SC_]*9@_W7WG]P=.?[UMNU]K^L(7'W=6_P!VKQ>F)HNC
MCU&]W'2CR1;@-MFS+EG;]E=2*/D[&25%O$/,-)B&!5",O5$D7->6CFEF:L5S
MMW"#D@-I!MR$.=,Z22A*1K*Q6?4].'&ZEA%Q0>PHJ$N7:%=.R+-IVX7*RND+
M:4JF6,1AA^7=$Z/5CZ\&.]VNP;*.VO;AM7WC#D;/L''5"T.\BX/L-5A<=5L)
MN)EYY87T::<&SRC]K&F9()-BE1`%S*J*`!`(>D:7T:];[XW<+A5THIV5$B2L
M58$#9QG%HO5_]ZMRJ>E9<]LX!.?+A(@D8',@2C%'0GZRU,V.;3$=I.[/;MNA
MKC.@VVV6/'F1Z!@:^7:-F8.Z2Z]CDH:T0[.-0F8R8AYIXY\%PBDX0<M54RB"
M:B9N>7KG2YO%S-VM3U.H.)`4A2Q-)2)3'3'AI>Z"AHO<JUI8DN8,QMV8D;8=
MIA).FYNQ7%RXQB\KC[+N/V;\T-98AU&.I*GWROD6-&S\#))I/8]P\AI04G31
M<A54C&,0Y0,`AI/+]I1U)Y?XEA?S3AS).P\,XO8]E5,@J'ZIQ)P/$<807V-]
M"JQ5?KM7O#-]J<F_VO;2K(AN(AY^5C53P-[I4G(%F<"54KU9/Z/DGBDP<B4D
M@0YC%)"N0,'`0XN^\ZY95HMM^G4/O!]OV9&T')2NG\D+>WZ94G42DO))I6U%
M6.1W<<<,=N,/^7ZZP>-Z-<LB6<7Y:Y1*O/6^?&*C7<S)EAJY&.I:2&.B&":S
MV3>@S:'\)NB0RBI^!2@(B&D<RVIYQ%.W+G49=K*9WF&8XZEELN*'82)F6<A"
M`_O#?54P9U'\/8)PWM:QMN(GS43)<GDBTV^XX9M]*B$D#5A]78^%BF$FR/,2
M3UV>3,LHJ****)$@#B<Q^!7A\/-/55@K':VO=IT(<:D`%@_\(6VK*]NZ4[5/
M1-K5RK)GA+=O,*KP-'R3"SD%-?P8Y"<!#343+BV"E6A(7`1<@V?BV!48@P)^
M.#?E`W`>''CP[--1^II'Z=QA+[25+3*94-T4ABCK67TNEM1"53AT;J6^\J3.
M9ML#["6QW;YN/HF0,MTLE>R5E#(5!E(1UBZ(F(_V2T5S'R$)])+3MI=H'4:$
MF#BV;-$5#+(D.L)!236G/A^S3W,5MY>IS3-K)2E*@2K'`JGAQEC##N^HGWJ$
MT]$TOVSB0%$RD)C$"1PW;(\="'K,[6-E^SBI;2=P>&<_XON=9N]IE"WNKX4N
M-UJ^1UKQ85G[>9F5(.//.Q%@CV[A"/5*NV41,W:IG(KPXD+\ZZTM6W&ZN76A
M>8=IB@325@*2$IV#*6'AV1]Z9NK5%1"EJVU(="R9I^=/?MPX3V90\`V<)NVS
M9VB)A1=MT7*0G(9,_A.$RJI<Z9@`Q#^&<.(#V@.E!@%%)S$7H&:0K81&"=S6
MY+&^TK#EESIEE*YKT:J+P[:42H%)L.0[2=6<E&T.Q"/JM69OYE^0';LHJF32
M$J*?$YN!0$=2J*BJ+A4II:8I#JI]X@#`3,R<,H\JFH:I6B\]/D$LA//`?+9%
M>%[PCN9P[U&L]89RCM.V[;F1G*;CV7IF3<@6_`=TI:5R:EF$Y&EQS.)6BEIE
MZO64W+\IGCHB7%)R1(@"5/B#\^'U'4:>HW:>Z5-.&UJYDI2L&4*S5JD7.I0[
M1-*)"0"K#'Q[H@XQ'`;J\&91Q[F3&.,\TUC(>,+?!WBG3K3&-\(M'3U??)/F
M9S`2"+XS5<4Q272$>59!0Y#<2F$-7:NJ+/<*5=+4NLJ96DA0*AB#M'$16J.G
MN='4)J6&U!U)$OE.+#_"'O*FV*R8@KMDSKM^W@8NS,C"H!=,;US;9DB[0RUD
M;MBE?'I=J8QR<>Y@I-V03M/I`[-PB0X$6#B43FY^K=`U[-8M%%44SM%/LJ+@
M!`.PCAM\6&$->EU"PNG#E0VZFIY<4B4B=I$S@"=\L(KZ=S$%F+.^XW/>;8O`
M&:8*+R[F+)&28R&>XTNJSZ*CKG;96?81[U5&!\$[QJT?D(J)!$GB`/`1#@.G
M[:ZJAH+:Q1.5#2EM-(23S@Y)`,*NOI:VJJW'PVN2UDXRVDG?$\?N[6_*L=,Z
MU[CH/<[@O<U'U3-D?0G<#=*9@R_6XD++TA2Q)KQ<Y`LH=*6!M*-9\#HN6Y%^
M0Z`E.0`.!@HOQ"M"=0(8>M3U.7F>;F!6!S!4I8\)<(M.E*I=K6XW6-+]FL#$
M2V=8WQ8,8%S;2MQ^(*%G''!+*E2,CPWT]7$[C5YFE6=-B#QRQ$LS5K`V9S4*
M[!PT/]R72(?EX&X<#`.D164SE!4FC?D7DF1D>8#H(S$,ZF?;J&N=L'V>R><(
MN^]']*R3QYEZ,Z@6!J7)2=*S?+MJWGVNU:'=R*E:R[[,)8>__1\:V663C<C1
M[7P7J@%$I)9KXAQYG@:=GPSU6VJF58K@L!;0["B<T'-/5LX0M=96%8=%?2":
M5=Z64\SX<3TS$+,[7LD[GMH&?<8[CL+5/(D'D/%MD:ST2H:EVWZ.F&7$6\W5
M[`@C&D%_7+/$JJLWJ`]AT%1X?*`H@R+JS9[O0.T%8XV6W`?G#`D8$8YC9%4M
MZ;G;ZI-4RA8*2,-XBPBQ?[SKLBL^.H6?R%A[=]0<EFBFZUDQG&;>[?=`9S)$
M@]N;0%IB2)P\K$BY`?`<+F9J"F(>(FF;B`<^5?P]NC%2I%.[3.4_-@OG`44\
M1PRAK,ZDI7&PZ\VM+_+*0E+IS'CQBOCW0(Y+SSN3S_F^'PGER$A\OYER1DJ*
MAY#']L5D8J+N=NE9Y@P?JH0XH'>MFCXA5>01)S@(`(AP'705MJ:*BMS5(Y4-
M%3;2$S"AG(`^"%17TU755CE0AI00I9(Z"28FH]WQZ@</TPLIY\3W%X.W%NL<
M9QJ],9MK!C_#MFLTC6;)2I*:705E899O&O7,3),)U0G,V%91-5(O%,2F$0I/
MQ`M3>HV67+=4,>\,J."E@!0.T2VY18]*53EH>7[RVOD6D#"6!!GM(XPQCNE]
MYIVZPN'K\UVN8#W:Y+S3(UN4BZ`%JV^VZD42,L$BS59L9RQR<L4\HK&PJBWM
M)V[=FHHZ%($@$@'%0J\MF@:IRK;-QJ*9JFY@5$+YE2F)R&6/3%MK]1M!A7NK
M3BW%)($Y83ZYPOG[OYU,`Z9]QS]4]QVWO<+-X\W".ZG9%KWC[%%KL%DJ]RJ1
M)YN"3^KJLH\\I!6!O8#B91L<7#9=(/N:A%!$E_U]86=1,L.6JIIP_3S`"E`%
M2<,]DXK.E[D_:W5IJV5>R5MPP].[9%@5M9W/XQWA8:@\Z8A;WAK2+!)SL2Q0
MR+1;%CBU)O*Y)+Q$D5[5;2S8R[5'VMN;P5#)^&NGP.01*(#I%5]`_;:DTK_)
MS@3[)"ACQ$,FEJ45;?M6P0B<L1*-A]0B)YQ(C$V<\&8IW*8GNV$,VTR)O^,L
MA0SB#L]9F4"JMW+98.9%XT6$/&CI>,<E(NS=HF(NU<)D43,4Q0'4FBJZBWU:
M:RB4I%2@S!V'A'C4TS-6P:9](4TK.>?5NX15E=9+I$95Z6N8G38`EKMMAR&^
MD5L*9?50$X>$!57)L>7QP@DFTC;]`M@\H)I2;4H.$`X^*FETOI+6%)J*WGGD
MBX-)[2#GE(J3O!/HA-WO3[UIKDJ:!52J6.4CI\VT=>46DNV4AT]N6WE-0HD.
MG@_$I%"&[R'+0H`IBC]D!US9=#.Y/?[ASUE0X*,2I&OLT^J(SSJ'$J.)O1'T
M?U7H_'H@C\]UZ2?X-[A^^O2\GS?V/AU]M?5;<_F]W_C'@]WQ]7E\[./93^;)
M][=P?-_-_J/L?!K)S^=&-_U<<P[P^9^+O[A[M8.7SHS\X?5^?JCCY`^]_P!#
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M\S7P?Z49'^%'O?W+6/#&3_AQX_N.L_UH!_A0!W?K/=Y.[^MK']:`9_LX\E[P
M^:\GH]_Q:#EMC[^<.YY^J/)_[7^K^/7Q'M'7^Q]$$'['T01H7U)N7\ER=YOR
M">7ZV53C_2.^+^3%]^*_AKP?NGULX_@KA^N\VM[I_P#$O]=]6?X7Z[_X[XUU
MU_AT_P`/WA]?W-N7'=PG&YU$_$FF</JEP^JM=_$;C]2_P.R_$[CV_5;_`,/X
K_P"">'K3U'\0OO=]7?[V9[WZ7YW&<3FOJDY9#N]W(9<-W"4?7:\H^X__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
